data_2leq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2leq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 121.704 0.764 . . . . 1.0 110.886 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -82.53 -161.65 0.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.738 -0.601 . . . . 1.0 111.108 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.412 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 9.7 mp -71.48 144.15 49.78 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.702 0.763 . . . . 1.0 111.399 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.87 129.36 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 121.451 0.643 . . . . 1.0 110.892 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.42 134.14 33.92 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.933 -0.479 . . . . 1.0 110.386 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -142.51 138.13 30.71 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.041 0.448 . . . . 1.0 110.684 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.4 m -140.8 156.13 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.147 0.499 . . . . 1.0 110.611 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -159.46 143.48 14.9 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 122.055 -0.403 . . . . 1.0 111.207 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 t -147.54 145.26 29.01 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.244 0.545 . . . . 1.0 111.361 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.6 t -84.05 112.35 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.318 0.58 . . . . 1.0 110.635 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.7 mm -115.07 130.14 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.822 0.82 . . . . 1.0 110.74 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -94.02 95.91 9.34 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.95 -0.469 . . . . 1.0 110.02 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.45 155.73 7.37 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.58 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -61.97 145.94 96.54 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.392 2.061 . . . . 1.0 112.212 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.3 tp -62.8 -38.0 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.125 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -54.48 -56.44 18.72 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.933 -0.479 . . . . 1.0 112.068 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -64.62 -41.78 95.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.935 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.3 t -65.6 -48.5 82.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -57.83 -42.61 84.73 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.29 -47.13 86.53 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 122.072 -0.392 . . . . 1.0 110.235 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.82 -28.74 66.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.636 0.255 . . . . 1.0 111.609 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.7 tp -72.97 -43.24 62.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 1.0 111.645 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.42 79.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 121.545 0.688 . . . . 1.0 110.992 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.682 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -160.72 113.41 1.34 Allowed Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.498 178.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.532 ' N ' HD21 ' A' ' 26' ' ' ASN . 55.5 Cg_endo -69.79 -15.26 36.89 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.885 1.723 . . . . 1.0 112.373 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.682 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 44.9 tp10 -83.47 -49.79 8.93 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -69.16 -41.73 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 mm -59.66 -26.11 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -77.78 -30.89 51.57 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.062 -0.347 . . . . 1.0 110.062 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -56.44 -43.44 79.5 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.792 -0.447 . . . . 1.0 109.792 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -69.62 -33.91 73.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.964 0.412 . . . . 1.0 110.486 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.6 mmt -89.01 151.85 22.03 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.57 0.7 . . . . 1.0 111.123 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -61.53 -40.72 95.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.731 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.55 37.44 0.13 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.088 -0.577 . . . . 1.0 111.953 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.1 m -74.6 128.93 36.78 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.663 0.744 . . . . 1.0 110.82 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.1 m -94.46 93.5 7.69 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.731 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.5 t -92.59 128.74 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.402 0.62 . . . . 1.0 110.4 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.63 129.03 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 121.346 0.593 . . . . 1.0 110.456 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.456 ' OG ' ' NE1' ' A' ' 43' ' ' TRP . 38.4 p -155.21 157.94 38.11 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.222 -0.445 . . . . 1.0 111.306 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -97.35 -18.01 19.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.872 0.844 . . . . 1.0 108.78 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.456 ' NE1' ' OG ' ' A' ' 41' ' ' SER . 2.8 m0 67.27 44.91 1.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.24 0.616 . . . . 1.0 111.607 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -150.17 157.97 43.67 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.443 0.64 . . . . 1.0 111.433 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -52.71 130.23 31.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.8 0.81 . . . . 1.0 112.267 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.62 3.8 90.36 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 115.713 -0.676 . . . . 1.0 112.082 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.2 t -71.83 134.09 45.9 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.282 -0.54 . . . . 1.0 111.608 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -81.38 148.85 29.12 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.2 tt -134.62 133.8 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.547 0.689 . . . . 1.0 111.353 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.8 t -134.72 140.15 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.599 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.407 ' CZ3' ' NE2' ' A' ' 79' ' ' HIS . 24.0 m0 -118.72 131.32 56.13 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.179 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -99.88 140.28 34.32 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.319 0.58 . . . . 1.0 109.738 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.23 178.78 42.24 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 110.989 -0.845 . . . . 1.0 110.989 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -128.66 134.32 48.49 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.914 0.864 . . . . 1.0 110.118 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -135.65 116.78 14.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.323 0.582 . . . . 1.0 110.375 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 58' ' ' LYS . 72.3 mmtt 52.92 40.25 30.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.33 0.586 . . . . 1.0 110.659 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.6 -8.3 15.07 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.682 -0.967 . . . . 1.0 110.682 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' A' ' 56' ' ' LYS . 63.4 tttp -97.74 115.57 28.24 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.435 0.636 . . . . 1.0 110.407 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.61 133.0 47.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.078 0.466 . . . . 1.0 110.216 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -136.4 154.12 50.9 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.721 0.772 . . . . 1.0 110.963 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -138.21 132.77 32.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.826 -0.624 . . . . 1.0 110.53 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -88.27 167.48 13.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.244 -0.65 . . . . 1.0 109.244 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -156.23 133.85 10.95 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.702 0.763 . . . . 1.0 112.663 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.95 -176.86 34.48 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.359 -1.096 . . . . 1.0 110.359 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 90.8 m -147.19 156.69 43.18 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.951 -0.735 . . . . 1.0 111.102 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.9 mm -73.94 115.4 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.555 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.0 tp -67.02 -41.84 85.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.611 0.72 . . . . 1.0 110.164 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.431 HE21 HD22 ' A' ' 70' ' ' ASN . 64.7 tt0 -159.56 149.32 18.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.546 -0.538 . . . . 1.0 109.546 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -133.89 111.39 10.43 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.962 0.887 . . . . 1.0 111.54 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.431 HD22 HE21 ' A' ' 68' ' ' GLN . 12.5 m120 -119.66 104.68 10.48 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.327 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -41.16 122.95 1.93 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.358 0.599 . . . . 1.0 112.247 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 41.35 55.1 3.44 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.09 0.556 . . . . 1.0 112.436 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.7 m -157.91 -68.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.723 -0.611 . . . . 1.0 112.107 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.4 mt -141.68 138.16 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-O 121.647 0.737 . . . . 1.0 111.509 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 tp -133.33 125.85 30.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.29 -0.868 . . . . 1.0 110.687 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -132.52 138.92 47.68 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.238 0.542 . . . . 1.0 110.203 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -150.75 143.94 24.81 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.939 0.876 . . . . 1.0 112.077 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 93.1 p -85.99 153.76 21.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.008 -1.108 . . . . 1.0 108.008 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.407 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 42.4 t-80 -147.47 142.29 26.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.732 0.777 . . . . 1.0 111.96 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -142.01 134.65 28.34 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.876 -1.056 . . . . 1.0 110.457 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 CA--C 1.55 0.952 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.666 179.429 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.48 ' OD1' ' N ' ' A' ' 93' ' ' TYR . 29.5 p30 . . . . . 0 N--CA 1.465 0.302 0 N-CA-C 112.421 0.526 . . . . 1.0 112.421 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.48 ' N ' ' OD1' ' A' ' 92' ' ' ASN . 30.1 p90 -108.99 178.07 4.58 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.469 0.652 . . . . 1.0 112.019 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.496 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.3 OUTLIER -135.4 163.12 30.76 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.936 0.874 . . . . 1.0 111.277 -179.297 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.4 p -103.31 131.64 51.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.028 -0.987 . . . . 1.0 109.673 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -97.53 134.0 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.025 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 t -125.6 121.31 33.23 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.704 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.1 mm -108.0 129.84 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.452 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.8 m -114.78 121.63 43.89 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.444 0.64 . . . . 1.0 109.953 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 70.8 mt -123.77 128.85 50.15 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.549 0.69 . . . . 1.0 110.907 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 69.5 p -135.55 144.39 46.21 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.37 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -99.79 108.09 20.3 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.456 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 106' ' ' GLY . 55.1 mt -96.12 171.53 8.55 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.04 0.448 . . . . 1.0 110.697 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.95 -42.62 99.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.247 0.462 . . . . 1.0 112.247 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -81.78 -32.55 31.32 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.099 0.56 . . . . 1.0 110.672 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 103' ' ' LEU . . . -176.69 -141.53 3.98 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.579 -1.008 . . . . 1.0 110.579 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 m -133.94 130.27 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.566 0.222 . . . . 1.0 111.179 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -92.46 141.98 27.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.336 0.589 . . . . 1.0 109.904 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.73 151.26 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.513 0.673 . . . . 1.0 110.396 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -151.77 135.1 16.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.107 0.479 . . . . 1.0 110.686 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 tt -125.21 126.23 44.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.956 -0.566 . . . . 1.0 109.928 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 m -120.78 144.68 48.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.421 0.629 . . . . 1.0 111.477 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.496 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 39.4 tt0 -143.79 130.22 19.96 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.507 -0.769 . . . . 1.0 110.141 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.442 ' O ' ' ND1' ' A' ' 94' ' ' HIS . 0.7 OUTLIER -105.23 -170.42 1.75 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.476 0.655 . . . . 1.0 112.467 -179.321 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.3 t30 63.46 38.0 10.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.655 0.983 . . . . 1.0 113.655 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -82.88 128.96 34.91 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -67.38 -41.31 85.26 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.083 -1.011 . . . . 1.0 111.83 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.454 ' OG1' ' N ' ' A' ' 119' ' ' GLU . 1.3 t -150.9 175.97 11.53 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.109 0.48 . . . . 1.0 111.079 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.454 ' N ' ' OG1' ' A' ' 118' ' ' THR . 96.5 mt-10 -59.19 -37.57 77.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.406 ' CD ' ' N ' ' A' ' 120' ' ' LYS . 13.0 mptt -59.57 -42.41 92.41 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -71.76 -39.78 69.75 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.919 -0.488 . . . . 1.0 109.97 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -63.33 -44.89 93.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -63.92 -43.1 96.92 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -59.95 -40.37 88.77 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 78.3 p -72.96 -46.9 49.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -57.08 -47.91 79.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.7 -0.481 . . . . 1.0 109.7 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.67 -37.37 87.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.44 ' O ' ' SD ' ' A' ' 132' ' ' MET . 42.3 t30 -65.27 -54.01 35.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 1.0 110.044 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.445 ' NE1' ' OE1' ' A' ' 113' ' ' GLN . 83.4 m95 -59.41 -36.83 76.58 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -59.27 -36.53 75.69 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.525 -0.917 . . . . 1.0 108.525 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.6 m -64.29 -43.08 95.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.994 -0.743 . . . . 1.0 108.994 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.509 ' N ' ' SD ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -63.18 -48.84 76.68 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.47 -39.99 95.2 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -66.74 -41.73 87.38 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.37 -36.99 93.88 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.003 -1.239 . . . . 1.0 110.003 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.21 -43.87 77.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.434 0.635 . . . . 1.0 110.114 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -65.44 -39.34 91.95 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.071 -0.393 . . . . 1.0 110.153 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.7 tptt -62.01 -39.34 91.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.011 0.434 . . . . 1.0 111.246 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -75.81 -46.57 29.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.128 0.489 . . . . 1.0 110.323 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.59 -42.62 95.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.06 0.457 . . . . 1.0 111.097 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -75.8 -1.36 24.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.242 0.544 . . . . 1.0 109.866 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -60.14 -33.08 71.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.411 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.0 pttt . . . . . 0 C--N 1.329 -0.32 0 O-C-N 122.221 -0.3 . . . . 1.0 111.097 -179.681 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.1 pt . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 121.72 0.771 . . . . 1.0 111.028 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -77.61 -167.76 1.03 Allowed 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.698 -0.626 . . . . 1.0 111.216 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.0 mp -75.09 143.79 43.24 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.605 0.717 . . . . 1.0 111.422 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.514 ' C ' HE21 ' A' ' 122' ' ' GLN . 93.5 mt -114.43 128.81 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.4 0.619 . . . . 1.0 111.201 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.69 143.43 44.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.041 0.448 . . . . 1.0 110.604 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -133.54 123.41 25.12 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.228 0.537 . . . . 1.0 111.011 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.7 m -141.76 140.08 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.24 0.543 . . . . 1.0 110.438 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -152.96 139.14 18.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.559 0.695 . . . . 1.0 110.902 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.5 t -147.04 145.43 29.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.996 -0.547 . . . . 1.0 111.022 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.4 t -93.44 124.51 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.32 0.581 . . . . 1.0 110.445 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 78.2 mt -129.43 131.34 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 121.453 0.644 . . . . 1.0 110.625 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -90.57 99.73 12.7 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.148 0.499 . . . . 1.0 110.263 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -169.31 153.55 5.41 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 118.894 -0.574 . . . . 1.0 111.487 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.98 146.75 78.45 Favored 'Trans proline' 0 N--CA 1.502 2.003 0 C-N-CA 121.295 1.33 . . . . 1.0 112.591 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.8 tp -65.48 -36.68 78.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.845 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -61.44 -50.77 71.46 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.812 -0.555 . . . . 1.0 111.753 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.97 -41.0 97.68 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.87 0.322 . . . . 1.0 111.87 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.1 t -66.17 -46.43 87.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 40.1 t-105 -59.8 -41.88 92.17 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.806 0.813 . . . . 1.0 109.07 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.48 -45.45 93.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.489 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.99 -31.86 65.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.026 0.441 . . . . 1.0 111.698 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.72 -48.04 49.8 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.151 -0.343 . . . . 1.0 111.823 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 m -112.07 77.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.871 0.843 . . . . 1.0 111.099 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.675 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -159.82 109.97 1.45 Allowed Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.49 179.203 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.473 ' N ' HD21 ' A' ' 26' ' ' ASN . 53.7 Cg_endo -67.34 -14.95 44.53 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 120.934 1.09 . . . . 1.0 112.33 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.675 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 83.1 tt0 -80.73 -50.9 9.29 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.358 -0.238 . . . . 1.0 110.358 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.79 -42.42 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.65 0.738 . . . . 1.0 109.209 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.8 mt -57.6 -41.93 80.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -64.53 -36.66 84.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 1.0 110.33 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -67.23 -32.07 72.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.94 0.4 . . . . 1.0 110.029 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -69.59 -34.18 73.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.947 0.403 . . . . 1.0 109.977 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.7 mmm -101.13 177.31 4.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.675 0.75 . . . . 1.0 110.941 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -64.43 -37.96 89.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.837 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.43 64.47 0.02 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.759 -0.536 . . . . 1.0 111.759 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -96.61 126.64 41.92 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.69 0.757 . . . . 1.0 110.704 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.8 p -78.34 92.5 4.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.86 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.2 t -95.52 131.56 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.275 0.56 . . . . 1.0 110.616 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.47 129.72 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 121.306 0.574 . . . . 1.0 110.419 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.461 ' OG ' ' NE1' ' A' ' 43' ' ' TRP . 60.3 p -153.54 150.94 29.22 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.314 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -94.38 -20.58 19.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.799 0.809 . . . . 1.0 109.018 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.461 ' NE1' ' OG ' ' A' ' 41' ' ' SER . 1.3 m0 68.76 46.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.896 -0.593 . . . . 1.0 111.363 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -148.86 156.33 42.17 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.562 0.696 . . . . 1.0 111.182 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -55.27 129.74 39.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.673 0.749 . . . . 1.0 112.184 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.2 -3.2 87.34 Favored Glycine 0 N--CA 1.469 0.841 0 CA-C-N 115.838 -0.619 . . . . 1.0 112.028 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.2 t -67.12 133.95 50.84 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.257 -0.555 . . . . 1.0 111.548 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -89.03 146.72 24.67 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.78 148.95 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.473 0.654 . . . . 1.0 111.328 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.57 155.16 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.461 -0.79 . . . . 1.0 110.7 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.538 ' CH2' ' NE2' ' A' ' 79' ' ' HIS . 14.7 m0 -128.54 123.17 32.79 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.234 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -89.93 140.48 29.58 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.68 173.82 42.06 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -121.76 128.41 51.72 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.752 0.787 . . . . 1.0 110.201 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 33.8 t90 -129.01 112.12 13.71 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.42 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 52.36 40.91 30.26 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.128 0.489 . . . . 1.0 110.655 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.63 -11.72 18.34 Favored Glycine 0 N--CA 1.468 0.793 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -96.41 116.93 29.85 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.208 0.527 . . . . 1.0 110.438 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.37 133.15 47.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.998 0.428 . . . . 1.0 110.251 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -132.57 152.91 51.45 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.615 0.721 . . . . 1.0 111.01 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -139.45 132.77 29.98 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.43 0.633 . . . . 1.0 110.592 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -87.67 168.11 13.29 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -153.64 129.37 10.1 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.677 0.751 . . . . 1.0 112.508 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.21 -179.48 31.28 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.24 -1.144 . . . . 1.0 110.24 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 91.0 m -149.5 154.55 38.95 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.948 -0.737 . . . . 1.0 111.312 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.8 mm -77.71 122.58 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.59 0.71 . . . . 1.0 110.251 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.438 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 3.8 mm? -86.13 -52.47 5.65 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.97 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -131.73 137.69 48.33 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.648 -0.501 . . . . 1.0 109.648 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -135.38 104.94 6.04 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.771 0.796 . . . . 1.0 111.482 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -124.46 93.59 3.95 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.25 122.04 3.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.852 -0.613 . . . . 1.0 112.049 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 61.82 51.97 3.64 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.266 0.626 . . . . 1.0 111.784 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 t -169.62 -72.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.707 -0.621 . . . . 1.0 111.992 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 95.0 mt -137.04 133.8 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-O 121.626 0.727 . . . . 1.0 111.564 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.4 tp -136.16 124.99 24.0 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.353 -0.84 . . . . 1.0 110.296 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -135.24 141.87 45.86 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.184 0.516 . . . . 1.0 109.966 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -149.14 152.51 36.23 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.1 0.952 . . . . 1.0 112.144 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.8 p -94.32 150.92 19.83 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.538 ' NE2' ' CH2' ' A' ' 51' ' ' TRP . 1.2 m80 -152.42 144.99 24.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 122.0 0.905 . . . . 1.0 111.561 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -141.95 136.61 30.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.66 -1.155 . . . . 1.0 110.236 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 118.445 -0.788 . . . . 1.0 110.664 179.838 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 112.471 0.545 . . . . 1.0 112.471 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.58 172.28 8.02 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.641 0.734 . . . . 1.0 111.738 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.456 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.7 OUTLIER -145.69 169.42 18.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.619 0.723 . . . . 1.0 111.213 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.0 p -107.32 132.63 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.205 -0.907 . . . . 1.0 109.841 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.6 t -94.14 135.13 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.398 0.618 . . . . 1.0 110.961 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.0 t -126.7 123.79 38.31 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.515 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.6 mt -120.91 131.87 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.723 -0.672 . . . . 1.0 110.244 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 59.1 m -117.59 122.16 42.88 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.02 -0.536 . . . . 1.0 109.904 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.6 mt -115.93 124.84 51.58 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.463 0.649 . . . . 1.0 110.792 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 74.4 p -128.05 137.62 52.25 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.513 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -96.42 105.7 17.82 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.349 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.8 mt -92.15 170.21 10.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.11 0.481 . . . . 1.0 110.41 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -61.97 -41.3 97.85 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.442 0.534 . . . . 1.0 112.442 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -75.4 -40.21 58.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.417 0.627 . . . . 1.0 110.845 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.1 -140.33 3.13 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.7 p -125.18 134.17 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.445 0.64 . . . . 1.0 111.029 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -99.2 141.06 32.45 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.543 -0.753 . . . . 1.0 109.602 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.82 138.73 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 121.278 0.561 . . . . 1.0 110.521 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -142.93 131.73 22.73 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.447 0.641 . . . . 1.0 110.509 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tt -125.15 131.68 53.2 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.719 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.8 m -128.67 143.01 50.85 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.45 0.643 . . . . 1.0 111.235 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.456 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 33.7 tt0 -142.53 138.3 30.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.086 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 12.4 p-10 -111.99 -167.12 1.14 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.538 0.685 . . . . 1.0 112.32 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.8 t30 60.73 37.52 18.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.758 1.021 . . . . 1.0 113.758 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -82.16 117.77 22.56 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.76 -1.2 . . . . 1.0 107.76 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -61.51 -39.87 92.57 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.011 -1.056 . . . . 1.0 111.866 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.6 p -144.78 168.31 20.51 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.923 -0.486 . . . . 1.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.46 -34.82 71.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.275 -0.639 . . . . 1.0 109.275 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.57 -40.88 93.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -69.44 -39.77 77.62 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.963 -0.461 . . . . 1.0 110.303 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.514 HE21 ' C ' ' A' ' 6' ' ' ILE . 50.6 tt0 -63.14 -47.82 81.12 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -59.93 -42.81 94.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -61.25 -39.05 88.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.333 -0.618 . . . . 1.0 109.333 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 62.4 m -68.03 -53.26 27.16 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.59 -44.91 73.43 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -62.55 -41.31 98.81 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -66.36 -54.0 29.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.02 0.438 . . . . 1.0 110.097 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.507 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 87.8 m95 -60.42 -39.42 87.34 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -59.44 -39.09 82.46 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.7 m -63.73 -41.98 97.96 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.507 ' SD ' ' CE3' ' A' ' 129' ' ' TRP . 79.0 mtp -64.93 -50.41 66.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.287 0.565 . . . . 1.0 109.617 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.02 -40.08 94.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -69.14 -39.46 78.81 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.078 -0.712 . . . . 1.0 109.078 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.36 -39.5 91.7 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 109.632 -1.387 . . . . 1.0 109.632 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.9 tt -65.9 -43.06 89.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.024 0.44 . . . . 1.0 110.033 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -61.69 -32.72 72.93 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -60.99 -37.99 84.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.982 0.42 . . . . 1.0 111.031 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -74.59 -49.93 19.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.422 0.63 . . . . 1.0 110.775 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.88 -42.66 99.85 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.785 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -75.37 -4.33 38.75 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.371 0.605 . . . . 1.0 110.253 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -62.12 -39.14 91.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.972 0.415 . . . . 1.0 110.449 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? . . . . . 0 N--CA 1.449 -0.5 0 CA-C-N 116.693 -0.231 . . . . 1.0 111.007 -179.683 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 121.465 0.65 . . . . 1.0 111.066 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -74.57 -156.3 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.479 0.657 . . . . 1.0 110.787 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.444 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 3.9 mm? -75.47 142.18 42.97 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.867 0.842 . . . . 1.0 111.512 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.95 129.62 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.393 0.616 . . . . 1.0 111.035 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.78 136.57 36.02 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.034 -0.416 . . . . 1.0 110.648 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -145.13 145.05 31.24 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.226 0.536 . . . . 1.0 110.753 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.49 155.79 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.329 0.585 . . . . 1.0 110.429 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -154.37 134.06 12.87 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.252 0.548 . . . . 1.0 110.922 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 t -148.56 146.92 28.49 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.102 0.477 . . . . 1.0 111.256 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 m -99.06 131.36 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.378 0.608 . . . . 1.0 110.249 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.3 mt -130.68 132.16 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 121.875 0.845 . . . . 1.0 110.553 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -85.83 96.41 9.75 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.314 0.578 . . . . 1.0 110.224 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.95 157.93 4.27 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.622 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -61.36 144.44 98.4 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.257 1.971 . . . . 1.0 112.358 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.5 tp -64.84 -33.84 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.752 -0.658 . . . . 1.0 111.4 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -58.15 -50.26 74.13 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.901 -0.499 . . . . 1.0 111.914 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -65.21 -40.44 94.17 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.996 0.369 . . . . 1.0 111.996 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.3 t -66.33 -47.46 84.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -60.05 -43.43 95.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -58.26 -49.16 78.11 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.044 -0.41 . . . . 1.0 110.258 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.04 -32.77 64.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.752 0.279 . . . . 1.0 111.752 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.7 -45.28 75.56 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.206 -0.309 . . . . 1.0 111.229 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 m -115.94 79.47 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.677 0.751 . . . . 1.0 111.383 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.715 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.2 OUTLIER -156.98 117.12 2.06 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.201 179.148 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.523 ' N ' HD21 ' A' ' 26' ' ' ASN . 70.8 Cg_endo -73.88 -5.3 16.81 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.344 1.363 . . . . 1.0 112.277 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.715 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 10.2 tm-20 -93.73 -52.39 4.47 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.209 -0.293 . . . . 1.0 110.209 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.88 -42.18 94.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.647 -0.872 . . . . 1.0 108.647 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.87 -40.18 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -66.14 -36.45 83.17 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.255 -0.278 . . . . 1.0 110.445 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -57.78 -36.64 72.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -68.91 -33.33 73.57 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.239 -0.282 . . . . 1.0 110.239 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 73.1 mmm -96.43 156.54 16.3 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.712 0.768 . . . . 1.0 110.906 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -61.58 -43.22 99.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.713 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.44 42.99 0.18 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 120.904 -0.665 . . . . 1.0 111.977 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.8 m -76.85 129.15 35.83 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.561 0.696 . . . . 1.0 110.58 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 48.7 m -93.05 92.07 7.64 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.693 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -99.03 132.64 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.441 0.639 . . . . 1.0 110.481 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.0 t -130.58 132.22 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.646 0.736 . . . . 1.0 110.264 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 m -156.09 166.68 32.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.565 . . . . 1.0 111.376 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -109.34 -19.67 13.2 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.98 0.895 . . . . 1.0 109.076 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.411 ' HE1' ' HD3' ' A' ' 27' ' ' PRO . 58.0 m95 58.23 56.32 4.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.795 -0.639 . . . . 1.0 111.76 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -152.4 156.83 40.29 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.418 0.628 . . . . 1.0 111.125 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.28 119.68 1.25 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.539 0.685 . . . . 1.0 112.422 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.04 11.2 84.72 Favored Glycine 0 N--CA 1.468 0.782 0 CA-C-N 115.918 -0.583 . . . . 1.0 112.065 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.1 t -72.26 130.46 40.85 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.3 -0.529 . . . . 1.0 111.523 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -87.45 150.47 23.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.747 -0.835 . . . . 1.0 108.747 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.9 pt -145.07 149.35 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.1 0.476 . . . . 1.0 111.107 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.6 m -143.51 154.53 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.782 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 10.3 m0 -129.2 131.72 47.16 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.34 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -91.57 139.69 30.45 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.45 172.71 39.45 Favored Glycine 0 N--CA 1.464 0.514 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -131.95 134.56 45.77 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.007 0.908 . . . . 1.0 110.231 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -138.3 118.04 13.16 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.374 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 52.92 37.1 23.49 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.112 0.482 . . . . 1.0 110.688 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.96 -6.06 44.29 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.932 -0.867 . . . . 1.0 110.932 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -97.15 112.51 24.26 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.346 0.593 . . . . 1.0 110.565 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.14 135.88 49.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.029 0.442 . . . . 1.0 110.239 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -141.26 155.89 45.95 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.642 0.734 . . . . 1.0 110.864 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.445 ' N ' ' CD ' ' A' ' 61' ' ' GLU . 1.5 pm0 -136.27 133.83 37.39 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.388 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -86.91 144.5 26.94 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -133.88 128.13 33.99 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.502 0.668 . . . . 1.0 112.731 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.08 -177.24 30.01 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.293 -1.123 . . . . 1.0 110.293 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.9 m -146.68 155.02 42.11 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.656 0.741 . . . . 1.0 111.056 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 50.7 mm -75.56 115.55 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.249 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.5 tp -69.93 -41.91 73.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.503 0.668 . . . . 1.0 110.111 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -152.07 147.8 26.92 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -132.52 104.08 6.5 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.989 0.899 . . . . 1.0 111.597 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -125.16 104.56 8.58 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -47.16 136.31 9.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.658 0.742 . . . . 1.0 111.98 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 36.91 53.72 1.14 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.666 -0.697 . . . . 1.0 112.552 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.5 t -161.12 -73.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.635 -0.666 . . . . 1.0 112.098 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.4 mt -136.89 131.82 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.464 0.65 . . . . 1.0 111.496 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.1 tp -136.98 124.97 22.77 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.525 -0.762 . . . . 1.0 110.333 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.02 144.53 32.32 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.409 0.623 . . . . 1.0 109.961 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -150.04 154.88 38.91 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.816 0.817 . . . . 1.0 112.061 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.4 p -87.0 151.44 23.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.004 -1.11 . . . . 1.0 108.004 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.404 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 52.9 t-80 -146.08 144.37 29.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.925 0.869 . . . . 1.0 111.887 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -143.38 135.11 26.51 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.718 -1.128 . . . . 1.0 110.315 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.9 p . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 118.622 -0.704 . . . . 1.0 110.33 179.409 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 56.2 t30 . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 112.457 0.539 . . . . 1.0 112.457 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 47.8 p90 -117.83 178.47 4.4 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.308 0.575 . . . . 1.0 112.246 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.19 167.25 21.01 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.058 0.932 . . . . 1.0 111.373 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 52.1 t -106.77 127.74 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 114.809 -1.087 . . . . 1.0 109.647 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.31 133.57 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.036 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.7 t -125.36 121.06 32.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.253 0.549 . . . . 1.0 110.657 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 75.7 mt -119.01 129.97 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.358 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 64.8 m -117.47 116.9 28.07 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.532 0.682 . . . . 1.0 109.957 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.3 mt -114.34 124.81 52.91 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.801 0.81 . . . . 1.0 110.812 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.5 m -138.31 143.36 39.93 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.325 -0.852 . . . . 1.0 110.49 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.03 123.98 38.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.266 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.8 mt -107.99 173.7 6.21 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.235 0.54 . . . . 1.0 110.332 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -61.7 -41.6 97.81 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.409 0.522 . . . . 1.0 112.409 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -74.2 -44.23 54.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.144 0.497 . . . . 1.0 110.779 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -172.55 -129.53 1.15 Allowed Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.892 -0.883 . . . . 1.0 110.892 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.3 t -128.81 133.9 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.539 0.685 . . . . 1.0 110.852 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -107.2 132.78 52.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.48 -0.782 . . . . 1.0 109.537 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.1 p -125.23 142.08 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.81 0.814 . . . . 1.0 110.25 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -140.03 135.12 32.34 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.567 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 tt -127.98 129.41 46.71 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.586 -0.733 . . . . 1.0 109.822 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.8 m -123.37 145.37 48.81 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.425 0.631 . . . . 1.0 111.379 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.419 ' OE1' ' NE1' ' A' ' 129' ' ' TRP . 37.6 tt0 -143.69 123.67 13.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.471 -0.786 . . . . 1.0 109.918 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -101.14 -167.62 1.45 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.392 0.615 . . . . 1.0 112.514 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.9 t30 59.58 38.38 22.23 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.455 0.909 . . . . 1.0 113.455 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -82.96 133.1 35.12 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.543 -1.28 . . . . 1.0 107.543 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -63.02 -43.34 98.99 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.045 -1.035 . . . . 1.0 111.977 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 119' ' ' GLU . 1.4 t -149.79 176.2 10.92 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.133 0.492 . . . . 1.0 110.884 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.422 ' N ' ' OG1' ' A' ' 118' ' ' THR . 95.1 mt-10 -58.81 -38.13 77.93 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -59.06 -40.09 84.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -70.42 -38.49 74.61 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.01 -0.431 . . . . 1.0 109.919 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -64.65 -47.06 79.88 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -61.81 -40.29 94.72 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.912 -0.773 . . . . 1.0 108.912 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -62.43 -39.95 94.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.44 -0.578 . . . . 1.0 109.44 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.7 m -71.69 -49.18 41.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 1.0 109.822 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -55.54 -47.36 76.45 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.28 -37.95 89.3 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.702 -0.481 . . . . 1.0 109.702 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -66.59 -54.55 22.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.135 0.493 . . . . 1.0 110.13 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.419 ' NE1' ' OE1' ' A' ' 113' ' ' GLN . 86.2 m95 -59.42 -37.37 77.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -56.78 -39.87 74.85 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.533 -0.914 . . . . 1.0 108.533 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.7 m -63.97 -41.17 97.62 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.73 -50.53 70.74 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.29 -38.63 90.09 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -67.35 -41.51 85.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.887 -0.783 . . . . 1.0 108.887 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.09 -40.57 98.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.026 -1.23 . . . . 1.0 110.026 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 64.9 tp -67.9 -42.63 80.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.372 0.606 . . . . 1.0 109.805 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.44 -44.25 95.06 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.102 -0.374 . . . . 1.0 110.477 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -61.3 -40.88 95.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.714 0.293 . . . . 1.0 110.728 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -66.38 -50.21 64.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.042 0.448 . . . . 1.0 110.637 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.35 -42.44 92.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.547 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -76.92 -0.41 24.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.269 0.557 . . . . 1.0 110.186 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -61.54 -36.5 80.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.59 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 27.1 pttm . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.682 0.277 . . . . 1.0 111.124 -179.719 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.496 ' CD1' ' N ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 121.684 0.754 . . . . 1.0 110.849 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -73.21 -160.96 0.09 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.363 0.602 . . . . 1.0 111.019 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 9.8 mp -73.7 141.27 46.4 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.622 0.725 . . . . 1.0 111.583 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.527 ' C ' HE21 ' A' ' 122' ' ' GLN . 80.2 mt -116.78 129.21 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.917 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.28 146.15 37.02 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.998 -0.438 . . . . 1.0 110.69 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -138.08 127.03 24.04 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.906 0.384 . . . . 1.0 110.952 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.7 m -140.53 139.13 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.05 0.453 . . . . 1.0 110.507 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -153.37 135.49 14.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.954 0.407 . . . . 1.0 111.023 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.8 t -146.44 145.01 30.07 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.251 0.548 . . . . 1.0 111.173 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -91.22 129.89 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.207 0.527 . . . . 1.0 110.545 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 75.7 mt -132.63 131.92 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.554 0.693 . . . . 1.0 110.4 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -89.36 95.19 10.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.287 0.565 . . . . 1.0 109.73 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.65 159.14 3.09 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 120.759 -0.376 . . . . 1.0 110.942 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.79 146.09 96.81 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 122.146 1.897 . . . . 1.0 112.521 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.2 tt -68.66 -29.84 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.72 0.771 . . . . 1.0 111.529 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -63.53 -48.17 78.63 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.909 -0.494 . . . . 1.0 112.16 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.02 -45.85 90.38 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.809 0.3 . . . . 1.0 111.809 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.44 -45.31 85.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 23.5 t-105 -56.46 -41.62 76.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -58.97 -45.56 90.22 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.043 -0.41 . . . . 1.0 110.342 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.78 -34.62 62.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.598 -0.273 . . . . 1.0 111.359 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -48.28 56.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.033 0.445 . . . . 1.0 111.796 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.7 m -107.39 74.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.437 0.637 . . . . 1.0 110.83 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.688 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -162.13 113.62 1.16 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 119.053 -0.499 . . . . 1.0 110.636 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.561 ' N ' HD21 ' A' ' 26' ' ' ASN . 57.4 Cg_endo -70.6 -18.38 33.09 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 121.812 1.675 . . . . 1.0 112.391 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.688 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 78.0 mm-40 -79.71 -46.93 16.17 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.645 0.259 . . . . 1.0 110.402 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -71.91 -42.13 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.938 -0.764 . . . . 1.0 108.938 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 mm -58.79 -41.51 82.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -69.43 -31.22 69.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.089 0.471 . . . . 1.0 110.181 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -60.86 -35.74 77.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.128 0.489 . . . . 1.0 110.043 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -69.1 -33.49 73.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.901 0.381 . . . . 1.0 110.034 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.8 mmm -98.05 162.62 13.13 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.824 0.821 . . . . 1.0 110.916 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -62.19 -41.21 98.13 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.749 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.85 42.27 0.14 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.106 -0.569 . . . . 1.0 111.924 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.7 m -70.16 128.37 36.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.378 0.609 . . . . 1.0 110.994 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.4 m -92.56 92.36 8.01 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.16 -0.337 . . . . 1.0 110.872 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.72 135.36 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 121.374 0.607 . . . . 1.0 110.483 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.2 p -126.96 137.45 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.27 0.557 . . . . 1.0 110.589 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.5 p -154.21 155.23 34.88 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.106 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -94.69 -20.04 19.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 122.121 0.962 . . . . 1.0 108.933 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.5 m0 72.16 45.56 0.38 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.422 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 pttt -153.34 153.44 32.6 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.768 -0.582 . . . . 1.0 111.447 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -50.38 132.01 24.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.736 0.779 . . . . 1.0 112.361 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.68 -6.44 83.44 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-N 115.873 -0.603 . . . . 1.0 112.034 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.1 m -65.14 137.11 57.43 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.188 -0.595 . . . . 1.0 111.885 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -88.77 150.25 23.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.7 pt -138.65 147.91 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-O 121.34 0.591 . . . . 1.0 111.355 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.3 t -143.77 141.32 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.617 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.451 ' CZ3' ' NE2' ' A' ' 79' ' ' HIS . 18.4 m0 -118.11 137.63 52.81 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.081 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -100.98 134.4 44.03 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.09 0.471 . . . . 1.0 109.968 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.12 173.71 37.6 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -125.99 134.56 51.44 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.636 0.731 . . . . 1.0 110.193 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -138.24 115.29 10.9 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.48 0.657 . . . . 1.0 110.302 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt 52.71 38.07 25.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.62 -9.02 38.23 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 110.451 -1.06 . . . . 1.0 110.451 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -98.41 116.32 30.39 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.372 0.606 . . . . 1.0 110.749 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.3 129.08 38.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.253 0.549 . . . . 1.0 110.32 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -128.56 150.99 49.96 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.724 0.773 . . . . 1.0 110.944 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 61' ' ' GLU . 1.2 pm0 -135.7 126.37 27.18 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.387 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -86.86 134.87 33.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.978 -0.749 . . . . 1.0 108.978 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -120.12 129.12 54.02 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.725 0.774 . . . . 1.0 112.53 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.14 175.52 30.03 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.35 -1.1 . . . . 1.0 110.35 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.1 m -144.41 151.99 40.03 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 122.07 -0.665 . . . . 1.0 111.33 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.7 mm -73.72 113.79 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.468 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.98 -51.25 57.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.612 0.72 . . . . 1.0 110.243 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -150.01 147.88 28.37 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.433 -0.581 . . . . 1.0 109.433 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -126.06 110.76 13.91 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.74 0.781 . . . . 1.0 111.351 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.25 91.47 3.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.295 -0.631 . . . . 1.0 109.295 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -36.73 128.84 0.83 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.189 0.518 . . . . 1.0 112.241 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 41.92 57.12 3.28 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.681 0.623 . . . . 1.0 112.681 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.5 t -165.1 -71.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.7 -0.625 . . . . 1.0 111.886 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.2 mt -138.07 131.25 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.573 0.701 . . . . 1.0 111.629 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.1 tp -133.95 123.22 24.27 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.371 -0.831 . . . . 1.0 110.634 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -138.93 142.96 38.45 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.192 0.52 . . . . 1.0 110.113 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -152.84 155.7 37.61 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.678 0.751 . . . . 1.0 112.15 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.6 p -86.7 151.19 23.62 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.451 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 16.5 t-80 -146.56 138.44 24.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.869 0.843 . . . . 1.0 111.846 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -138.1 127.55 24.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.813 -1.085 . . . . 1.0 110.529 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.5 t . . . . . 0 CA--C 1.547 0.854 0 CA-C-O 118.913 -0.565 . . . . 1.0 110.64 179.11 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.417 ' C ' ' ND2' ' A' ' 115' ' ' ASN . 12.0 m120 . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 112.272 0.471 . . . . 1.0 112.272 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -101.55 175.5 5.54 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.493 0.663 . . . . 1.0 112.145 -179.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.563 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.3 OUTLIER -142.54 161.01 39.17 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.953 0.882 . . . . 1.0 111.172 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.0 t -106.24 114.08 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 115.025 -0.989 . . . . 1.0 109.455 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.4 m -82.69 139.92 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.097 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 t -130.2 129.8 43.85 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.303 0.573 . . . . 1.0 110.917 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.86 130.08 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.542 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 59.4 m -117.8 118.13 31.21 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.446 0.641 . . . . 1.0 109.989 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.0 mt -114.15 130.85 56.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.401 0.62 . . . . 1.0 110.894 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.438 ' OG1' ' CG ' ' A' ' 108' ' ' GLU . 30.0 p -135.07 128.34 32.07 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.639 -0.709 . . . . 1.0 110.587 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -88.67 111.83 22.4 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.03 0.443 . . . . 1.0 110.139 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 25.3 mt -96.35 175.74 6.31 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.297 0.57 . . . . 1.0 110.485 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.54 -40.71 96.1 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.384 0.512 . . . . 1.0 112.384 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -79.57 -40.77 28.68 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.003 0.521 . . . . 1.0 110.875 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -171.55 -143.18 3.94 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.8 p -129.13 132.77 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.039 0.447 . . . . 1.0 111.225 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.438 ' CG ' ' OG1' ' A' ' 101' ' ' THR . 12.4 pt-20 -98.62 144.59 27.74 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.65 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.59 135.37 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.242 0.544 . . . . 1.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -141.24 129.48 22.26 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.091 0.472 . . . . 1.0 110.592 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -124.63 140.72 52.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.142 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.1 m -132.54 144.39 50.39 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.501 0.667 . . . . 1.0 111.428 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.563 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 40.3 tt0 -143.43 139.36 29.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.872 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -114.41 -162.65 0.82 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.399 0.619 . . . . 1.0 112.309 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.417 ' ND2' ' C ' ' A' ' 92' ' ' ASN . 49.8 t30 58.54 35.56 24.67 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.641 0.978 . . . . 1.0 113.641 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -82.23 122.17 27.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.681 -1.229 . . . . 1.0 107.681 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.48 -40.44 93.14 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.01 -1.056 . . . . 1.0 111.79 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.1 p -145.58 171.58 14.49 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.839 -0.538 . . . . 1.0 111.065 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -57.17 -38.51 73.69 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -58.69 -41.21 85.71 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -69.84 -39.67 76.29 Favored 'General case' 0 C--N 1.33 -0.283 0 O-C-N 121.937 -0.477 . . . . 1.0 110.15 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.527 HE21 ' C ' ' A' ' 6' ' ' ILE . 50.2 tt0 -64.7 -45.14 87.87 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -62.73 -44.77 95.34 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.068 -0.716 . . . . 1.0 109.068 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -58.63 -40.12 82.46 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.7 m -72.14 -47.85 47.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.201 0.524 . . . . 1.0 109.67 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -55.68 -48.51 74.96 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -64.55 -37.37 87.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.036 0.446 . . . . 1.0 109.81 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -65.52 -56.5 12.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.943 0.401 . . . . 1.0 110.138 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.477 ' NE1' ' OE1' ' A' ' 113' ' ' GLN . 86.6 m95 -58.6 -39.23 79.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -54.68 -41.03 69.71 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.0 m -63.6 -41.56 98.32 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.624 0.726 . . . . 1.0 109.211 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.9 tpt -64.42 -51.51 62.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.56 -41.24 89.68 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -68.16 -36.64 79.96 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.57 -41.57 99.6 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.011 -1.236 . . . . 1.0 110.011 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.47 -42.42 83.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.323 0.582 . . . . 1.0 110.099 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.4 -37.6 86.41 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.049 -0.407 . . . . 1.0 110.266 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -59.76 -38.51 82.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.975 0.417 . . . . 1.0 111.095 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -76.32 -44.91 34.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.282 0.563 . . . . 1.0 110.473 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 65.0 mt -64.8 -41.98 95.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.044 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.74 0.05 21.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.048 0.452 . . . . 1.0 109.838 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.35 -39.01 93.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.91 0.386 . . . . 1.0 110.604 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt . . . . . 0 N--CA 1.452 -0.347 0 O-C-N 122.23 -0.294 . . . . 1.0 110.947 -179.506 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.448 ' CD1' ' N ' ' A' ' 3' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 121.376 0.608 . . . . 1.0 111.034 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -77.38 -161.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.68 -0.638 . . . . 1.0 111.046 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.3 mp -73.76 139.66 45.38 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.652 0.739 . . . . 1.0 111.376 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.498 ' C ' HE21 ' A' ' 122' ' ' GLN . 83.1 mt -113.7 129.34 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.328 0.585 . . . . 1.0 111.009 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.68 141.33 39.44 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.062 0.458 . . . . 1.0 110.736 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -138.5 117.98 12.93 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.189 0.518 . . . . 1.0 110.976 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.78 155.91 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.072 0.463 . . . . 1.0 110.627 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -174.18 151.04 1.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.199 0.523 . . . . 1.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 t -145.6 145.43 30.97 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.364 0.602 . . . . 1.0 111.162 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.69 124.59 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.277 0.56 . . . . 1.0 110.542 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.4 mt -130.27 132.69 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 121.669 0.747 . . . . 1.0 110.541 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -87.86 96.49 10.49 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.402 0.62 . . . . 1.0 110.188 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.31 155.86 2.81 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 119.139 -0.458 . . . . 1.0 111.051 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.56 147.57 94.06 Favored 'Trans proline' 0 N--CA 1.506 2.217 0 C-N-CA 121.599 1.533 . . . . 1.0 112.528 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.2 tt -68.09 -26.34 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.187 0.518 . . . . 1.0 111.185 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -59.48 -49.89 76.03 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.885 -0.509 . . . . 1.0 111.604 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.436 ' CD ' ' N ' ' A' ' 19' ' ' LYS . 3.9 mptp? -65.48 -41.51 93.22 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.709 0.263 . . . . 1.0 111.709 -178.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.48 -48.25 81.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -57.45 -43.14 83.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.627 0.727 . . . . 1.0 109.224 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -58.28 -45.8 87.25 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.877 -0.515 . . . . 1.0 110.436 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.17 -35.43 64.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.957 0.408 . . . . 1.0 111.856 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.84 -46.0 76.45 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.1 -0.375 . . . . 1.0 111.652 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 m -112.98 79.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.794 0.807 . . . . 1.0 111.014 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.656 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -159.75 111.32 1.46 Allowed Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.416 179.152 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.482 ' N ' HD21 ' A' ' 26' ' ' ASN . 61.1 Cg_endo -71.41 -1.7 10.11 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.195 1.263 . . . . 1.0 112.503 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.656 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 81.3 mm-40 -96.86 -48.51 5.42 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 110.172 -0.307 . . . . 1.0 110.172 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -68.25 -43.03 84.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.223 -0.658 . . . . 1.0 109.223 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mm -61.03 -42.16 92.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -69.22 -31.13 69.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.046 0.45 . . . . 1.0 110.271 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -58.32 -42.99 87.96 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.812 -0.44 . . . . 1.0 109.812 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -69.37 -33.55 73.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.759 0.314 . . . . 1.0 110.163 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.424 ' SD ' ' OG1' ' A' ' 37' ' ' THR . 66.6 mtt -89.12 152.01 21.88 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.684 0.754 . . . . 1.0 111.053 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -59.47 -46.97 87.26 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.697 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.9 48.92 0.22 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.064 -0.589 . . . . 1.0 111.975 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.424 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 49.6 m -82.33 111.26 18.23 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.77 0.795 . . . . 1.0 110.776 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.7 m -77.79 91.94 4.16 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.909 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -102.79 135.12 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.987 0.899 . . . . 1.0 110.5 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 m -128.27 138.75 53.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.55 0.691 . . . . 1.0 110.508 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.474 ' HG ' ' HE1' ' A' ' 43' ' ' TRP . 33.2 p -155.53 158.35 38.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.966 -0.561 . . . . 1.0 111.153 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 50.9 t0 -97.14 -23.63 16.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.89 0.852 . . . . 1.0 108.995 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.474 ' HE1' ' HG ' ' A' ' 41' ' ' SER . 1.5 m0 71.17 47.83 0.39 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.465 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.56 152.54 27.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.645 0.736 . . . . 1.0 111.206 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -48.91 131.35 18.64 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.746 0.784 . . . . 1.0 112.373 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.67 4.7 85.07 Favored Glycine 0 N--CA 1.47 0.956 0 CA-C-N 115.721 -0.672 . . . . 1.0 112.105 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.3 t -76.89 134.8 38.87 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.214 -0.58 . . . . 1.0 111.539 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 64' ' ' GLY . 66.0 tp60 -81.11 146.2 30.7 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.76 -0.83 . . . . 1.0 108.76 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.02 134.58 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.577 0.703 . . . . 1.0 111.348 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 p -140.21 150.25 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.399 -0.819 . . . . 1.0 110.395 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -128.45 137.2 51.71 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.085 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -104.47 129.87 52.43 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.304 0.573 . . . . 1.0 109.693 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.66 -179.32 29.81 Favored Glycine 0 N--CA 1.464 0.519 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -134.34 134.59 41.95 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.835 0.826 . . . . 1.0 110.117 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 35.0 t90 -140.71 124.46 17.1 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.252 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm 52.5 36.18 19.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.179 0.514 . . . . 1.0 110.704 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.53 -6.06 26.02 Favored Glycine 0 N--CA 1.464 0.535 0 N-CA-C 110.746 -0.942 . . . . 1.0 110.746 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -98.88 115.63 29.29 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.346 0.593 . . . . 1.0 110.4 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.25 133.59 47.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.09 0.471 . . . . 1.0 110.197 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -136.69 154.2 50.68 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.543 0.687 . . . . 1.0 110.851 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -136.46 133.57 36.75 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.437 0.637 . . . . 1.0 110.695 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -90.6 167.65 12.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -158.07 133.77 9.05 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.459 0.647 . . . . 1.0 112.369 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 48' ' ' GLN . . . -160.43 -174.68 30.54 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.41 -1.076 . . . . 1.0 110.41 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.2 m -146.36 155.98 43.0 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.961 -0.729 . . . . 1.0 111.194 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 38.8 mm -75.89 119.78 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.336 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 tp -77.25 -48.94 16.18 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.621 0.724 . . . . 1.0 110.224 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -140.76 151.21 44.27 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.729 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -146.46 99.97 3.29 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.509 0.671 . . . . 1.0 111.367 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -125.46 106.88 10.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -38.27 133.17 0.98 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.531 0.681 . . . . 1.0 112.417 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 37.19 53.76 1.25 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.759 -0.655 . . . . 1.0 112.524 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.3 m -152.92 -66.87 0.16 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.793 -0.567 . . . . 1.0 111.862 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 tt -150.47 138.73 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.11 0.481 . . . . 1.0 111.517 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.25 122.24 27.66 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.827 -0.624 . . . . 1.0 109.705 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -133.61 136.68 45.01 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.961 0.41 . . . . 1.0 110.271 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.441 ' CD1' ' ND1' ' A' ' 79' ' ' HIS . 19.9 p90 -148.06 156.85 43.1 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.056 0.931 . . . . 1.0 111.994 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 92.4 p -101.25 151.43 21.87 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.488 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.9 m80 -153.19 153.16 32.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.698 0.761 . . . . 1.0 111.736 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -143.32 133.18 23.99 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.873 -1.058 . . . . 1.0 110.4 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.2 t . . . . . 0 CA--C 1.546 0.793 0 CA-C-O 118.741 -0.647 . . . . 1.0 110.512 179.684 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 112.095 0.406 . . . . 1.0 112.095 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 33.9 p90 -100.1 177.16 5.16 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.686 0.755 . . . . 1.0 112.011 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.491 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.1 OUTLIER -132.18 160.76 35.14 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.277 1.037 . . . . 1.0 111.089 -179.331 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.7 t -102.6 114.6 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 114.709 -1.132 . . . . 1.0 109.613 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.38 135.64 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.956 -0.565 . . . . 1.0 111.118 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 t -126.22 122.42 35.53 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.335 0.588 . . . . 1.0 110.773 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.1 mm -105.56 128.19 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.453 -0.794 . . . . 1.0 110.243 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.3 m -117.46 126.52 52.76 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.014 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.6 mt -129.13 125.58 37.43 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.649 0.738 . . . . 1.0 110.778 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 64.5 p -129.7 129.45 44.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.47 -0.786 . . . . 1.0 110.506 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -91.59 107.96 19.57 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.156 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.1 mt -96.94 172.81 7.63 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.183 0.516 . . . . 1.0 110.441 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -61.7 -40.0 93.47 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.255 0.465 . . . . 1.0 112.255 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -77.03 -42.15 39.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.22 0.534 . . . . 1.0 110.882 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.75 -141.99 3.75 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.7 p -129.6 134.07 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.361 0.6 . . . . 1.0 111.205 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -99.18 144.62 28.11 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.813 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -131.74 141.35 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.867 0.841 . . . . 1.0 110.501 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -146.95 134.08 20.46 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.562 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -121.7 128.88 52.3 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.873 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.9 m -119.74 141.49 49.38 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.525 0.679 . . . . 1.0 111.243 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.491 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 39.4 tt0 -143.08 126.25 16.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.953 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.425 ' O ' ' ND1' ' A' ' 94' ' ' HIS . 7.7 p-10 -103.03 -170.14 1.75 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.705 0.764 . . . . 1.0 112.257 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.1 t30 62.59 37.78 12.81 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.604 0.964 . . . . 1.0 113.604 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -82.37 121.67 27.0 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.641 -1.244 . . . . 1.0 107.641 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -63.56 -41.82 98.4 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.933 -1.104 . . . . 1.0 111.902 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.4 p -144.71 172.28 13.22 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.874 -0.516 . . . . 1.0 110.854 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.72 -38.8 86.32 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.26 -0.644 . . . . 1.0 109.26 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -58.11 -40.84 82.25 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -70.34 -38.32 74.82 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.991 -0.443 . . . . 1.0 110.211 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.498 HE21 ' C ' ' A' ' 6' ' ' ILE . 51.8 tt0 -64.22 -47.57 79.18 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.72 -0.844 . . . . 1.0 108.72 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -60.53 -42.2 95.99 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -59.22 -38.66 80.49 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.7 t -71.39 -52.73 17.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -55.57 -47.06 77.04 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.933 -0.395 . . . . 1.0 109.933 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.48 -38.2 88.92 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -69.11 -52.84 24.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.278 0.561 . . . . 1.0 110.244 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -61.74 -38.01 86.37 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -58.06 -39.75 79.28 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.347 -0.983 . . . . 1.0 108.347 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.0 m -62.87 -38.36 90.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.906 -0.775 . . . . 1.0 108.906 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 40.9 tpp -67.62 -50.39 58.34 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.43 -41.7 97.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -69.1 -42.6 75.91 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.59 -37.29 94.51 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.012 -1.235 . . . . 1.0 110.012 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.2 tp -66.68 -41.63 87.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.298 0.57 . . . . 1.0 109.704 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -60.58 -36.24 78.05 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.053 -0.404 . . . . 1.0 109.952 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -61.51 -39.23 90.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.853 0.358 . . . . 1.0 110.784 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -73.2 -49.96 25.11 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.066 0.46 . . . . 1.0 110.788 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.13 -41.89 97.04 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.89 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -76.68 -1.51 28.17 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.128 0.489 . . . . 1.0 110.063 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -61.0 -38.74 87.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.768 0.318 . . . . 1.0 110.394 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.3 pttt . . . . . 0 N--CA 1.451 -0.387 0 O-C-N 122.3 -0.25 . . . . 1.0 110.849 -179.706 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.463 ' CD1' ' N ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 121.59 0.71 . . . . 1.0 110.724 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -73.23 -168.79 0.55 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.756 -0.59 . . . . 1.0 110.712 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.41 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.0 mp -73.94 139.57 44.98 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.809 0.814 . . . . 1.0 111.187 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.5 ' C ' HE21 ' A' ' 122' ' ' GLN . 75.5 mt -112.47 128.39 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.843 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.95 145.03 48.69 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.005 -0.434 . . . . 1.0 110.69 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -138.63 123.39 18.71 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.115 0.483 . . . . 1.0 111.026 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -141.72 152.15 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 121.172 0.51 . . . . 1.0 110.462 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -166.96 143.11 4.4 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.99 -0.444 . . . . 1.0 111.101 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 t -147.1 146.11 29.84 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.641 0.734 . . . . 1.0 111.343 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p -107.27 132.63 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 115.89 -0.596 . . . . 1.0 110.798 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 tp -142.67 150.69 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.467 0.651 . . . . 1.0 110.759 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -87.04 95.3 9.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.521 0.677 . . . . 1.0 109.856 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.62 149.78 5.37 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.12 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.75 147.74 92.35 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 121.769 1.646 . . . . 1.0 112.484 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.75 -29.74 44.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.818 -0.628 . . . . 1.0 111.38 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -55.37 -53.2 59.15 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.972 -0.455 . . . . 1.0 111.726 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' CD ' ' N ' ' A' ' 19' ' ' LYS . 3.9 mptp? -67.48 -40.45 85.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 1.0 111.686 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.0 t -66.77 -48.71 79.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -55.95 -42.1 75.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.876 0.846 . . . . 1.0 109.208 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -58.76 -45.79 88.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.486 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.58 -29.12 67.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.726 0.298 . . . . 1.0 111.755 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.55 -44.65 77.79 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.344 -0.222 . . . . 1.0 111.222 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.4 m -118.3 79.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 121.87 0.843 . . . . 1.0 111.476 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.664 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.2 OUTLIER -157.09 115.99 2.0 Allowed Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.717 179.253 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.511 ' N ' HD21 ' A' ' 26' ' ' ASN . 73.9 Cg_endo -73.27 -5.71 17.62 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 121.176 1.251 . . . . 1.0 112.349 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.664 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 80.6 mm-40 -94.12 -45.86 7.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.61 -0.268 . . . . 1.0 110.345 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 64.6 mt -72.53 -42.21 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.7 mt -60.6 -42.38 91.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.22 -29.36 70.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 1.0 110.327 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -55.22 -43.4 74.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -69.98 -33.67 72.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.365 . . . . 1.0 110.337 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 76.2 mmm -85.61 152.22 23.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.65 0.738 . . . . 1.0 110.888 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.65 -42.34 98.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.745 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.85 46.81 0.13 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.821 -0.704 . . . . 1.0 111.908 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.2 m -86.12 125.95 33.86 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.762 0.791 . . . . 1.0 110.768 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.3 m -87.55 95.86 10.19 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.717 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.9 t -92.84 127.6 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.174 0.511 . . . . 1.0 110.656 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.4 p -127.26 125.53 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.304 0.573 . . . . 1.0 110.466 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.6 t -158.24 153.42 25.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.508 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -97.15 -12.82 22.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.785 0.802 . . . . 1.0 108.928 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 64.0 m95 54.22 62.46 2.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.872 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.46 157.77 34.53 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.541 0.686 . . . . 1.0 110.988 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.83 117.33 4.88 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.129 0.49 . . . . 1.0 112.086 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.27 -13.01 55.2 Favored Glycine 0 N--CA 1.469 0.865 0 CA-C-N 116.304 -0.407 . . . . 1.0 112.163 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.3 m -76.42 138.54 40.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.391 0.615 . . . . 1.0 111.218 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -93.06 158.45 15.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.291 -0.868 . . . . 1.0 108.794 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.2 pt -144.77 149.51 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.512 0.672 . . . . 1.0 110.884 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.3 m -143.05 154.74 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.58 -0.737 . . . . 1.0 110.507 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 18.3 m0 -127.17 112.77 15.51 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.148 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.63 137.38 32.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.78 -171.51 31.11 Favored Glycine 0 N--CA 1.464 0.51 0 N-CA-C 111.088 -0.805 . . . . 1.0 111.088 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -126.12 131.87 51.99 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.854 0.835 . . . . 1.0 110.189 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -138.14 117.09 12.43 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.405 0.621 . . . . 1.0 110.263 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 54.37 38.37 29.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.587 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.34 -8.3 19.23 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 110.853 -0.899 . . . . 1.0 110.853 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -101.73 118.18 36.4 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.286 0.565 . . . . 1.0 110.556 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.99 129.98 41.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.11 0.481 . . . . 1.0 110.258 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -128.09 151.62 48.97 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.806 0.813 . . . . 1.0 110.811 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -135.11 129.71 34.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.698 0.761 . . . . 1.0 110.46 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -85.24 168.84 14.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.277 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -155.6 126.16 6.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.482 0.658 . . . . 1.0 112.358 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.17 178.37 32.73 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.401 -1.08 . . . . 1.0 110.401 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 90.3 m -145.48 154.24 42.01 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 122.029 -0.689 . . . . 1.0 111.282 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.83 114.45 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.294 0.569 . . . . 1.0 110.068 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.7 mt -77.26 -44.34 30.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.401 0.619 . . . . 1.0 110.086 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -151.24 149.39 29.36 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -138.63 112.63 8.52 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.602 0.715 . . . . 1.0 111.448 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -126.37 103.45 7.64 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.441 -0.577 . . . . 1.0 109.441 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.456 ' OE2' ' NH1' ' A' ' 72' ' ' ARG . 79.2 tt0 -46.43 129.69 10.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.493 0.663 . . . . 1.0 112.14 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.456 ' NH1' ' OE2' ' A' ' 71' ' ' GLU . 85.6 mtt85 42.58 55.91 4.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.852 -0.613 . . . . 1.0 112.549 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.7 t -167.2 -70.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.797 -0.565 . . . . 1.0 111.925 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 87.8 mt -135.27 130.74 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.654 0.74 . . . . 1.0 111.497 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.8 tp -140.27 120.95 14.31 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.287 -0.87 . . . . 1.0 110.382 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -141.0 146.54 37.4 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.181 0.515 . . . . 1.0 110.259 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -151.68 158.17 43.07 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.884 0.849 . . . . 1.0 112.215 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 p -82.23 148.61 28.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -142.52 133.75 26.12 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.707 0.765 . . . . 1.0 111.84 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -144.42 133.41 22.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.013 -0.994 . . . . 1.0 110.548 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.4 p . . . . . 0 N--CA 1.475 0.78 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.555 179.691 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.465 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 52.9 t30 . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 112.409 0.522 . . . . 1.0 112.409 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -99.61 176.83 5.34 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.271 0.558 . . . . 1.0 112.039 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -141.0 161.43 37.87 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 122.006 0.907 . . . . 1.0 111.199 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -106.94 130.17 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 114.943 -1.026 . . . . 1.0 109.62 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.41 131.85 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.747 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -124.3 121.89 36.24 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.341 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 60.8 mt -121.26 132.99 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.286 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.2 m -129.1 118.0 21.76 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.195 0.521 . . . . 1.0 110.451 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.3 mp -105.19 135.26 46.88 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.922 0.868 . . . . 1.0 110.598 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 74.0 p -129.79 131.21 46.13 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.19 -0.914 . . . . 1.0 110.575 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.01 108.34 20.41 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.175 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -96.19 166.79 11.57 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.12 0.486 . . . . 1.0 110.47 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -59.48 -40.47 87.07 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.313 0.486 . . . . 1.0 112.313 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -75.47 -39.83 58.15 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.058 0.543 . . . . 1.0 110.93 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.67 -140.1 3.11 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 p -133.09 138.92 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.63 0.728 . . . . 1.0 110.935 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -115.74 143.78 44.9 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.377 -0.829 . . . . 1.0 109.812 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.43 154.06 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.994 0.902 . . . . 1.0 110.229 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -145.07 134.78 23.46 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.676 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -131.58 146.4 52.19 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.928 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.5 p -142.63 151.91 41.94 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.577 0.703 . . . . 1.0 111.356 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -142.22 112.57 7.11 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.445 -0.798 . . . . 1.0 110.063 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -84.59 -169.71 2.76 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.457 0.646 . . . . 1.0 112.514 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 92' ' ' ASN . 43.2 t-20 56.85 39.42 29.55 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.561 0.948 . . . . 1.0 113.561 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -82.76 120.6 25.81 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.793 -1.188 . . . . 1.0 107.793 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -62.39 -38.03 88.05 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.869 -1.144 . . . . 1.0 111.873 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.7 t -149.3 168.96 21.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.272 0.558 . . . . 1.0 110.911 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -57.6 -37.65 73.59 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -57.4 -40.66 78.73 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.524 -0.547 . . . . 1.0 109.524 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -70.53 -39.14 74.22 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 121.906 -0.496 . . . . 1.0 110.043 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.5 HE21 ' C ' ' A' ' 6' ' ' ILE . 52.3 tt0 -64.53 -45.98 84.87 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.566 -0.902 . . . . 1.0 108.566 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -62.57 -41.48 98.96 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.102 -0.703 . . . . 1.0 109.102 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -60.28 -41.42 93.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.9 m -73.62 -48.17 34.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.13 0.49 . . . . 1.0 109.756 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -55.68 -50.48 70.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -62.47 -38.05 88.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -65.36 -51.98 56.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.074 0.464 . . . . 1.0 110.198 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.512 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 80.7 m95 -61.12 -39.78 91.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.539 -0.541 . . . . 1.0 109.539 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -58.18 -39.04 77.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.7 m -64.62 -42.31 95.59 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.512 ' SD ' ' CE3' ' A' ' 129' ' ' TRP . 81.5 mtp -64.2 -49.99 69.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.7 -40.47 95.14 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -62.17 -44.45 96.57 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.99 -0.744 . . . . 1.0 108.99 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.59 -34.01 82.71 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.295 -1.122 . . . . 1.0 110.295 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.7 tt -66.86 -52.95 37.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.653 0.74 . . . . 1.0 109.906 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -62.06 -36.82 82.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.433 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -59.94 -37.98 81.09 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.424 -0.173 . . . . 1.0 110.558 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -63.72 -48.85 75.4 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.183 -0.323 . . . . 1.0 110.541 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.73 -40.14 88.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.683 0.277 . . . . 1.0 110.546 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -70.24 -1.54 10.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.038 0.447 . . . . 1.0 110.128 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -66.35 -37.15 84.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.033 0.444 . . . . 1.0 110.663 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt . . . . . 0 C--N 1.328 -0.333 0 O-C-N 122.23 -0.294 . . . . 1.0 111.356 -179.312 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 122.226 1.012 . . . . 1.0 110.911 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -80.52 -172.57 3.65 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.706 0.765 . . . . 1.0 110.585 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.4 mp -70.17 141.56 52.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.982 0.896 . . . . 1.0 111.444 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.0 mt -114.64 130.62 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 115.648 -0.706 . . . . 1.0 110.91 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.37 142.94 47.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.06 0.457 . . . . 1.0 110.645 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -135.97 115.76 13.05 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.875 0.369 . . . . 1.0 110.971 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.91 137.14 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 120.98 0.419 . . . . 1.0 110.612 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -155.39 144.09 20.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.996 0.427 . . . . 1.0 111.164 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 t -146.81 143.49 28.66 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.233 0.539 . . . . 1.0 111.401 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.2 t -85.18 126.56 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.334 0.588 . . . . 1.0 110.631 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.7 mt -130.18 133.36 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.63 0.729 . . . . 1.0 110.49 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -90.5 95.85 10.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.39 0.614 . . . . 1.0 109.813 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.45 156.25 2.26 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.926 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.06 146.95 92.55 Favored 'Trans proline' 0 N--CA 1.506 2.238 0 C-N-CA 122.018 1.812 . . . . 1.0 112.621 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.1 tt -68.47 -27.47 36.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.446 0.641 . . . . 1.0 111.466 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.44 ' OE2' ' NE ' ' A' ' 72' ' ' ARG . 71.4 mm-40 -62.03 -47.26 85.55 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.88 -0.513 . . . . 1.0 112.286 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -62.77 -46.31 88.63 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.993 0.368 . . . . 1.0 111.993 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.0 m -69.18 -46.47 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.833 -0.803 . . . . 1.0 108.833 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -55.2 -50.51 69.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -60.74 -44.8 96.23 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.018 -0.426 . . . . 1.0 110.357 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.75 -21.48 28.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.468 -0.333 . . . . 1.0 111.755 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.03 -41.46 15.77 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.061 0.458 . . . . 1.0 111.555 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 m -108.14 75.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.308 0.575 . . . . 1.0 110.69 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.405 ' O ' ' CG1' ' A' ' 30' ' ' ILE . 0.2 OUTLIER -159.4 124.64 2.26 Favored Pre-proline 0 CA--C 1.548 0.867 0 CA-C-O 119.184 -0.436 . . . . 1.0 110.783 178.536 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.52 -11.62 20.55 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 121.805 1.67 . . . . 1.0 112.34 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -91.03 -47.74 7.38 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 110.269 -0.271 . . . . 1.0 110.269 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.91 -42.69 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.919 -0.771 . . . . 1.0 108.919 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.405 ' CG1' ' O ' ' A' ' 26' ' ' ASN . 5.4 mm -60.34 -42.14 89.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.271 -0.64 . . . . 1.0 109.271 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -64.5 -31.26 72.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.686 0.279 . . . . 1.0 110.357 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -65.24 -45.98 82.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.425 ' OH ' ' CG ' ' A' ' 139' ' ' PHE . 56.8 m-85 -72.04 -34.07 68.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.089 0.471 . . . . 1.0 110.589 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.549 ' O ' ' N ' ' A' ' 36' ' ' GLY . 68.6 mmm -93.94 59.82 2.79 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.554 0.692 . . . . 1.0 111.098 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 38.03 -84.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.135 -0.484 . . . . 1.0 112.2 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 34' ' ' MET . . . -146.34 48.26 0.68 Allowed Glycine 0 N--CA 1.469 0.865 0 O-C-N 121.948 -0.47 . . . . 1.0 112.021 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.7 m -93.48 117.57 30.25 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.675 0.75 . . . . 1.0 110.712 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 51.9 m -83.19 124.72 30.8 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.708 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.88 145.05 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.374 0.607 . . . . 1.0 110.631 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.5 t -120.74 130.65 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.41 0.624 . . . . 1.0 110.428 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.6 t -152.34 131.28 12.55 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.085 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.408 ' OD2' ' NZ ' ' A' ' 44' ' ' LYS . 93.9 m-20 -75.68 -19.08 59.39 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.119 0.961 . . . . 1.0 109.387 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.1 m0 68.16 45.47 1.27 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.65 -0.705 . . . . 1.0 111.488 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.408 ' NZ ' ' OD2' ' A' ' 42' ' ' ASP . 25.0 pttm -148.44 156.43 42.47 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.46 0.647 . . . . 1.0 111.369 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -48.19 127.69 12.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.687 0.756 . . . . 1.0 112.385 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.79 1.97 89.78 Favored Glycine 0 N--CA 1.465 0.609 0 CA-C-N 115.722 -0.672 . . . . 1.0 112.044 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.0 t -64.89 132.58 49.78 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.301 -0.529 . . . . 1.0 111.75 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -83.02 143.69 30.45 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.2 mt -134.1 136.08 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.791 0.805 . . . . 1.0 110.944 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.7 t -128.58 142.1 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.213 -0.903 . . . . 1.0 110.632 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 20.8 m-90 -117.18 123.26 46.25 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.014 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -97.0 126.63 42.27 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.25 178.26 34.59 Favored Glycine 0 N--CA 1.461 0.32 0 N-CA-C 110.997 -0.841 . . . . 1.0 110.997 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -128.68 136.59 50.82 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.571 0.701 . . . . 1.0 110.163 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -138.53 117.7 12.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.038 0.447 . . . . 1.0 110.466 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? 53.57 38.71 28.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.348 0.594 . . . . 1.0 110.747 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.7 -8.37 21.36 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.516 -1.034 . . . . 1.0 110.516 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -98.83 116.56 31.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.107 0.479 . . . . 1.0 110.664 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.09 128.44 36.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.251 0.548 . . . . 1.0 110.247 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -129.96 150.45 51.23 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.618 0.723 . . . . 1.0 110.971 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -135.77 131.66 35.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.437 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -89.54 162.6 15.6 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -141.18 126.99 19.16 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.558 0.694 . . . . 1.0 112.424 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.66 170.56 31.16 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.333 -1.107 . . . . 1.0 110.333 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.7 m -146.51 153.73 40.74 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 122.054 -0.674 . . . . 1.0 111.243 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.4 mm -77.9 116.49 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.37 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.4 tp -76.13 -44.9 36.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.653 0.74 . . . . 1.0 110.065 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -145.4 148.44 33.34 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -136.3 105.51 6.0 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.843 0.83 . . . . 1.0 111.439 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -125.45 107.95 11.16 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.25 -0.648 . . . . 1.0 109.25 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 -46.69 134.54 9.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.546 0.688 . . . . 1.0 111.969 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.44 ' NE ' ' OE2' ' A' ' 18' ' ' GLU . 14.4 ptp180 36.76 53.46 1.09 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.78 -0.645 . . . . 1.0 112.445 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 m -157.59 -69.9 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.822 -0.549 . . . . 1.0 111.618 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.6 mt -142.4 134.87 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-O 121.588 0.708 . . . . 1.0 111.535 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.6 tp -132.0 119.52 21.18 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.317 -0.856 . . . . 1.0 110.792 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -133.54 138.3 46.0 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.257 0.551 . . . . 1.0 110.299 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -151.06 153.26 34.75 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.975 0.893 . . . . 1.0 112.073 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.8 p -84.59 151.79 24.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.253 -1.017 . . . . 1.0 108.253 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -149.84 137.32 19.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.632 0.73 . . . . 1.0 112.105 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -150.67 150.09 30.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.001 -0.999 . . . . 1.0 110.655 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.5 t . . . . . 0 CA--C 1.549 0.91 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.612 179.236 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 112.313 0.486 . . . . 1.0 112.313 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.428 ' CD1' ' C ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -151.26 170.58 19.16 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.405 0.621 . . . . 1.0 111.722 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.492 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.3 OUTLIER -144.68 160.67 40.82 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.761 0.791 . . . . 1.0 111.318 179.354 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -104.5 129.19 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 115.171 -0.922 . . . . 1.0 109.458 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.8 t -96.26 132.79 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.987 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -123.18 121.63 36.42 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.378 0.609 . . . . 1.0 110.612 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.1 mm -107.15 131.76 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.468 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.1 m -118.89 114.36 22.48 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.356 0.598 . . . . 1.0 110.115 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.4 mt -122.94 122.94 39.81 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.641 0.734 . . . . 1.0 110.829 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 m -131.29 132.39 44.51 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.491 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -85.28 123.42 30.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.043 0.449 . . . . 1.0 110.38 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.6 mt -93.21 -152.56 0.33 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.007 0.432 . . . . 1.0 110.508 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.466 ' H ' ' CD ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -77.7 -48.73 16.0 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.187 0.44 . . . . 1.0 112.187 -178.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -136.95 35.47 2.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.81 0.844 . . . . 1.0 110.001 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 179.21 169.14 39.3 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.915 -0.874 . . . . 1.0 110.915 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.8 p -127.07 133.08 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.04 0.448 . . . . 1.0 111.302 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -88.72 139.87 30.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.589 . . . . 1.0 109.741 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.77 138.7 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.536 0.684 . . . . 1.0 110.248 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -150.33 136.37 18.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.307 0.575 . . . . 1.0 110.513 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 tt -122.12 132.59 54.55 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.982 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.2 m -124.2 143.38 50.55 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.491 0.662 . . . . 1.0 111.419 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.492 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 43.1 tt0 -145.4 135.5 23.82 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.419 -0.81 . . . . 1.0 109.947 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -110.24 -165.25 0.98 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.474 0.654 . . . . 1.0 112.407 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.0 t30 60.01 37.16 21.39 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.751 1.019 . . . . 1.0 113.751 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -83.63 113.15 20.64 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.663 -1.236 . . . . 1.0 107.663 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -62.58 -35.77 80.55 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.006 -1.058 . . . . 1.0 111.584 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.0 p -143.89 164.91 29.21 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.877 -0.514 . . . . 1.0 111.067 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -58.66 -35.65 72.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.57 0.7 . . . . 1.0 109.23 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -58.66 -41.14 85.43 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.443 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -68.28 -41.45 80.99 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.981 -0.45 . . . . 1.0 110.084 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -64.16 -47.64 79.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -59.26 -42.93 92.3 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -63.32 -37.78 88.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 71.0 m -67.95 -54.51 18.1 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -52.6 -43.95 65.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.34 -0.391 . . . . 1.0 109.963 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -62.97 -39.44 94.7 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.758 -0.46 . . . . 1.0 109.758 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -67.39 -51.69 48.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.045 0.45 . . . . 1.0 110.175 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -64.05 -42.25 97.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -58.39 -39.79 80.6 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.628 -0.878 . . . . 1.0 108.628 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.2 m -63.94 -40.93 97.56 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.919 -0.771 . . . . 1.0 108.919 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 39.5 ttm -65.8 -50.39 64.82 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.7 -40.7 95.93 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -66.23 -44.21 84.45 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.16 -37.25 91.26 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.106 -1.198 . . . . 1.0 110.106 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 49.0 tp -71.44 -44.78 64.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.4 0.619 . . . . 1.0 110.072 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -60.87 -43.93 97.74 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.108 -0.37 . . . . 1.0 110.461 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.67 -36.29 76.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.69 0.281 . . . . 1.0 110.847 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.425 ' CG ' ' OH ' ' A' ' 33' ' ' TYR . 26.2 t80 -62.02 -48.5 80.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.215 0.531 . . . . 1.0 110.399 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.31 -37.18 84.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.653 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.88 -0.54 13.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.296 0.569 . . . . 1.0 110.152 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -62.41 -35.96 80.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.665 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt . . . . . 0 C--N 1.329 -0.287 0 O-C-N 122.388 -0.195 . . . . 1.0 110.864 -179.278 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.48 ' CD1' ' N ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 121.44 0.638 . . . . 1.0 110.951 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -75.8 -153.82 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.21 0.528 . . . . 1.0 110.805 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.481 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 3.3 mm? -79.0 141.6 37.34 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.618 0.723 . . . . 1.0 111.57 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.9 mt -117.92 128.64 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.0 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.17 138.99 33.42 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.991 -0.443 . . . . 1.0 110.651 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -136.35 126.5 26.27 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.265 0.555 . . . . 1.0 111.01 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.52 156.15 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.053 0.454 . . . . 1.0 110.626 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -170.75 144.59 2.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.018 0.437 . . . . 1.0 111.013 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 t -147.09 145.15 29.52 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.365 0.602 . . . . 1.0 111.034 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.5 p -90.03 128.6 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.245 0.545 . . . . 1.0 110.439 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.5 mt -131.77 135.37 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.724 0.773 . . . . 1.0 110.613 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -88.01 94.4 9.78 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.476 0.655 . . . . 1.0 110.052 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.68 156.65 2.19 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.683 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.93 149.64 90.14 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.208 1.939 . . . . 1.0 112.401 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.9 tt -68.93 -29.01 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.91 -0.586 . . . . 1.0 111.263 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.44 -54.23 43.56 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.953 -0.467 . . . . 1.0 111.859 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.46 -40.06 89.17 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.97 0.359 . . . . 1.0 111.97 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.7 t -66.11 -46.93 86.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 30.2 t-105 -58.08 -41.53 83.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.727 0.775 . . . . 1.0 109.01 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -60.67 -44.13 96.85 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.993 -0.442 . . . . 1.0 110.38 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.2 69.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.578 -0.283 . . . . 1.0 111.687 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 tt -70.2 -41.74 73.29 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.231 -0.293 . . . . 1.0 111.469 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 m -121.21 79.06 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 121.749 0.785 . . . . 1.0 111.149 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.605 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -160.75 103.19 1.31 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.228 179.138 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -54.08 -27.33 45.47 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.064 1.843 . . . . 1.0 112.791 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.605 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 96.2 mt-10 -70.12 -53.44 17.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.147 0.499 . . . . 1.0 110.533 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.04 -42.19 88.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.401 0.619 . . . . 1.0 109.334 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.1 mm -59.43 -42.49 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.003 -0.74 . . . . 1.0 109.003 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -69.93 -31.76 69.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.016 0.436 . . . . 1.0 110.4 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -57.39 -41.98 81.29 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -70.27 -34.1 72.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.848 0.356 . . . . 1.0 110.37 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.2 mmt -85.07 148.25 26.25 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.582 0.706 . . . . 1.0 111.052 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -60.67 -43.68 97.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.633 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.41 41.58 0.24 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.106 -0.569 . . . . 1.0 112.061 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.7 m -85.27 126.96 34.12 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.448 0.642 . . . . 1.0 110.675 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.1 m -92.71 106.33 18.32 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.954 0.407 . . . . 1.0 110.599 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.0 t -106.19 135.32 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.659 0.743 . . . . 1.0 110.484 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.2 m -129.73 130.96 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.512 0.672 . . . . 1.0 110.549 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.2 t -155.78 154.18 31.0 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.535 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -92.75 -18.77 22.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.854 0.835 . . . . 1.0 108.948 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 2.2 m0 66.68 46.84 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 1.0 111.409 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -149.76 157.19 42.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.576 0.703 . . . . 1.0 111.334 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -52.22 129.55 28.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.865 0.84 . . . . 1.0 112.296 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.04 1.68 90.37 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.648 -0.706 . . . . 1.0 112.172 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.0 t -68.17 133.41 48.85 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 122.305 -0.527 . . . . 1.0 111.589 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -79.46 144.58 33.9 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.9 tt -138.25 136.93 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.608 0.718 . . . . 1.0 111.205 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.2 m -140.56 151.58 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.542 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -124.36 131.54 53.51 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.238 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -94.16 137.17 33.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.515 0.674 . . . . 1.0 109.694 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.78 169.9 37.34 Favored Glycine 0 C--N 1.33 0.239 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.55 122.78 40.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.816 0.817 . . . . 1.0 110.017 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' A' ' 58' ' ' LYS . 43.1 t-105 -117.58 115.87 25.96 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.576 0.703 . . . . 1.0 109.913 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.409 ' HG2' ' CD1' ' A' ' 55' ' ' TRP . 9.5 ptmm? 40.07 46.33 1.8 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.89 -0.596 . . . . 1.0 111.548 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.15 -17.77 9.19 Favored Glycine 0 N--CA 1.472 1.045 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 55' ' ' TRP . 37.5 ttmt -91.22 114.78 27.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.404 0.621 . . . . 1.0 110.299 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.37 136.59 46.16 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.108 -0.37 . . . . 1.0 110.33 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -138.61 155.82 47.99 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.558 0.695 . . . . 1.0 110.948 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.446 ' N ' ' CD ' ' A' ' 61' ' ' GLU . 1.5 pm0 -138.73 131.78 29.72 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.542 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -87.09 136.81 32.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -120.52 127.74 52.46 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.56 0.695 . . . . 1.0 112.478 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.95 178.79 33.18 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.362 -1.095 . . . . 1.0 110.362 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.1 m -148.12 157.9 43.77 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.86 -0.788 . . . . 1.0 111.132 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.8 mm -73.39 115.54 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.506 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.3 tp -69.73 -44.34 70.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.363 0.602 . . . . 1.0 110.137 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -155.97 147.53 22.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -131.06 110.17 11.02 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.649 0.738 . . . . 1.0 111.597 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.39 95.36 4.44 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.338 -0.615 . . . . 1.0 109.338 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -40.78 131.76 2.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.388 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.6 mtm-85 40.38 55.04 2.86 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.5 m -163.37 -70.65 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.757 -0.589 . . . . 1.0 111.976 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.1 mt -140.88 133.97 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 121.491 0.662 . . . . 1.0 111.408 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 tp -136.19 126.31 26.23 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.377 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -142.97 146.43 33.92 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.114 0.483 . . . . 1.0 110.226 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -150.26 155.03 38.94 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.142 0.973 . . . . 1.0 112.204 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 93.8 p -95.18 152.68 18.15 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.469 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -152.06 151.42 31.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.844 0.83 . . . . 1.0 111.554 -179.482 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -142.35 134.72 27.81 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.752 -1.113 . . . . 1.0 110.463 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.0 m . . . . . 0 CA--C 1.545 0.775 0 CA-C-O 118.686 -0.673 . . . . 1.0 110.546 179.797 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.48 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 43.7 t30 . . . . . 0 CA--C 1.529 0.144 0 N-CA-C 112.292 0.479 . . . . 1.0 112.292 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.469 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 39.5 p90 -101.38 177.65 4.87 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.626 0.726 . . . . 1.0 112.053 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -134.96 162.5 32.27 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.892 0.853 . . . . 1.0 111.416 -179.316 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.6 p -101.3 129.86 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.012 -0.995 . . . . 1.0 109.8 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 t -94.76 133.5 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.9 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.4 t -128.75 121.96 29.56 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.494 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.15 132.4 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.35 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.3 m -111.88 124.63 52.79 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.421 0.629 . . . . 1.0 109.999 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 74.9 mt -125.51 117.67 24.12 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.428 0.632 . . . . 1.0 110.794 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.9 m -133.25 134.67 44.28 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.431 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -85.7 126.3 33.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.296 0.57 . . . . 1.0 110.29 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 47.7 mt -110.14 172.24 6.98 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.167 0.508 . . . . 1.0 110.589 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -64.54 -40.28 95.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.47 0.545 . . . . 1.0 112.47 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -83.73 -34.98 24.76 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.276 0.56 . . . . 1.0 110.875 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.25 -146.58 5.86 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.909 -0.876 . . . . 1.0 110.909 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.2 p -125.44 128.64 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.248 0.547 . . . . 1.0 111.016 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -95.81 142.15 28.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.611 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.3 m -130.14 148.7 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.622 0.725 . . . . 1.0 110.558 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -151.1 133.07 15.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.152 0.501 . . . . 1.0 110.514 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.6 tt -124.6 131.82 53.46 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.806 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.8 m -123.28 143.34 50.13 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.648 0.737 . . . . 1.0 111.142 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.438 ' OE1' ' ND2' ' A' ' 116' ' ' ASN . 0.9 OUTLIER -142.32 136.74 30.01 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.309 -0.86 . . . . 1.0 110.034 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 0.7 OUTLIER -114.23 -164.67 0.95 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.631 0.729 . . . . 1.0 112.334 -179.04 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 92' ' ' ASN . 64.4 t30 59.03 35.39 23.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.469 0.915 . . . . 1.0 113.469 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.438 ' ND2' ' OE1' ' A' ' 113' ' ' GLN . 83.5 m-20 -83.64 133.75 34.82 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.557 -1.275 . . . . 1.0 107.557 177.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -64.07 -46.17 85.49 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.028 -1.045 . . . . 1.0 112.066 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 62.0 p -147.79 179.71 7.51 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.843 -0.535 . . . . 1.0 110.835 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -60.39 -37.07 79.63 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -61.34 -43.96 98.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -71.32 -41.69 69.54 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.967 -0.458 . . . . 1.0 110.075 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.8 tm0? -63.24 -44.89 93.92 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -62.8 -42.82 99.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.698 -0.852 . . . . 1.0 108.698 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -59.57 -39.94 85.75 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 16.8 t -69.73 -44.75 69.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -56.01 -47.73 77.23 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.98 -39.15 91.21 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.787 -0.449 . . . . 1.0 109.787 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -64.28 -53.11 54.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 1.0 110.068 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.506 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 86.5 m95 -60.61 -39.18 87.21 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -59.08 -39.89 83.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.396 -0.965 . . . . 1.0 108.396 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.4 m -63.5 -43.13 98.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.506 ' SD ' ' CE3' ' A' ' 129' ' ' TRP . 77.2 mtp -62.7 -50.7 70.07 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.497 -0.556 . . . . 1.0 109.497 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.54 -38.8 88.76 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -65.66 -34.04 77.28 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.68 -32.34 33.78 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.155 -1.178 . . . . 1.0 110.155 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.7 tt -68.56 -54.13 18.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.641 0.734 . . . . 1.0 109.871 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -27.0 68.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.534 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -56.36 -32.18 64.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.891 0.377 . . . . 1.0 110.613 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -79.22 -41.95 27.11 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.036 0.446 . . . . 1.0 110.7 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 140' ' ' LEU . 4.1 mm? -63.24 -41.87 99.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.838 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -75.74 -1.98 27.52 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.338 0.59 . . . . 1.0 110.231 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -63.5 -41.2 98.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.661 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.748 0.308 . . . . 1.0 110.902 -179.753 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.1 pt . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 121.903 0.859 . . . . 1.0 110.931 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -74.9 -175.8 2.67 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.7 -0.625 . . . . 1.0 110.971 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 9.7 mp -68.2 140.2 56.08 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.03 0.919 . . . . 1.0 111.182 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.522 ' C ' HE21 ' A' ' 122' ' ' GLN . 5.1 mp -112.21 124.33 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.687 -0.688 . . . . 1.0 111.099 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.08 134.21 36.75 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.029 -0.42 . . . . 1.0 110.372 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -133.7 122.36 23.27 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.976 0.417 . . . . 1.0 110.804 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.3 m -139.89 135.59 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.099 0.476 . . . . 1.0 110.576 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -152.64 150.69 29.75 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.089 0.471 . . . . 1.0 111.033 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.87 142.39 28.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.541 0.686 . . . . 1.0 111.143 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 t -85.62 114.51 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.416 0.627 . . . . 1.0 110.715 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.9 mm -127.84 138.77 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 122.183 0.992 . . . . 1.0 110.733 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -98.04 105.93 18.15 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.397 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.24 160.6 3.46 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 120.977 -0.289 . . . . 1.0 110.416 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -59.85 140.5 93.45 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.341 2.027 . . . . 1.0 112.135 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.1 tp -68.21 -32.87 57.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.649 0.738 . . . . 1.0 111.221 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -57.4 -52.39 65.58 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.886 -0.508 . . . . 1.0 111.859 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.451 ' CD ' ' N ' ' A' ' 19' ' ' LYS . 12.2 mptt -64.49 -42.91 95.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.52 -47.54 91.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.46 ' CH2' ' O ' ' A' ' 70' ' ' ASN . 62.3 t-105 -60.23 -42.42 95.19 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -58.99 -47.39 85.34 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.977 -0.452 . . . . 1.0 110.206 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.79 -28.82 69.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.647 0.261 . . . . 1.0 111.702 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -70.56 -41.73 72.07 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.237 -0.289 . . . . 1.0 111.489 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 m -120.27 78.89 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 121.759 0.79 . . . . 1.0 111.226 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.708 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -158.63 113.22 1.66 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.56 179.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.534 ' N ' HD21 ' A' ' 26' ' ' ASN . 57.0 Cg_endo -68.99 -11.34 31.59 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.237 1.291 . . . . 1.0 112.649 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.708 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 45.6 mt-10 -86.28 -47.66 9.21 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.804 0.335 . . . . 1.0 110.332 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.18 -41.46 66.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.295 -0.632 . . . . 1.0 109.295 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.31 -42.3 86.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -65.46 -31.26 72.24 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.292 -0.262 . . . . 1.0 110.292 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -56.6 -42.77 79.28 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.824 -0.435 . . . . 1.0 109.824 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -69.81 -33.8 72.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.942 0.401 . . . . 1.0 110.389 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 79.8 mmm -85.22 153.72 22.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.66 0.743 . . . . 1.0 110.816 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -62.56 -35.83 80.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.63 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.28 42.62 0.07 OUTLIER Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.017 -0.611 . . . . 1.0 111.943 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.2 m -85.8 125.73 33.48 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.601 0.715 . . . . 1.0 110.74 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.0 p -88.95 102.42 15.05 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.636 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.53 130.64 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.471 0.653 . . . . 1.0 110.419 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.05 128.42 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.408 0.623 . . . . 1.0 110.264 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.5 t -155.6 153.42 30.07 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.125 -0.488 . . . . 1.0 111.384 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 8.1 t0 -92.77 -20.61 20.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.945 0.879 . . . . 1.0 108.958 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 2.6 m0 67.8 49.75 0.91 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.828 -0.624 . . . . 1.0 111.559 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -151.77 155.18 37.73 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.519 0.676 . . . . 1.0 111.186 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -49.64 127.41 15.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.794 0.807 . . . . 1.0 112.176 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.4 0.75 90.2 Favored Glycine 0 N--CA 1.468 0.833 0 CA-C-N 115.678 -0.692 . . . . 1.0 112.115 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.0 t -66.31 135.9 55.06 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.232 -0.57 . . . . 1.0 111.694 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 64' ' ' GLY . 68.0 tp60 -84.67 147.01 27.16 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.8 tt -136.91 136.15 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.539 0.685 . . . . 1.0 111.338 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -138.66 142.47 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 115.505 -0.77 . . . . 1.0 110.556 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.413 ' CZ3' ' NE2' ' A' ' 79' ' ' HIS . 14.1 m0 -119.67 136.64 54.32 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.052 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -101.97 143.53 31.71 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.332 0.587 . . . . 1.0 109.578 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.41 175.41 43.68 Favored Glycine 0 C--N 1.329 0.167 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -125.53 127.01 45.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.97 0.89 . . . . 1.0 109.791 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.587 ' O ' ' N ' ' A' ' 58' ' ' LYS . 36.2 t-105 -120.34 119.17 32.33 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.384 0.612 . . . . 1.0 109.645 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.407 ' HG2' ' CD1' ' A' ' 55' ' ' TRP . 9.9 ptmm? 39.66 42.02 0.88 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.346 0.594 . . . . 1.0 111.7 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.02 -18.01 19.12 Favored Glycine 0 N--CA 1.476 1.316 0 N-CA-C 110.768 -0.933 . . . . 1.0 110.768 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.587 ' N ' ' O ' ' A' ' 55' ' ' TRP . 74.4 mmtt -91.36 110.5 21.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.98 0.895 . . . . 1.0 110.655 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.03 132.15 47.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.65 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -134.38 152.56 51.87 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.612 0.72 . . . . 1.0 110.909 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.448 ' N ' ' CD ' ' A' ' 61' ' ' GLU . 2.0 pm0 -138.03 136.07 36.5 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.497 0.665 . . . . 1.0 110.498 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -88.49 167.85 13.09 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -153.69 127.19 8.64 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.139 -0.624 . . . . 1.0 112.37 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.429 ' O ' ' NE2' ' A' ' 48' ' ' GLN . . . -153.78 178.23 30.84 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.399 -1.081 . . . . 1.0 110.399 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 79.2 m -148.51 154.03 39.25 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.997 -0.708 . . . . 1.0 111.24 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 32.1 mm -80.4 121.95 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.403 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -90.97 -44.54 9.28 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.426 0.631 . . . . 1.0 109.964 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.632 HE21 ' ND2' ' A' ' 70' ' ' ASN . 58.5 tt0 -133.8 135.24 43.71 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.718 -0.475 . . . . 1.0 109.718 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -135.08 102.64 5.27 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.726 0.774 . . . . 1.0 111.516 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.632 ' ND2' HE21 ' A' ' 68' ' ' GLN . 82.6 m-20 -124.83 102.89 7.78 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.345 -0.613 . . . . 1.0 109.345 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -42.94 127.53 4.12 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.729 -0.668 . . . . 1.0 112.261 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 45.15 53.98 7.45 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.051 0.54 . . . . 1.0 112.352 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.7 t -160.05 -74.32 0.07 Allowed 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.782 -0.574 . . . . 1.0 112.027 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.5 mt -138.15 133.02 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.656 0.741 . . . . 1.0 111.374 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.1 tp -132.08 125.48 31.49 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.32 -0.855 . . . . 1.0 110.57 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -135.13 136.71 42.12 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.452 0.644 . . . . 1.0 110.235 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -149.7 152.98 36.21 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.019 0.914 . . . . 1.0 112.0 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 p -86.94 151.07 23.62 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.152 -1.055 . . . . 1.0 108.152 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.413 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 15.2 t-80 -151.19 142.11 22.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.544 0.688 . . . . 1.0 111.939 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -144.91 148.65 34.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.048 -0.978 . . . . 1.0 110.351 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 74.8 m . . . . . 0 CA--C 1.548 0.903 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.63 179.699 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 66.9 t30 . . . . . 0 N--CA 1.465 0.284 0 N-CA-C 112.227 0.454 . . . . 1.0 112.227 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.59 173.2 12.94 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.616 0.722 . . . . 1.0 112.031 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -139.61 165.15 28.03 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 122.138 0.97 . . . . 1.0 111.19 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.2 t -107.28 128.9 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 114.829 -1.078 . . . . 1.0 109.657 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.0 t -92.82 134.13 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.919 -0.582 . . . . 1.0 111.14 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.9 t -132.03 124.78 29.97 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.51 0.671 . . . . 1.0 110.443 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.95 129.96 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.17 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.5 m -106.87 120.85 43.15 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.555 0.693 . . . . 1.0 109.831 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 mp -117.21 124.1 48.27 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.613 0.721 . . . . 1.0 110.816 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.7 p -131.02 134.08 46.35 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.824 0.821 . . . . 1.0 110.477 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.98 111.37 23.61 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.119 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.5 mt -77.76 -168.98 1.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.042 0.449 . . . . 1.0 110.464 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -64.47 -48.34 75.62 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.515 0.561 . . . . 1.0 112.515 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -137.48 38.5 2.46 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.407 0.683 . . . . 1.0 109.942 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.91 168.84 41.31 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.9 p -134.4 144.4 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.742 0.782 . . . . 1.0 110.776 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -120.27 143.03 48.54 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.698 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.0 m -129.91 149.98 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.643 0.735 . . . . 1.0 110.345 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -152.2 134.14 14.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.698 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.9 tt -119.98 131.05 55.04 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.365 0.603 . . . . 1.0 109.957 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 m -120.67 142.65 49.27 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.415 0.626 . . . . 1.0 111.265 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -145.52 136.63 24.77 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.462 -0.79 . . . . 1.0 110.046 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 10.9 p-10 -116.48 -171.09 1.94 Allowed 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.655 0.74 . . . . 1.0 112.341 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.0 t30 65.01 38.76 6.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.627 0.973 . . . . 1.0 113.627 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -84.91 116.65 23.46 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 107.638 -1.245 . . . . 1.0 107.638 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -58.87 -36.92 75.41 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 120.954 -1.092 . . . . 1.0 111.773 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.6 p -140.96 163.6 32.52 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.872 -0.518 . . . . 1.0 111.045 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.1 -34.59 77.92 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -57.9 -38.94 76.73 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.535 -0.542 . . . . 1.0 109.535 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.49 -35.04 70.66 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.87 -0.519 . . . . 1.0 110.21 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.522 HE21 ' C ' ' A' ' 6' ' ' ILE . 54.9 tt0 -62.16 -47.72 83.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.792 -0.818 . . . . 1.0 108.792 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -60.23 -42.46 95.28 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.827 -0.805 . . . . 1.0 108.827 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -61.0 -38.38 85.84 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.6 t -68.42 -53.46 23.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.638 -0.505 . . . . 1.0 109.638 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -55.41 -45.46 76.71 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.999 -0.371 . . . . 1.0 109.999 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -62.76 -40.2 96.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -66.74 -51.6 54.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.373 0.606 . . . . 1.0 110.136 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -61.26 -35.68 77.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.495 -0.557 . . . . 1.0 109.495 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -59.69 -40.4 87.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.569 -0.9 . . . . 1.0 108.569 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.7 m -63.77 -43.01 97.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.252 -0.647 . . . . 1.0 109.252 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 83.4 mmm -61.42 -50.34 73.22 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.52 -40.35 94.32 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -62.8 -44.25 96.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.91 -41.94 86.93 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.224 -1.15 . . . . 1.0 110.224 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.4 tt -63.03 -50.41 70.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.691 0.758 . . . . 1.0 110.179 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.54 -36.86 83.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.229 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.68 -35.1 54.74 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 122.378 -0.201 . . . . 1.0 110.761 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -65.48 -51.06 62.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.915 0.388 . . . . 1.0 110.423 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.75 -41.05 88.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.488 -0.324 . . . . 1.0 110.905 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -68.58 -18.08 64.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.249 0.547 . . . . 1.0 109.935 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -48.7 -30.87 6.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 1.0 110.721 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.3 pttt . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.722 0.296 . . . . 1.0 111.278 -179.709 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.1 pt . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 121.757 0.789 . . . . 1.0 110.928 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -77.26 -165.23 0.55 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.771 -0.581 . . . . 1.0 111.059 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.425 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 9.3 mp -68.61 139.12 55.51 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.65 0.738 . . . . 1.0 111.306 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.459 ' C ' HE21 ' A' ' 122' ' ' GLN . 28.5 mm -110.0 124.81 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.934 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.31 136.31 42.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.956 0.407 . . . . 1.0 110.637 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -131.92 119.84 21.71 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.079 0.466 . . . . 1.0 110.935 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.9 m -143.95 136.29 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 121.095 0.474 . . . . 1.0 110.609 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -150.66 149.97 30.52 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.989 0.423 . . . . 1.0 111.305 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 t -146.98 144.56 29.27 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.404 0.621 . . . . 1.0 111.136 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.1 t -85.27 113.34 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.262 0.553 . . . . 1.0 110.586 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mm -110.51 126.83 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.682 0.753 . . . . 1.0 110.512 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -92.51 94.95 9.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.21 0.529 . . . . 1.0 109.806 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.62 169.7 2.91 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.806 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.52 148.13 93.74 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 122.286 1.991 . . . . 1.0 112.477 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 tp -68.41 -36.25 74.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.17 0.509 . . . . 1.0 111.336 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -66.29 -48.46 70.32 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.878 -0.514 . . . . 1.0 112.084 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.13 -42.72 99.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.916 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.2 t -68.26 -45.6 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -59.47 -41.59 90.1 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.086 -0.709 . . . . 1.0 109.086 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -56.3 -43.22 78.67 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 122.044 -0.41 . . . . 1.0 110.367 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.43 -31.81 66.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.336 . . . . 1.0 111.669 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.42 -45.88 78.41 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.766 0.317 . . . . 1.0 111.643 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 m -116.5 82.01 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.585 0.707 . . . . 1.0 110.78 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.659 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -160.2 113.78 1.42 Allowed Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.491 179.15 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.515 ' N ' HD21 ' A' ' 26' ' ' ASN . 61.3 Cg_endo -71.94 -12.65 28.58 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 121.635 1.556 . . . . 1.0 112.362 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.659 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 50.0 mt-10 -86.43 -46.24 10.41 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.647 0.26 . . . . 1.0 110.453 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.7 mt -71.75 -43.36 70.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.5 mt -59.66 -43.08 90.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.03 -0.73 . . . . 1.0 109.03 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -70.9 -29.28 65.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.997 0.427 . . . . 1.0 110.353 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -57.25 -40.93 78.66 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -70.08 -33.52 72.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 1.0 110.249 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.413 ' CE ' ' OG1' ' A' ' 37' ' ' THR . 64.7 mtp -87.81 154.85 20.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.602 0.715 . . . . 1.0 111.167 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -60.75 -43.7 97.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.696 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.26 49.82 0.14 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.966 -0.635 . . . . 1.0 111.919 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.413 ' OG1' ' CE ' ' A' ' 34' ' ' MET . 88.8 m -81.94 128.87 34.51 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.73 0.776 . . . . 1.0 110.761 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.4 m -91.29 91.83 8.35 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.755 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p -103.93 134.1 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.702 0.763 . . . . 1.0 110.383 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.6 t -126.41 134.54 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.671 0.748 . . . . 1.0 110.409 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.1 t -155.45 143.37 19.9 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.386 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -81.92 -19.53 40.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.84 0.829 . . . . 1.0 109.098 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.2 m0 69.42 48.11 0.65 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.523 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.525 ' H ' ' HG ' ' A' ' 47' ' ' SER . 21.4 ptmt -157.46 168.47 27.23 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.428 0.633 . . . . 1.0 111.195 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -58.68 127.63 33.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.689 0.757 . . . . 1.0 112.294 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.23 -1.42 84.51 Favored Glycine 0 N--CA 1.47 0.934 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.994 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.525 ' HG ' ' H ' ' A' ' 44' ' ' LYS . 19.2 m -67.59 133.2 48.98 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.235 -0.568 . . . . 1.0 111.805 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 64' ' ' GLY . 68.0 tp60 -83.24 145.88 28.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.821 -0.807 . . . . 1.0 108.821 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.0 tt -136.83 137.35 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.457 0.646 . . . . 1.0 111.134 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -143.46 149.73 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.696 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.511 ' CZ3' ' NE2' ' A' ' 79' ' ' HIS . 9.6 m0 -124.55 140.45 52.93 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.039 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -103.61 137.46 41.64 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.099 0.476 . . . . 1.0 109.798 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.95 176.35 40.73 Favored Glycine 0 N--CA 1.46 0.27 0 N-CA-C 111.041 -0.824 . . . . 1.0 111.041 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -127.09 138.65 53.24 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.802 0.811 . . . . 1.0 110.19 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -143.16 117.43 9.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.285 0.564 . . . . 1.0 110.293 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 54.56 34.85 22.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.581 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.85 -9.34 38.16 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -97.99 117.3 32.03 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.656 0.741 . . . . 1.0 110.147 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.38 129.06 38.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.301 0.572 . . . . 1.0 110.085 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -128.9 150.37 50.39 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.66 0.743 . . . . 1.0 110.803 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -136.58 133.72 36.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.493 0.663 . . . . 1.0 110.341 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -92.71 142.52 27.26 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -127.69 129.37 47.03 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.62 0.724 . . . . 1.0 112.517 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.469 ' O ' ' NE2' ' A' ' 48' ' ' GLN . . . -151.71 177.97 29.29 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.378 -1.089 . . . . 1.0 110.378 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.5 m -149.96 156.06 41.06 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 122.047 -0.679 . . . . 1.0 111.193 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 38.4 mm -77.68 115.29 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.269 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.4 tp -73.3 -44.28 59.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.707 0.765 . . . . 1.0 110.154 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -150.15 147.87 28.26 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.63 -0.507 . . . . 1.0 109.63 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -132.04 110.05 10.45 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.97 0.89 . . . . 1.0 111.494 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -124.84 94.57 4.22 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.355 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -40.15 130.46 2.16 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.935 -0.575 . . . . 1.0 112.533 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 42.93 54.57 4.71 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.194 0.598 . . . . 1.0 112.432 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.0 t -163.46 -71.06 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.716 -0.615 . . . . 1.0 112.192 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 94.8 mt -138.0 136.31 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 121.511 0.672 . . . . 1.0 111.448 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.83 120.28 18.08 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.429 -0.805 . . . . 1.0 110.328 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -133.37 138.75 46.45 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.474 0.654 . . . . 1.0 110.34 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -149.46 150.86 33.02 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.944 0.878 . . . . 1.0 111.922 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.2 p -85.33 152.29 23.39 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.511 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 45.8 t-80 -148.77 136.82 20.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.686 0.755 . . . . 1.0 111.986 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -138.04 144.31 40.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.918 -1.037 . . . . 1.0 110.31 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.476 0.84 0 CA-C-N 115.746 -0.661 . . . . 1.0 110.767 179.318 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.2 t30 . . . . . 0 N--CA 1.466 0.367 0 N-CA-C 112.587 0.588 . . . . 1.0 112.587 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -101.55 172.09 7.18 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.519 0.676 . . . . 1.0 112.0 -178.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -140.66 162.75 34.65 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.849 0.833 . . . . 1.0 111.342 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.2 p -106.62 131.23 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 115.057 -0.974 . . . . 1.0 109.677 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.1 t -96.51 131.41 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.238 0.542 . . . . 1.0 110.679 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.1 t -121.82 120.76 35.5 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.604 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.6 mm -110.3 131.77 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.591 -0.731 . . . . 1.0 110.414 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.7 m -124.09 120.42 32.32 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.391 0.615 . . . . 1.0 110.288 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.6 mp -115.31 131.61 56.87 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 122.119 0.961 . . . . 1.0 110.772 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.42 ' OG1' ' CG ' ' A' ' 108' ' ' GLU . 32.0 p -133.45 128.83 36.3 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.076 -0.966 . . . . 1.0 110.337 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -84.57 108.82 17.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.13 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 106' ' ' GLY . 25.8 mt -91.79 170.76 9.63 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.072 0.463 . . . . 1.0 110.482 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -63.87 -39.03 93.25 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.452 0.538 . . . . 1.0 112.452 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -84.08 -33.35 24.41 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.298 0.571 . . . . 1.0 110.728 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 103' ' ' LEU . . . -175.86 -139.06 3.01 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.8 p -134.22 139.27 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.437 0.637 . . . . 1.0 110.79 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.42 ' CG ' ' OG1' ' A' ' 101' ' ' THR . 19.0 pt-20 -105.49 142.02 35.97 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.463 -0.789 . . . . 1.0 109.768 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -124.06 139.33 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.716 0.769 . . . . 1.0 110.408 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -135.76 132.08 36.33 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.349 0.595 . . . . 1.0 110.77 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 tt -128.41 134.73 48.86 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.073 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 75.6 p -131.29 150.57 52.09 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.654 0.74 . . . . 1.0 111.357 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -146.14 108.92 4.54 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.278 -0.874 . . . . 1.0 110.053 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -82.38 -170.19 2.81 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.646 0.736 . . . . 1.0 112.521 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.9 t30 62.25 36.71 14.6 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.737 1.014 . . . . 1.0 113.737 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -81.44 122.12 27.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.597 -1.261 . . . . 1.0 107.597 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -65.23 -36.25 83.58 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 120.999 -1.063 . . . . 1.0 111.839 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.509 ' HG1' ' N ' ' A' ' 119' ' ' GLU . 1.6 t -151.08 168.48 24.48 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.17 0.509 . . . . 1.0 111.042 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.509 ' N ' ' HG1' ' A' ' 118' ' ' THR . 98.5 mt-10 -57.53 -36.67 71.89 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.464 ' H ' ' HG1' ' A' ' 118' ' ' THR . 88.9 tttt -58.39 -41.9 85.86 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.422 ' H ' HG21 ' A' ' 118' ' ' THR . 78.6 tt0 -70.43 -39.72 74.21 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.932 -0.48 . . . . 1.0 110.213 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.459 HE21 ' C ' ' A' ' 6' ' ' ILE . 53.2 tt0 -64.01 -48.91 74.49 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.729 -0.841 . . . . 1.0 108.729 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -59.35 -46.84 87.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -57.81 -39.55 77.85 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.1 t -67.78 -56.09 10.55 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.647 -0.501 . . . . 1.0 109.647 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -54.29 -44.03 71.57 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.13 -39.22 91.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.008 0.432 . . . . 1.0 109.951 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -69.91 -51.28 34.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.188 0.518 . . . . 1.0 110.146 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -62.59 -39.18 92.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -57.71 -40.26 79.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.0 m -61.59 -39.51 91.43 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -65.81 -48.21 72.48 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.0 -41.51 96.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.372 -0.603 . . . . 1.0 109.372 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -64.99 -41.39 95.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.78 -35.65 87.17 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.83 -48.32 54.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.199 0.523 . . . . 1.0 109.971 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -59.02 -43.91 91.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.931 -0.396 . . . . 1.0 109.931 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.99 -41.99 98.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.713 0.292 . . . . 1.0 110.775 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -71.66 -45.86 60.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.222 0.534 . . . . 1.0 110.755 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.09 -45.66 84.31 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.859 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -73.45 -1.62 19.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.105 0.479 . . . . 1.0 109.767 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -61.41 -37.34 83.12 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.272 -0.268 . . . . 1.0 110.445 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.1 pttt . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.74 0.305 . . . . 1.0 111.291 -179.957 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.533 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 108.531 -0.914 . . . . 1.0 108.531 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -168.16 -164.2 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.743 0.306 . . . . 1.0 110.262 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt -55.38 145.63 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.704 0.764 . . . . 1.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -82.53 -161.65 0.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.738 -0.601 . . . . 1.0 111.108 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.412 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 9.7 mp -71.48 144.15 49.78 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.702 0.763 . . . . 1.0 111.399 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.87 129.36 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 121.451 0.643 . . . . 1.0 110.892 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.42 134.14 33.92 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.933 -0.479 . . . . 1.0 110.386 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -142.51 138.13 30.71 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.041 0.448 . . . . 1.0 110.684 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.4 m -140.8 156.13 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.147 0.499 . . . . 1.0 110.611 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -159.46 143.48 14.9 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 122.055 -0.403 . . . . 1.0 111.207 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 t -147.54 145.26 29.01 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.244 0.545 . . . . 1.0 111.361 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.6 t -84.05 112.35 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.318 0.58 . . . . 1.0 110.635 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.7 mm -115.07 130.14 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.822 0.82 . . . . 1.0 110.74 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -94.02 95.91 9.34 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.95 -0.469 . . . . 1.0 110.02 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.45 155.73 7.37 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.58 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -61.97 145.94 96.54 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.392 2.061 . . . . 1.0 112.212 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.3 tp -62.8 -38.0 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.125 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -54.48 -56.44 18.72 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.933 -0.479 . . . . 1.0 112.068 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -64.62 -41.78 95.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.935 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.3 t -65.6 -48.5 82.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -57.83 -42.61 84.73 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.29 -47.13 86.53 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 122.072 -0.392 . . . . 1.0 110.235 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.82 -28.74 66.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.636 0.255 . . . . 1.0 111.609 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.7 tp -72.97 -43.24 62.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 1.0 111.645 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.42 79.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 121.545 0.688 . . . . 1.0 110.992 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.682 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -160.72 113.41 1.34 Allowed Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.498 178.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.532 ' N ' HD21 ' A' ' 26' ' ' ASN . 55.5 Cg_endo -69.79 -15.26 36.89 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.885 1.723 . . . . 1.0 112.373 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.682 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 44.9 tp10 -83.47 -49.79 8.93 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -69.16 -41.73 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 mm -59.66 -26.11 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -77.78 -30.89 51.57 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.062 -0.347 . . . . 1.0 110.062 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -56.44 -43.44 79.5 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.792 -0.447 . . . . 1.0 109.792 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -69.62 -33.91 73.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.964 0.412 . . . . 1.0 110.486 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.6 mmt -89.01 151.85 22.03 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.57 0.7 . . . . 1.0 111.123 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -61.53 -40.72 95.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.731 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.55 37.44 0.13 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.088 -0.577 . . . . 1.0 111.953 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.1 m -74.6 128.93 36.78 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.663 0.744 . . . . 1.0 110.82 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.1 m -94.46 93.5 7.69 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.731 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.5 t -92.59 128.74 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.402 0.62 . . . . 1.0 110.4 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.63 129.03 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 121.346 0.593 . . . . 1.0 110.456 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.456 ' OG ' ' NE1' ' A' ' 43' ' ' TRP . 38.4 p -155.21 157.94 38.11 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.222 -0.445 . . . . 1.0 111.306 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -97.35 -18.01 19.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.872 0.844 . . . . 1.0 108.78 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.456 ' NE1' ' OG ' ' A' ' 41' ' ' SER . 2.8 m0 67.27 44.91 1.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.24 0.616 . . . . 1.0 111.607 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -150.17 157.97 43.67 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.443 0.64 . . . . 1.0 111.433 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -52.71 130.23 31.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.8 0.81 . . . . 1.0 112.267 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.62 3.8 90.36 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 115.713 -0.676 . . . . 1.0 112.082 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.2 t -71.83 134.09 45.9 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.282 -0.54 . . . . 1.0 111.608 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -81.38 148.85 29.12 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.2 tt -134.62 133.8 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.547 0.689 . . . . 1.0 111.353 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.8 t -134.72 140.15 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.599 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.407 ' CZ3' ' NE2' ' A' ' 79' ' ' HIS . 24.0 m0 -118.72 131.32 56.13 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.179 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -99.88 140.28 34.32 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.319 0.58 . . . . 1.0 109.738 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.23 178.78 42.24 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 110.989 -0.845 . . . . 1.0 110.989 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -128.66 134.32 48.49 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.914 0.864 . . . . 1.0 110.118 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -135.65 116.78 14.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.323 0.582 . . . . 1.0 110.375 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 58' ' ' LYS . 72.3 mmtt 52.92 40.25 30.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.33 0.586 . . . . 1.0 110.659 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.6 -8.3 15.07 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.682 -0.967 . . . . 1.0 110.682 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' A' ' 56' ' ' LYS . 63.4 tttp -97.74 115.57 28.24 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.435 0.636 . . . . 1.0 110.407 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.61 133.0 47.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.078 0.466 . . . . 1.0 110.216 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -136.4 154.12 50.9 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.721 0.772 . . . . 1.0 110.963 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -138.21 132.77 32.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.826 -0.624 . . . . 1.0 110.53 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -88.27 167.48 13.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.244 -0.65 . . . . 1.0 109.244 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -156.23 133.85 10.95 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.702 0.763 . . . . 1.0 112.663 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.95 -176.86 34.48 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.359 -1.096 . . . . 1.0 110.359 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 90.8 m -147.19 156.69 43.18 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.951 -0.735 . . . . 1.0 111.102 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.9 mm -73.94 115.4 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.555 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.0 tp -67.02 -41.84 85.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.611 0.72 . . . . 1.0 110.164 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.431 HE21 HD22 ' A' ' 70' ' ' ASN . 64.7 tt0 -159.56 149.32 18.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.546 -0.538 . . . . 1.0 109.546 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -133.89 111.39 10.43 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.962 0.887 . . . . 1.0 111.54 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.431 HD22 HE21 ' A' ' 68' ' ' GLN . 12.5 m120 -119.66 104.68 10.48 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.327 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -41.16 122.95 1.93 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.358 0.599 . . . . 1.0 112.247 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 41.35 55.1 3.44 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.09 0.556 . . . . 1.0 112.436 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.7 m -157.91 -68.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.723 -0.611 . . . . 1.0 112.107 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.4 mt -141.68 138.16 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-O 121.647 0.737 . . . . 1.0 111.509 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 tp -133.33 125.85 30.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.29 -0.868 . . . . 1.0 110.687 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -132.52 138.92 47.68 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.238 0.542 . . . . 1.0 110.203 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -150.75 143.94 24.81 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.939 0.876 . . . . 1.0 112.077 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 93.1 p -85.99 153.76 21.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.008 -1.108 . . . . 1.0 108.008 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.407 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 42.4 t-80 -147.47 142.29 26.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.732 0.777 . . . . 1.0 111.96 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -142.01 134.65 28.34 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.876 -1.056 . . . . 1.0 110.457 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.1 t -111.84 119.37 44.69 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.666 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -71.91 -20.0 26.32 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 121.375 1.383 . . . . 1.0 112.271 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.6 mt -59.49 -12.08 5.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.897 0.379 . . . . 1.0 110.346 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.4 p -64.87 -34.99 79.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.557 -0.292 . . . . 1.0 110.659 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.6 29.76 33.06 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.836 -0.906 . . . . 1.0 110.836 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -90.27 153.29 46.48 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 120.914 -0.314 . . . . 1.0 111.351 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.64 149.5 24.47 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 121.666 1.577 . . . . 1.0 111.679 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -44.97 97.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.591 0.71 . . . . 1.0 111.969 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.486 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 7.0 tp -152.09 89.91 3.9 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 121.954 -0.466 . . . . 1.0 110.367 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.488 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 51.5 Cg_exo -51.28 -27.92 24.86 Favored 'Trans proline' 0 N--CA 1.502 2.019 0 C-N-CA 122.45 2.1 . . . . 1.0 112.516 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.0 mp0 -69.2 -1.85 8.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.169 0.509 . . . . 1.0 110.322 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 89' ' ' LEU . 29.5 p30 -70.14 -23.04 62.94 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.421 0.526 . . . . 1.0 112.421 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 90' ' ' PRO . 30.1 p90 -108.99 178.07 4.58 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.469 0.652 . . . . 1.0 112.019 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.496 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.3 OUTLIER -135.4 163.12 30.76 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.936 0.874 . . . . 1.0 111.277 -179.297 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.4 p -103.31 131.64 51.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.028 -0.987 . . . . 1.0 109.673 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -97.53 134.0 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.025 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 t -125.6 121.31 33.23 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.704 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.1 mm -108.0 129.84 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.452 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.8 m -114.78 121.63 43.89 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.444 0.64 . . . . 1.0 109.953 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 70.8 mt -123.77 128.85 50.15 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.549 0.69 . . . . 1.0 110.907 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 69.5 p -135.55 144.39 46.21 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.37 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -99.79 108.09 20.3 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.456 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 106' ' ' GLY . 55.1 mt -96.12 171.53 8.55 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.04 0.448 . . . . 1.0 110.697 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.95 -42.62 99.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.247 0.462 . . . . 1.0 112.247 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -81.78 -32.55 31.32 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.099 0.56 . . . . 1.0 110.672 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 103' ' ' LEU . . . -176.69 -141.53 3.98 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.579 -1.008 . . . . 1.0 110.579 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 m -133.94 130.27 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.566 0.222 . . . . 1.0 111.179 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -92.46 141.98 27.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.336 0.589 . . . . 1.0 109.904 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.73 151.26 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.513 0.673 . . . . 1.0 110.396 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -151.77 135.1 16.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.107 0.479 . . . . 1.0 110.686 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 tt -125.21 126.23 44.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.956 -0.566 . . . . 1.0 109.928 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 m -120.78 144.68 48.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.421 0.629 . . . . 1.0 111.477 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.496 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 39.4 tt0 -143.79 130.22 19.96 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.507 -0.769 . . . . 1.0 110.141 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.442 ' O ' ' ND1' ' A' ' 94' ' ' HIS . 0.7 OUTLIER -105.23 -170.42 1.75 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.476 0.655 . . . . 1.0 112.467 -179.321 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.3 t30 63.46 38.0 10.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.655 0.983 . . . . 1.0 113.655 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -82.88 128.96 34.91 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -67.38 -41.31 85.26 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.083 -1.011 . . . . 1.0 111.83 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.454 ' OG1' ' N ' ' A' ' 119' ' ' GLU . 1.3 t -150.9 175.97 11.53 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.109 0.48 . . . . 1.0 111.079 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.454 ' N ' ' OG1' ' A' ' 118' ' ' THR . 96.5 mt-10 -59.19 -37.57 77.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.406 ' N ' ' CD ' ' A' ' 120' ' ' LYS . 13.0 mptt -59.57 -42.41 92.41 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -71.76 -39.78 69.75 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.919 -0.488 . . . . 1.0 109.97 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -63.33 -44.89 93.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -63.92 -43.1 96.92 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -59.95 -40.37 88.77 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 78.3 p -72.96 -46.9 49.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -57.08 -47.91 79.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.7 -0.481 . . . . 1.0 109.7 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.67 -37.37 87.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.44 ' O ' ' SD ' ' A' ' 132' ' ' MET . 42.3 t30 -65.27 -54.01 35.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 1.0 110.044 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.445 ' NE1' ' OE1' ' A' ' 113' ' ' GLN . 83.4 m95 -59.41 -36.83 76.58 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -59.27 -36.53 75.69 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.525 -0.917 . . . . 1.0 108.525 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.6 m -64.29 -43.08 95.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.994 -0.743 . . . . 1.0 108.994 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.509 ' N ' ' SD ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -63.18 -48.84 76.68 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.47 -39.99 95.2 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -66.74 -41.73 87.38 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.37 -36.99 93.88 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.003 -1.239 . . . . 1.0 110.003 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.21 -43.87 77.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.434 0.635 . . . . 1.0 110.114 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -65.44 -39.34 91.95 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.071 -0.393 . . . . 1.0 110.153 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.7 tptt -62.01 -39.34 91.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.011 0.434 . . . . 1.0 111.246 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -75.81 -46.57 29.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.128 0.489 . . . . 1.0 110.323 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.59 -42.62 95.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.06 0.457 . . . . 1.0 111.097 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -75.8 -1.36 24.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.242 0.544 . . . . 1.0 109.866 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -60.14 -33.08 71.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.411 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -46.12 -20.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.221 -0.3 . . . . 1.0 111.097 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.77 -36.77 75.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.692 0.282 . . . . 1.0 110.359 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.6 m -59.11 -41.63 88.61 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.125 -0.359 . . . . 1.0 110.36 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 117.95 -1.024 . . . . 1.0 110.442 179.882 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.4 mtm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.69 -42.98 90.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.56 -0.291 . . . . 1.0 110.754 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.1 pt -143.71 165.2 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.72 0.771 . . . . 1.0 111.028 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -77.61 -167.76 1.03 Allowed 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.698 -0.626 . . . . 1.0 111.216 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.0 mp -75.09 143.79 43.24 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.605 0.717 . . . . 1.0 111.422 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.514 ' C ' HE21 ' A' ' 122' ' ' GLN . 93.5 mt -114.43 128.81 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.4 0.619 . . . . 1.0 111.201 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.69 143.43 44.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.041 0.448 . . . . 1.0 110.604 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -133.54 123.41 25.12 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.228 0.537 . . . . 1.0 111.011 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.7 m -141.76 140.08 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.24 0.543 . . . . 1.0 110.438 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -152.96 139.14 18.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.559 0.695 . . . . 1.0 110.902 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.5 t -147.04 145.43 29.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.996 -0.547 . . . . 1.0 111.022 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.4 t -93.44 124.51 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.32 0.581 . . . . 1.0 110.445 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 78.2 mt -129.43 131.34 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 121.453 0.644 . . . . 1.0 110.625 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -90.57 99.73 12.7 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.148 0.499 . . . . 1.0 110.263 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -169.31 153.55 5.41 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 118.894 -0.574 . . . . 1.0 111.487 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.98 146.75 78.45 Favored 'Trans proline' 0 N--CA 1.502 2.003 0 C-N-CA 121.295 1.33 . . . . 1.0 112.591 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.8 tp -65.48 -36.68 78.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.845 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -61.44 -50.77 71.46 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.812 -0.555 . . . . 1.0 111.753 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.97 -41.0 97.68 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.87 0.322 . . . . 1.0 111.87 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.1 t -66.17 -46.43 87.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 40.1 t-105 -59.8 -41.88 92.17 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.806 0.813 . . . . 1.0 109.07 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.48 -45.45 93.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.489 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.99 -31.86 65.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.026 0.441 . . . . 1.0 111.698 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.72 -48.04 49.8 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.151 -0.343 . . . . 1.0 111.823 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 m -112.07 77.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.871 0.843 . . . . 1.0 111.099 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.675 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -159.82 109.97 1.45 Allowed Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.49 179.203 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.473 ' N ' HD21 ' A' ' 26' ' ' ASN . 53.7 Cg_endo -67.34 -14.95 44.53 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 120.934 1.09 . . . . 1.0 112.33 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.675 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 83.1 tt0 -80.73 -50.9 9.29 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.358 -0.238 . . . . 1.0 110.358 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.79 -42.42 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.65 0.738 . . . . 1.0 109.209 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.8 mt -57.6 -41.93 80.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -64.53 -36.66 84.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 1.0 110.33 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -67.23 -32.07 72.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.94 0.4 . . . . 1.0 110.029 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -69.59 -34.18 73.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.947 0.403 . . . . 1.0 109.977 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.7 mmm -101.13 177.31 4.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.675 0.75 . . . . 1.0 110.941 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -64.43 -37.96 89.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.837 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.43 64.47 0.02 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.759 -0.536 . . . . 1.0 111.759 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -96.61 126.64 41.92 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.69 0.757 . . . . 1.0 110.704 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.8 p -78.34 92.5 4.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.86 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.2 t -95.52 131.56 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.275 0.56 . . . . 1.0 110.616 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.47 129.72 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 121.306 0.574 . . . . 1.0 110.419 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.461 ' OG ' ' NE1' ' A' ' 43' ' ' TRP . 60.3 p -153.54 150.94 29.22 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.314 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -94.38 -20.58 19.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.799 0.809 . . . . 1.0 109.018 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.461 ' NE1' ' OG ' ' A' ' 41' ' ' SER . 1.3 m0 68.76 46.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.896 -0.593 . . . . 1.0 111.363 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -148.86 156.33 42.17 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.562 0.696 . . . . 1.0 111.182 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -55.27 129.74 39.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.673 0.749 . . . . 1.0 112.184 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.2 -3.2 87.34 Favored Glycine 0 N--CA 1.469 0.841 0 CA-C-N 115.838 -0.619 . . . . 1.0 112.028 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.2 t -67.12 133.95 50.84 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.257 -0.555 . . . . 1.0 111.548 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -89.03 146.72 24.67 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.78 148.95 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.473 0.654 . . . . 1.0 111.328 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.57 155.16 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.461 -0.79 . . . . 1.0 110.7 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.538 ' CH2' ' NE2' ' A' ' 79' ' ' HIS . 14.7 m0 -128.54 123.17 32.79 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.234 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -89.93 140.48 29.58 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.68 173.82 42.06 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -121.76 128.41 51.72 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.752 0.787 . . . . 1.0 110.201 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 33.8 t90 -129.01 112.12 13.71 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.42 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 52.36 40.91 30.26 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.128 0.489 . . . . 1.0 110.655 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.63 -11.72 18.34 Favored Glycine 0 N--CA 1.468 0.793 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -96.41 116.93 29.85 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.208 0.527 . . . . 1.0 110.438 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.37 133.15 47.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.998 0.428 . . . . 1.0 110.251 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -132.57 152.91 51.45 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.615 0.721 . . . . 1.0 111.01 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -139.45 132.77 29.98 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.43 0.633 . . . . 1.0 110.592 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -87.67 168.11 13.29 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -153.64 129.37 10.1 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.677 0.751 . . . . 1.0 112.508 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.21 -179.48 31.28 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.24 -1.144 . . . . 1.0 110.24 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 91.0 m -149.5 154.55 38.95 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.948 -0.737 . . . . 1.0 111.312 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.8 mm -77.71 122.58 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.59 0.71 . . . . 1.0 110.251 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.438 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 3.8 mm? -86.13 -52.47 5.65 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.97 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -131.73 137.69 48.33 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.648 -0.501 . . . . 1.0 109.648 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -135.38 104.94 6.04 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.771 0.796 . . . . 1.0 111.482 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -124.46 93.59 3.95 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.25 122.04 3.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.852 -0.613 . . . . 1.0 112.049 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 61.82 51.97 3.64 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.266 0.626 . . . . 1.0 111.784 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 t -169.62 -72.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.707 -0.621 . . . . 1.0 111.992 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 95.0 mt -137.04 133.8 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-O 121.626 0.727 . . . . 1.0 111.564 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.4 tp -136.16 124.99 24.0 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.353 -0.84 . . . . 1.0 110.296 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -135.24 141.87 45.86 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.184 0.516 . . . . 1.0 109.966 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -149.14 152.51 36.23 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.1 0.952 . . . . 1.0 112.144 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.8 p -94.32 150.92 19.83 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.538 ' NE2' ' CH2' ' A' ' 51' ' ' TRP . 1.2 m80 -152.42 144.99 24.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 122.0 0.905 . . . . 1.0 111.561 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -141.95 136.61 30.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.66 -1.155 . . . . 1.0 110.236 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.5 t -108.13 115.99 57.55 Favored Pre-proline 0 N--CA 1.476 0.849 0 CA-C-O 118.445 -0.788 . . . . 1.0 110.664 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.76 -18.22 28.67 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 120.991 1.127 . . . . 1.0 112.252 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.4 mt -72.07 -11.97 61.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.121 0.486 . . . . 1.0 110.355 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.7 m -65.01 -29.66 70.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.96 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.62 24.46 56.09 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -114.1 95.57 38.99 Favored Pre-proline 0 N--CA 1.475 0.806 0 CA-C-O 119.427 -0.321 . . . . 1.0 111.34 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 89' ' ' LEU . 73.8 Cg_exo -49.13 -178.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.93 1.754 . . . . 1.0 111.702 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -39.16 91.42 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.769 0.795 . . . . 1.0 112.233 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 87' ' ' PRO . 13.5 mt -136.15 89.09 20.54 Favored Pre-proline 0 N--CA 1.476 0.836 0 O-C-N 121.97 -0.457 . . . . 1.0 109.941 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.81 -18.18 12.0 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 C-N-CA 122.187 1.925 . . . . 1.0 112.427 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.476 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 80.9 mm-40 -87.06 -20.06 27.71 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.139 0.495 . . . . 1.0 110.47 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -76.19 -39.18 55.41 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.471 0.545 . . . . 1.0 112.471 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.58 172.28 8.02 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.641 0.734 . . . . 1.0 111.738 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.456 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.7 OUTLIER -145.69 169.42 18.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.619 0.723 . . . . 1.0 111.213 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.0 p -107.32 132.63 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.205 -0.907 . . . . 1.0 109.841 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.6 t -94.14 135.13 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.398 0.618 . . . . 1.0 110.961 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.0 t -126.7 123.79 38.31 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.515 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.6 mt -120.91 131.87 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.723 -0.672 . . . . 1.0 110.244 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 59.1 m -117.59 122.16 42.88 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.02 -0.536 . . . . 1.0 109.904 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.6 mt -115.93 124.84 51.58 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.463 0.649 . . . . 1.0 110.792 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 74.4 p -128.05 137.62 52.25 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.513 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -96.42 105.7 17.82 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.349 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.8 mt -92.15 170.21 10.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.11 0.481 . . . . 1.0 110.41 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -61.97 -41.3 97.85 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.442 0.534 . . . . 1.0 112.442 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -75.4 -40.21 58.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.417 0.627 . . . . 1.0 110.845 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.1 -140.33 3.13 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.7 p -125.18 134.17 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.445 0.64 . . . . 1.0 111.029 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -99.2 141.06 32.45 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.543 -0.753 . . . . 1.0 109.602 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.82 138.73 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 121.278 0.561 . . . . 1.0 110.521 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -142.93 131.73 22.73 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.447 0.641 . . . . 1.0 110.509 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tt -125.15 131.68 53.2 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.719 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.8 m -128.67 143.01 50.85 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.45 0.643 . . . . 1.0 111.235 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.456 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 33.7 tt0 -142.53 138.3 30.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.086 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 12.4 p-10 -111.99 -167.12 1.14 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.538 0.685 . . . . 1.0 112.32 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 91' ' ' GLU . 66.8 t30 60.73 37.52 18.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.758 1.021 . . . . 1.0 113.758 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -82.16 117.77 22.56 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.76 -1.2 . . . . 1.0 107.76 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -61.51 -39.87 92.57 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.011 -1.056 . . . . 1.0 111.866 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.6 p -144.78 168.31 20.51 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.923 -0.486 . . . . 1.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.46 -34.82 71.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.275 -0.639 . . . . 1.0 109.275 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.57 -40.88 93.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -69.44 -39.77 77.62 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.963 -0.461 . . . . 1.0 110.303 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.514 HE21 ' C ' ' A' ' 6' ' ' ILE . 50.6 tt0 -63.14 -47.82 81.12 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -59.93 -42.81 94.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -61.25 -39.05 88.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.333 -0.618 . . . . 1.0 109.333 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 62.4 m -68.03 -53.26 27.16 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.59 -44.91 73.43 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -62.55 -41.31 98.81 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -66.36 -54.0 29.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.02 0.438 . . . . 1.0 110.097 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.507 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 87.8 m95 -60.42 -39.42 87.34 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -59.44 -39.09 82.46 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.7 m -63.73 -41.98 97.96 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.507 ' SD ' ' CE3' ' A' ' 129' ' ' TRP . 79.0 mtp -64.93 -50.41 66.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.287 0.565 . . . . 1.0 109.617 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.02 -40.08 94.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -69.14 -39.46 78.81 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.078 -0.712 . . . . 1.0 109.078 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.36 -39.5 91.7 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 109.632 -1.387 . . . . 1.0 109.632 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.9 tt -65.9 -43.06 89.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.024 0.44 . . . . 1.0 110.033 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -61.69 -32.72 72.93 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -60.99 -37.99 84.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.982 0.42 . . . . 1.0 111.031 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -74.59 -49.93 19.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.422 0.63 . . . . 1.0 110.775 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.88 -42.66 99.85 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.785 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -75.37 -4.33 38.75 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.371 0.605 . . . . 1.0 110.253 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -62.12 -39.14 91.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.972 0.415 . . . . 1.0 110.449 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -61.69 -44.79 96.27 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.693 -0.231 . . . . 1.0 111.007 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.42 -44.02 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 120.8 0.333 . . . . 1.0 110.246 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.7 m -60.47 -41.1 93.49 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.032 -0.417 . . . . 1.0 110.359 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.572 0 CA-C-O 117.961 -1.019 . . . . 1.0 110.638 -179.923 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 tpt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -66.86 -36.61 82.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.499 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -143.37 175.51 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.465 0.65 . . . . 1.0 111.066 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -74.57 -156.3 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.479 0.657 . . . . 1.0 110.787 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.444 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 3.9 mm? -75.47 142.18 42.97 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.867 0.842 . . . . 1.0 111.512 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.95 129.62 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.393 0.616 . . . . 1.0 111.035 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.78 136.57 36.02 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.034 -0.416 . . . . 1.0 110.648 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -145.13 145.05 31.24 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.226 0.536 . . . . 1.0 110.753 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.49 155.79 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.329 0.585 . . . . 1.0 110.429 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -154.37 134.06 12.87 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.252 0.548 . . . . 1.0 110.922 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 t -148.56 146.92 28.49 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.102 0.477 . . . . 1.0 111.256 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 m -99.06 131.36 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.378 0.608 . . . . 1.0 110.249 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.3 mt -130.68 132.16 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 121.875 0.845 . . . . 1.0 110.553 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -85.83 96.41 9.75 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.314 0.578 . . . . 1.0 110.224 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.95 157.93 4.27 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.622 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -61.36 144.44 98.4 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.257 1.971 . . . . 1.0 112.358 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.5 tp -64.84 -33.84 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.752 -0.658 . . . . 1.0 111.4 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -58.15 -50.26 74.13 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.901 -0.499 . . . . 1.0 111.914 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -65.21 -40.44 94.17 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.996 0.369 . . . . 1.0 111.996 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.3 t -66.33 -47.46 84.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -60.05 -43.43 95.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -58.26 -49.16 78.11 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.044 -0.41 . . . . 1.0 110.258 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.04 -32.77 64.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.752 0.279 . . . . 1.0 111.752 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.7 -45.28 75.56 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.206 -0.309 . . . . 1.0 111.229 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 m -115.94 79.47 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.677 0.751 . . . . 1.0 111.383 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.715 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.2 OUTLIER -156.98 117.12 2.06 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.201 179.148 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.523 ' N ' HD21 ' A' ' 26' ' ' ASN . 70.8 Cg_endo -73.88 -5.3 16.81 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.344 1.363 . . . . 1.0 112.277 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.715 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 10.2 tm-20 -93.73 -52.39 4.47 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.209 -0.293 . . . . 1.0 110.209 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.88 -42.18 94.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.647 -0.872 . . . . 1.0 108.647 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.87 -40.18 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -66.14 -36.45 83.17 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.255 -0.278 . . . . 1.0 110.445 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -57.78 -36.64 72.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -68.91 -33.33 73.57 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.239 -0.282 . . . . 1.0 110.239 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 73.1 mmm -96.43 156.54 16.3 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.712 0.768 . . . . 1.0 110.906 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -61.58 -43.22 99.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.713 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.44 42.99 0.18 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 120.904 -0.665 . . . . 1.0 111.977 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.8 m -76.85 129.15 35.83 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.561 0.696 . . . . 1.0 110.58 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 48.7 m -93.05 92.07 7.64 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.693 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -99.03 132.64 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.441 0.639 . . . . 1.0 110.481 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.0 t -130.58 132.22 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.646 0.736 . . . . 1.0 110.264 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 m -156.09 166.68 32.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.565 . . . . 1.0 111.376 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -109.34 -19.67 13.2 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.98 0.895 . . . . 1.0 109.076 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.411 ' HE1' ' HD3' ' A' ' 27' ' ' PRO . 58.0 m95 58.23 56.32 4.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.795 -0.639 . . . . 1.0 111.76 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -152.4 156.83 40.29 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.418 0.628 . . . . 1.0 111.125 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.28 119.68 1.25 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.539 0.685 . . . . 1.0 112.422 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.04 11.2 84.72 Favored Glycine 0 N--CA 1.468 0.782 0 CA-C-N 115.918 -0.583 . . . . 1.0 112.065 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.1 t -72.26 130.46 40.85 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.3 -0.529 . . . . 1.0 111.523 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -87.45 150.47 23.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.747 -0.835 . . . . 1.0 108.747 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.9 pt -145.07 149.35 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.1 0.476 . . . . 1.0 111.107 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.6 m -143.51 154.53 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.782 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 10.3 m0 -129.2 131.72 47.16 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.34 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -91.57 139.69 30.45 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.45 172.71 39.45 Favored Glycine 0 N--CA 1.464 0.514 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -131.95 134.56 45.77 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.007 0.908 . . . . 1.0 110.231 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -138.3 118.04 13.16 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.374 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 52.92 37.1 23.49 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.112 0.482 . . . . 1.0 110.688 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.96 -6.06 44.29 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.932 -0.867 . . . . 1.0 110.932 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -97.15 112.51 24.26 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.346 0.593 . . . . 1.0 110.565 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.14 135.88 49.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.029 0.442 . . . . 1.0 110.239 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -141.26 155.89 45.95 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.642 0.734 . . . . 1.0 110.864 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.445 ' N ' ' CD ' ' A' ' 61' ' ' GLU . 1.5 pm0 -136.27 133.83 37.39 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.388 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -86.91 144.5 26.94 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -133.88 128.13 33.99 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.502 0.668 . . . . 1.0 112.731 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.08 -177.24 30.01 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.293 -1.123 . . . . 1.0 110.293 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.9 m -146.68 155.02 42.11 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.656 0.741 . . . . 1.0 111.056 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 50.7 mm -75.56 115.55 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.249 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.5 tp -69.93 -41.91 73.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.503 0.668 . . . . 1.0 110.111 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -152.07 147.8 26.92 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -132.52 104.08 6.5 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.989 0.899 . . . . 1.0 111.597 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -125.16 104.56 8.58 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -47.16 136.31 9.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.658 0.742 . . . . 1.0 111.98 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 36.91 53.72 1.14 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.666 -0.697 . . . . 1.0 112.552 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.5 t -161.12 -73.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.635 -0.666 . . . . 1.0 112.098 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.4 mt -136.89 131.82 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.464 0.65 . . . . 1.0 111.496 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.1 tp -136.98 124.97 22.77 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.525 -0.762 . . . . 1.0 110.333 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.02 144.53 32.32 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.409 0.623 . . . . 1.0 109.961 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -150.04 154.88 38.91 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.816 0.817 . . . . 1.0 112.061 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.4 p -87.0 151.44 23.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.004 -1.11 . . . . 1.0 108.004 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.404 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 52.9 t-80 -146.08 144.37 29.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.925 0.869 . . . . 1.0 111.887 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -143.38 135.11 26.51 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.718 -1.128 . . . . 1.0 110.315 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.9 p -111.12 119.12 46.46 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-O 118.622 -0.704 . . . . 1.0 110.33 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.72 -17.84 29.13 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 120.999 1.133 . . . . 1.0 112.342 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 55.9 mt -60.33 -16.54 35.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.989 0.423 . . . . 1.0 110.321 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 49.3 p -65.43 -32.66 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.928 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.31 -6.82 49.66 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.819 -0.912 . . . . 1.0 110.819 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -91.83 152.57 43.22 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 119.26 -0.4 . . . . 1.0 111.363 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -49.39 144.24 18.55 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 121.037 1.158 . . . . 1.0 111.953 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -78.39 86.52 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.532 0.682 . . . . 1.0 111.643 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.4 mt -128.83 148.6 69.37 Favored Pre-proline 0 N--CA 1.479 0.988 0 O-C-N 121.944 -0.472 . . . . 1.0 111.104 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -46.28 -32.52 10.74 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 122.08 1.853 . . . . 1.0 112.845 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.77 -35.31 78.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.326 0.584 . . . . 1.0 110.572 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -69.66 -39.1 77.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.007 -0.542 . . . . 1.0 112.457 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 47.8 p90 -117.83 178.47 4.4 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.308 0.575 . . . . 1.0 112.246 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.19 167.25 21.01 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.058 0.932 . . . . 1.0 111.373 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 52.1 t -106.77 127.74 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 114.809 -1.087 . . . . 1.0 109.647 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.31 133.57 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.036 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.7 t -125.36 121.06 32.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.253 0.549 . . . . 1.0 110.657 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 75.7 mt -119.01 129.97 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.358 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 64.8 m -117.47 116.9 28.07 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.532 0.682 . . . . 1.0 109.957 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.3 mt -114.34 124.81 52.91 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.801 0.81 . . . . 1.0 110.812 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.5 m -138.31 143.36 39.93 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.325 -0.852 . . . . 1.0 110.49 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.03 123.98 38.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.266 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.8 mt -107.99 173.7 6.21 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.235 0.54 . . . . 1.0 110.332 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -61.7 -41.6 97.81 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.409 0.522 . . . . 1.0 112.409 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -74.2 -44.23 54.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.144 0.497 . . . . 1.0 110.779 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -172.55 -129.53 1.15 Allowed Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.892 -0.883 . . . . 1.0 110.892 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.3 t -128.81 133.9 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.539 0.685 . . . . 1.0 110.852 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -107.2 132.78 52.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.48 -0.782 . . . . 1.0 109.537 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.1 p -125.23 142.08 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.81 0.814 . . . . 1.0 110.25 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -140.03 135.12 32.34 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.567 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 tt -127.98 129.41 46.71 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.586 -0.733 . . . . 1.0 109.822 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.8 m -123.37 145.37 48.81 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.425 0.631 . . . . 1.0 111.379 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.419 ' OE1' ' NE1' ' A' ' 129' ' ' TRP . 37.6 tt0 -143.69 123.67 13.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.471 -0.786 . . . . 1.0 109.918 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -101.14 -167.62 1.45 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.392 0.615 . . . . 1.0 112.514 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.9 t30 59.58 38.38 22.23 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.455 0.909 . . . . 1.0 113.455 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -82.96 133.1 35.12 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.543 -1.28 . . . . 1.0 107.543 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -63.02 -43.34 98.99 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.045 -1.035 . . . . 1.0 111.977 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 119' ' ' GLU . 1.4 t -149.79 176.2 10.92 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.133 0.492 . . . . 1.0 110.884 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.422 ' N ' ' OG1' ' A' ' 118' ' ' THR . 95.1 mt-10 -58.81 -38.13 77.93 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -59.06 -40.09 84.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -70.42 -38.49 74.61 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.01 -0.431 . . . . 1.0 109.919 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -64.65 -47.06 79.88 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -61.81 -40.29 94.72 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.912 -0.773 . . . . 1.0 108.912 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -62.43 -39.95 94.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.44 -0.578 . . . . 1.0 109.44 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.7 m -71.69 -49.18 41.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 1.0 109.822 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -55.54 -47.36 76.45 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.28 -37.95 89.3 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.702 -0.481 . . . . 1.0 109.702 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -66.59 -54.55 22.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.135 0.493 . . . . 1.0 110.13 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.419 ' NE1' ' OE1' ' A' ' 113' ' ' GLN . 86.2 m95 -59.42 -37.37 77.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -56.78 -39.87 74.85 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.533 -0.914 . . . . 1.0 108.533 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.7 m -63.97 -41.17 97.62 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.73 -50.53 70.74 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.29 -38.63 90.09 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -67.35 -41.51 85.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.887 -0.783 . . . . 1.0 108.887 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.09 -40.57 98.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.026 -1.23 . . . . 1.0 110.026 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 64.9 tp -67.9 -42.63 80.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.372 0.606 . . . . 1.0 109.805 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.44 -44.25 95.06 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.102 -0.374 . . . . 1.0 110.477 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -61.3 -40.88 95.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.714 0.293 . . . . 1.0 110.728 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -66.38 -50.21 64.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.042 0.448 . . . . 1.0 110.637 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.35 -42.44 92.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.547 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -76.92 -0.41 24.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.269 0.557 . . . . 1.0 110.186 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -61.54 -36.5 80.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.59 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 27.1 pttm -59.85 -37.71 80.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.682 0.277 . . . . 1.0 111.124 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.28 -44.18 99.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 122.264 -0.273 . . . . 1.0 110.324 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.4 m -59.16 -41.82 89.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.771 0.319 . . . . 1.0 110.449 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 117.928 -1.034 . . . . 1.0 110.51 -179.915 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 mtt . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -167.4 124.76 1.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.319 0.58 . . . . 1.0 110.278 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.496 ' CD1' ' N ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -144.95 179.1 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.684 0.754 . . . . 1.0 110.849 -179.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -73.21 -160.96 0.09 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.363 0.602 . . . . 1.0 111.019 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 9.8 mp -73.7 141.27 46.4 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.622 0.725 . . . . 1.0 111.583 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.527 ' C ' HE21 ' A' ' 122' ' ' GLN . 80.2 mt -116.78 129.21 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.917 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.28 146.15 37.02 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.998 -0.438 . . . . 1.0 110.69 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -138.08 127.03 24.04 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.906 0.384 . . . . 1.0 110.952 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.7 m -140.53 139.13 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.05 0.453 . . . . 1.0 110.507 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -153.37 135.49 14.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.954 0.407 . . . . 1.0 111.023 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.8 t -146.44 145.01 30.07 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.251 0.548 . . . . 1.0 111.173 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -91.22 129.89 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.207 0.527 . . . . 1.0 110.545 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 75.7 mt -132.63 131.92 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.554 0.693 . . . . 1.0 110.4 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -89.36 95.19 10.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.287 0.565 . . . . 1.0 109.73 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.65 159.14 3.09 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 120.759 -0.376 . . . . 1.0 110.942 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.79 146.09 96.81 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 122.146 1.897 . . . . 1.0 112.521 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.2 tt -68.66 -29.84 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.72 0.771 . . . . 1.0 111.529 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -63.53 -48.17 78.63 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.909 -0.494 . . . . 1.0 112.16 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.02 -45.85 90.38 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.809 0.3 . . . . 1.0 111.809 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.44 -45.31 85.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 23.5 t-105 -56.46 -41.62 76.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -58.97 -45.56 90.22 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.043 -0.41 . . . . 1.0 110.342 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.78 -34.62 62.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.598 -0.273 . . . . 1.0 111.359 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -48.28 56.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.033 0.445 . . . . 1.0 111.796 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.7 m -107.39 74.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.437 0.637 . . . . 1.0 110.83 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.688 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -162.13 113.62 1.16 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 119.053 -0.499 . . . . 1.0 110.636 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.561 ' N ' HD21 ' A' ' 26' ' ' ASN . 57.4 Cg_endo -70.6 -18.38 33.09 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 121.812 1.675 . . . . 1.0 112.391 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.688 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 78.0 mm-40 -79.71 -46.93 16.17 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.645 0.259 . . . . 1.0 110.402 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -71.91 -42.13 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.938 -0.764 . . . . 1.0 108.938 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 mm -58.79 -41.51 82.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -69.43 -31.22 69.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.089 0.471 . . . . 1.0 110.181 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -60.86 -35.74 77.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.128 0.489 . . . . 1.0 110.043 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -69.1 -33.49 73.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.901 0.381 . . . . 1.0 110.034 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.8 mmm -98.05 162.62 13.13 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.824 0.821 . . . . 1.0 110.916 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -62.19 -41.21 98.13 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.749 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.85 42.27 0.14 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.106 -0.569 . . . . 1.0 111.924 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.7 m -70.16 128.37 36.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.378 0.609 . . . . 1.0 110.994 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.4 m -92.56 92.36 8.01 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.16 -0.337 . . . . 1.0 110.872 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.72 135.36 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 121.374 0.607 . . . . 1.0 110.483 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.2 p -126.96 137.45 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.27 0.557 . . . . 1.0 110.589 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.5 p -154.21 155.23 34.88 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.106 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -94.69 -20.04 19.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 122.121 0.962 . . . . 1.0 108.933 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.5 m0 72.16 45.56 0.38 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.422 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 pttt -153.34 153.44 32.6 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.768 -0.582 . . . . 1.0 111.447 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -50.38 132.01 24.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.736 0.779 . . . . 1.0 112.361 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.68 -6.44 83.44 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-N 115.873 -0.603 . . . . 1.0 112.034 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.1 m -65.14 137.11 57.43 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.188 -0.595 . . . . 1.0 111.885 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -88.77 150.25 23.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.7 pt -138.65 147.91 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-O 121.34 0.591 . . . . 1.0 111.355 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.3 t -143.77 141.32 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.617 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.451 ' CZ3' ' NE2' ' A' ' 79' ' ' HIS . 18.4 m0 -118.11 137.63 52.81 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.081 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -100.98 134.4 44.03 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.09 0.471 . . . . 1.0 109.968 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.12 173.71 37.6 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -125.99 134.56 51.44 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.636 0.731 . . . . 1.0 110.193 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -138.24 115.29 10.9 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.48 0.657 . . . . 1.0 110.302 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt 52.71 38.07 25.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.62 -9.02 38.23 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 110.451 -1.06 . . . . 1.0 110.451 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -98.41 116.32 30.39 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.372 0.606 . . . . 1.0 110.749 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.3 129.08 38.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.253 0.549 . . . . 1.0 110.32 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -128.56 150.99 49.96 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.724 0.773 . . . . 1.0 110.944 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 61' ' ' GLU . 1.2 pm0 -135.7 126.37 27.18 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.387 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -86.86 134.87 33.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.978 -0.749 . . . . 1.0 108.978 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -120.12 129.12 54.02 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.725 0.774 . . . . 1.0 112.53 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.14 175.52 30.03 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.35 -1.1 . . . . 1.0 110.35 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.1 m -144.41 151.99 40.03 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 122.07 -0.665 . . . . 1.0 111.33 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.7 mm -73.72 113.79 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.468 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.98 -51.25 57.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.612 0.72 . . . . 1.0 110.243 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -150.01 147.88 28.37 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.433 -0.581 . . . . 1.0 109.433 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -126.06 110.76 13.91 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.74 0.781 . . . . 1.0 111.351 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.25 91.47 3.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.295 -0.631 . . . . 1.0 109.295 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -36.73 128.84 0.83 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.189 0.518 . . . . 1.0 112.241 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 41.92 57.12 3.28 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.681 0.623 . . . . 1.0 112.681 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.5 t -165.1 -71.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.7 -0.625 . . . . 1.0 111.886 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.2 mt -138.07 131.25 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.573 0.701 . . . . 1.0 111.629 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.1 tp -133.95 123.22 24.27 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.371 -0.831 . . . . 1.0 110.634 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -138.93 142.96 38.45 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.192 0.52 . . . . 1.0 110.113 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -152.84 155.7 37.61 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.678 0.751 . . . . 1.0 112.15 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.6 p -86.7 151.19 23.62 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.451 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 16.5 t-80 -146.56 138.44 24.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.869 0.843 . . . . 1.0 111.846 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.549 ' CD2' ' NZ ' ' A' ' 86' ' ' LYS . 37.3 t80 -138.1 127.55 24.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.813 -1.085 . . . . 1.0 110.529 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.5 t -139.95 125.13 11.44 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 118.913 -0.565 . . . . 1.0 110.64 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.45 -20.91 30.96 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 121.411 1.408 . . . . 1.0 112.212 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.7 mt -76.21 -3.38 36.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.121 0.486 . . . . 1.0 110.452 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.7 m -64.33 -22.37 66.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.787 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.33 -21.11 6.9 Favored Glycine 0 N--CA 1.473 1.16 0 N-CA-C 110.812 -0.915 . . . . 1.0 110.812 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.549 ' NZ ' ' CD2' ' A' ' 80' ' ' PHE . 56.3 pttt -76.9 147.12 76.94 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 121.093 -0.243 . . . . 1.0 111.432 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.9 -86.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.709 1.606 . . . . 1.0 111.837 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -145.57 80.18 1.59 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.794 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.2 tp -152.89 116.29 2.83 Favored Pre-proline 0 CA--C 1.552 1.023 0 O-C-N 121.888 -0.508 . . . . 1.0 110.772 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.536 ' O ' ' CD1' ' A' ' 93' ' ' TYR . 58.1 Cg_endo -73.8 -6.01 17.95 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 122.154 1.903 . . . . 1.0 112.381 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -81.74 -12.57 58.53 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.362 0.601 . . . . 1.0 110.598 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.417 ' C ' ' ND2' ' A' ' 115' ' ' ASN . 12.0 m120 -92.66 10.49 30.37 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.016 -0.538 . . . . 1.0 112.272 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.536 ' CD1' ' O ' ' A' ' 90' ' ' PRO . 0.1 OUTLIER -101.55 175.5 5.54 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.493 0.663 . . . . 1.0 112.145 -179.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.563 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.3 OUTLIER -142.54 161.01 39.17 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.953 0.882 . . . . 1.0 111.172 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.0 t -106.24 114.08 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 115.025 -0.989 . . . . 1.0 109.455 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.4 m -82.69 139.92 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.097 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 t -130.2 129.8 43.85 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.303 0.573 . . . . 1.0 110.917 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.86 130.08 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.542 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 59.4 m -117.8 118.13 31.21 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.446 0.641 . . . . 1.0 109.989 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.0 mt -114.15 130.85 56.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.401 0.62 . . . . 1.0 110.894 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.438 ' OG1' ' CG ' ' A' ' 108' ' ' GLU . 30.0 p -135.07 128.34 32.07 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.639 -0.709 . . . . 1.0 110.587 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -88.67 111.83 22.4 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.03 0.443 . . . . 1.0 110.139 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 25.3 mt -96.35 175.74 6.31 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.297 0.57 . . . . 1.0 110.485 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.54 -40.71 96.1 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.384 0.512 . . . . 1.0 112.384 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -79.57 -40.77 28.68 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.003 0.521 . . . . 1.0 110.875 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -171.55 -143.18 3.94 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.8 p -129.13 132.77 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.039 0.447 . . . . 1.0 111.225 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.438 ' CG ' ' OG1' ' A' ' 101' ' ' THR . 12.4 pt-20 -98.62 144.59 27.74 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.65 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.59 135.37 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.242 0.544 . . . . 1.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -141.24 129.48 22.26 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.091 0.472 . . . . 1.0 110.592 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -124.63 140.72 52.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.142 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.1 m -132.54 144.39 50.39 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.501 0.667 . . . . 1.0 111.428 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.563 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 40.3 tt0 -143.43 139.36 29.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.872 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -114.41 -162.65 0.82 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.399 0.619 . . . . 1.0 112.309 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.417 ' ND2' ' C ' ' A' ' 92' ' ' ASN . 49.8 t30 58.54 35.56 24.67 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.641 0.978 . . . . 1.0 113.641 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -82.23 122.17 27.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.681 -1.229 . . . . 1.0 107.681 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.48 -40.44 93.14 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.01 -1.056 . . . . 1.0 111.79 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.1 p -145.58 171.58 14.49 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.839 -0.538 . . . . 1.0 111.065 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -57.17 -38.51 73.69 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -58.69 -41.21 85.71 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -69.84 -39.67 76.29 Favored 'General case' 0 C--N 1.33 -0.283 0 O-C-N 121.937 -0.477 . . . . 1.0 110.15 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.527 HE21 ' C ' ' A' ' 6' ' ' ILE . 50.2 tt0 -64.7 -45.14 87.87 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -62.73 -44.77 95.34 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.068 -0.716 . . . . 1.0 109.068 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -58.63 -40.12 82.46 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.7 m -72.14 -47.85 47.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.201 0.524 . . . . 1.0 109.67 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -55.68 -48.51 74.96 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -64.55 -37.37 87.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.036 0.446 . . . . 1.0 109.81 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -65.52 -56.5 12.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.943 0.401 . . . . 1.0 110.138 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.477 ' NE1' ' OE1' ' A' ' 113' ' ' GLN . 86.6 m95 -58.6 -39.23 79.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -54.68 -41.03 69.71 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.0 m -63.6 -41.56 98.32 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.624 0.726 . . . . 1.0 109.211 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.9 tpt -64.42 -51.51 62.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.56 -41.24 89.68 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -68.16 -36.64 79.96 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.57 -41.57 99.6 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.011 -1.236 . . . . 1.0 110.011 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.47 -42.42 83.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.323 0.582 . . . . 1.0 110.099 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.4 -37.6 86.41 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.049 -0.407 . . . . 1.0 110.266 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -59.76 -38.51 82.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.975 0.417 . . . . 1.0 111.095 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -76.32 -44.91 34.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.282 0.563 . . . . 1.0 110.473 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 65.0 mt -64.8 -41.98 95.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.044 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.74 0.05 21.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.048 0.452 . . . . 1.0 109.838 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.35 -39.01 93.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.91 0.386 . . . . 1.0 110.604 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -61.1 -56.91 15.35 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.23 -0.294 . . . . 1.0 110.947 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.9 p -65.07 -38.43 82.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.751 0.31 . . . . 1.0 110.611 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.5 t -62.65 -42.73 99.77 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.144 -0.348 . . . . 1.0 110.403 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.043 -0.979 . . . . 1.0 110.334 -179.857 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttp . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.0 155.63 16.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.014 0.435 . . . . 1.0 110.149 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.448 ' CD1' ' N ' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -63.82 168.71 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.376 0.608 . . . . 1.0 111.034 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -77.38 -161.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.68 -0.638 . . . . 1.0 111.046 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.3 mp -73.76 139.66 45.38 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.652 0.739 . . . . 1.0 111.376 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.498 ' C ' HE21 ' A' ' 122' ' ' GLN . 83.1 mt -113.7 129.34 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.328 0.585 . . . . 1.0 111.009 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.68 141.33 39.44 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.062 0.458 . . . . 1.0 110.736 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -138.5 117.98 12.93 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.189 0.518 . . . . 1.0 110.976 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.78 155.91 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.072 0.463 . . . . 1.0 110.627 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -174.18 151.04 1.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.199 0.523 . . . . 1.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 t -145.6 145.43 30.97 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.364 0.602 . . . . 1.0 111.162 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.69 124.59 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.277 0.56 . . . . 1.0 110.542 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.4 mt -130.27 132.69 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 121.669 0.747 . . . . 1.0 110.541 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -87.86 96.49 10.49 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.402 0.62 . . . . 1.0 110.188 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.31 155.86 2.81 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 119.139 -0.458 . . . . 1.0 111.051 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.56 147.57 94.06 Favored 'Trans proline' 0 N--CA 1.506 2.217 0 C-N-CA 121.599 1.533 . . . . 1.0 112.528 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.2 tt -68.09 -26.34 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.187 0.518 . . . . 1.0 111.185 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -59.48 -49.89 76.03 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.885 -0.509 . . . . 1.0 111.604 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.436 ' CD ' ' N ' ' A' ' 19' ' ' LYS . 3.9 mptp? -65.48 -41.51 93.22 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.709 0.263 . . . . 1.0 111.709 -178.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.48 -48.25 81.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -57.45 -43.14 83.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.627 0.727 . . . . 1.0 109.224 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -58.28 -45.8 87.25 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.877 -0.515 . . . . 1.0 110.436 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.17 -35.43 64.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.957 0.408 . . . . 1.0 111.856 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.84 -46.0 76.45 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.1 -0.375 . . . . 1.0 111.652 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 m -112.98 79.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.794 0.807 . . . . 1.0 111.014 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.656 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -159.75 111.32 1.46 Allowed Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.416 179.152 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.482 ' N ' HD21 ' A' ' 26' ' ' ASN . 61.1 Cg_endo -71.41 -1.7 10.11 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.195 1.263 . . . . 1.0 112.503 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.656 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 81.3 mm-40 -96.86 -48.51 5.42 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 110.172 -0.307 . . . . 1.0 110.172 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -68.25 -43.03 84.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.223 -0.658 . . . . 1.0 109.223 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mm -61.03 -42.16 92.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -69.22 -31.13 69.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.046 0.45 . . . . 1.0 110.271 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -58.32 -42.99 87.96 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.812 -0.44 . . . . 1.0 109.812 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -69.37 -33.55 73.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.759 0.314 . . . . 1.0 110.163 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.424 ' SD ' ' OG1' ' A' ' 37' ' ' THR . 66.6 mtt -89.12 152.01 21.88 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.684 0.754 . . . . 1.0 111.053 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -59.47 -46.97 87.26 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.697 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.9 48.92 0.22 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.064 -0.589 . . . . 1.0 111.975 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.424 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 49.6 m -82.33 111.26 18.23 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.77 0.795 . . . . 1.0 110.776 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.7 m -77.79 91.94 4.16 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.909 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -102.79 135.12 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.987 0.899 . . . . 1.0 110.5 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 m -128.27 138.75 53.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.55 0.691 . . . . 1.0 110.508 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.474 ' HG ' ' HE1' ' A' ' 43' ' ' TRP . 33.2 p -155.53 158.35 38.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.966 -0.561 . . . . 1.0 111.153 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 50.9 t0 -97.14 -23.63 16.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.89 0.852 . . . . 1.0 108.995 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.474 ' HE1' ' HG ' ' A' ' 41' ' ' SER . 1.5 m0 71.17 47.83 0.39 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.465 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.56 152.54 27.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.645 0.736 . . . . 1.0 111.206 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -48.91 131.35 18.64 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.746 0.784 . . . . 1.0 112.373 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.67 4.7 85.07 Favored Glycine 0 N--CA 1.47 0.956 0 CA-C-N 115.721 -0.672 . . . . 1.0 112.105 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.3 t -76.89 134.8 38.87 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.214 -0.58 . . . . 1.0 111.539 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 64' ' ' GLY . 66.0 tp60 -81.11 146.2 30.7 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.76 -0.83 . . . . 1.0 108.76 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.02 134.58 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.577 0.703 . . . . 1.0 111.348 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 p -140.21 150.25 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.399 -0.819 . . . . 1.0 110.395 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -128.45 137.2 51.71 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.085 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -104.47 129.87 52.43 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.304 0.573 . . . . 1.0 109.693 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.66 -179.32 29.81 Favored Glycine 0 N--CA 1.464 0.519 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -134.34 134.59 41.95 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.835 0.826 . . . . 1.0 110.117 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 35.0 t90 -140.71 124.46 17.1 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.252 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm 52.5 36.18 19.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.179 0.514 . . . . 1.0 110.704 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.53 -6.06 26.02 Favored Glycine 0 N--CA 1.464 0.535 0 N-CA-C 110.746 -0.942 . . . . 1.0 110.746 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -98.88 115.63 29.29 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.346 0.593 . . . . 1.0 110.4 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.25 133.59 47.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.09 0.471 . . . . 1.0 110.197 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -136.69 154.2 50.68 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.543 0.687 . . . . 1.0 110.851 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -136.46 133.57 36.75 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.437 0.637 . . . . 1.0 110.695 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -90.6 167.65 12.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -158.07 133.77 9.05 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.459 0.647 . . . . 1.0 112.369 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 48' ' ' GLN . . . -160.43 -174.68 30.54 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.41 -1.076 . . . . 1.0 110.41 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.2 m -146.36 155.98 43.0 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.961 -0.729 . . . . 1.0 111.194 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 38.8 mm -75.89 119.78 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.336 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 tp -77.25 -48.94 16.18 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.621 0.724 . . . . 1.0 110.224 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -140.76 151.21 44.27 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.729 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -146.46 99.97 3.29 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.509 0.671 . . . . 1.0 111.367 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -125.46 106.88 10.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -38.27 133.17 0.98 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.531 0.681 . . . . 1.0 112.417 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 37.19 53.76 1.25 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.759 -0.655 . . . . 1.0 112.524 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.3 m -152.92 -66.87 0.16 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.793 -0.567 . . . . 1.0 111.862 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 tt -150.47 138.73 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.11 0.481 . . . . 1.0 111.517 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.25 122.24 27.66 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.827 -0.624 . . . . 1.0 109.705 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -133.61 136.68 45.01 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.961 0.41 . . . . 1.0 110.271 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.441 ' CD1' ' ND1' ' A' ' 79' ' ' HIS . 19.9 p90 -148.06 156.85 43.1 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.056 0.931 . . . . 1.0 111.994 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 92.4 p -101.25 151.43 21.87 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.488 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.9 m80 -153.19 153.16 32.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.698 0.761 . . . . 1.0 111.736 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -143.32 133.18 23.99 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.873 -1.058 . . . . 1.0 110.4 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.2 t -105.43 116.61 59.95 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-O 118.741 -0.647 . . . . 1.0 110.512 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.88 -18.07 24.89 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 120.985 1.123 . . . . 1.0 112.234 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.4 mt -62.9 -7.42 5.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.013 0.435 . . . . 1.0 110.319 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.0 p -65.32 -32.32 73.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.84 12.97 68.6 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -91.34 150.29 41.11 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 121.203 -0.199 . . . . 1.0 111.296 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.07 -179.72 2.34 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 121.87 1.713 . . . . 1.0 111.5 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.1 p-10 -53.82 88.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.763 0.792 . . . . 1.0 112.028 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.7 mt -133.03 88.61 36.28 Favored Pre-proline 0 N--CA 1.475 0.78 0 O-C-N 121.955 -0.466 . . . . 1.0 109.933 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.08 -34.57 68.71 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 122.365 2.044 . . . . 1.0 112.644 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.34 -4.09 13.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.286 0.565 . . . . 1.0 110.431 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -68.59 -37.33 79.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.482 . . . . 1.0 112.095 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 33.9 p90 -100.1 177.16 5.16 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.686 0.755 . . . . 1.0 112.011 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.491 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.1 OUTLIER -132.18 160.76 35.14 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.277 1.037 . . . . 1.0 111.089 -179.331 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.7 t -102.6 114.6 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 114.709 -1.132 . . . . 1.0 109.613 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.38 135.64 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.956 -0.565 . . . . 1.0 111.118 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 t -126.22 122.42 35.53 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.335 0.588 . . . . 1.0 110.773 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.1 mm -105.56 128.19 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.453 -0.794 . . . . 1.0 110.243 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.3 m -117.46 126.52 52.76 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.014 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.6 mt -129.13 125.58 37.43 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.649 0.738 . . . . 1.0 110.778 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 64.5 p -129.7 129.45 44.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.47 -0.786 . . . . 1.0 110.506 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -91.59 107.96 19.57 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.156 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.1 mt -96.94 172.81 7.63 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.183 0.516 . . . . 1.0 110.441 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -61.7 -40.0 93.47 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.255 0.465 . . . . 1.0 112.255 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -77.03 -42.15 39.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.22 0.534 . . . . 1.0 110.882 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.75 -141.99 3.75 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.7 p -129.6 134.07 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.361 0.6 . . . . 1.0 111.205 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -99.18 144.62 28.11 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.813 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -131.74 141.35 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.867 0.841 . . . . 1.0 110.501 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -146.95 134.08 20.46 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.562 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -121.7 128.88 52.3 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.873 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.9 m -119.74 141.49 49.38 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.525 0.679 . . . . 1.0 111.243 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.491 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 39.4 tt0 -143.08 126.25 16.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.953 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.425 ' O ' ' ND1' ' A' ' 94' ' ' HIS . 7.7 p-10 -103.03 -170.14 1.75 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.705 0.764 . . . . 1.0 112.257 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.1 t30 62.59 37.78 12.81 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.604 0.964 . . . . 1.0 113.604 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -82.37 121.67 27.0 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.641 -1.244 . . . . 1.0 107.641 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -63.56 -41.82 98.4 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.933 -1.104 . . . . 1.0 111.902 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.4 p -144.71 172.28 13.22 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.874 -0.516 . . . . 1.0 110.854 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.72 -38.8 86.32 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.26 -0.644 . . . . 1.0 109.26 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -58.11 -40.84 82.25 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -70.34 -38.32 74.82 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.991 -0.443 . . . . 1.0 110.211 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.498 HE21 ' C ' ' A' ' 6' ' ' ILE . 51.8 tt0 -64.22 -47.57 79.18 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.72 -0.844 . . . . 1.0 108.72 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -60.53 -42.2 95.99 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -59.22 -38.66 80.49 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.7 t -71.39 -52.73 17.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -55.57 -47.06 77.04 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.933 -0.395 . . . . 1.0 109.933 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.48 -38.2 88.92 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -69.11 -52.84 24.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.278 0.561 . . . . 1.0 110.244 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -61.74 -38.01 86.37 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -58.06 -39.75 79.28 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.347 -0.983 . . . . 1.0 108.347 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.0 m -62.87 -38.36 90.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.906 -0.775 . . . . 1.0 108.906 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 40.9 tpp -67.62 -50.39 58.34 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.43 -41.7 97.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -69.1 -42.6 75.91 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.59 -37.29 94.51 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.012 -1.235 . . . . 1.0 110.012 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.2 tp -66.68 -41.63 87.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.298 0.57 . . . . 1.0 109.704 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -60.58 -36.24 78.05 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.053 -0.404 . . . . 1.0 109.952 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -61.51 -39.23 90.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.853 0.358 . . . . 1.0 110.784 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -73.2 -49.96 25.11 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.066 0.46 . . . . 1.0 110.788 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.13 -41.89 97.04 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.89 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -76.68 -1.51 28.17 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.128 0.489 . . . . 1.0 110.063 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -61.0 -38.74 87.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.768 0.318 . . . . 1.0 110.394 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -56.76 -39.96 74.95 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 122.3 -0.25 . . . . 1.0 110.849 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.56 -46.69 94.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.36 -0.237 . . . . 1.0 110.36 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.6 t -62.14 -42.58 99.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.847 0.356 . . . . 1.0 110.547 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.904 -1.046 . . . . 1.0 110.556 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 2' ' ' GLU . 67.0 mtt . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 1' ' ' MET . 75.4 mt-10 57.32 152.24 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.248 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.463 ' N ' ' CD1' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -56.34 -179.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.59 0.71 . . . . 1.0 110.724 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -73.23 -168.79 0.55 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.756 -0.59 . . . . 1.0 110.712 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.41 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.0 mp -73.94 139.57 44.98 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.809 0.814 . . . . 1.0 111.187 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.5 ' C ' HE21 ' A' ' 122' ' ' GLN . 75.5 mt -112.47 128.39 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.843 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.95 145.03 48.69 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.005 -0.434 . . . . 1.0 110.69 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -138.63 123.39 18.71 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.115 0.483 . . . . 1.0 111.026 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -141.72 152.15 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 121.172 0.51 . . . . 1.0 110.462 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -166.96 143.11 4.4 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.99 -0.444 . . . . 1.0 111.101 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 t -147.1 146.11 29.84 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.641 0.734 . . . . 1.0 111.343 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p -107.27 132.63 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 115.89 -0.596 . . . . 1.0 110.798 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 tp -142.67 150.69 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.467 0.651 . . . . 1.0 110.759 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -87.04 95.3 9.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.521 0.677 . . . . 1.0 109.856 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.62 149.78 5.37 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.12 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.75 147.74 92.35 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 121.769 1.646 . . . . 1.0 112.484 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.75 -29.74 44.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.818 -0.628 . . . . 1.0 111.38 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -55.37 -53.2 59.15 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.972 -0.455 . . . . 1.0 111.726 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' N ' ' CD ' ' A' ' 19' ' ' LYS . 3.9 mptp? -67.48 -40.45 85.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 1.0 111.686 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.0 t -66.77 -48.71 79.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -55.95 -42.1 75.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.876 0.846 . . . . 1.0 109.208 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -58.76 -45.79 88.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.486 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.58 -29.12 67.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.726 0.298 . . . . 1.0 111.755 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.55 -44.65 77.79 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.344 -0.222 . . . . 1.0 111.222 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.4 m -118.3 79.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 121.87 0.843 . . . . 1.0 111.476 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.664 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.2 OUTLIER -157.09 115.99 2.0 Allowed Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.717 179.253 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.511 ' N ' HD21 ' A' ' 26' ' ' ASN . 73.9 Cg_endo -73.27 -5.71 17.62 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 121.176 1.251 . . . . 1.0 112.349 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.664 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 80.6 mm-40 -94.12 -45.86 7.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.61 -0.268 . . . . 1.0 110.345 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 64.6 mt -72.53 -42.21 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.7 mt -60.6 -42.38 91.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.22 -29.36 70.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 1.0 110.327 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -55.22 -43.4 74.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -69.98 -33.67 72.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.365 . . . . 1.0 110.337 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 76.2 mmm -85.61 152.22 23.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.65 0.738 . . . . 1.0 110.888 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.65 -42.34 98.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.745 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.85 46.81 0.13 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.821 -0.704 . . . . 1.0 111.908 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.2 m -86.12 125.95 33.86 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.762 0.791 . . . . 1.0 110.768 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.3 m -87.55 95.86 10.19 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.717 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.9 t -92.84 127.6 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.174 0.511 . . . . 1.0 110.656 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.4 p -127.26 125.53 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.304 0.573 . . . . 1.0 110.466 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.6 t -158.24 153.42 25.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.508 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -97.15 -12.82 22.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.785 0.802 . . . . 1.0 108.928 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 64.0 m95 54.22 62.46 2.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.872 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.46 157.77 34.53 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.541 0.686 . . . . 1.0 110.988 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.83 117.33 4.88 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.129 0.49 . . . . 1.0 112.086 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.27 -13.01 55.2 Favored Glycine 0 N--CA 1.469 0.865 0 CA-C-N 116.304 -0.407 . . . . 1.0 112.163 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.3 m -76.42 138.54 40.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.391 0.615 . . . . 1.0 111.218 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -93.06 158.45 15.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.291 -0.868 . . . . 1.0 108.794 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.2 pt -144.77 149.51 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.512 0.672 . . . . 1.0 110.884 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.3 m -143.05 154.74 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.58 -0.737 . . . . 1.0 110.507 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 18.3 m0 -127.17 112.77 15.51 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.148 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.63 137.38 32.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.78 -171.51 31.11 Favored Glycine 0 N--CA 1.464 0.51 0 N-CA-C 111.088 -0.805 . . . . 1.0 111.088 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -126.12 131.87 51.99 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.854 0.835 . . . . 1.0 110.189 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -138.14 117.09 12.43 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.405 0.621 . . . . 1.0 110.263 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 54.37 38.37 29.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.587 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.34 -8.3 19.23 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 110.853 -0.899 . . . . 1.0 110.853 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -101.73 118.18 36.4 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.286 0.565 . . . . 1.0 110.556 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.99 129.98 41.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.11 0.481 . . . . 1.0 110.258 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -128.09 151.62 48.97 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.806 0.813 . . . . 1.0 110.811 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -135.11 129.71 34.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.698 0.761 . . . . 1.0 110.46 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -85.24 168.84 14.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.277 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -155.6 126.16 6.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.482 0.658 . . . . 1.0 112.358 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.17 178.37 32.73 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.401 -1.08 . . . . 1.0 110.401 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 90.3 m -145.48 154.24 42.01 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 122.029 -0.689 . . . . 1.0 111.282 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.83 114.45 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.294 0.569 . . . . 1.0 110.068 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.7 mt -77.26 -44.34 30.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.401 0.619 . . . . 1.0 110.086 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -151.24 149.39 29.36 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -138.63 112.63 8.52 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.602 0.715 . . . . 1.0 111.448 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -126.37 103.45 7.64 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.441 -0.577 . . . . 1.0 109.441 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.456 ' OE2' ' NH1' ' A' ' 72' ' ' ARG . 79.2 tt0 -46.43 129.69 10.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.493 0.663 . . . . 1.0 112.14 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.456 ' NH1' ' OE2' ' A' ' 71' ' ' GLU . 85.6 mtt85 42.58 55.91 4.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.852 -0.613 . . . . 1.0 112.549 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.7 t -167.2 -70.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.797 -0.565 . . . . 1.0 111.925 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 87.8 mt -135.27 130.74 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.654 0.74 . . . . 1.0 111.497 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.8 tp -140.27 120.95 14.31 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.287 -0.87 . . . . 1.0 110.382 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -141.0 146.54 37.4 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.181 0.515 . . . . 1.0 110.259 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -151.68 158.17 43.07 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.884 0.849 . . . . 1.0 112.215 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 p -82.23 148.61 28.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -142.52 133.75 26.12 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.707 0.765 . . . . 1.0 111.84 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -144.42 133.41 22.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.013 -0.994 . . . . 1.0 110.548 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.4 p -142.52 131.54 11.88 Favored Pre-proline 0 N--CA 1.475 0.78 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.555 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.471 ' C ' ' H ' ' A' ' 84' ' ' THR . 65.1 Cg_endo -71.86 -21.57 24.57 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 121.132 1.221 . . . . 1.0 112.317 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 64.6 mt -62.26 -1.58 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.092 0.473 . . . . 1.0 110.607 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.471 ' H ' ' C ' ' A' ' 82' ' ' PRO . 21.7 p -67.16 -16.53 64.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.09 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.86 13.97 82.52 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.851 -0.9 . . . . 1.0 110.851 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.47 ' C ' ' H ' ' A' ' 88' ' ' ASP . 25.3 mtpp -144.91 81.29 10.8 Favored Pre-proline 0 N--CA 1.471 0.622 0 CA-C-O 119.104 -0.474 . . . . 1.0 111.113 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.77 21.91 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.589 1.526 . . . . 1.0 111.819 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 86' ' ' LYS . 96.9 m-20 -59.93 -179.71 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.945 0.878 . . . . 1.0 111.298 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.7 mt -42.7 149.69 0.47 Allowed Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 123.211 0.604 . . . . 1.0 111.337 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.431 ' C ' ' N ' ' A' ' 92' ' ' ASN . 59.3 Cg_exo -48.87 -36.53 34.21 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 121.35 1.367 . . . . 1.0 112.878 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -47.49 -17.29 0.08 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.532 0.682 . . . . 1.0 110.631 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.465 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 52.9 t30 -70.6 -7.72 46.25 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.927 -0.579 . . . . 1.0 112.409 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -99.61 176.83 5.34 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.271 0.558 . . . . 1.0 112.039 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -141.0 161.43 37.87 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 122.006 0.907 . . . . 1.0 111.199 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -106.94 130.17 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 114.943 -1.026 . . . . 1.0 109.62 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.41 131.85 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.747 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -124.3 121.89 36.24 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.341 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 60.8 mt -121.26 132.99 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.286 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.2 m -129.1 118.0 21.76 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.195 0.521 . . . . 1.0 110.451 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.3 mp -105.19 135.26 46.88 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.922 0.868 . . . . 1.0 110.598 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 74.0 p -129.79 131.21 46.13 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.19 -0.914 . . . . 1.0 110.575 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.01 108.34 20.41 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.175 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -96.19 166.79 11.57 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.12 0.486 . . . . 1.0 110.47 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -59.48 -40.47 87.07 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.313 0.486 . . . . 1.0 112.313 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -75.47 -39.83 58.15 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.058 0.543 . . . . 1.0 110.93 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.67 -140.1 3.11 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 p -133.09 138.92 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.63 0.728 . . . . 1.0 110.935 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -115.74 143.78 44.9 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.377 -0.829 . . . . 1.0 109.812 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.43 154.06 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.994 0.902 . . . . 1.0 110.229 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -145.07 134.78 23.46 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.676 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -131.58 146.4 52.19 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.928 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.5 p -142.63 151.91 41.94 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.577 0.703 . . . . 1.0 111.356 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -142.22 112.57 7.11 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.445 -0.798 . . . . 1.0 110.063 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -84.59 -169.71 2.76 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.457 0.646 . . . . 1.0 112.514 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 92' ' ' ASN . 43.2 t-20 56.85 39.42 29.55 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.561 0.948 . . . . 1.0 113.561 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -82.76 120.6 25.81 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.793 -1.188 . . . . 1.0 107.793 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -62.39 -38.03 88.05 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.869 -1.144 . . . . 1.0 111.873 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.7 t -149.3 168.96 21.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.272 0.558 . . . . 1.0 110.911 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -57.6 -37.65 73.59 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -57.4 -40.66 78.73 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.524 -0.547 . . . . 1.0 109.524 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -70.53 -39.14 74.22 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 121.906 -0.496 . . . . 1.0 110.043 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.5 HE21 ' C ' ' A' ' 6' ' ' ILE . 52.3 tt0 -64.53 -45.98 84.87 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.566 -0.902 . . . . 1.0 108.566 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -62.57 -41.48 98.96 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.102 -0.703 . . . . 1.0 109.102 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -60.28 -41.42 93.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.9 m -73.62 -48.17 34.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.13 0.49 . . . . 1.0 109.756 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -55.68 -50.48 70.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -62.47 -38.05 88.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -65.36 -51.98 56.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.074 0.464 . . . . 1.0 110.198 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.512 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 80.7 m95 -61.12 -39.78 91.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.539 -0.541 . . . . 1.0 109.539 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -58.18 -39.04 77.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.7 m -64.62 -42.31 95.59 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.512 ' SD ' ' CE3' ' A' ' 129' ' ' TRP . 81.5 mtp -64.2 -49.99 69.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.7 -40.47 95.14 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -62.17 -44.45 96.57 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.99 -0.744 . . . . 1.0 108.99 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.59 -34.01 82.71 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.295 -1.122 . . . . 1.0 110.295 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.7 tt -66.86 -52.95 37.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.653 0.74 . . . . 1.0 109.906 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -62.06 -36.82 82.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.433 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -59.94 -37.98 81.09 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.424 -0.173 . . . . 1.0 110.558 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -63.72 -48.85 75.4 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.183 -0.323 . . . . 1.0 110.541 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.73 -40.14 88.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.683 0.277 . . . . 1.0 110.546 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -70.24 -1.54 10.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.038 0.447 . . . . 1.0 110.128 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -66.35 -37.15 84.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.033 0.444 . . . . 1.0 110.663 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -62.15 -54.35 42.43 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.23 -0.294 . . . . 1.0 111.356 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.1 p -66.07 -38.1 81.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.79 0.328 . . . . 1.0 110.411 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.0 m -60.05 -41.23 91.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.814 0.34 . . . . 1.0 110.462 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.975 -1.012 . . . . 1.0 110.52 179.947 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.184 -0.673 . . . . 1.0 109.184 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -66.33 -38.93 88.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.53 -0.305 . . . . 1.0 110.557 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pp -137.39 165.92 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 122.226 1.012 . . . . 1.0 110.911 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -80.52 -172.57 3.65 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.706 0.765 . . . . 1.0 110.585 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.4 mp -70.17 141.56 52.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.982 0.896 . . . . 1.0 111.444 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.0 mt -114.64 130.62 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 115.648 -0.706 . . . . 1.0 110.91 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.37 142.94 47.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.06 0.457 . . . . 1.0 110.645 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -135.97 115.76 13.05 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.875 0.369 . . . . 1.0 110.971 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.91 137.14 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 120.98 0.419 . . . . 1.0 110.612 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -155.39 144.09 20.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.996 0.427 . . . . 1.0 111.164 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 t -146.81 143.49 28.66 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.233 0.539 . . . . 1.0 111.401 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.2 t -85.18 126.56 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.334 0.588 . . . . 1.0 110.631 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.7 mt -130.18 133.36 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.63 0.729 . . . . 1.0 110.49 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -90.5 95.85 10.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.39 0.614 . . . . 1.0 109.813 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.45 156.25 2.26 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.926 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.06 146.95 92.55 Favored 'Trans proline' 0 N--CA 1.506 2.238 0 C-N-CA 122.018 1.812 . . . . 1.0 112.621 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.1 tt -68.47 -27.47 36.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.446 0.641 . . . . 1.0 111.466 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.44 ' OE2' ' NE ' ' A' ' 72' ' ' ARG . 71.4 mm-40 -62.03 -47.26 85.55 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.88 -0.513 . . . . 1.0 112.286 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -62.77 -46.31 88.63 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.993 0.368 . . . . 1.0 111.993 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.0 m -69.18 -46.47 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.833 -0.803 . . . . 1.0 108.833 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -55.2 -50.51 69.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -60.74 -44.8 96.23 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.018 -0.426 . . . . 1.0 110.357 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.75 -21.48 28.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.468 -0.333 . . . . 1.0 111.755 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.03 -41.46 15.77 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.061 0.458 . . . . 1.0 111.555 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 m -108.14 75.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.308 0.575 . . . . 1.0 110.69 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.405 ' O ' ' CG1' ' A' ' 30' ' ' ILE . 0.2 OUTLIER -159.4 124.64 2.26 Favored Pre-proline 0 CA--C 1.548 0.867 0 CA-C-O 119.184 -0.436 . . . . 1.0 110.783 178.536 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.52 -11.62 20.55 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 121.805 1.67 . . . . 1.0 112.34 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -91.03 -47.74 7.38 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 110.269 -0.271 . . . . 1.0 110.269 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.91 -42.69 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.919 -0.771 . . . . 1.0 108.919 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.405 ' CG1' ' O ' ' A' ' 26' ' ' ASN . 5.4 mm -60.34 -42.14 89.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.271 -0.64 . . . . 1.0 109.271 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -64.5 -31.26 72.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.686 0.279 . . . . 1.0 110.357 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -65.24 -45.98 82.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.425 ' OH ' ' CG ' ' A' ' 139' ' ' PHE . 56.8 m-85 -72.04 -34.07 68.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.089 0.471 . . . . 1.0 110.589 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.549 ' O ' ' N ' ' A' ' 36' ' ' GLY . 68.6 mmm -93.94 59.82 2.79 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.554 0.692 . . . . 1.0 111.098 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 38.03 -84.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.135 -0.484 . . . . 1.0 112.2 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 34' ' ' MET . . . -146.34 48.26 0.68 Allowed Glycine 0 N--CA 1.469 0.865 0 O-C-N 121.948 -0.47 . . . . 1.0 112.021 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.7 m -93.48 117.57 30.25 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.675 0.75 . . . . 1.0 110.712 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 51.9 m -83.19 124.72 30.8 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.708 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.88 145.05 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.374 0.607 . . . . 1.0 110.631 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.5 t -120.74 130.65 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.41 0.624 . . . . 1.0 110.428 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.6 t -152.34 131.28 12.55 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.085 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.408 ' OD2' ' NZ ' ' A' ' 44' ' ' LYS . 93.9 m-20 -75.68 -19.08 59.39 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.119 0.961 . . . . 1.0 109.387 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.1 m0 68.16 45.47 1.27 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.65 -0.705 . . . . 1.0 111.488 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.408 ' NZ ' ' OD2' ' A' ' 42' ' ' ASP . 25.0 pttm -148.44 156.43 42.47 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.46 0.647 . . . . 1.0 111.369 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -48.19 127.69 12.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.687 0.756 . . . . 1.0 112.385 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.79 1.97 89.78 Favored Glycine 0 N--CA 1.465 0.609 0 CA-C-N 115.722 -0.672 . . . . 1.0 112.044 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.0 t -64.89 132.58 49.78 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.301 -0.529 . . . . 1.0 111.75 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -83.02 143.69 30.45 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.2 mt -134.1 136.08 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.791 0.805 . . . . 1.0 110.944 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.7 t -128.58 142.1 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.213 -0.903 . . . . 1.0 110.632 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 20.8 m-90 -117.18 123.26 46.25 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.014 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -97.0 126.63 42.27 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.25 178.26 34.59 Favored Glycine 0 N--CA 1.461 0.32 0 N-CA-C 110.997 -0.841 . . . . 1.0 110.997 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -128.68 136.59 50.82 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.571 0.701 . . . . 1.0 110.163 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -138.53 117.7 12.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.038 0.447 . . . . 1.0 110.466 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? 53.57 38.71 28.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.348 0.594 . . . . 1.0 110.747 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.7 -8.37 21.36 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.516 -1.034 . . . . 1.0 110.516 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -98.83 116.56 31.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.107 0.479 . . . . 1.0 110.664 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.09 128.44 36.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.251 0.548 . . . . 1.0 110.247 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -129.96 150.45 51.23 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.618 0.723 . . . . 1.0 110.971 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -135.77 131.66 35.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.437 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -89.54 162.6 15.6 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -141.18 126.99 19.16 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.558 0.694 . . . . 1.0 112.424 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.66 170.56 31.16 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.333 -1.107 . . . . 1.0 110.333 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.7 m -146.51 153.73 40.74 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 122.054 -0.674 . . . . 1.0 111.243 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.4 mm -77.9 116.49 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.37 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.4 tp -76.13 -44.9 36.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.653 0.74 . . . . 1.0 110.065 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -145.4 148.44 33.34 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -136.3 105.51 6.0 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.843 0.83 . . . . 1.0 111.439 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -125.45 107.95 11.16 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.25 -0.648 . . . . 1.0 109.25 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 -46.69 134.54 9.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.546 0.688 . . . . 1.0 111.969 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.44 ' NE ' ' OE2' ' A' ' 18' ' ' GLU . 14.4 ptp180 36.76 53.46 1.09 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.78 -0.645 . . . . 1.0 112.445 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 m -157.59 -69.9 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.822 -0.549 . . . . 1.0 111.618 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.6 mt -142.4 134.87 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-O 121.588 0.708 . . . . 1.0 111.535 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.6 tp -132.0 119.52 21.18 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.317 -0.856 . . . . 1.0 110.792 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -133.54 138.3 46.0 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.257 0.551 . . . . 1.0 110.299 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -151.06 153.26 34.75 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.975 0.893 . . . . 1.0 112.073 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.8 p -84.59 151.79 24.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.253 -1.017 . . . . 1.0 108.253 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -149.84 137.32 19.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.632 0.73 . . . . 1.0 112.105 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -150.67 150.09 30.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.001 -0.999 . . . . 1.0 110.655 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.5 t -143.39 139.58 16.65 Favored Pre-proline 0 CA--C 1.549 0.91 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.612 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' A' ' 84' ' ' THR . 48.6 Cg_endo -70.05 -20.63 33.22 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 121.603 1.535 . . . . 1.0 112.149 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.1 mt -58.21 -6.85 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.002 0.429 . . . . 1.0 110.332 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.462 ' H ' ' C ' ' A' ' 82' ' ' PRO . 26.1 p -66.01 -18.62 65.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.958 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.4 22.77 72.34 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.535 -1.026 . . . . 1.0 110.535 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -145.16 149.93 43.49 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.462 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.52 153.46 77.09 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.863 1.708 . . . . 1.0 111.646 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.7 p-10 -50.97 105.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.359 0.6 . . . . 1.0 111.788 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 19.9 mt -138.75 150.95 67.53 Favored Pre-proline 0 N--CA 1.473 0.722 0 O-C-N 121.854 -0.529 . . . . 1.0 110.893 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.33 -22.87 59.59 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.693 2.262 . . . . 1.0 112.226 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -89.07 -9.39 51.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.278 0.561 . . . . 1.0 110.563 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -100.35 11.45 39.39 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.078 -0.51 . . . . 1.0 112.313 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.428 ' CD1' ' C ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -151.26 170.58 19.16 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.405 0.621 . . . . 1.0 111.722 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.492 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.3 OUTLIER -144.68 160.67 40.82 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.761 0.791 . . . . 1.0 111.318 179.354 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -104.5 129.19 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 115.171 -0.922 . . . . 1.0 109.458 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.8 t -96.26 132.79 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.987 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -123.18 121.63 36.42 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.378 0.609 . . . . 1.0 110.612 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.1 mm -107.15 131.76 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.468 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.1 m -118.89 114.36 22.48 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.356 0.598 . . . . 1.0 110.115 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.4 mt -122.94 122.94 39.81 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.641 0.734 . . . . 1.0 110.829 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 m -131.29 132.39 44.51 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.491 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -85.28 123.42 30.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.043 0.449 . . . . 1.0 110.38 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.6 mt -93.21 -152.56 0.33 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.007 0.432 . . . . 1.0 110.508 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.466 ' H ' ' CD ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -77.7 -48.73 16.0 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.187 0.44 . . . . 1.0 112.187 -178.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -136.95 35.47 2.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.81 0.844 . . . . 1.0 110.001 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 179.21 169.14 39.3 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.915 -0.874 . . . . 1.0 110.915 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.8 p -127.07 133.08 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.04 0.448 . . . . 1.0 111.302 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -88.72 139.87 30.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.589 . . . . 1.0 109.741 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.77 138.7 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.536 0.684 . . . . 1.0 110.248 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -150.33 136.37 18.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.307 0.575 . . . . 1.0 110.513 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 tt -122.12 132.59 54.55 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.982 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.2 m -124.2 143.38 50.55 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.491 0.662 . . . . 1.0 111.419 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.492 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 43.1 tt0 -145.4 135.5 23.82 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.419 -0.81 . . . . 1.0 109.947 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -110.24 -165.25 0.98 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.474 0.654 . . . . 1.0 112.407 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.0 t30 60.01 37.16 21.39 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.751 1.019 . . . . 1.0 113.751 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -83.63 113.15 20.64 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.663 -1.236 . . . . 1.0 107.663 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -62.58 -35.77 80.55 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.006 -1.058 . . . . 1.0 111.584 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.0 p -143.89 164.91 29.21 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.877 -0.514 . . . . 1.0 111.067 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -58.66 -35.65 72.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.57 0.7 . . . . 1.0 109.23 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -58.66 -41.14 85.43 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.443 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -68.28 -41.45 80.99 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.981 -0.45 . . . . 1.0 110.084 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -64.16 -47.64 79.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -59.26 -42.93 92.3 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -63.32 -37.78 88.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 71.0 m -67.95 -54.51 18.1 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -52.6 -43.95 65.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.34 -0.391 . . . . 1.0 109.963 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -62.97 -39.44 94.7 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.758 -0.46 . . . . 1.0 109.758 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -67.39 -51.69 48.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.045 0.45 . . . . 1.0 110.175 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -64.05 -42.25 97.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -58.39 -39.79 80.6 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.628 -0.878 . . . . 1.0 108.628 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.2 m -63.94 -40.93 97.56 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.919 -0.771 . . . . 1.0 108.919 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 39.5 ttm -65.8 -50.39 64.82 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.7 -40.7 95.93 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -66.23 -44.21 84.45 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.16 -37.25 91.26 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.106 -1.198 . . . . 1.0 110.106 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 49.0 tp -71.44 -44.78 64.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.4 0.619 . . . . 1.0 110.072 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -60.87 -43.93 97.74 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.108 -0.37 . . . . 1.0 110.461 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.67 -36.29 76.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.69 0.281 . . . . 1.0 110.847 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.425 ' CG ' ' OH ' ' A' ' 33' ' ' TYR . 26.2 t80 -62.02 -48.5 80.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.215 0.531 . . . . 1.0 110.399 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.31 -37.18 84.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.653 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.88 -0.54 13.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.296 0.569 . . . . 1.0 110.152 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -62.41 -35.96 80.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.665 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -61.69 -54.05 47.82 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 122.388 -0.195 . . . . 1.0 110.864 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.21 -31.03 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 1.0 110.564 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.5 t -59.64 -44.13 93.62 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.152 -0.343 . . . . 1.0 110.446 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.579 0 CA-C-O 118.018 -0.991 . . . . 1.0 110.329 179.933 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.529 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -163.08 147.56 11.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.166 0.508 . . . . 1.0 109.946 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.48 ' CD1' ' N ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -144.07 -179.22 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-O 121.44 0.638 . . . . 1.0 110.951 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -75.8 -153.82 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.21 0.528 . . . . 1.0 110.805 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.481 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 3.3 mm? -79.0 141.6 37.34 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.618 0.723 . . . . 1.0 111.57 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.9 mt -117.92 128.64 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.0 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.17 138.99 33.42 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.991 -0.443 . . . . 1.0 110.651 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -136.35 126.5 26.27 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.265 0.555 . . . . 1.0 111.01 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.52 156.15 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.053 0.454 . . . . 1.0 110.626 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -170.75 144.59 2.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.018 0.437 . . . . 1.0 111.013 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 t -147.09 145.15 29.52 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.365 0.602 . . . . 1.0 111.034 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.5 p -90.03 128.6 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.245 0.545 . . . . 1.0 110.439 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.5 mt -131.77 135.37 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.724 0.773 . . . . 1.0 110.613 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -88.01 94.4 9.78 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.476 0.655 . . . . 1.0 110.052 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.68 156.65 2.19 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.683 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.93 149.64 90.14 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.208 1.939 . . . . 1.0 112.401 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.9 tt -68.93 -29.01 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.91 -0.586 . . . . 1.0 111.263 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.44 -54.23 43.56 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.953 -0.467 . . . . 1.0 111.859 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.46 -40.06 89.17 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.97 0.359 . . . . 1.0 111.97 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.7 t -66.11 -46.93 86.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 30.2 t-105 -58.08 -41.53 83.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.727 0.775 . . . . 1.0 109.01 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -60.67 -44.13 96.85 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.993 -0.442 . . . . 1.0 110.38 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.2 69.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.578 -0.283 . . . . 1.0 111.687 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 tt -70.2 -41.74 73.29 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.231 -0.293 . . . . 1.0 111.469 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 m -121.21 79.06 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 121.749 0.785 . . . . 1.0 111.149 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.605 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -160.75 103.19 1.31 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.228 179.138 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -54.08 -27.33 45.47 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.064 1.843 . . . . 1.0 112.791 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.605 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 96.2 mt-10 -70.12 -53.44 17.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.147 0.499 . . . . 1.0 110.533 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.04 -42.19 88.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.401 0.619 . . . . 1.0 109.334 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.1 mm -59.43 -42.49 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.003 -0.74 . . . . 1.0 109.003 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -69.93 -31.76 69.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.016 0.436 . . . . 1.0 110.4 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -57.39 -41.98 81.29 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -70.27 -34.1 72.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.848 0.356 . . . . 1.0 110.37 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.2 mmt -85.07 148.25 26.25 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.582 0.706 . . . . 1.0 111.052 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -60.67 -43.68 97.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.633 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.41 41.58 0.24 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.106 -0.569 . . . . 1.0 112.061 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.7 m -85.27 126.96 34.12 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.448 0.642 . . . . 1.0 110.675 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.1 m -92.71 106.33 18.32 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.954 0.407 . . . . 1.0 110.599 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.0 t -106.19 135.32 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.659 0.743 . . . . 1.0 110.484 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.2 m -129.73 130.96 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.512 0.672 . . . . 1.0 110.549 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.2 t -155.78 154.18 31.0 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.535 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -92.75 -18.77 22.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.854 0.835 . . . . 1.0 108.948 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 2.2 m0 66.68 46.84 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 1.0 111.409 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -149.76 157.19 42.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.576 0.703 . . . . 1.0 111.334 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -52.22 129.55 28.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.865 0.84 . . . . 1.0 112.296 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.04 1.68 90.37 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.648 -0.706 . . . . 1.0 112.172 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.0 t -68.17 133.41 48.85 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 122.305 -0.527 . . . . 1.0 111.589 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -79.46 144.58 33.9 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.9 tt -138.25 136.93 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.608 0.718 . . . . 1.0 111.205 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.2 m -140.56 151.58 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.542 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -124.36 131.54 53.51 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.238 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -94.16 137.17 33.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.515 0.674 . . . . 1.0 109.694 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.78 169.9 37.34 Favored Glycine 0 C--N 1.33 0.239 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.55 122.78 40.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.816 0.817 . . . . 1.0 110.017 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' A' ' 58' ' ' LYS . 43.1 t-105 -117.58 115.87 25.96 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.576 0.703 . . . . 1.0 109.913 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.409 ' HG2' ' CD1' ' A' ' 55' ' ' TRP . 9.5 ptmm? 40.07 46.33 1.8 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.89 -0.596 . . . . 1.0 111.548 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.15 -17.77 9.19 Favored Glycine 0 N--CA 1.472 1.045 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 55' ' ' TRP . 37.5 ttmt -91.22 114.78 27.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.404 0.621 . . . . 1.0 110.299 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.37 136.59 46.16 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.108 -0.37 . . . . 1.0 110.33 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -138.61 155.82 47.99 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.558 0.695 . . . . 1.0 110.948 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.446 ' N ' ' CD ' ' A' ' 61' ' ' GLU . 1.5 pm0 -138.73 131.78 29.72 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.542 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -87.09 136.81 32.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -120.52 127.74 52.46 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.56 0.695 . . . . 1.0 112.478 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.95 178.79 33.18 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.362 -1.095 . . . . 1.0 110.362 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.1 m -148.12 157.9 43.77 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.86 -0.788 . . . . 1.0 111.132 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.8 mm -73.39 115.54 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.506 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.3 tp -69.73 -44.34 70.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.363 0.602 . . . . 1.0 110.137 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -155.97 147.53 22.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -131.06 110.17 11.02 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.649 0.738 . . . . 1.0 111.597 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.39 95.36 4.44 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.338 -0.615 . . . . 1.0 109.338 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -40.78 131.76 2.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.388 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.6 mtm-85 40.38 55.04 2.86 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.5 m -163.37 -70.65 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.757 -0.589 . . . . 1.0 111.976 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.1 mt -140.88 133.97 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 121.491 0.662 . . . . 1.0 111.408 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 tp -136.19 126.31 26.23 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.377 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -142.97 146.43 33.92 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.114 0.483 . . . . 1.0 110.226 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -150.26 155.03 38.94 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.142 0.973 . . . . 1.0 112.204 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 93.8 p -95.18 152.68 18.15 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.469 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -152.06 151.42 31.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.844 0.83 . . . . 1.0 111.554 -179.482 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -142.35 134.72 27.81 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.752 -1.113 . . . . 1.0 110.463 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.0 m -104.49 114.19 64.35 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-O 118.686 -0.673 . . . . 1.0 110.546 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.17 -18.25 23.85 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 120.945 1.097 . . . . 1.0 112.137 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.9 mt -60.51 -14.29 18.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.979 0.419 . . . . 1.0 110.379 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.2 p -65.35 -34.58 78.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.015 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.02 29.31 27.65 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.972 -0.851 . . . . 1.0 110.972 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -90.69 153.89 45.73 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 120.791 -0.363 . . . . 1.0 111.249 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.94 148.16 23.9 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 121.124 1.216 . . . . 1.0 111.964 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -45.13 101.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.693 0.758 . . . . 1.0 111.981 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.1 tp -152.38 91.42 3.6 Favored Pre-proline 0 CA--C 1.544 0.741 0 O-C-N 121.994 -0.441 . . . . 1.0 110.293 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 92' ' ' ASN . 65.4 Cg_exo -51.03 -32.98 40.91 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.064 1.843 . . . . 1.0 112.738 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.4 -3.77 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.267 0.556 . . . . 1.0 110.493 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.48 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 43.7 t30 -68.77 -35.45 77.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 1.0 112.292 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.469 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 39.5 p90 -101.38 177.65 4.87 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.626 0.726 . . . . 1.0 112.053 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -134.96 162.5 32.27 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.892 0.853 . . . . 1.0 111.416 -179.316 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.6 p -101.3 129.86 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.012 -0.995 . . . . 1.0 109.8 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 t -94.76 133.5 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.9 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.4 t -128.75 121.96 29.56 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.494 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.15 132.4 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.35 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.3 m -111.88 124.63 52.79 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.421 0.629 . . . . 1.0 109.999 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 74.9 mt -125.51 117.67 24.12 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.428 0.632 . . . . 1.0 110.794 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.9 m -133.25 134.67 44.28 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.431 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -85.7 126.3 33.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.296 0.57 . . . . 1.0 110.29 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 47.7 mt -110.14 172.24 6.98 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.167 0.508 . . . . 1.0 110.589 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -64.54 -40.28 95.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.47 0.545 . . . . 1.0 112.47 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -83.73 -34.98 24.76 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.276 0.56 . . . . 1.0 110.875 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.25 -146.58 5.86 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.909 -0.876 . . . . 1.0 110.909 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.2 p -125.44 128.64 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.248 0.547 . . . . 1.0 111.016 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -95.81 142.15 28.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.611 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.3 m -130.14 148.7 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.622 0.725 . . . . 1.0 110.558 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -151.1 133.07 15.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.152 0.501 . . . . 1.0 110.514 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.6 tt -124.6 131.82 53.46 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.806 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.8 m -123.28 143.34 50.13 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.648 0.737 . . . . 1.0 111.142 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.438 ' OE1' ' ND2' ' A' ' 116' ' ' ASN . 0.9 OUTLIER -142.32 136.74 30.01 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.309 -0.86 . . . . 1.0 110.034 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 0.7 OUTLIER -114.23 -164.67 0.95 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.631 0.729 . . . . 1.0 112.334 -179.04 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 92' ' ' ASN . 64.4 t30 59.03 35.39 23.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.469 0.915 . . . . 1.0 113.469 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.438 ' ND2' ' OE1' ' A' ' 113' ' ' GLN . 83.5 m-20 -83.64 133.75 34.82 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.557 -1.275 . . . . 1.0 107.557 177.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -64.07 -46.17 85.49 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.028 -1.045 . . . . 1.0 112.066 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 62.0 p -147.79 179.71 7.51 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.843 -0.535 . . . . 1.0 110.835 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -60.39 -37.07 79.63 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -61.34 -43.96 98.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -71.32 -41.69 69.54 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.967 -0.458 . . . . 1.0 110.075 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.8 tm0? -63.24 -44.89 93.92 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -62.8 -42.82 99.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.698 -0.852 . . . . 1.0 108.698 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -59.57 -39.94 85.75 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 16.8 t -69.73 -44.75 69.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -56.01 -47.73 77.23 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.98 -39.15 91.21 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.787 -0.449 . . . . 1.0 109.787 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -64.28 -53.11 54.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 1.0 110.068 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.506 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 86.5 m95 -60.61 -39.18 87.21 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -59.08 -39.89 83.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.396 -0.965 . . . . 1.0 108.396 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.4 m -63.5 -43.13 98.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.506 ' SD ' ' CE3' ' A' ' 129' ' ' TRP . 77.2 mtp -62.7 -50.7 70.07 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.497 -0.556 . . . . 1.0 109.497 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.54 -38.8 88.76 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -65.66 -34.04 77.28 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.68 -32.34 33.78 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.155 -1.178 . . . . 1.0 110.155 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.7 tt -68.56 -54.13 18.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.641 0.734 . . . . 1.0 109.871 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -27.0 68.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.534 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -56.36 -32.18 64.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.891 0.377 . . . . 1.0 110.613 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -79.22 -41.95 27.11 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.036 0.446 . . . . 1.0 110.7 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 140' ' ' LEU . 4.1 mm? -63.24 -41.87 99.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.838 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -75.74 -1.98 27.52 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.338 0.59 . . . . 1.0 110.231 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -63.5 -41.2 98.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.661 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -60.39 -56.47 21.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.748 0.308 . . . . 1.0 110.902 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.48 -43.52 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 110.155 -0.313 . . . . 1.0 110.155 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.9 m -60.51 -41.29 94.06 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.152 -0.343 . . . . 1.0 110.211 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.966 -1.016 . . . . 1.0 110.372 -179.961 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.439 ' O ' ' N ' ' A' ' 3' ' ' ILE . 79.1 mtp . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.41 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 23.7 mp0 51.94 -88.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.549 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 1' ' ' MET . 39.1 pt -140.73 168.38 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.903 0.859 . . . . 1.0 110.931 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -74.9 -175.8 2.67 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.7 -0.625 . . . . 1.0 110.971 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 9.7 mp -68.2 140.2 56.08 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.03 0.919 . . . . 1.0 111.182 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.522 ' C ' HE21 ' A' ' 122' ' ' GLN . 5.1 mp -112.21 124.33 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.687 -0.688 . . . . 1.0 111.099 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.08 134.21 36.75 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.029 -0.42 . . . . 1.0 110.372 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -133.7 122.36 23.27 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.976 0.417 . . . . 1.0 110.804 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.3 m -139.89 135.59 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.099 0.476 . . . . 1.0 110.576 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -152.64 150.69 29.75 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.089 0.471 . . . . 1.0 111.033 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.87 142.39 28.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.541 0.686 . . . . 1.0 111.143 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 t -85.62 114.51 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.416 0.627 . . . . 1.0 110.715 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.9 mm -127.84 138.77 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 122.183 0.992 . . . . 1.0 110.733 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -98.04 105.93 18.15 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.397 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.24 160.6 3.46 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 120.977 -0.289 . . . . 1.0 110.416 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -59.85 140.5 93.45 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.341 2.027 . . . . 1.0 112.135 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.1 tp -68.21 -32.87 57.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.649 0.738 . . . . 1.0 111.221 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -57.4 -52.39 65.58 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.886 -0.508 . . . . 1.0 111.859 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' CD ' ' N ' ' A' ' 19' ' ' LYS . 12.2 mptt -64.49 -42.91 95.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.52 -47.54 91.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.46 ' CH2' ' O ' ' A' ' 70' ' ' ASN . 62.3 t-105 -60.23 -42.42 95.19 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -58.99 -47.39 85.34 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.977 -0.452 . . . . 1.0 110.206 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.79 -28.82 69.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.647 0.261 . . . . 1.0 111.702 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -70.56 -41.73 72.07 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.237 -0.289 . . . . 1.0 111.489 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 m -120.27 78.89 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 121.759 0.79 . . . . 1.0 111.226 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.708 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -158.63 113.22 1.66 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.56 179.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.534 ' N ' HD21 ' A' ' 26' ' ' ASN . 57.0 Cg_endo -68.99 -11.34 31.59 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.237 1.291 . . . . 1.0 112.649 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.708 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 45.6 mt-10 -86.28 -47.66 9.21 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.804 0.335 . . . . 1.0 110.332 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.18 -41.46 66.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.295 -0.632 . . . . 1.0 109.295 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.31 -42.3 86.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -65.46 -31.26 72.24 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.292 -0.262 . . . . 1.0 110.292 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -56.6 -42.77 79.28 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.824 -0.435 . . . . 1.0 109.824 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -69.81 -33.8 72.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.942 0.401 . . . . 1.0 110.389 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 79.8 mmm -85.22 153.72 22.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.66 0.743 . . . . 1.0 110.816 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -62.56 -35.83 80.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.63 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.28 42.62 0.07 OUTLIER Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.017 -0.611 . . . . 1.0 111.943 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.2 m -85.8 125.73 33.48 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.601 0.715 . . . . 1.0 110.74 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.0 p -88.95 102.42 15.05 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.636 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.53 130.64 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.471 0.653 . . . . 1.0 110.419 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.05 128.42 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.408 0.623 . . . . 1.0 110.264 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.5 t -155.6 153.42 30.07 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.125 -0.488 . . . . 1.0 111.384 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 8.1 t0 -92.77 -20.61 20.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.945 0.879 . . . . 1.0 108.958 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 2.6 m0 67.8 49.75 0.91 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.828 -0.624 . . . . 1.0 111.559 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -151.77 155.18 37.73 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.519 0.676 . . . . 1.0 111.186 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -49.64 127.41 15.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.794 0.807 . . . . 1.0 112.176 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.4 0.75 90.2 Favored Glycine 0 N--CA 1.468 0.833 0 CA-C-N 115.678 -0.692 . . . . 1.0 112.115 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.0 t -66.31 135.9 55.06 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.232 -0.57 . . . . 1.0 111.694 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 64' ' ' GLY . 68.0 tp60 -84.67 147.01 27.16 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.8 tt -136.91 136.15 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.539 0.685 . . . . 1.0 111.338 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -138.66 142.47 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 115.505 -0.77 . . . . 1.0 110.556 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.413 ' CZ3' ' NE2' ' A' ' 79' ' ' HIS . 14.1 m0 -119.67 136.64 54.32 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.052 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -101.97 143.53 31.71 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.332 0.587 . . . . 1.0 109.578 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.41 175.41 43.68 Favored Glycine 0 C--N 1.329 0.167 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -125.53 127.01 45.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.97 0.89 . . . . 1.0 109.791 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.587 ' O ' ' N ' ' A' ' 58' ' ' LYS . 36.2 t-105 -120.34 119.17 32.33 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.384 0.612 . . . . 1.0 109.645 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.407 ' HG2' ' CD1' ' A' ' 55' ' ' TRP . 9.9 ptmm? 39.66 42.02 0.88 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.346 0.594 . . . . 1.0 111.7 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.02 -18.01 19.12 Favored Glycine 0 N--CA 1.476 1.316 0 N-CA-C 110.768 -0.933 . . . . 1.0 110.768 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.587 ' N ' ' O ' ' A' ' 55' ' ' TRP . 74.4 mmtt -91.36 110.5 21.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.98 0.895 . . . . 1.0 110.655 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.03 132.15 47.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.65 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -134.38 152.56 51.87 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.612 0.72 . . . . 1.0 110.909 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.448 ' N ' ' CD ' ' A' ' 61' ' ' GLU . 2.0 pm0 -138.03 136.07 36.5 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.497 0.665 . . . . 1.0 110.498 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -88.49 167.85 13.09 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -153.69 127.19 8.64 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.139 -0.624 . . . . 1.0 112.37 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.429 ' O ' ' NE2' ' A' ' 48' ' ' GLN . . . -153.78 178.23 30.84 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.399 -1.081 . . . . 1.0 110.399 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 79.2 m -148.51 154.03 39.25 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.997 -0.708 . . . . 1.0 111.24 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 32.1 mm -80.4 121.95 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.403 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -90.97 -44.54 9.28 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.426 0.631 . . . . 1.0 109.964 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.632 HE21 ' ND2' ' A' ' 70' ' ' ASN . 58.5 tt0 -133.8 135.24 43.71 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.718 -0.475 . . . . 1.0 109.718 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -135.08 102.64 5.27 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.726 0.774 . . . . 1.0 111.516 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.632 ' ND2' HE21 ' A' ' 68' ' ' GLN . 82.6 m-20 -124.83 102.89 7.78 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.345 -0.613 . . . . 1.0 109.345 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -42.94 127.53 4.12 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.729 -0.668 . . . . 1.0 112.261 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 45.15 53.98 7.45 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.051 0.54 . . . . 1.0 112.352 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.7 t -160.05 -74.32 0.07 Allowed 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.782 -0.574 . . . . 1.0 112.027 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.5 mt -138.15 133.02 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.656 0.741 . . . . 1.0 111.374 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.1 tp -132.08 125.48 31.49 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.32 -0.855 . . . . 1.0 110.57 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -135.13 136.71 42.12 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.452 0.644 . . . . 1.0 110.235 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -149.7 152.98 36.21 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.019 0.914 . . . . 1.0 112.0 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 p -86.94 151.07 23.62 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.152 -1.055 . . . . 1.0 108.152 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.413 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 15.2 t-80 -151.19 142.11 22.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.544 0.688 . . . . 1.0 111.939 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -144.91 148.65 34.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.048 -0.978 . . . . 1.0 110.351 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 74.8 m -122.25 118.85 28.8 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.63 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.58 -16.82 26.92 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 121.008 1.139 . . . . 1.0 112.354 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.2 mt -65.2 -12.19 48.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.948 0.404 . . . . 1.0 110.35 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.6 p -64.61 -33.04 74.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.791 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.1 3.8 32.22 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.648 -0.981 . . . . 1.0 110.648 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -88.25 150.11 46.35 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-O 119.352 -0.356 . . . . 1.0 111.398 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.34 141.45 18.85 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 121.163 1.242 . . . . 1.0 111.708 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -79.52 77.82 6.09 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.364 0.602 . . . . 1.0 111.642 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.7 mp -115.79 161.27 31.45 Favored Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.936 -0.477 . . . . 1.0 110.778 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.29 -31.74 38.53 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 122.465 2.11 . . . . 1.0 112.626 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.442 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 80.9 mm-40 -86.47 -7.2 58.61 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.223 0.535 . . . . 1.0 110.44 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -77.22 -10.14 59.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 1.0 112.227 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.59 173.2 12.94 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.616 0.722 . . . . 1.0 112.031 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -139.61 165.15 28.03 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 122.138 0.97 . . . . 1.0 111.19 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.2 t -107.28 128.9 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 114.829 -1.078 . . . . 1.0 109.657 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.0 t -92.82 134.13 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.919 -0.582 . . . . 1.0 111.14 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.9 t -132.03 124.78 29.97 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.51 0.671 . . . . 1.0 110.443 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.95 129.96 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.17 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.5 m -106.87 120.85 43.15 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.555 0.693 . . . . 1.0 109.831 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 mp -117.21 124.1 48.27 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.613 0.721 . . . . 1.0 110.816 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.7 p -131.02 134.08 46.35 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.824 0.821 . . . . 1.0 110.477 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.98 111.37 23.61 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.119 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.5 mt -77.76 -168.98 1.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.042 0.449 . . . . 1.0 110.464 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -64.47 -48.34 75.62 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.515 0.561 . . . . 1.0 112.515 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -137.48 38.5 2.46 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.407 0.683 . . . . 1.0 109.942 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.91 168.84 41.31 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.9 p -134.4 144.4 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.742 0.782 . . . . 1.0 110.776 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -120.27 143.03 48.54 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.698 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.0 m -129.91 149.98 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.643 0.735 . . . . 1.0 110.345 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -152.2 134.14 14.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.698 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.9 tt -119.98 131.05 55.04 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.365 0.603 . . . . 1.0 109.957 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 m -120.67 142.65 49.27 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.415 0.626 . . . . 1.0 111.265 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -145.52 136.63 24.77 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.462 -0.79 . . . . 1.0 110.046 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 10.9 p-10 -116.48 -171.09 1.94 Allowed 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.655 0.74 . . . . 1.0 112.341 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 91' ' ' GLU . 67.0 t30 65.01 38.76 6.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.627 0.973 . . . . 1.0 113.627 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -84.91 116.65 23.46 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 107.638 -1.245 . . . . 1.0 107.638 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -58.87 -36.92 75.41 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 120.954 -1.092 . . . . 1.0 111.773 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.6 p -140.96 163.6 32.52 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.872 -0.518 . . . . 1.0 111.045 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.1 -34.59 77.92 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -57.9 -38.94 76.73 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.535 -0.542 . . . . 1.0 109.535 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.49 -35.04 70.66 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.87 -0.519 . . . . 1.0 110.21 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.522 HE21 ' C ' ' A' ' 6' ' ' ILE . 54.9 tt0 -62.16 -47.72 83.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.792 -0.818 . . . . 1.0 108.792 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -60.23 -42.46 95.28 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.827 -0.805 . . . . 1.0 108.827 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -61.0 -38.38 85.84 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.6 t -68.42 -53.46 23.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.638 -0.505 . . . . 1.0 109.638 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -55.41 -45.46 76.71 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.999 -0.371 . . . . 1.0 109.999 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -62.76 -40.2 96.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -66.74 -51.6 54.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.373 0.606 . . . . 1.0 110.136 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -61.26 -35.68 77.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.495 -0.557 . . . . 1.0 109.495 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -59.69 -40.4 87.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.569 -0.9 . . . . 1.0 108.569 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.7 m -63.77 -43.01 97.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.252 -0.647 . . . . 1.0 109.252 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 83.4 mmm -61.42 -50.34 73.22 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.52 -40.35 94.32 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -62.8 -44.25 96.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.91 -41.94 86.93 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.224 -1.15 . . . . 1.0 110.224 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.4 tt -63.03 -50.41 70.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.691 0.758 . . . . 1.0 110.179 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.54 -36.86 83.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.229 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.68 -35.1 54.74 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 122.378 -0.201 . . . . 1.0 110.761 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -65.48 -51.06 62.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.915 0.388 . . . . 1.0 110.423 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.75 -41.05 88.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.488 -0.324 . . . . 1.0 110.905 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -68.58 -18.08 64.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.249 0.547 . . . . 1.0 109.935 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -48.7 -30.87 6.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 1.0 110.721 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -45.71 -25.29 0.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.722 0.296 . . . . 1.0 111.278 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.1 p -60.25 -42.44 90.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 O-C-N 122.255 -0.278 . . . . 1.0 110.454 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -61.79 -35.0 76.89 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 122.117 -0.365 . . . . 1.0 110.419 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.969 -1.015 . . . . 1.0 110.488 -179.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.9 ttp . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.7 mp0 -66.23 -45.53 80.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.51 -0.314 . . . . 1.0 110.749 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.1 pt -138.45 148.84 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.757 0.789 . . . . 1.0 110.928 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -77.26 -165.23 0.55 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.771 -0.581 . . . . 1.0 111.059 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.425 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 9.3 mp -68.61 139.12 55.51 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.65 0.738 . . . . 1.0 111.306 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.459 ' C ' HE21 ' A' ' 122' ' ' GLN . 28.5 mm -110.0 124.81 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.934 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.31 136.31 42.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.956 0.407 . . . . 1.0 110.637 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -131.92 119.84 21.71 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.079 0.466 . . . . 1.0 110.935 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.9 m -143.95 136.29 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 121.095 0.474 . . . . 1.0 110.609 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -150.66 149.97 30.52 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.989 0.423 . . . . 1.0 111.305 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 t -146.98 144.56 29.27 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.404 0.621 . . . . 1.0 111.136 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.1 t -85.27 113.34 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.262 0.553 . . . . 1.0 110.586 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mm -110.51 126.83 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.682 0.753 . . . . 1.0 110.512 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -92.51 94.95 9.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.21 0.529 . . . . 1.0 109.806 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.62 169.7 2.91 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.806 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.52 148.13 93.74 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 122.286 1.991 . . . . 1.0 112.477 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 tp -68.41 -36.25 74.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.17 0.509 . . . . 1.0 111.336 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -66.29 -48.46 70.32 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.878 -0.514 . . . . 1.0 112.084 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.13 -42.72 99.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.916 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.2 t -68.26 -45.6 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -59.47 -41.59 90.1 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.086 -0.709 . . . . 1.0 109.086 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -56.3 -43.22 78.67 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 122.044 -0.41 . . . . 1.0 110.367 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.43 -31.81 66.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.336 . . . . 1.0 111.669 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.42 -45.88 78.41 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.766 0.317 . . . . 1.0 111.643 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 m -116.5 82.01 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.585 0.707 . . . . 1.0 110.78 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.659 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -160.2 113.78 1.42 Allowed Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.491 179.15 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.515 ' N ' HD21 ' A' ' 26' ' ' ASN . 61.3 Cg_endo -71.94 -12.65 28.58 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 121.635 1.556 . . . . 1.0 112.362 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.659 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 50.0 mt-10 -86.43 -46.24 10.41 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.647 0.26 . . . . 1.0 110.453 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.7 mt -71.75 -43.36 70.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.5 mt -59.66 -43.08 90.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.03 -0.73 . . . . 1.0 109.03 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -70.9 -29.28 65.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.997 0.427 . . . . 1.0 110.353 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -57.25 -40.93 78.66 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -70.08 -33.52 72.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 1.0 110.249 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.413 ' CE ' ' OG1' ' A' ' 37' ' ' THR . 64.7 mtp -87.81 154.85 20.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.602 0.715 . . . . 1.0 111.167 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -60.75 -43.7 97.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.696 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.26 49.82 0.14 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.966 -0.635 . . . . 1.0 111.919 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.413 ' OG1' ' CE ' ' A' ' 34' ' ' MET . 88.8 m -81.94 128.87 34.51 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.73 0.776 . . . . 1.0 110.761 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.4 m -91.29 91.83 8.35 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.755 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p -103.93 134.1 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.702 0.763 . . . . 1.0 110.383 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.6 t -126.41 134.54 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.671 0.748 . . . . 1.0 110.409 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.1 t -155.45 143.37 19.9 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.386 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -81.92 -19.53 40.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.84 0.829 . . . . 1.0 109.098 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.2 m0 69.42 48.11 0.65 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.523 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.525 ' H ' ' HG ' ' A' ' 47' ' ' SER . 21.4 ptmt -157.46 168.47 27.23 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.428 0.633 . . . . 1.0 111.195 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -58.68 127.63 33.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.689 0.757 . . . . 1.0 112.294 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.23 -1.42 84.51 Favored Glycine 0 N--CA 1.47 0.934 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.994 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.525 ' HG ' ' H ' ' A' ' 44' ' ' LYS . 19.2 m -67.59 133.2 48.98 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.235 -0.568 . . . . 1.0 111.805 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 64' ' ' GLY . 68.0 tp60 -83.24 145.88 28.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.821 -0.807 . . . . 1.0 108.821 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.0 tt -136.83 137.35 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.457 0.646 . . . . 1.0 111.134 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -143.46 149.73 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.696 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.511 ' CZ3' ' NE2' ' A' ' 79' ' ' HIS . 9.6 m0 -124.55 140.45 52.93 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.039 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -103.61 137.46 41.64 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.099 0.476 . . . . 1.0 109.798 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.95 176.35 40.73 Favored Glycine 0 N--CA 1.46 0.27 0 N-CA-C 111.041 -0.824 . . . . 1.0 111.041 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -127.09 138.65 53.24 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.802 0.811 . . . . 1.0 110.19 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -143.16 117.43 9.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.285 0.564 . . . . 1.0 110.293 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 54.56 34.85 22.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.581 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.85 -9.34 38.16 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -97.99 117.3 32.03 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.656 0.741 . . . . 1.0 110.147 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.38 129.06 38.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.301 0.572 . . . . 1.0 110.085 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -128.9 150.37 50.39 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.66 0.743 . . . . 1.0 110.803 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -136.58 133.72 36.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.493 0.663 . . . . 1.0 110.341 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -92.71 142.52 27.26 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -127.69 129.37 47.03 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.62 0.724 . . . . 1.0 112.517 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.469 ' O ' ' NE2' ' A' ' 48' ' ' GLN . . . -151.71 177.97 29.29 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.378 -1.089 . . . . 1.0 110.378 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.5 m -149.96 156.06 41.06 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 122.047 -0.679 . . . . 1.0 111.193 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 38.4 mm -77.68 115.29 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.269 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.4 tp -73.3 -44.28 59.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.707 0.765 . . . . 1.0 110.154 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -150.15 147.87 28.26 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.63 -0.507 . . . . 1.0 109.63 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -132.04 110.05 10.45 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.97 0.89 . . . . 1.0 111.494 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -124.84 94.57 4.22 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.355 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -40.15 130.46 2.16 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.935 -0.575 . . . . 1.0 112.533 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 42.93 54.57 4.71 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.194 0.598 . . . . 1.0 112.432 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.0 t -163.46 -71.06 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.716 -0.615 . . . . 1.0 112.192 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 94.8 mt -138.0 136.31 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 121.511 0.672 . . . . 1.0 111.448 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.83 120.28 18.08 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.429 -0.805 . . . . 1.0 110.328 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -133.37 138.75 46.45 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.474 0.654 . . . . 1.0 110.34 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -149.46 150.86 33.02 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.944 0.878 . . . . 1.0 111.922 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.2 p -85.33 152.29 23.39 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.511 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 45.8 t-80 -148.77 136.82 20.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.686 0.755 . . . . 1.0 111.986 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -138.04 144.31 40.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.918 -1.037 . . . . 1.0 110.31 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.9 t -134.69 129.67 19.46 Favored Pre-proline 0 N--CA 1.476 0.84 0 CA-C-N 115.746 -0.661 . . . . 1.0 110.767 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.487 ' C ' ' H ' ' A' ' 84' ' ' THR . 56.1 Cg_endo -71.38 -22.14 25.47 Favored 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 121.356 1.371 . . . . 1.0 112.29 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.4 mt -56.04 -6.53 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.448 . . . . 1.0 110.523 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 82' ' ' PRO . 3.6 t -64.4 -35.87 82.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.692 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 73.3 -1.02 44.71 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -98.7 146.1 31.05 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 119.273 -0.394 . . . . 1.0 111.451 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -46.97 160.09 0.28 Allowed 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 121.426 1.417 . . . . 1.0 112.016 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -76.74 86.37 3.36 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.721 0.772 . . . . 1.0 111.474 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.3 mt -117.01 146.05 37.05 Favored Pre-proline 0 N--CA 1.48 1.073 0 O-C-N 121.874 -0.516 . . . . 1.0 110.957 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.51 -20.28 60.67 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 122.216 1.944 . . . . 1.0 112.481 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.502 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 98.0 mt-10 -87.07 -16.42 35.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.936 0.398 . . . . 1.0 110.31 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -71.36 -39.56 71.18 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.587 0.588 . . . . 1.0 112.587 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -101.55 172.09 7.18 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.519 0.676 . . . . 1.0 112.0 -178.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -140.66 162.75 34.65 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.849 0.833 . . . . 1.0 111.342 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.2 p -106.62 131.23 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 115.057 -0.974 . . . . 1.0 109.677 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.1 t -96.51 131.41 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.238 0.542 . . . . 1.0 110.679 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.1 t -121.82 120.76 35.5 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.604 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.6 mm -110.3 131.77 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.591 -0.731 . . . . 1.0 110.414 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.7 m -124.09 120.42 32.32 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.391 0.615 . . . . 1.0 110.288 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.6 mp -115.31 131.61 56.87 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 122.119 0.961 . . . . 1.0 110.772 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.42 ' OG1' ' CG ' ' A' ' 108' ' ' GLU . 32.0 p -133.45 128.83 36.3 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.076 -0.966 . . . . 1.0 110.337 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -84.57 108.82 17.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.13 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 106' ' ' GLY . 25.8 mt -91.79 170.76 9.63 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.072 0.463 . . . . 1.0 110.482 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -63.87 -39.03 93.25 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.452 0.538 . . . . 1.0 112.452 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -84.08 -33.35 24.41 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.298 0.571 . . . . 1.0 110.728 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 103' ' ' LEU . . . -175.86 -139.06 3.01 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.8 p -134.22 139.27 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.437 0.637 . . . . 1.0 110.79 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.42 ' CG ' ' OG1' ' A' ' 101' ' ' THR . 19.0 pt-20 -105.49 142.02 35.97 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.463 -0.789 . . . . 1.0 109.768 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -124.06 139.33 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.716 0.769 . . . . 1.0 110.408 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -135.76 132.08 36.33 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.349 0.595 . . . . 1.0 110.77 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 tt -128.41 134.73 48.86 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.073 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 75.6 p -131.29 150.57 52.09 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.654 0.74 . . . . 1.0 111.357 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -146.14 108.92 4.54 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.278 -0.874 . . . . 1.0 110.053 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -82.38 -170.19 2.81 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.646 0.736 . . . . 1.0 112.521 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.502 ' ND2' ' O ' ' A' ' 91' ' ' GLU . 65.9 t30 62.25 36.71 14.6 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.737 1.014 . . . . 1.0 113.737 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -81.44 122.12 27.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.597 -1.261 . . . . 1.0 107.597 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -65.23 -36.25 83.58 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 120.999 -1.063 . . . . 1.0 111.839 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.509 ' HG1' ' N ' ' A' ' 119' ' ' GLU . 1.6 t -151.08 168.48 24.48 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.17 0.509 . . . . 1.0 111.042 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.509 ' N ' ' HG1' ' A' ' 118' ' ' THR . 98.5 mt-10 -57.53 -36.67 71.89 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.464 ' H ' ' HG1' ' A' ' 118' ' ' THR . 88.9 tttt -58.39 -41.9 85.86 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.422 ' H ' HG21 ' A' ' 118' ' ' THR . 78.6 tt0 -70.43 -39.72 74.21 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.932 -0.48 . . . . 1.0 110.213 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.459 HE21 ' C ' ' A' ' 6' ' ' ILE . 53.2 tt0 -64.01 -48.91 74.49 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.729 -0.841 . . . . 1.0 108.729 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -59.35 -46.84 87.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -57.81 -39.55 77.85 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.1 t -67.78 -56.09 10.55 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.647 -0.501 . . . . 1.0 109.647 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -54.29 -44.03 71.57 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.13 -39.22 91.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.008 0.432 . . . . 1.0 109.951 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -69.91 -51.28 34.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.188 0.518 . . . . 1.0 110.146 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -62.59 -39.18 92.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -57.71 -40.26 79.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.0 m -61.59 -39.51 91.43 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -65.81 -48.21 72.48 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.0 -41.51 96.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.372 -0.603 . . . . 1.0 109.372 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -64.99 -41.39 95.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.78 -35.65 87.17 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.83 -48.32 54.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.199 0.523 . . . . 1.0 109.971 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -59.02 -43.91 91.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.931 -0.396 . . . . 1.0 109.931 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.99 -41.99 98.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.713 0.292 . . . . 1.0 110.775 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -71.66 -45.86 60.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.222 0.534 . . . . 1.0 110.755 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.09 -45.66 84.31 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.859 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -73.45 -1.62 19.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.105 0.479 . . . . 1.0 109.767 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.434 ' C ' ' H ' ' A' ' 144' ' ' VAL . 15.1 t-20 -61.41 -37.34 83.12 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.272 -0.268 . . . . 1.0 110.445 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -46.55 -15.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.74 0.305 . . . . 1.0 111.291 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.434 ' H ' ' C ' ' A' ' 142' ' ' ASN . 12.1 p -60.35 -40.9 85.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 O-C-N 122.309 -0.244 . . . . 1.0 110.387 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.1 m -58.72 -40.68 84.46 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 122.239 -0.288 . . . . 1.0 110.354 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.985 -1.007 . . . . 1.0 110.441 179.923 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 121.704 0.764 . . . . 1.0 110.886 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -82.53 -161.65 0.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.738 -0.601 . . . . 1.0 111.108 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.504 ' N ' HD12 ' A' ' 5' ' ' LEU . 9.7 mp -71.48 144.15 49.78 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.702 0.763 . . . . 1.0 111.399 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.87 129.36 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 121.451 0.643 . . . . 1.0 110.892 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.42 134.14 33.92 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.933 -0.479 . . . . 1.0 110.386 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -142.51 138.13 30.71 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.041 0.448 . . . . 1.0 110.684 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.4 m -140.8 156.13 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.147 0.499 . . . . 1.0 110.611 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -159.46 143.48 14.9 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 122.055 -0.403 . . . . 1.0 111.207 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 t -147.54 145.26 29.01 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.244 0.545 . . . . 1.0 111.361 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.6 t -84.05 112.35 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.318 0.58 . . . . 1.0 110.635 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.7 mm -115.07 130.14 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.822 0.82 . . . . 1.0 110.74 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -94.02 95.91 9.34 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.95 -0.469 . . . . 1.0 110.02 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.45 155.73 7.37 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.58 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -61.97 145.94 96.54 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.392 2.061 . . . . 1.0 112.212 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.403 HG23 ' N ' ' A' ' 18' ' ' GLU . 10.3 tp -62.8 -38.0 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.125 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.403 ' N ' HG23 ' A' ' 17' ' ' ILE . 79.8 mm-40 -54.48 -56.44 18.72 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.933 -0.479 . . . . 1.0 112.068 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -64.62 -41.78 95.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.935 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.3 t -65.6 -48.5 82.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -57.83 -42.61 84.73 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.29 -47.13 86.53 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 122.072 -0.392 . . . . 1.0 110.235 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.82 -28.74 66.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.636 0.255 . . . . 1.0 111.609 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.7 tp -72.97 -43.24 62.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 1.0 111.645 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.42 79.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 121.545 0.688 . . . . 1.0 110.992 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -160.72 113.41 1.34 Allowed Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.498 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.79 -15.26 36.89 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.885 1.723 . . . . 1.0 112.373 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -83.47 -49.79 8.93 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -69.16 -41.73 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 mm -59.66 -26.11 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -77.78 -30.89 51.57 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.062 -0.347 . . . . 1.0 110.062 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -56.44 -43.44 79.5 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.792 -0.447 . . . . 1.0 109.792 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -69.62 -33.91 73.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.964 0.412 . . . . 1.0 110.486 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.6 mmt -89.01 151.85 22.03 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.57 0.7 . . . . 1.0 111.123 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -61.53 -40.72 95.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.731 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.55 37.44 0.13 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.088 -0.577 . . . . 1.0 111.953 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.1 m -74.6 128.93 36.78 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.663 0.744 . . . . 1.0 110.82 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.1 m -94.46 93.5 7.69 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.731 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.5 t -92.59 128.74 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.402 0.62 . . . . 1.0 110.4 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.63 129.03 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 121.346 0.593 . . . . 1.0 110.456 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.545 ' HG ' ' HE1' ' A' ' 43' ' ' TRP . 38.4 p -155.21 157.94 38.11 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.222 -0.445 . . . . 1.0 111.306 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -97.35 -18.01 19.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.872 0.844 . . . . 1.0 108.78 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.545 ' HE1' ' HG ' ' A' ' 41' ' ' SER . 2.8 m0 67.27 44.91 1.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.24 0.616 . . . . 1.0 111.607 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -150.17 157.97 43.67 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.443 0.64 . . . . 1.0 111.433 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -52.71 130.23 31.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.8 0.81 . . . . 1.0 112.267 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.62 3.8 90.36 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 115.713 -0.676 . . . . 1.0 112.082 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.2 t -71.83 134.09 45.9 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.282 -0.54 . . . . 1.0 111.608 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -81.38 148.85 29.12 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.463 HD11 ' HE1' ' A' ' 51' ' ' TRP . 20.2 tt -134.62 133.8 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.547 0.689 . . . . 1.0 111.353 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.8 t -134.72 140.15 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.599 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.463 ' HE1' HD11 ' A' ' 49' ' ' ILE . 24.0 m0 -118.72 131.32 56.13 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.179 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -99.88 140.28 34.32 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.319 0.58 . . . . 1.0 109.738 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.23 178.78 42.24 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 110.989 -0.845 . . . . 1.0 110.989 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -128.66 134.32 48.49 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.914 0.864 . . . . 1.0 110.118 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -135.65 116.78 14.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.323 0.582 . . . . 1.0 110.375 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt 52.92 40.25 30.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.33 0.586 . . . . 1.0 110.659 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.6 -8.3 15.07 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.682 -0.967 . . . . 1.0 110.682 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -97.74 115.57 28.24 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.435 0.636 . . . . 1.0 110.407 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.61 133.0 47.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.078 0.466 . . . . 1.0 110.216 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -136.4 154.12 50.9 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.721 0.772 . . . . 1.0 110.963 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -138.21 132.77 32.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.826 -0.624 . . . . 1.0 110.53 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -88.27 167.48 13.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.244 -0.65 . . . . 1.0 109.244 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -156.23 133.85 10.95 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.702 0.763 . . . . 1.0 112.663 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.95 -176.86 34.48 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.359 -1.096 . . . . 1.0 110.359 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 66' ' ' ILE . 90.8 m -147.19 156.69 43.18 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.951 -0.735 . . . . 1.0 111.102 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.445 ' N ' HG22 ' A' ' 65' ' ' THR . 42.9 mm -73.94 115.4 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.555 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.415 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 46.0 tp -67.02 -41.84 85.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.611 0.72 . . . . 1.0 110.164 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -159.56 149.32 18.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.546 -0.538 . . . . 1.0 109.546 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -133.89 111.39 10.43 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.962 0.887 . . . . 1.0 111.54 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.402 ' HB2' ' H ' ' A' ' 74' ' ' ILE . 12.5 m120 -119.66 104.68 10.48 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.327 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -41.16 122.95 1.93 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.358 0.599 . . . . 1.0 112.247 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 41.35 55.1 3.44 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.09 0.556 . . . . 1.0 112.436 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.7 m -157.91 -68.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.723 -0.611 . . . . 1.0 112.107 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.402 ' H ' ' HB2' ' A' ' 70' ' ' ASN . 91.4 mt -141.68 138.16 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-O 121.647 0.737 . . . . 1.0 111.509 -178.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 tp -133.33 125.85 30.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.29 -0.868 . . . . 1.0 110.687 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -132.52 138.92 47.68 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.238 0.542 . . . . 1.0 110.203 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.415 ' HA ' ' H ' ' A' ' 67' ' ' LEU . 49.8 p90 -150.75 143.94 24.81 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.939 0.876 . . . . 1.0 112.077 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 93.1 p -85.99 153.76 21.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.008 -1.108 . . . . 1.0 108.008 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.407 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 42.4 t-80 -147.47 142.29 26.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.732 0.777 . . . . 1.0 111.96 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -142.01 134.65 28.34 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.876 -1.056 . . . . 1.0 110.457 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 CA--C 1.55 0.952 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.666 179.429 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.48 ' OD1' ' N ' ' A' ' 93' ' ' TYR . 29.5 p30 . . . . . 0 N--CA 1.465 0.302 0 N-CA-C 112.421 0.526 . . . . 1.0 112.421 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.48 ' N ' ' OD1' ' A' ' 92' ' ' ASN . 30.1 p90 -108.99 178.07 4.58 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.469 0.652 . . . . 1.0 112.019 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.496 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.3 OUTLIER -135.4 163.12 30.76 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.936 0.874 . . . . 1.0 111.277 -179.297 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.4 p -103.31 131.64 51.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.028 -0.987 . . . . 1.0 109.673 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -97.53 134.0 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.025 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 t -125.6 121.31 33.23 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.704 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.1 mm -108.0 129.84 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.452 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.8 m -114.78 121.63 43.89 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.444 0.64 . . . . 1.0 109.953 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 70.8 mt -123.77 128.85 50.15 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.549 0.69 . . . . 1.0 110.907 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 69.5 p -135.55 144.39 46.21 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.37 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -99.79 108.09 20.3 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.456 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 106' ' ' GLY . 55.1 mt -96.12 171.53 8.55 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.04 0.448 . . . . 1.0 110.697 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.95 -42.62 99.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.247 0.462 . . . . 1.0 112.247 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -81.78 -32.55 31.32 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.099 0.56 . . . . 1.0 110.672 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 103' ' ' LEU . . . -176.69 -141.53 3.98 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.579 -1.008 . . . . 1.0 110.579 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 m -133.94 130.27 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.566 0.222 . . . . 1.0 111.179 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -92.46 141.98 27.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.336 0.589 . . . . 1.0 109.904 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.73 151.26 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.513 0.673 . . . . 1.0 110.396 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -151.77 135.1 16.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.107 0.479 . . . . 1.0 110.686 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 tt -125.21 126.23 44.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.956 -0.566 . . . . 1.0 109.928 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 m -120.78 144.68 48.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.421 0.629 . . . . 1.0 111.477 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.496 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 39.4 tt0 -143.79 130.22 19.96 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.507 -0.769 . . . . 1.0 110.141 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.442 ' O ' ' ND1' ' A' ' 94' ' ' HIS . 0.7 OUTLIER -105.23 -170.42 1.75 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.476 0.655 . . . . 1.0 112.467 -179.321 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.3 t30 63.46 38.0 10.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.655 0.983 . . . . 1.0 113.655 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -82.88 128.96 34.91 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -67.38 -41.31 85.26 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.083 -1.011 . . . . 1.0 111.83 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.454 ' OG1' ' N ' ' A' ' 119' ' ' GLU . 1.3 t -150.9 175.97 11.53 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.109 0.48 . . . . 1.0 111.079 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.454 ' N ' ' OG1' ' A' ' 118' ' ' THR . 96.5 mt-10 -59.19 -37.57 77.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.406 ' N ' ' CD ' ' A' ' 120' ' ' LYS . 13.0 mptt -59.57 -42.41 92.41 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -71.76 -39.78 69.75 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.919 -0.488 . . . . 1.0 109.97 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -63.33 -44.89 93.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -63.92 -43.1 96.92 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -59.95 -40.37 88.77 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 78.3 p -72.96 -46.9 49.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -57.08 -47.91 79.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.7 -0.481 . . . . 1.0 109.7 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.67 -37.37 87.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.44 ' O ' ' SD ' ' A' ' 132' ' ' MET . 42.3 t30 -65.27 -54.01 35.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 1.0 110.044 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.445 ' NE1' ' OE1' ' A' ' 113' ' ' GLN . 83.4 m95 -59.41 -36.83 76.58 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -59.27 -36.53 75.69 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.525 -0.917 . . . . 1.0 108.525 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.6 m -64.29 -43.08 95.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.994 -0.743 . . . . 1.0 108.994 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.509 ' SD ' ' N ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -63.18 -48.84 76.68 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 133' ' ' LEU . 4.2 mm? -62.47 -39.99 95.2 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -66.74 -41.73 87.38 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.37 -36.99 93.88 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.003 -1.239 . . . . 1.0 110.003 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.21 -43.87 77.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.434 0.635 . . . . 1.0 110.114 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -65.44 -39.34 91.95 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.071 -0.393 . . . . 1.0 110.153 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.7 tptt -62.01 -39.34 91.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.011 0.434 . . . . 1.0 111.246 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -75.81 -46.57 29.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.128 0.489 . . . . 1.0 110.323 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.525 ' O ' HD13 ' A' ' 140' ' ' LEU . 0.2 OUTLIER -64.59 -42.62 95.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.06 0.457 . . . . 1.0 111.097 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -75.8 -1.36 24.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.242 0.544 . . . . 1.0 109.866 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -60.14 -33.08 71.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.411 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.0 pttt . . . . . 0 C--N 1.329 -0.32 0 O-C-N 122.221 -0.3 . . . . 1.0 111.097 -179.681 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.1 pt . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 121.72 0.771 . . . . 1.0 111.028 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -77.61 -167.76 1.03 Allowed 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.698 -0.626 . . . . 1.0 111.216 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 5' ' ' LEU . 10.0 mp -75.09 143.79 43.24 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.605 0.717 . . . . 1.0 111.422 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.5 mt -114.43 128.81 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.4 0.619 . . . . 1.0 111.201 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.69 143.43 44.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.041 0.448 . . . . 1.0 110.604 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -133.54 123.41 25.12 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.228 0.537 . . . . 1.0 111.011 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.7 m -141.76 140.08 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.24 0.543 . . . . 1.0 110.438 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -152.96 139.14 18.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.559 0.695 . . . . 1.0 110.902 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.5 t -147.04 145.43 29.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.996 -0.547 . . . . 1.0 111.022 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.4 t -93.44 124.51 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.32 0.581 . . . . 1.0 110.445 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 78.2 mt -129.43 131.34 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 121.453 0.644 . . . . 1.0 110.625 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -90.57 99.73 12.7 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.148 0.499 . . . . 1.0 110.263 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -169.31 153.55 5.41 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 118.894 -0.574 . . . . 1.0 111.487 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.98 146.75 78.45 Favored 'Trans proline' 0 N--CA 1.502 2.003 0 C-N-CA 121.295 1.33 . . . . 1.0 112.591 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.402 HG21 ' NE ' ' A' ' 72' ' ' ARG . 9.8 tp -65.48 -36.68 78.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.845 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -61.44 -50.77 71.46 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.812 -0.555 . . . . 1.0 111.753 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.97 -41.0 97.68 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.87 0.322 . . . . 1.0 111.87 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.1 t -66.17 -46.43 87.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 40.1 t-105 -59.8 -41.88 92.17 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.806 0.813 . . . . 1.0 109.07 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.48 -45.45 93.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.489 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.99 -31.86 65.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.026 0.441 . . . . 1.0 111.698 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -71.72 -48.04 49.8 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.151 -0.343 . . . . 1.0 111.823 -179.113 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 m -112.07 77.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.871 0.843 . . . . 1.0 111.099 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -159.82 109.97 1.45 Allowed Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.49 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.431 ' HD3' ' HE1' ' A' ' 43' ' ' TRP . 53.7 Cg_endo -67.34 -14.95 44.53 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 120.934 1.09 . . . . 1.0 112.33 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -80.73 -50.9 9.29 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.358 -0.238 . . . . 1.0 110.358 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.79 -42.42 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.65 0.738 . . . . 1.0 109.209 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.8 mt -57.6 -41.93 80.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -64.53 -36.66 84.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 1.0 110.33 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -67.23 -32.07 72.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.94 0.4 . . . . 1.0 110.029 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -69.59 -34.18 73.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.947 0.403 . . . . 1.0 109.977 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.7 mmm -101.13 177.31 4.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.675 0.75 . . . . 1.0 110.941 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -64.43 -37.96 89.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.837 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.43 64.47 0.02 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.759 -0.536 . . . . 1.0 111.759 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -96.61 126.64 41.92 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.69 0.757 . . . . 1.0 110.704 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.8 p -78.34 92.5 4.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.86 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.2 t -95.52 131.56 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.275 0.56 . . . . 1.0 110.616 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.47 129.72 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 121.306 0.574 . . . . 1.0 110.419 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.561 ' HG ' ' HE1' ' A' ' 43' ' ' TRP . 60.3 p -153.54 150.94 29.22 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.314 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -94.38 -20.58 19.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.799 0.809 . . . . 1.0 109.018 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.561 ' HE1' ' HG ' ' A' ' 41' ' ' SER . 1.3 m0 68.76 46.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.896 -0.593 . . . . 1.0 111.363 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -148.86 156.33 42.17 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.562 0.696 . . . . 1.0 111.182 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -55.27 129.74 39.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.673 0.749 . . . . 1.0 112.184 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.2 -3.2 87.34 Favored Glycine 0 N--CA 1.469 0.841 0 CA-C-N 115.838 -0.619 . . . . 1.0 112.028 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.2 t -67.12 133.95 50.84 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.257 -0.555 . . . . 1.0 111.548 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -89.03 146.72 24.67 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.78 148.95 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.473 0.654 . . . . 1.0 111.328 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.57 155.16 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.461 -0.79 . . . . 1.0 110.7 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.538 ' CH2' ' NE2' ' A' ' 79' ' ' HIS . 14.7 m0 -128.54 123.17 32.79 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.234 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -89.93 140.48 29.58 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.68 173.82 42.06 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -121.76 128.41 51.72 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.752 0.787 . . . . 1.0 110.201 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 33.8 t90 -129.01 112.12 13.71 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.42 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 52.36 40.91 30.26 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.128 0.489 . . . . 1.0 110.655 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.63 -11.72 18.34 Favored Glycine 0 N--CA 1.468 0.793 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -96.41 116.93 29.85 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.208 0.527 . . . . 1.0 110.438 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.37 133.15 47.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.998 0.428 . . . . 1.0 110.251 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -132.57 152.91 51.45 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.615 0.721 . . . . 1.0 111.01 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -139.45 132.77 29.98 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.43 0.633 . . . . 1.0 110.592 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -87.67 168.11 13.29 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -153.64 129.37 10.1 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.677 0.751 . . . . 1.0 112.508 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.21 -179.48 31.28 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.24 -1.144 . . . . 1.0 110.24 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 66' ' ' ILE . 91.0 m -149.5 154.55 38.95 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.948 -0.737 . . . . 1.0 111.312 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.408 ' N ' HG22 ' A' ' 65' ' ' THR . 39.8 mm -77.71 122.58 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.59 0.71 . . . . 1.0 110.251 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 67' ' ' LEU . 3.8 mm? -86.13 -52.47 5.65 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.97 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -131.73 137.69 48.33 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.648 -0.501 . . . . 1.0 109.648 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -135.38 104.94 6.04 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.771 0.796 . . . . 1.0 111.482 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -124.46 93.59 3.95 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.25 122.04 3.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.852 -0.613 . . . . 1.0 112.049 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.402 ' NE ' HG21 ' A' ' 17' ' ' ILE . 67.8 ttt180 61.82 51.97 3.64 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.266 0.626 . . . . 1.0 111.784 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 t -169.62 -72.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.707 -0.621 . . . . 1.0 111.992 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 95.0 mt -137.04 133.8 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-O 121.626 0.727 . . . . 1.0 111.564 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.4 tp -136.16 124.99 24.0 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.353 -0.84 . . . . 1.0 110.296 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -135.24 141.87 45.86 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.184 0.516 . . . . 1.0 109.966 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -149.14 152.51 36.23 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.1 0.952 . . . . 1.0 112.144 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.8 p -94.32 150.92 19.83 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.538 ' NE2' ' CH2' ' A' ' 51' ' ' TRP . 1.2 m80 -152.42 144.99 24.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 122.0 0.905 . . . . 1.0 111.561 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -141.95 136.61 30.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.66 -1.155 . . . . 1.0 110.236 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 118.445 -0.788 . . . . 1.0 110.664 179.838 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 112.471 0.545 . . . . 1.0 112.471 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.58 172.28 8.02 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.641 0.734 . . . . 1.0 111.738 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.456 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.7 OUTLIER -145.69 169.42 18.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.619 0.723 . . . . 1.0 111.213 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.0 p -107.32 132.63 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.205 -0.907 . . . . 1.0 109.841 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.6 t -94.14 135.13 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.398 0.618 . . . . 1.0 110.961 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.0 t -126.7 123.79 38.31 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.515 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.6 mt -120.91 131.87 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.723 -0.672 . . . . 1.0 110.244 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 59.1 m -117.59 122.16 42.88 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.02 -0.536 . . . . 1.0 109.904 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.6 mt -115.93 124.84 51.58 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.463 0.649 . . . . 1.0 110.792 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 74.4 p -128.05 137.62 52.25 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.513 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -96.42 105.7 17.82 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.349 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.8 mt -92.15 170.21 10.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.11 0.481 . . . . 1.0 110.41 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -61.97 -41.3 97.85 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.442 0.534 . . . . 1.0 112.442 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -75.4 -40.21 58.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.417 0.627 . . . . 1.0 110.845 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.1 -140.33 3.13 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.7 p -125.18 134.17 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.445 0.64 . . . . 1.0 111.029 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -99.2 141.06 32.45 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.543 -0.753 . . . . 1.0 109.602 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.82 138.73 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 121.278 0.561 . . . . 1.0 110.521 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -142.93 131.73 22.73 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.447 0.641 . . . . 1.0 110.509 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tt -125.15 131.68 53.2 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.719 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.8 m -128.67 143.01 50.85 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.45 0.643 . . . . 1.0 111.235 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.456 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 33.7 tt0 -142.53 138.3 30.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.086 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 12.4 p-10 -111.99 -167.12 1.14 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.538 0.685 . . . . 1.0 112.32 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.8 t30 60.73 37.52 18.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.758 1.021 . . . . 1.0 113.758 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -82.16 117.77 22.56 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.76 -1.2 . . . . 1.0 107.76 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -61.51 -39.87 92.57 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.011 -1.056 . . . . 1.0 111.866 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.6 p -144.78 168.31 20.51 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.923 -0.486 . . . . 1.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.46 -34.82 71.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.275 -0.639 . . . . 1.0 109.275 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.57 -40.88 93.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -69.44 -39.77 77.62 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.963 -0.461 . . . . 1.0 110.303 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -63.14 -47.82 81.12 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -59.93 -42.81 94.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -61.25 -39.05 88.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.333 -0.618 . . . . 1.0 109.333 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 62.4 m -68.03 -53.26 27.16 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.59 -44.91 73.43 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -62.55 -41.31 98.81 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -66.36 -54.0 29.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.02 0.438 . . . . 1.0 110.097 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.507 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 87.8 m95 -60.42 -39.42 87.34 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -59.44 -39.09 82.46 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.7 m -63.73 -41.98 97.96 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.507 ' SD ' ' CE3' ' A' ' 129' ' ' TRP . 79.0 mtp -64.93 -50.41 66.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.287 0.565 . . . . 1.0 109.617 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.02 -40.08 94.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -69.14 -39.46 78.81 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.078 -0.712 . . . . 1.0 109.078 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.36 -39.5 91.7 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 109.632 -1.387 . . . . 1.0 109.632 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.9 tt -65.9 -43.06 89.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.024 0.44 . . . . 1.0 110.033 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -61.69 -32.72 72.93 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -60.99 -37.99 84.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.982 0.42 . . . . 1.0 111.031 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -74.59 -49.93 19.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.422 0.63 . . . . 1.0 110.775 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.88 -42.66 99.85 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.785 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -75.37 -4.33 38.75 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.371 0.605 . . . . 1.0 110.253 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -62.12 -39.14 91.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.972 0.415 . . . . 1.0 110.449 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? . . . . . 0 N--CA 1.449 -0.5 0 CA-C-N 116.693 -0.231 . . . . 1.0 111.007 -179.683 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.478 HD13 ' N ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 121.465 0.65 . . . . 1.0 111.066 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -74.57 -156.3 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.479 0.657 . . . . 1.0 110.787 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.49 HD22 ' N ' ' A' ' 5' ' ' LEU . 3.9 mm? -75.47 142.18 42.97 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.867 0.842 . . . . 1.0 111.512 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.95 129.62 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.393 0.616 . . . . 1.0 111.035 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.78 136.57 36.02 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.034 -0.416 . . . . 1.0 110.648 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -145.13 145.05 31.24 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.226 0.536 . . . . 1.0 110.753 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.49 155.79 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.329 0.585 . . . . 1.0 110.429 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -154.37 134.06 12.87 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.252 0.548 . . . . 1.0 110.922 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 t -148.56 146.92 28.49 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.102 0.477 . . . . 1.0 111.256 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 m -99.06 131.36 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.378 0.608 . . . . 1.0 110.249 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.3 mt -130.68 132.16 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 121.875 0.845 . . . . 1.0 110.553 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -85.83 96.41 9.75 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.314 0.578 . . . . 1.0 110.224 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.95 157.93 4.27 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.622 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -61.36 144.44 98.4 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.257 1.971 . . . . 1.0 112.358 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.5 tp -64.84 -33.84 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.752 -0.658 . . . . 1.0 111.4 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -58.15 -50.26 74.13 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.901 -0.499 . . . . 1.0 111.914 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -65.21 -40.44 94.17 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.996 0.369 . . . . 1.0 111.996 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.3 t -66.33 -47.46 84.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -60.05 -43.43 95.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -58.26 -49.16 78.11 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.044 -0.41 . . . . 1.0 110.258 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.04 -32.77 64.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.752 0.279 . . . . 1.0 111.752 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.54 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.4 tt -67.7 -45.28 75.56 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.206 -0.309 . . . . 1.0 111.229 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 m -115.94 79.47 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.677 0.751 . . . . 1.0 111.383 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -156.98 117.12 2.06 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.201 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.457 ' HD3' ' HE1' ' A' ' 43' ' ' TRP . 70.8 Cg_endo -73.88 -5.3 16.81 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.344 1.363 . . . . 1.0 112.277 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -93.73 -52.39 4.47 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.209 -0.293 . . . . 1.0 110.209 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.88 -42.18 94.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.647 -0.872 . . . . 1.0 108.647 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.87 -40.18 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -66.14 -36.45 83.17 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.255 -0.278 . . . . 1.0 110.445 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -57.78 -36.64 72.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -68.91 -33.33 73.57 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.239 -0.282 . . . . 1.0 110.239 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 73.1 mmm -96.43 156.54 16.3 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.712 0.768 . . . . 1.0 110.906 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -61.58 -43.22 99.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.713 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.44 42.99 0.18 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 120.904 -0.665 . . . . 1.0 111.977 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.8 m -76.85 129.15 35.83 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.561 0.696 . . . . 1.0 110.58 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 48.7 m -93.05 92.07 7.64 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.693 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -99.03 132.64 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.441 0.639 . . . . 1.0 110.481 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.0 t -130.58 132.22 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.646 0.736 . . . . 1.0 110.264 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 m -156.09 166.68 32.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.565 . . . . 1.0 111.376 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -109.34 -19.67 13.2 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.98 0.895 . . . . 1.0 109.076 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.457 ' HE1' ' HD3' ' A' ' 27' ' ' PRO . 58.0 m95 58.23 56.32 4.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.795 -0.639 . . . . 1.0 111.76 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -152.4 156.83 40.29 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.418 0.628 . . . . 1.0 111.125 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.28 119.68 1.25 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.539 0.685 . . . . 1.0 112.422 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.04 11.2 84.72 Favored Glycine 0 N--CA 1.468 0.782 0 CA-C-N 115.918 -0.583 . . . . 1.0 112.065 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.1 t -72.26 130.46 40.85 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.3 -0.529 . . . . 1.0 111.523 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -87.45 150.47 23.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.747 -0.835 . . . . 1.0 108.747 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.9 pt -145.07 149.35 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.1 0.476 . . . . 1.0 111.107 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.6 m -143.51 154.53 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.782 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 10.3 m0 -129.2 131.72 47.16 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.34 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -91.57 139.69 30.45 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.45 172.71 39.45 Favored Glycine 0 N--CA 1.464 0.514 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -131.95 134.56 45.77 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.007 0.908 . . . . 1.0 110.231 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -138.3 118.04 13.16 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.374 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 52.92 37.1 23.49 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.112 0.482 . . . . 1.0 110.688 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.96 -6.06 44.29 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.932 -0.867 . . . . 1.0 110.932 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -97.15 112.51 24.26 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.346 0.593 . . . . 1.0 110.565 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.14 135.88 49.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.029 0.442 . . . . 1.0 110.239 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -141.26 155.89 45.95 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.642 0.734 . . . . 1.0 110.864 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 1.5 pm0 -136.27 133.83 37.39 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.388 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -86.91 144.5 26.94 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -133.88 128.13 33.99 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.502 0.668 . . . . 1.0 112.731 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.08 -177.24 30.01 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.293 -1.123 . . . . 1.0 110.293 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.414 HG22 ' N ' ' A' ' 66' ' ' ILE . 85.9 m -146.68 155.02 42.11 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.656 0.741 . . . . 1.0 111.056 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.414 ' N ' HG22 ' A' ' 65' ' ' THR . 50.7 mm -75.56 115.55 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.249 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.401 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 42.5 tp -69.93 -41.91 73.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.503 0.668 . . . . 1.0 110.111 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -152.07 147.8 26.92 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -132.52 104.08 6.5 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.989 0.899 . . . . 1.0 111.597 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -125.16 104.56 8.58 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -47.16 136.31 9.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.658 0.742 . . . . 1.0 111.98 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 36.91 53.72 1.14 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.666 -0.697 . . . . 1.0 112.552 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.5 t -161.12 -73.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.635 -0.666 . . . . 1.0 112.098 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.4 mt -136.89 131.82 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.464 0.65 . . . . 1.0 111.496 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.1 tp -136.98 124.97 22.77 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.525 -0.762 . . . . 1.0 110.333 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.02 144.53 32.32 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.409 0.623 . . . . 1.0 109.961 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.401 ' HA ' ' H ' ' A' ' 67' ' ' LEU . 46.6 p90 -150.04 154.88 38.91 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.816 0.817 . . . . 1.0 112.061 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.4 p -87.0 151.44 23.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.004 -1.11 . . . . 1.0 108.004 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.404 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 52.9 t-80 -146.08 144.37 29.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.925 0.869 . . . . 1.0 111.887 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -143.38 135.11 26.51 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.718 -1.128 . . . . 1.0 110.315 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.9 p . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 118.622 -0.704 . . . . 1.0 110.33 179.409 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 56.2 t30 . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 112.457 0.539 . . . . 1.0 112.457 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 47.8 p90 -117.83 178.47 4.4 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.308 0.575 . . . . 1.0 112.246 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.19 167.25 21.01 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.058 0.932 . . . . 1.0 111.373 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 52.1 t -106.77 127.74 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 114.809 -1.087 . . . . 1.0 109.647 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.31 133.57 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.036 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.7 t -125.36 121.06 32.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.253 0.549 . . . . 1.0 110.657 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 75.7 mt -119.01 129.97 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.358 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 64.8 m -117.47 116.9 28.07 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.532 0.682 . . . . 1.0 109.957 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.3 mt -114.34 124.81 52.91 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.801 0.81 . . . . 1.0 110.812 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.5 m -138.31 143.36 39.93 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.325 -0.852 . . . . 1.0 110.49 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.03 123.98 38.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.266 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.8 mt -107.99 173.7 6.21 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.235 0.54 . . . . 1.0 110.332 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -61.7 -41.6 97.81 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.409 0.522 . . . . 1.0 112.409 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -74.2 -44.23 54.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.144 0.497 . . . . 1.0 110.779 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -172.55 -129.53 1.15 Allowed Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.892 -0.883 . . . . 1.0 110.892 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.3 t -128.81 133.9 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.539 0.685 . . . . 1.0 110.852 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -107.2 132.78 52.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.48 -0.782 . . . . 1.0 109.537 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.1 p -125.23 142.08 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.81 0.814 . . . . 1.0 110.25 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -140.03 135.12 32.34 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.567 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 tt -127.98 129.41 46.71 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.586 -0.733 . . . . 1.0 109.822 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.8 m -123.37 145.37 48.81 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.425 0.631 . . . . 1.0 111.379 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.419 ' OE1' ' NE1' ' A' ' 129' ' ' TRP . 37.6 tt0 -143.69 123.67 13.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.471 -0.786 . . . . 1.0 109.918 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -101.14 -167.62 1.45 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.392 0.615 . . . . 1.0 112.514 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.9 t30 59.58 38.38 22.23 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.455 0.909 . . . . 1.0 113.455 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -82.96 133.1 35.12 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.543 -1.28 . . . . 1.0 107.543 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -63.02 -43.34 98.99 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.045 -1.035 . . . . 1.0 111.977 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 119' ' ' GLU . 1.4 t -149.79 176.2 10.92 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.133 0.492 . . . . 1.0 110.884 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.422 ' N ' ' OG1' ' A' ' 118' ' ' THR . 95.1 mt-10 -58.81 -38.13 77.93 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -59.06 -40.09 84.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -70.42 -38.49 74.61 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.01 -0.431 . . . . 1.0 109.919 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -64.65 -47.06 79.88 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -61.81 -40.29 94.72 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.912 -0.773 . . . . 1.0 108.912 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -62.43 -39.95 94.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.44 -0.578 . . . . 1.0 109.44 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.7 m -71.69 -49.18 41.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 1.0 109.822 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -55.54 -47.36 76.45 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.28 -37.95 89.3 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.702 -0.481 . . . . 1.0 109.702 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -66.59 -54.55 22.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.135 0.493 . . . . 1.0 110.13 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.419 ' NE1' ' OE1' ' A' ' 113' ' ' GLN . 86.2 m95 -59.42 -37.37 77.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -56.78 -39.87 74.85 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.533 -0.914 . . . . 1.0 108.533 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.7 m -63.97 -41.17 97.62 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.73 -50.53 70.74 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.29 -38.63 90.09 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -67.35 -41.51 85.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.887 -0.783 . . . . 1.0 108.887 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.09 -40.57 98.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.026 -1.23 . . . . 1.0 110.026 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 64.9 tp -67.9 -42.63 80.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.372 0.606 . . . . 1.0 109.805 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.44 -44.25 95.06 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.102 -0.374 . . . . 1.0 110.477 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -61.3 -40.88 95.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.714 0.293 . . . . 1.0 110.728 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -66.38 -50.21 64.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.042 0.448 . . . . 1.0 110.637 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.502 ' O ' HD23 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -65.35 -42.44 92.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.547 -179.562 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -76.92 -0.41 24.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.269 0.557 . . . . 1.0 110.186 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -61.54 -36.5 80.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.59 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 27.1 pttm . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.682 0.277 . . . . 1.0 111.124 -179.719 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.533 HD13 ' N ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 121.684 0.754 . . . . 1.0 110.849 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -73.21 -160.96 0.09 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.363 0.602 . . . . 1.0 111.019 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.49 ' N ' HD12 ' A' ' 5' ' ' LEU . 9.8 mp -73.7 141.27 46.4 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.622 0.725 . . . . 1.0 111.583 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.2 mt -116.78 129.21 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.917 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.28 146.15 37.02 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.998 -0.438 . . . . 1.0 110.69 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -138.08 127.03 24.04 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.906 0.384 . . . . 1.0 110.952 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.7 m -140.53 139.13 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.05 0.453 . . . . 1.0 110.507 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -153.37 135.49 14.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.954 0.407 . . . . 1.0 111.023 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.8 t -146.44 145.01 30.07 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.251 0.548 . . . . 1.0 111.173 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 12' ' ' VAL . 14.9 p -91.22 129.89 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.207 0.527 . . . . 1.0 110.545 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 75.7 mt -132.63 131.92 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.554 0.693 . . . . 1.0 110.4 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -89.36 95.19 10.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.287 0.565 . . . . 1.0 109.73 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.65 159.14 3.09 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 120.759 -0.376 . . . . 1.0 110.942 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.79 146.09 96.81 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 122.146 1.897 . . . . 1.0 112.521 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.2 tt -68.66 -29.84 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.72 0.771 . . . . 1.0 111.529 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -63.53 -48.17 78.63 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.909 -0.494 . . . . 1.0 112.16 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.02 -45.85 90.38 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.809 0.3 . . . . 1.0 111.809 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.44 -45.31 85.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 23.5 t-105 -56.46 -41.62 76.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -58.97 -45.56 90.22 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.043 -0.41 . . . . 1.0 110.342 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.78 -34.62 62.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.598 -0.273 . . . . 1.0 111.359 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.527 HD13 ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -70.42 -48.28 56.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.033 0.445 . . . . 1.0 111.796 -179.184 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.7 m -107.39 74.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.437 0.637 . . . . 1.0 110.83 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -162.13 113.62 1.16 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 119.053 -0.499 . . . . 1.0 110.636 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HD3' ' HE1' ' A' ' 43' ' ' TRP . 57.4 Cg_endo -70.6 -18.38 33.09 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 121.812 1.675 . . . . 1.0 112.391 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -79.71 -46.93 16.17 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.645 0.259 . . . . 1.0 110.402 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -71.91 -42.13 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.938 -0.764 . . . . 1.0 108.938 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 mm -58.79 -41.51 82.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -69.43 -31.22 69.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.089 0.471 . . . . 1.0 110.181 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -60.86 -35.74 77.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.128 0.489 . . . . 1.0 110.043 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -69.1 -33.49 73.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.901 0.381 . . . . 1.0 110.034 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.8 mmm -98.05 162.62 13.13 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.824 0.821 . . . . 1.0 110.916 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -62.19 -41.21 98.13 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.749 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.85 42.27 0.14 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.106 -0.569 . . . . 1.0 111.924 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.7 m -70.16 128.37 36.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.378 0.609 . . . . 1.0 110.994 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.4 m -92.56 92.36 8.01 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.16 -0.337 . . . . 1.0 110.872 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.72 135.36 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 121.374 0.607 . . . . 1.0 110.483 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.2 p -126.96 137.45 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.27 0.557 . . . . 1.0 110.589 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.5 p -154.21 155.23 34.88 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.106 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -94.69 -20.04 19.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 122.121 0.962 . . . . 1.0 108.933 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.44 ' HE1' ' HD3' ' A' ' 27' ' ' PRO . 1.5 m0 72.16 45.56 0.38 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.422 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 pttt -153.34 153.44 32.6 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.768 -0.582 . . . . 1.0 111.447 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -50.38 132.01 24.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.736 0.779 . . . . 1.0 112.361 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.68 -6.44 83.44 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-N 115.873 -0.603 . . . . 1.0 112.034 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.1 m -65.14 137.11 57.43 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.188 -0.595 . . . . 1.0 111.885 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -88.77 150.25 23.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.7 pt -138.65 147.91 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-O 121.34 0.591 . . . . 1.0 111.355 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.3 t -143.77 141.32 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.617 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.451 ' CZ3' ' NE2' ' A' ' 79' ' ' HIS . 18.4 m0 -118.11 137.63 52.81 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.081 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -100.98 134.4 44.03 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.09 0.471 . . . . 1.0 109.968 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.12 173.71 37.6 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -125.99 134.56 51.44 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.636 0.731 . . . . 1.0 110.193 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -138.24 115.29 10.9 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.48 0.657 . . . . 1.0 110.302 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt 52.71 38.07 25.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.62 -9.02 38.23 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 110.451 -1.06 . . . . 1.0 110.451 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -98.41 116.32 30.39 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.372 0.606 . . . . 1.0 110.749 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.3 129.08 38.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.253 0.549 . . . . 1.0 110.32 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -128.56 150.99 49.96 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.724 0.773 . . . . 1.0 110.944 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.437 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 1.2 pm0 -135.7 126.37 27.18 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.387 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -86.86 134.87 33.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.978 -0.749 . . . . 1.0 108.978 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -120.12 129.12 54.02 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.725 0.774 . . . . 1.0 112.53 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.14 175.52 30.03 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.35 -1.1 . . . . 1.0 110.35 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.1 m -144.41 151.99 40.03 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 122.07 -0.665 . . . . 1.0 111.33 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.7 mm -73.72 113.79 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.468 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -66.98 -51.25 57.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.612 0.72 . . . . 1.0 110.243 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -150.01 147.88 28.37 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.433 -0.581 . . . . 1.0 109.433 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -126.06 110.76 13.91 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.74 0.781 . . . . 1.0 111.351 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.4 ' HB3' ' H ' ' A' ' 74' ' ' ILE . 39.0 t-20 -126.25 91.47 3.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.295 -0.631 . . . . 1.0 109.295 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -36.73 128.84 0.83 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.189 0.518 . . . . 1.0 112.241 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 41.92 57.12 3.28 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.681 0.623 . . . . 1.0 112.681 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.5 t -165.1 -71.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.7 -0.625 . . . . 1.0 111.886 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.4 ' H ' ' HB3' ' A' ' 70' ' ' ASN . 91.2 mt -138.07 131.25 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.573 0.701 . . . . 1.0 111.629 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.1 tp -133.95 123.22 24.27 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.371 -0.831 . . . . 1.0 110.634 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -138.93 142.96 38.45 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.192 0.52 . . . . 1.0 110.113 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -152.84 155.7 37.61 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.678 0.751 . . . . 1.0 112.15 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.6 p -86.7 151.19 23.62 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.451 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 16.5 t-80 -146.56 138.44 24.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.869 0.843 . . . . 1.0 111.846 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -138.1 127.55 24.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.813 -1.085 . . . . 1.0 110.529 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.5 t . . . . . 0 CA--C 1.547 0.854 0 CA-C-O 118.913 -0.565 . . . . 1.0 110.64 179.11 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 112.272 0.471 . . . . 1.0 112.272 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -101.55 175.5 5.54 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.493 0.663 . . . . 1.0 112.145 -179.494 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.563 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.3 OUTLIER -142.54 161.01 39.17 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.953 0.882 . . . . 1.0 111.172 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.0 t -106.24 114.08 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 115.025 -0.989 . . . . 1.0 109.455 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.4 m -82.69 139.92 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.097 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 t -130.2 129.8 43.85 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.303 0.573 . . . . 1.0 110.917 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.86 130.08 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.542 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 59.4 m -117.8 118.13 31.21 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.446 0.641 . . . . 1.0 109.989 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.0 mt -114.15 130.85 56.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.401 0.62 . . . . 1.0 110.894 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.438 ' OG1' ' CG ' ' A' ' 108' ' ' GLU . 30.0 p -135.07 128.34 32.07 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.639 -0.709 . . . . 1.0 110.587 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -88.67 111.83 22.4 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.03 0.443 . . . . 1.0 110.139 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 25.3 mt -96.35 175.74 6.31 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.297 0.57 . . . . 1.0 110.485 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.54 -40.71 96.1 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.384 0.512 . . . . 1.0 112.384 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -79.57 -40.77 28.68 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.003 0.521 . . . . 1.0 110.875 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -171.55 -143.18 3.94 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.8 p -129.13 132.77 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.039 0.447 . . . . 1.0 111.225 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.438 ' CG ' ' OG1' ' A' ' 101' ' ' THR . 12.4 pt-20 -98.62 144.59 27.74 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.65 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.59 135.37 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.242 0.544 . . . . 1.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -141.24 129.48 22.26 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.091 0.472 . . . . 1.0 110.592 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -124.63 140.72 52.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.142 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.1 m -132.54 144.39 50.39 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.501 0.667 . . . . 1.0 111.428 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.563 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 40.3 tt0 -143.43 139.36 29.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.872 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -114.41 -162.65 0.82 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.399 0.619 . . . . 1.0 112.309 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.403 ' HA ' HD21 ' A' ' 115' ' ' ASN . 1.1 t-20 58.54 35.56 24.67 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.641 0.978 . . . . 1.0 113.641 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -82.23 122.17 27.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.681 -1.229 . . . . 1.0 107.681 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.48 -40.44 93.14 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.01 -1.056 . . . . 1.0 111.79 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.1 p -145.58 171.58 14.49 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.839 -0.538 . . . . 1.0 111.065 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -57.17 -38.51 73.69 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -58.69 -41.21 85.71 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -69.84 -39.67 76.29 Favored 'General case' 0 C--N 1.33 -0.283 0 O-C-N 121.937 -0.477 . . . . 1.0 110.15 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -64.7 -45.14 87.87 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -62.73 -44.77 95.34 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.068 -0.716 . . . . 1.0 109.068 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -58.63 -40.12 82.46 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.7 m -72.14 -47.85 47.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.201 0.524 . . . . 1.0 109.67 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -55.68 -48.51 74.96 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -64.55 -37.37 87.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.036 0.446 . . . . 1.0 109.81 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -65.52 -56.5 12.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.943 0.401 . . . . 1.0 110.138 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.477 ' NE1' ' OE1' ' A' ' 113' ' ' GLN . 86.6 m95 -58.6 -39.23 79.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -54.68 -41.03 69.71 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.0 m -63.6 -41.56 98.32 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.624 0.726 . . . . 1.0 109.211 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.9 tpt -64.42 -51.51 62.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 133' ' ' LEU . 4.4 mm? -59.56 -41.24 89.68 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -68.16 -36.64 79.96 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.57 -41.57 99.6 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.011 -1.236 . . . . 1.0 110.011 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.47 -42.42 83.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.323 0.582 . . . . 1.0 110.099 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.4 -37.6 86.41 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.049 -0.407 . . . . 1.0 110.266 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -59.76 -38.51 82.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.975 0.417 . . . . 1.0 111.095 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -76.32 -44.91 34.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.282 0.563 . . . . 1.0 110.473 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 65.0 mt -64.8 -41.98 95.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.044 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.74 0.05 21.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.048 0.452 . . . . 1.0 109.838 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.35 -39.01 93.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.91 0.386 . . . . 1.0 110.604 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt . . . . . 0 N--CA 1.452 -0.347 0 O-C-N 122.23 -0.294 . . . . 1.0 110.947 -179.506 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.493 HD13 ' N ' ' A' ' 3' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 121.376 0.608 . . . . 1.0 111.034 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -77.38 -161.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.68 -0.638 . . . . 1.0 111.046 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 5' ' ' LEU . 10.3 mp -73.76 139.66 45.38 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.652 0.739 . . . . 1.0 111.376 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.1 mt -113.7 129.34 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.328 0.585 . . . . 1.0 111.009 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.68 141.33 39.44 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.062 0.458 . . . . 1.0 110.736 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -138.5 117.98 12.93 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.189 0.518 . . . . 1.0 110.976 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.78 155.91 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.072 0.463 . . . . 1.0 110.627 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -174.18 151.04 1.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.199 0.523 . . . . 1.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 t -145.6 145.43 30.97 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.364 0.602 . . . . 1.0 111.162 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.69 124.59 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.277 0.56 . . . . 1.0 110.542 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.4 mt -130.27 132.69 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 121.669 0.747 . . . . 1.0 110.541 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -87.86 96.49 10.49 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.402 0.62 . . . . 1.0 110.188 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.31 155.86 2.81 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 119.139 -0.458 . . . . 1.0 111.051 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.56 147.57 94.06 Favored 'Trans proline' 0 N--CA 1.506 2.217 0 C-N-CA 121.599 1.533 . . . . 1.0 112.528 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.2 tt -68.09 -26.34 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.187 0.518 . . . . 1.0 111.185 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -59.48 -49.89 76.03 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.885 -0.509 . . . . 1.0 111.604 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.436 ' N ' ' CD ' ' A' ' 19' ' ' LYS . 3.9 mptp? -65.48 -41.51 93.22 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.709 0.263 . . . . 1.0 111.709 -178.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.48 -48.25 81.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -57.45 -43.14 83.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.627 0.727 . . . . 1.0 109.224 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -58.28 -45.8 87.25 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.877 -0.515 . . . . 1.0 110.436 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.17 -35.43 64.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.957 0.408 . . . . 1.0 111.856 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -66.84 -46.0 76.45 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.1 -0.375 . . . . 1.0 111.652 -179.21 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 m -112.98 79.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.794 0.807 . . . . 1.0 111.014 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -159.75 111.32 1.46 Allowed Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.416 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.41 -1.7 10.11 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.195 1.263 . . . . 1.0 112.503 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -96.86 -48.51 5.42 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 110.172 -0.307 . . . . 1.0 110.172 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -68.25 -43.03 84.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.223 -0.658 . . . . 1.0 109.223 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mm -61.03 -42.16 92.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -69.22 -31.13 69.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.046 0.45 . . . . 1.0 110.271 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -58.32 -42.99 87.96 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.812 -0.44 . . . . 1.0 109.812 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -69.37 -33.55 73.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.759 0.314 . . . . 1.0 110.163 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 66.6 mtt -89.12 152.01 21.88 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.684 0.754 . . . . 1.0 111.053 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -59.47 -46.97 87.26 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.697 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.9 48.92 0.22 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.064 -0.589 . . . . 1.0 111.975 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.6 m -82.33 111.26 18.23 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.77 0.795 . . . . 1.0 110.776 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.7 m -77.79 91.94 4.16 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.909 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -102.79 135.12 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.987 0.899 . . . . 1.0 110.5 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 m -128.27 138.75 53.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.55 0.691 . . . . 1.0 110.508 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.455 ' OG ' ' NE1' ' A' ' 43' ' ' TRP . 33.2 p -155.53 158.35 38.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.966 -0.561 . . . . 1.0 111.153 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 50.9 t0 -97.14 -23.63 16.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.89 0.852 . . . . 1.0 108.995 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.455 ' NE1' ' OG ' ' A' ' 41' ' ' SER . 1.5 m0 71.17 47.83 0.39 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.465 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.56 152.54 27.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.645 0.736 . . . . 1.0 111.206 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -48.91 131.35 18.64 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.746 0.784 . . . . 1.0 112.373 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.67 4.7 85.07 Favored Glycine 0 N--CA 1.47 0.956 0 CA-C-N 115.721 -0.672 . . . . 1.0 112.105 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.3 t -76.89 134.8 38.87 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.214 -0.58 . . . . 1.0 111.539 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 64' ' ' GLY . 66.0 tp60 -81.11 146.2 30.7 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.76 -0.83 . . . . 1.0 108.76 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.02 134.58 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.577 0.703 . . . . 1.0 111.348 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 p -140.21 150.25 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.399 -0.819 . . . . 1.0 110.395 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -128.45 137.2 51.71 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.085 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -104.47 129.87 52.43 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.304 0.573 . . . . 1.0 109.693 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.66 -179.32 29.81 Favored Glycine 0 N--CA 1.464 0.519 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -134.34 134.59 41.95 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.835 0.826 . . . . 1.0 110.117 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 35.0 t90 -140.71 124.46 17.1 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.252 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm 52.5 36.18 19.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.179 0.514 . . . . 1.0 110.704 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.53 -6.06 26.02 Favored Glycine 0 N--CA 1.464 0.535 0 N-CA-C 110.746 -0.942 . . . . 1.0 110.746 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -98.88 115.63 29.29 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.346 0.593 . . . . 1.0 110.4 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.25 133.59 47.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.09 0.471 . . . . 1.0 110.197 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -136.69 154.2 50.68 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.543 0.687 . . . . 1.0 110.851 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -136.46 133.57 36.75 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.437 0.637 . . . . 1.0 110.695 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -90.6 167.65 12.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -158.07 133.77 9.05 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.459 0.647 . . . . 1.0 112.369 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 48' ' ' GLN . . . -160.43 -174.68 30.54 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.41 -1.076 . . . . 1.0 110.41 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 66' ' ' ILE . 35.2 m -146.36 155.98 43.0 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.961 -0.729 . . . . 1.0 111.194 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.416 ' N ' HG22 ' A' ' 65' ' ' THR . 38.8 mm -75.89 119.78 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.336 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 tp -77.25 -48.94 16.18 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.621 0.724 . . . . 1.0 110.224 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -140.76 151.21 44.27 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.729 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -146.46 99.97 3.29 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.509 0.671 . . . . 1.0 111.367 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -125.46 106.88 10.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -38.27 133.17 0.98 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.531 0.681 . . . . 1.0 112.417 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 37.19 53.76 1.25 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.759 -0.655 . . . . 1.0 112.524 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.3 m -152.92 -66.87 0.16 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.793 -0.567 . . . . 1.0 111.862 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 74' ' ' ILE . 7.1 tt -150.47 138.73 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.11 0.481 . . . . 1.0 111.517 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.561 HD13 ' N ' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -130.25 122.24 27.66 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.827 -0.624 . . . . 1.0 109.705 178.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.561 ' N ' HD13 ' A' ' 75' ' ' LEU . 74.6 mt-30 -133.61 136.68 45.01 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.961 0.41 . . . . 1.0 110.271 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.441 ' CD1' ' ND1' ' A' ' 79' ' ' HIS . 19.9 p90 -148.06 156.85 43.1 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.056 0.931 . . . . 1.0 111.994 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 92.4 p -101.25 151.43 21.87 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.488 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.9 m80 -153.19 153.16 32.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.698 0.761 . . . . 1.0 111.736 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -143.32 133.18 23.99 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.873 -1.058 . . . . 1.0 110.4 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.2 t . . . . . 0 CA--C 1.546 0.793 0 CA-C-O 118.741 -0.647 . . . . 1.0 110.512 179.684 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 42.9 t30 . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 112.095 0.406 . . . . 1.0 112.095 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 33.9 p90 -100.1 177.16 5.16 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.686 0.755 . . . . 1.0 112.011 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.491 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.1 OUTLIER -132.18 160.76 35.14 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.277 1.037 . . . . 1.0 111.089 -179.331 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.7 t -102.6 114.6 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 114.709 -1.132 . . . . 1.0 109.613 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.38 135.64 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.956 -0.565 . . . . 1.0 111.118 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 t -126.22 122.42 35.53 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.335 0.588 . . . . 1.0 110.773 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.1 mm -105.56 128.19 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.453 -0.794 . . . . 1.0 110.243 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.3 m -117.46 126.52 52.76 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.014 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.6 mt -129.13 125.58 37.43 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.649 0.738 . . . . 1.0 110.778 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 64.5 p -129.7 129.45 44.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.47 -0.786 . . . . 1.0 110.506 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -91.59 107.96 19.57 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.156 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.1 mt -96.94 172.81 7.63 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.183 0.516 . . . . 1.0 110.441 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -61.7 -40.0 93.47 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.255 0.465 . . . . 1.0 112.255 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -77.03 -42.15 39.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.22 0.534 . . . . 1.0 110.882 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.75 -141.99 3.75 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.7 p -129.6 134.07 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.361 0.6 . . . . 1.0 111.205 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -99.18 144.62 28.11 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.813 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -131.74 141.35 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.867 0.841 . . . . 1.0 110.501 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -146.95 134.08 20.46 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.562 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -121.7 128.88 52.3 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.873 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.9 m -119.74 141.49 49.38 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.525 0.679 . . . . 1.0 111.243 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.491 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 39.4 tt0 -143.08 126.25 16.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.953 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.425 ' O ' ' ND1' ' A' ' 94' ' ' HIS . 7.7 p-10 -103.03 -170.14 1.75 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.705 0.764 . . . . 1.0 112.257 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.1 t30 62.59 37.78 12.81 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.604 0.964 . . . . 1.0 113.604 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -82.37 121.67 27.0 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.641 -1.244 . . . . 1.0 107.641 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -63.56 -41.82 98.4 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.933 -1.104 . . . . 1.0 111.902 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.4 p -144.71 172.28 13.22 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.874 -0.516 . . . . 1.0 110.854 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.72 -38.8 86.32 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.26 -0.644 . . . . 1.0 109.26 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -58.11 -40.84 82.25 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -70.34 -38.32 74.82 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.991 -0.443 . . . . 1.0 110.211 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -64.22 -47.57 79.18 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.72 -0.844 . . . . 1.0 108.72 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -60.53 -42.2 95.99 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -59.22 -38.66 80.49 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.7 t -71.39 -52.73 17.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -55.57 -47.06 77.04 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.933 -0.395 . . . . 1.0 109.933 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.48 -38.2 88.92 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -69.11 -52.84 24.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.278 0.561 . . . . 1.0 110.244 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -61.74 -38.01 86.37 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -58.06 -39.75 79.28 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.347 -0.983 . . . . 1.0 108.347 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.0 m -62.87 -38.36 90.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.906 -0.775 . . . . 1.0 108.906 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 40.9 tpp -67.62 -50.39 58.34 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.43 -41.7 97.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -69.1 -42.6 75.91 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.59 -37.29 94.51 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.012 -1.235 . . . . 1.0 110.012 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.2 tp -66.68 -41.63 87.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.298 0.57 . . . . 1.0 109.704 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -60.58 -36.24 78.05 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.053 -0.404 . . . . 1.0 109.952 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -61.51 -39.23 90.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.853 0.358 . . . . 1.0 110.784 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -73.2 -49.96 25.11 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.066 0.46 . . . . 1.0 110.788 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.13 -41.89 97.04 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.89 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -76.68 -1.51 28.17 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.128 0.489 . . . . 1.0 110.063 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -61.0 -38.74 87.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.768 0.318 . . . . 1.0 110.394 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.3 pttt . . . . . 0 N--CA 1.451 -0.387 0 O-C-N 122.3 -0.25 . . . . 1.0 110.849 -179.706 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.489 HD13 ' N ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 121.59 0.71 . . . . 1.0 110.724 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -73.23 -168.79 0.55 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.756 -0.59 . . . . 1.0 110.712 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 5' ' ' LEU . 10.0 mp -73.94 139.57 44.98 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.809 0.814 . . . . 1.0 111.187 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 75.5 mt -112.47 128.39 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.843 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.95 145.03 48.69 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.005 -0.434 . . . . 1.0 110.69 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -138.63 123.39 18.71 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.115 0.483 . . . . 1.0 111.026 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -141.72 152.15 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 121.172 0.51 . . . . 1.0 110.462 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -166.96 143.11 4.4 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.99 -0.444 . . . . 1.0 111.101 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.426 HG23 ' HZ1' ' A' ' 137' ' ' LYS . 1.3 t -147.1 146.11 29.84 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.641 0.734 . . . . 1.0 111.343 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p -107.27 132.63 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 115.89 -0.596 . . . . 1.0 110.798 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 tp -142.67 150.69 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.467 0.651 . . . . 1.0 110.759 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -87.04 95.3 9.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.521 0.677 . . . . 1.0 109.856 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.62 149.78 5.37 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.12 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.75 147.74 92.35 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 121.769 1.646 . . . . 1.0 112.484 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.75 -29.74 44.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.818 -0.628 . . . . 1.0 111.38 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.402 ' HG2' ' HE ' ' A' ' 72' ' ' ARG . 95.4 mt-10 -55.37 -53.2 59.15 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.972 -0.455 . . . . 1.0 111.726 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' N ' ' CD ' ' A' ' 19' ' ' LYS . 3.9 mptp? -67.48 -40.45 85.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 1.0 111.686 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.0 t -66.77 -48.71 79.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -55.95 -42.1 75.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.876 0.846 . . . . 1.0 109.208 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -58.76 -45.79 88.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.486 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.58 -29.12 67.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.726 0.298 . . . . 1.0 111.755 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.522 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.2 tt -67.55 -44.65 77.79 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.344 -0.222 . . . . 1.0 111.222 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.4 m -118.3 79.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 121.87 0.843 . . . . 1.0 111.476 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -157.09 115.99 2.0 Allowed Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.717 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.415 ' HD3' ' HE1' ' A' ' 43' ' ' TRP . 73.9 Cg_endo -73.27 -5.71 17.62 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 121.176 1.251 . . . . 1.0 112.349 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -94.12 -45.86 7.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.61 -0.268 . . . . 1.0 110.345 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 64.6 mt -72.53 -42.21 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.7 mt -60.6 -42.38 91.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.22 -29.36 70.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 1.0 110.327 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -55.22 -43.4 74.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -69.98 -33.67 72.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.365 . . . . 1.0 110.337 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 76.2 mmm -85.61 152.22 23.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.65 0.738 . . . . 1.0 110.888 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.65 -42.34 98.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.745 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.85 46.81 0.13 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.821 -0.704 . . . . 1.0 111.908 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.2 m -86.12 125.95 33.86 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.762 0.791 . . . . 1.0 110.768 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.3 m -87.55 95.86 10.19 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.717 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.9 t -92.84 127.6 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.174 0.511 . . . . 1.0 110.656 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 40' ' ' VAL . 13.4 p -127.26 125.53 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.304 0.573 . . . . 1.0 110.466 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.6 t -158.24 153.42 25.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.508 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -97.15 -12.82 22.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.785 0.802 . . . . 1.0 108.928 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.415 ' HE1' ' HD3' ' A' ' 27' ' ' PRO . 64.0 m95 54.22 62.46 2.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.872 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.46 157.77 34.53 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.541 0.686 . . . . 1.0 110.988 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.83 117.33 4.88 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.129 0.49 . . . . 1.0 112.086 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.27 -13.01 55.2 Favored Glycine 0 N--CA 1.469 0.865 0 CA-C-N 116.304 -0.407 . . . . 1.0 112.163 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.3 m -76.42 138.54 40.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.391 0.615 . . . . 1.0 111.218 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -93.06 158.45 15.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.291 -0.868 . . . . 1.0 108.794 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.2 pt -144.77 149.51 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.512 0.672 . . . . 1.0 110.884 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.3 m -143.05 154.74 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.58 -0.737 . . . . 1.0 110.507 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 18.3 m0 -127.17 112.77 15.51 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.148 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.63 137.38 32.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.78 -171.51 31.11 Favored Glycine 0 N--CA 1.464 0.51 0 N-CA-C 111.088 -0.805 . . . . 1.0 111.088 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -126.12 131.87 51.99 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.854 0.835 . . . . 1.0 110.189 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -138.14 117.09 12.43 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.405 0.621 . . . . 1.0 110.263 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 54.37 38.37 29.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.587 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.34 -8.3 19.23 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 110.853 -0.899 . . . . 1.0 110.853 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -101.73 118.18 36.4 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.286 0.565 . . . . 1.0 110.556 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.99 129.98 41.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.11 0.481 . . . . 1.0 110.258 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -128.09 151.62 48.97 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.806 0.813 . . . . 1.0 110.811 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -135.11 129.71 34.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.698 0.761 . . . . 1.0 110.46 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -85.24 168.84 14.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.277 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -155.6 126.16 6.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.482 0.658 . . . . 1.0 112.358 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.17 178.37 32.73 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.401 -1.08 . . . . 1.0 110.401 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 90.3 m -145.48 154.24 42.01 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 122.029 -0.689 . . . . 1.0 111.282 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.83 114.45 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.294 0.569 . . . . 1.0 110.068 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.7 mt -77.26 -44.34 30.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.401 0.619 . . . . 1.0 110.086 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -151.24 149.39 29.36 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -138.63 112.63 8.52 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.602 0.715 . . . . 1.0 111.448 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.423 ' HB3' ' H ' ' A' ' 74' ' ' ILE . 47.6 t-20 -126.37 103.45 7.64 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.441 -0.577 . . . . 1.0 109.441 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.456 ' OE2' ' NH1' ' A' ' 72' ' ' ARG . 79.2 tt0 -46.43 129.69 10.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.493 0.663 . . . . 1.0 112.14 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.456 ' NH1' ' OE2' ' A' ' 71' ' ' GLU . 85.6 mtt85 42.58 55.91 4.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.852 -0.613 . . . . 1.0 112.549 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.7 t -167.2 -70.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.797 -0.565 . . . . 1.0 111.925 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.423 ' H ' ' HB3' ' A' ' 70' ' ' ASN . 87.8 mt -135.27 130.74 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.654 0.74 . . . . 1.0 111.497 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.8 tp -140.27 120.95 14.31 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.287 -0.87 . . . . 1.0 110.382 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -141.0 146.54 37.4 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.181 0.515 . . . . 1.0 110.259 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -151.68 158.17 43.07 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.884 0.849 . . . . 1.0 112.215 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 p -82.23 148.61 28.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -142.52 133.75 26.12 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.707 0.765 . . . . 1.0 111.84 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -144.42 133.41 22.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.013 -0.994 . . . . 1.0 110.548 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.4 p . . . . . 0 N--CA 1.475 0.78 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.555 179.691 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.9 t30 . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 112.409 0.522 . . . . 1.0 112.409 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -99.61 176.83 5.34 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.271 0.558 . . . . 1.0 112.039 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -141.0 161.43 37.87 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 122.006 0.907 . . . . 1.0 111.199 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -106.94 130.17 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 114.943 -1.026 . . . . 1.0 109.62 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.41 131.85 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.747 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -124.3 121.89 36.24 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.341 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 60.8 mt -121.26 132.99 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.286 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.2 m -129.1 118.0 21.76 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.195 0.521 . . . . 1.0 110.451 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.3 mp -105.19 135.26 46.88 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.922 0.868 . . . . 1.0 110.598 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 74.0 p -129.79 131.21 46.13 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.19 -0.914 . . . . 1.0 110.575 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.01 108.34 20.41 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.175 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -96.19 166.79 11.57 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.12 0.486 . . . . 1.0 110.47 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -59.48 -40.47 87.07 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.313 0.486 . . . . 1.0 112.313 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -75.47 -39.83 58.15 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.058 0.543 . . . . 1.0 110.93 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.67 -140.1 3.11 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 p -133.09 138.92 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.63 0.728 . . . . 1.0 110.935 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -115.74 143.78 44.9 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.377 -0.829 . . . . 1.0 109.812 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.43 154.06 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.994 0.902 . . . . 1.0 110.229 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -145.07 134.78 23.46 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.676 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -131.58 146.4 52.19 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.928 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.5 p -142.63 151.91 41.94 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.577 0.703 . . . . 1.0 111.356 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -142.22 112.57 7.11 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.445 -0.798 . . . . 1.0 110.063 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -84.59 -169.71 2.76 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.457 0.646 . . . . 1.0 112.514 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.85 39.42 29.55 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.561 0.948 . . . . 1.0 113.561 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -82.76 120.6 25.81 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.793 -1.188 . . . . 1.0 107.793 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -62.39 -38.03 88.05 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.869 -1.144 . . . . 1.0 111.873 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.7 t -149.3 168.96 21.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.272 0.558 . . . . 1.0 110.911 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -57.6 -37.65 73.59 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -57.4 -40.66 78.73 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.524 -0.547 . . . . 1.0 109.524 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -70.53 -39.14 74.22 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 121.906 -0.496 . . . . 1.0 110.043 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -64.53 -45.98 84.87 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.566 -0.902 . . . . 1.0 108.566 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -62.57 -41.48 98.96 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.102 -0.703 . . . . 1.0 109.102 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -60.28 -41.42 93.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.9 m -73.62 -48.17 34.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.13 0.49 . . . . 1.0 109.756 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -55.68 -50.48 70.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -62.47 -38.05 88.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -65.36 -51.98 56.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.074 0.464 . . . . 1.0 110.198 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.512 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 80.7 m95 -61.12 -39.78 91.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.539 -0.541 . . . . 1.0 109.539 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -58.18 -39.04 77.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.7 m -64.62 -42.31 95.59 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.512 ' SD ' ' CE3' ' A' ' 129' ' ' TRP . 81.5 mtp -64.2 -49.99 69.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.7 -40.47 95.14 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -62.17 -44.45 96.57 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.99 -0.744 . . . . 1.0 108.99 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.59 -34.01 82.71 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.295 -1.122 . . . . 1.0 110.295 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.47 HD23 ' O ' ' A' ' 136' ' ' LEU . 1.7 tt -66.86 -52.95 37.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.653 0.74 . . . . 1.0 109.906 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.426 ' HZ1' HG23 ' A' ' 11' ' ' THR . 45.6 mmtm -62.06 -36.82 82.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.433 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -59.94 -37.98 81.09 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.424 -0.173 . . . . 1.0 110.558 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -63.72 -48.85 75.4 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.183 -0.323 . . . . 1.0 110.541 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 140' ' ' LEU . 11.0 mp -66.73 -40.14 88.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.683 0.277 . . . . 1.0 110.546 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -70.24 -1.54 10.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.038 0.447 . . . . 1.0 110.128 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -66.35 -37.15 84.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.033 0.444 . . . . 1.0 110.663 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt . . . . . 0 C--N 1.328 -0.333 0 O-C-N 122.23 -0.294 . . . . 1.0 111.356 -179.312 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.531 ' O ' HD12 ' A' ' 3' ' ' ILE . 1.2 pp . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 122.226 1.012 . . . . 1.0 110.911 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -80.52 -172.57 3.65 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.706 0.765 . . . . 1.0 110.585 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.478 ' N ' HD12 ' A' ' 5' ' ' LEU . 10.4 mp -70.17 141.56 52.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.982 0.896 . . . . 1.0 111.444 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.0 mt -114.64 130.62 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 115.648 -0.706 . . . . 1.0 110.91 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.37 142.94 47.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.06 0.457 . . . . 1.0 110.645 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -135.97 115.76 13.05 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.875 0.369 . . . . 1.0 110.971 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.91 137.14 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 120.98 0.419 . . . . 1.0 110.612 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -155.39 144.09 20.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.996 0.427 . . . . 1.0 111.164 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 t -146.81 143.49 28.66 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.233 0.539 . . . . 1.0 111.401 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.2 t -85.18 126.56 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.334 0.588 . . . . 1.0 110.631 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.7 mt -130.18 133.36 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.63 0.729 . . . . 1.0 110.49 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -90.5 95.85 10.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.39 0.614 . . . . 1.0 109.813 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.45 156.25 2.26 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.926 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.06 146.95 92.55 Favored 'Trans proline' 0 N--CA 1.506 2.238 0 C-N-CA 122.018 1.812 . . . . 1.0 112.621 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.1 tt -68.47 -27.47 36.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.446 0.641 . . . . 1.0 111.466 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.44 ' OE2' ' NE ' ' A' ' 72' ' ' ARG . 71.4 mm-40 -62.03 -47.26 85.55 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.88 -0.513 . . . . 1.0 112.286 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -62.77 -46.31 88.63 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.993 0.368 . . . . 1.0 111.993 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 21' ' ' TRP . 19.0 m -69.18 -46.47 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.833 -0.803 . . . . 1.0 108.833 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.429 ' N ' HG23 ' A' ' 20' ' ' VAL . 58.1 t-105 -55.2 -50.51 69.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -60.74 -44.8 96.23 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.018 -0.426 . . . . 1.0 110.357 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.75 -21.48 28.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.468 -0.333 . . . . 1.0 111.755 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.03 -41.46 15.77 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.061 0.458 . . . . 1.0 111.555 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 m -108.14 75.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.308 0.575 . . . . 1.0 110.69 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.405 ' O ' ' CG1' ' A' ' 30' ' ' ILE . 0.2 OUTLIER -159.4 124.64 2.26 Favored Pre-proline 0 CA--C 1.548 0.867 0 CA-C-O 119.184 -0.436 . . . . 1.0 110.783 178.536 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.52 -11.62 20.55 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 121.805 1.67 . . . . 1.0 112.34 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -91.03 -47.74 7.38 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 110.269 -0.271 . . . . 1.0 110.269 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.91 -42.69 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.919 -0.771 . . . . 1.0 108.919 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.405 ' CG1' ' O ' ' A' ' 26' ' ' ASN . 5.4 mm -60.34 -42.14 89.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.271 -0.64 . . . . 1.0 109.271 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -64.5 -31.26 72.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.686 0.279 . . . . 1.0 110.357 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -65.24 -45.98 82.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -72.04 -34.07 68.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.089 0.471 . . . . 1.0 110.589 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.549 ' O ' ' N ' ' A' ' 36' ' ' GLY . 68.6 mmm -93.94 59.82 2.79 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.554 0.692 . . . . 1.0 111.098 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 38.03 -84.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.135 -0.484 . . . . 1.0 112.2 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 34' ' ' MET . . . -146.34 48.26 0.68 Allowed Glycine 0 N--CA 1.469 0.865 0 O-C-N 121.948 -0.47 . . . . 1.0 112.021 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.7 m -93.48 117.57 30.25 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.675 0.75 . . . . 1.0 110.712 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 51.9 m -83.19 124.72 30.8 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.708 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.88 145.05 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.374 0.607 . . . . 1.0 110.631 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.5 t -120.74 130.65 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.41 0.624 . . . . 1.0 110.428 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.6 t -152.34 131.28 12.55 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.085 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.408 ' OD2' ' NZ ' ' A' ' 44' ' ' LYS . 93.9 m-20 -75.68 -19.08 59.39 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.119 0.961 . . . . 1.0 109.387 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.1 m0 68.16 45.47 1.27 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.65 -0.705 . . . . 1.0 111.488 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.408 ' NZ ' ' OD2' ' A' ' 42' ' ' ASP . 25.0 pttm -148.44 156.43 42.47 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.46 0.647 . . . . 1.0 111.369 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -48.19 127.69 12.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.687 0.756 . . . . 1.0 112.385 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.79 1.97 89.78 Favored Glycine 0 N--CA 1.465 0.609 0 CA-C-N 115.722 -0.672 . . . . 1.0 112.044 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.0 t -64.89 132.58 49.78 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.301 -0.529 . . . . 1.0 111.75 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -83.02 143.69 30.45 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.2 mt -134.1 136.08 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.791 0.805 . . . . 1.0 110.944 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.7 t -128.58 142.1 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.213 -0.903 . . . . 1.0 110.632 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 20.8 m-90 -117.18 123.26 46.25 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.014 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -97.0 126.63 42.27 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.25 178.26 34.59 Favored Glycine 0 N--CA 1.461 0.32 0 N-CA-C 110.997 -0.841 . . . . 1.0 110.997 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -128.68 136.59 50.82 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.571 0.701 . . . . 1.0 110.163 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -138.53 117.7 12.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.038 0.447 . . . . 1.0 110.466 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? 53.57 38.71 28.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.348 0.594 . . . . 1.0 110.747 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.7 -8.37 21.36 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.516 -1.034 . . . . 1.0 110.516 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -98.83 116.56 31.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.107 0.479 . . . . 1.0 110.664 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.09 128.44 36.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.251 0.548 . . . . 1.0 110.247 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -129.96 150.45 51.23 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.618 0.723 . . . . 1.0 110.971 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -135.77 131.66 35.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.437 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -89.54 162.6 15.6 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -141.18 126.99 19.16 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.558 0.694 . . . . 1.0 112.424 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.66 170.56 31.16 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.333 -1.107 . . . . 1.0 110.333 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.7 m -146.51 153.73 40.74 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 122.054 -0.674 . . . . 1.0 111.243 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.4 mm -77.9 116.49 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.37 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.4 tp -76.13 -44.9 36.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.653 0.74 . . . . 1.0 110.065 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -145.4 148.44 33.34 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -136.3 105.51 6.0 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.843 0.83 . . . . 1.0 111.439 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -125.45 107.95 11.16 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.25 -0.648 . . . . 1.0 109.25 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.464 ' H ' ' CD ' ' A' ' 71' ' ' GLU . 56.3 mp0 -46.69 134.54 9.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.546 0.688 . . . . 1.0 111.969 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.44 ' NE ' ' OE2' ' A' ' 18' ' ' GLU . 14.4 ptp180 36.76 53.46 1.09 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.78 -0.645 . . . . 1.0 112.445 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 m -157.59 -69.9 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.822 -0.549 . . . . 1.0 111.618 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.6 mt -142.4 134.87 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-O 121.588 0.708 . . . . 1.0 111.535 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.6 tp -132.0 119.52 21.18 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.317 -0.856 . . . . 1.0 110.792 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -133.54 138.3 46.0 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.257 0.551 . . . . 1.0 110.299 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -151.06 153.26 34.75 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.975 0.893 . . . . 1.0 112.073 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.8 p -84.59 151.79 24.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.253 -1.017 . . . . 1.0 108.253 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -149.84 137.32 19.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.632 0.73 . . . . 1.0 112.105 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -150.67 150.09 30.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.001 -0.999 . . . . 1.0 110.655 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.5 t . . . . . 0 CA--C 1.549 0.91 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.612 179.236 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 112.313 0.486 . . . . 1.0 112.313 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.428 ' C ' ' CD1' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -151.26 170.58 19.16 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.405 0.621 . . . . 1.0 111.722 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.492 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.3 OUTLIER -144.68 160.67 40.82 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.761 0.791 . . . . 1.0 111.318 179.354 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -104.5 129.19 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 115.171 -0.922 . . . . 1.0 109.458 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.8 t -96.26 132.79 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.987 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -123.18 121.63 36.42 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.378 0.609 . . . . 1.0 110.612 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.1 mm -107.15 131.76 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.468 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.1 m -118.89 114.36 22.48 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.356 0.598 . . . . 1.0 110.115 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.4 mt -122.94 122.94 39.81 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.641 0.734 . . . . 1.0 110.829 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 m -131.29 132.39 44.51 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.491 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -85.28 123.42 30.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.043 0.449 . . . . 1.0 110.38 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.6 mt -93.21 -152.56 0.33 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.007 0.432 . . . . 1.0 110.508 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.555 ' CD ' ' H ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -77.7 -48.73 16.0 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.187 0.44 . . . . 1.0 112.187 -178.802 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -136.95 35.47 2.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.81 0.844 . . . . 1.0 110.001 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 179.21 169.14 39.3 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.915 -0.874 . . . . 1.0 110.915 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.8 p -127.07 133.08 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.04 0.448 . . . . 1.0 111.302 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -88.72 139.87 30.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.589 . . . . 1.0 109.741 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.77 138.7 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.536 0.684 . . . . 1.0 110.248 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -150.33 136.37 18.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.307 0.575 . . . . 1.0 110.513 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 tt -122.12 132.59 54.55 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.982 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.2 m -124.2 143.38 50.55 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.491 0.662 . . . . 1.0 111.419 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.492 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 43.1 tt0 -145.4 135.5 23.82 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.419 -0.81 . . . . 1.0 109.947 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -110.24 -165.25 0.98 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.474 0.654 . . . . 1.0 112.407 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.0 t30 60.01 37.16 21.39 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.751 1.019 . . . . 1.0 113.751 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -83.63 113.15 20.64 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.663 -1.236 . . . . 1.0 107.663 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -62.58 -35.77 80.55 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.006 -1.058 . . . . 1.0 111.584 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.0 p -143.89 164.91 29.21 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.877 -0.514 . . . . 1.0 111.067 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -58.66 -35.65 72.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.57 0.7 . . . . 1.0 109.23 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -58.66 -41.14 85.43 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.443 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -68.28 -41.45 80.99 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.981 -0.45 . . . . 1.0 110.084 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -64.16 -47.64 79.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -59.26 -42.93 92.3 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -63.32 -37.78 88.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 71.0 m -67.95 -54.51 18.1 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -52.6 -43.95 65.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.34 -0.391 . . . . 1.0 109.963 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -62.97 -39.44 94.7 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.758 -0.46 . . . . 1.0 109.758 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -67.39 -51.69 48.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.045 0.45 . . . . 1.0 110.175 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -64.05 -42.25 97.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -58.39 -39.79 80.6 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.628 -0.878 . . . . 1.0 108.628 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.2 m -63.94 -40.93 97.56 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.919 -0.771 . . . . 1.0 108.919 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 39.5 ttm -65.8 -50.39 64.82 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.7 -40.7 95.93 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -66.23 -44.21 84.45 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.16 -37.25 91.26 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.106 -1.198 . . . . 1.0 110.106 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 49.0 tp -71.44 -44.78 64.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.4 0.619 . . . . 1.0 110.072 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -60.87 -43.93 97.74 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.108 -0.37 . . . . 1.0 110.461 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.67 -36.29 76.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.69 0.281 . . . . 1.0 110.847 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -62.02 -48.5 80.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.215 0.531 . . . . 1.0 110.399 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.31 -37.18 84.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.653 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.88 -0.54 13.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.296 0.569 . . . . 1.0 110.152 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -62.41 -35.96 80.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.665 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt . . . . . 0 C--N 1.329 -0.287 0 O-C-N 122.388 -0.195 . . . . 1.0 110.864 -179.278 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.509 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 121.44 0.638 . . . . 1.0 110.951 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -75.8 -153.82 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.21 0.528 . . . . 1.0 110.805 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 5' ' ' LEU . 3.3 mm? -79.0 141.6 37.34 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.618 0.723 . . . . 1.0 111.57 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.9 mt -117.92 128.64 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.0 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.17 138.99 33.42 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.991 -0.443 . . . . 1.0 110.651 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -136.35 126.5 26.27 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.265 0.555 . . . . 1.0 111.01 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.52 156.15 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.053 0.454 . . . . 1.0 110.626 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -170.75 144.59 2.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.018 0.437 . . . . 1.0 111.013 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 t -147.09 145.15 29.52 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.365 0.602 . . . . 1.0 111.034 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 12' ' ' VAL . 13.5 p -90.03 128.6 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.245 0.545 . . . . 1.0 110.439 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.5 mt -131.77 135.37 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.724 0.773 . . . . 1.0 110.613 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -88.01 94.4 9.78 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.476 0.655 . . . . 1.0 110.052 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.68 156.65 2.19 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.683 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.93 149.64 90.14 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.208 1.939 . . . . 1.0 112.401 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.9 tt -68.93 -29.01 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.91 -0.586 . . . . 1.0 111.263 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.44 -54.23 43.56 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.953 -0.467 . . . . 1.0 111.859 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.46 -40.06 89.17 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.97 0.359 . . . . 1.0 111.97 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.7 t -66.11 -46.93 86.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 30.2 t-105 -58.08 -41.53 83.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.727 0.775 . . . . 1.0 109.01 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -60.67 -44.13 96.85 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.993 -0.442 . . . . 1.0 110.38 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.2 69.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.578 -0.283 . . . . 1.0 111.687 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.55 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.1 tt -70.2 -41.74 73.29 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.231 -0.293 . . . . 1.0 111.469 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 m -121.21 79.06 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 121.749 0.785 . . . . 1.0 111.149 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -160.75 103.19 1.31 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.228 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -54.08 -27.33 45.47 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.064 1.843 . . . . 1.0 112.791 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -70.12 -53.44 17.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.147 0.499 . . . . 1.0 110.533 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.04 -42.19 88.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.401 0.619 . . . . 1.0 109.334 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.1 mm -59.43 -42.49 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.003 -0.74 . . . . 1.0 109.003 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -69.93 -31.76 69.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.016 0.436 . . . . 1.0 110.4 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -57.39 -41.98 81.29 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -70.27 -34.1 72.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.848 0.356 . . . . 1.0 110.37 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.2 mmt -85.07 148.25 26.25 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.582 0.706 . . . . 1.0 111.052 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -60.67 -43.68 97.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.633 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.41 41.58 0.24 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.106 -0.569 . . . . 1.0 112.061 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.7 m -85.27 126.96 34.12 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.448 0.642 . . . . 1.0 110.675 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.1 m -92.71 106.33 18.32 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.954 0.407 . . . . 1.0 110.599 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.0 t -106.19 135.32 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.659 0.743 . . . . 1.0 110.484 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.2 m -129.73 130.96 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.512 0.672 . . . . 1.0 110.549 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.2 t -155.78 154.18 31.0 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.535 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -92.75 -18.77 22.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.854 0.835 . . . . 1.0 108.948 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 2.2 m0 66.68 46.84 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 1.0 111.409 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -149.76 157.19 42.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.576 0.703 . . . . 1.0 111.334 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -52.22 129.55 28.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.865 0.84 . . . . 1.0 112.296 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.04 1.68 90.37 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.648 -0.706 . . . . 1.0 112.172 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.0 t -68.17 133.41 48.85 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 122.305 -0.527 . . . . 1.0 111.589 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -79.46 144.58 33.9 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.9 tt -138.25 136.93 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.608 0.718 . . . . 1.0 111.205 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.2 m -140.56 151.58 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.542 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -124.36 131.54 53.51 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.238 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -94.16 137.17 33.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.515 0.674 . . . . 1.0 109.694 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.78 169.9 37.34 Favored Glycine 0 C--N 1.33 0.239 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.55 122.78 40.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.816 0.817 . . . . 1.0 110.017 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' A' ' 58' ' ' LYS . 43.1 t-105 -117.58 115.87 25.96 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.576 0.703 . . . . 1.0 109.913 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.432 ' HG2' ' CD1' ' A' ' 55' ' ' TRP . 9.5 ptmm? 40.07 46.33 1.8 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.89 -0.596 . . . . 1.0 111.548 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.15 -17.77 9.19 Favored Glycine 0 N--CA 1.472 1.045 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 55' ' ' TRP . 37.5 ttmt -91.22 114.78 27.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.404 0.621 . . . . 1.0 110.299 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.37 136.59 46.16 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.108 -0.37 . . . . 1.0 110.33 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -138.61 155.82 47.99 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.558 0.695 . . . . 1.0 110.948 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.446 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 1.5 pm0 -138.73 131.78 29.72 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.542 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -87.09 136.81 32.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -120.52 127.74 52.46 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.56 0.695 . . . . 1.0 112.478 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.95 178.79 33.18 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.362 -1.095 . . . . 1.0 110.362 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 66' ' ' ILE . 58.1 m -148.12 157.9 43.77 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.86 -0.788 . . . . 1.0 111.132 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.454 ' N ' HG22 ' A' ' 65' ' ' THR . 31.8 mm -73.39 115.54 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.506 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.402 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 38.3 tp -69.73 -44.34 70.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.363 0.602 . . . . 1.0 110.137 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -155.97 147.53 22.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -131.06 110.17 11.02 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.649 0.738 . . . . 1.0 111.597 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -125.39 95.36 4.44 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.338 -0.615 . . . . 1.0 109.338 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -40.78 131.76 2.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.388 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.6 mtm-85 40.38 55.04 2.86 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.5 m -163.37 -70.65 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.757 -0.589 . . . . 1.0 111.976 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.1 mt -140.88 133.97 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 121.491 0.662 . . . . 1.0 111.408 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 tp -136.19 126.31 26.23 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.377 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -142.97 146.43 33.92 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.114 0.483 . . . . 1.0 110.226 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.402 ' HA ' ' H ' ' A' ' 67' ' ' LEU . 29.5 p90 -150.26 155.03 38.94 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.142 0.973 . . . . 1.0 112.204 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 93.8 p -95.18 152.68 18.15 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.469 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -152.06 151.42 31.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.844 0.83 . . . . 1.0 111.554 -179.482 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -142.35 134.72 27.81 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.752 -1.113 . . . . 1.0 110.463 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.0 m . . . . . 0 CA--C 1.545 0.775 0 CA-C-O 118.686 -0.673 . . . . 1.0 110.546 179.797 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.48 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 43.7 t30 . . . . . 0 CA--C 1.529 0.144 0 N-CA-C 112.292 0.479 . . . . 1.0 112.292 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.469 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 39.5 p90 -101.38 177.65 4.87 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.626 0.726 . . . . 1.0 112.053 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -134.96 162.5 32.27 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.892 0.853 . . . . 1.0 111.416 -179.316 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.6 p -101.3 129.86 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.012 -0.995 . . . . 1.0 109.8 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 t -94.76 133.5 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.9 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.4 t -128.75 121.96 29.56 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.494 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.15 132.4 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.35 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.3 m -111.88 124.63 52.79 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.421 0.629 . . . . 1.0 109.999 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 74.9 mt -125.51 117.67 24.12 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.428 0.632 . . . . 1.0 110.794 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.9 m -133.25 134.67 44.28 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.431 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -85.7 126.3 33.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.296 0.57 . . . . 1.0 110.29 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 47.7 mt -110.14 172.24 6.98 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.167 0.508 . . . . 1.0 110.589 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -64.54 -40.28 95.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.47 0.545 . . . . 1.0 112.47 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -83.73 -34.98 24.76 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.276 0.56 . . . . 1.0 110.875 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.25 -146.58 5.86 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.909 -0.876 . . . . 1.0 110.909 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.2 p -125.44 128.64 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.248 0.547 . . . . 1.0 111.016 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -95.81 142.15 28.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.611 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.3 m -130.14 148.7 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.622 0.725 . . . . 1.0 110.558 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -151.1 133.07 15.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.152 0.501 . . . . 1.0 110.514 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.6 tt -124.6 131.82 53.46 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.806 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.8 m -123.28 143.34 50.13 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.648 0.737 . . . . 1.0 111.142 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.438 ' OE1' ' ND2' ' A' ' 116' ' ' ASN . 0.9 OUTLIER -142.32 136.74 30.01 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.309 -0.86 . . . . 1.0 110.034 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 0.7 OUTLIER -114.23 -164.67 0.95 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.631 0.729 . . . . 1.0 112.334 -179.04 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 92' ' ' ASN . 64.4 t30 59.03 35.39 23.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.469 0.915 . . . . 1.0 113.469 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.438 ' ND2' ' OE1' ' A' ' 113' ' ' GLN . 83.5 m-20 -83.64 133.75 34.82 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.557 -1.275 . . . . 1.0 107.557 177.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -64.07 -46.17 85.49 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.028 -1.045 . . . . 1.0 112.066 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 62.0 p -147.79 179.71 7.51 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.843 -0.535 . . . . 1.0 110.835 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -60.39 -37.07 79.63 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -61.34 -43.96 98.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -71.32 -41.69 69.54 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.967 -0.458 . . . . 1.0 110.075 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -63.24 -44.89 93.92 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -62.8 -42.82 99.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.698 -0.852 . . . . 1.0 108.698 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -59.57 -39.94 85.75 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 16.8 t -69.73 -44.75 69.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -56.01 -47.73 77.23 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.98 -39.15 91.21 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.787 -0.449 . . . . 1.0 109.787 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -64.28 -53.11 54.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 1.0 110.068 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.506 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 86.5 m95 -60.61 -39.18 87.21 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -59.08 -39.89 83.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.396 -0.965 . . . . 1.0 108.396 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.4 m -63.5 -43.13 98.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.506 ' SD ' ' CE3' ' A' ' 129' ' ' TRP . 77.2 mtp -62.7 -50.7 70.07 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.497 -0.556 . . . . 1.0 109.497 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.54 -38.8 88.76 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.41 ' HA ' ' HZ3' ' A' ' 137' ' ' LYS . 78.8 tt0 -65.66 -34.04 77.28 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.68 -32.34 33.78 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.155 -1.178 . . . . 1.0 110.155 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.453 ' O ' HD23 ' A' ' 136' ' ' LEU . 1.7 tt -68.56 -54.13 18.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.641 0.734 . . . . 1.0 109.871 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.41 ' HZ3' ' HA ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -61.84 -27.0 68.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.534 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -56.36 -32.18 64.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.891 0.377 . . . . 1.0 110.613 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -79.22 -41.95 27.11 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.036 0.446 . . . . 1.0 110.7 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 140' ' ' LEU . 4.1 mm? -63.24 -41.87 99.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.838 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -75.74 -1.98 27.52 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.338 0.59 . . . . 1.0 110.231 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -63.5 -41.2 98.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.661 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.748 0.308 . . . . 1.0 110.902 -179.753 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.1 pt . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 121.903 0.859 . . . . 1.0 110.931 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -74.9 -175.8 2.67 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.7 -0.625 . . . . 1.0 110.971 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 5' ' ' LEU . 9.7 mp -68.2 140.2 56.08 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.03 0.919 . . . . 1.0 111.182 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.1 mp -112.21 124.33 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.687 -0.688 . . . . 1.0 111.099 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.08 134.21 36.75 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.029 -0.42 . . . . 1.0 110.372 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -133.7 122.36 23.27 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.976 0.417 . . . . 1.0 110.804 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.3 m -139.89 135.59 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.099 0.476 . . . . 1.0 110.576 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -152.64 150.69 29.75 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.089 0.471 . . . . 1.0 111.033 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.479 HG23 ' NZ ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -145.87 142.39 28.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.541 0.686 . . . . 1.0 111.143 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 t -85.62 114.51 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.416 0.627 . . . . 1.0 110.715 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.9 mm -127.84 138.77 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 122.183 0.992 . . . . 1.0 110.733 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -98.04 105.93 18.15 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.397 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' A' ' 16' ' ' PRO . . . -173.24 160.6 3.46 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 120.977 -0.289 . . . . 1.0 110.416 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.436 ' HD2' ' HB1' ' A' ' 15' ' ' ALA . 26.0 Cg_endo -59.85 140.5 93.45 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.341 2.027 . . . . 1.0 112.135 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.1 tp -68.21 -32.87 57.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.649 0.738 . . . . 1.0 111.221 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -57.4 -52.39 65.58 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.886 -0.508 . . . . 1.0 111.859 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.451 ' N ' ' CD ' ' A' ' 19' ' ' LYS . 12.2 mptt -64.49 -42.91 95.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.52 -47.54 91.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.46 ' CH2' ' O ' ' A' ' 70' ' ' ASN . 62.3 t-105 -60.23 -42.42 95.19 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -58.99 -47.39 85.34 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.977 -0.452 . . . . 1.0 110.206 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.79 -28.82 69.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.647 0.261 . . . . 1.0 111.702 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -70.56 -41.73 72.07 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.237 -0.289 . . . . 1.0 111.489 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 m -120.27 78.89 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 121.759 0.79 . . . . 1.0 111.226 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -158.63 113.22 1.66 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.56 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.99 -11.34 31.59 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.237 1.291 . . . . 1.0 112.649 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -86.28 -47.66 9.21 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.804 0.335 . . . . 1.0 110.332 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.18 -41.46 66.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.295 -0.632 . . . . 1.0 109.295 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.31 -42.3 86.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -65.46 -31.26 72.24 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.292 -0.262 . . . . 1.0 110.292 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -56.6 -42.77 79.28 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.824 -0.435 . . . . 1.0 109.824 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -69.81 -33.8 72.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.942 0.401 . . . . 1.0 110.389 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 79.8 mmm -85.22 153.72 22.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.66 0.743 . . . . 1.0 110.816 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -62.56 -35.83 80.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.63 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.28 42.62 0.07 OUTLIER Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.017 -0.611 . . . . 1.0 111.943 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.2 m -85.8 125.73 33.48 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.601 0.715 . . . . 1.0 110.74 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.0 p -88.95 102.42 15.05 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.636 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.53 130.64 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.471 0.653 . . . . 1.0 110.419 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.05 128.42 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.408 0.623 . . . . 1.0 110.264 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.507 ' HG ' ' HD1' ' A' ' 43' ' ' TRP . 31.5 t -155.6 153.42 30.07 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.125 -0.488 . . . . 1.0 111.384 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 8.1 t0 -92.77 -20.61 20.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.945 0.879 . . . . 1.0 108.958 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.507 ' HD1' ' HG ' ' A' ' 41' ' ' SER . 2.6 m0 67.8 49.75 0.91 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.828 -0.624 . . . . 1.0 111.559 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -151.77 155.18 37.73 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.519 0.676 . . . . 1.0 111.186 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -49.64 127.41 15.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.794 0.807 . . . . 1.0 112.176 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.4 0.75 90.2 Favored Glycine 0 N--CA 1.468 0.833 0 CA-C-N 115.678 -0.692 . . . . 1.0 112.115 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.0 t -66.31 135.9 55.06 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.232 -0.57 . . . . 1.0 111.694 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -84.67 147.01 27.16 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.44 HD11 ' HE1' ' A' ' 51' ' ' TRP . 19.8 tt -136.91 136.15 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.539 0.685 . . . . 1.0 111.338 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -138.66 142.47 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 115.505 -0.77 . . . . 1.0 110.556 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.44 ' HE1' HD11 ' A' ' 49' ' ' ILE . 14.1 m0 -119.67 136.64 54.32 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.052 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -101.97 143.53 31.71 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.332 0.587 . . . . 1.0 109.578 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.41 175.41 43.68 Favored Glycine 0 C--N 1.329 0.167 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -125.53 127.01 45.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.97 0.89 . . . . 1.0 109.791 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.587 ' O ' ' N ' ' A' ' 58' ' ' LYS . 36.2 t-105 -120.34 119.17 32.33 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.384 0.612 . . . . 1.0 109.645 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.415 ' HG2' ' CD1' ' A' ' 55' ' ' TRP . 9.9 ptmm? 39.66 42.02 0.88 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.346 0.594 . . . . 1.0 111.7 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.02 -18.01 19.12 Favored Glycine 0 N--CA 1.476 1.316 0 N-CA-C 110.768 -0.933 . . . . 1.0 110.768 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.587 ' N ' ' O ' ' A' ' 55' ' ' TRP . 74.4 mmtt -91.36 110.5 21.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.98 0.895 . . . . 1.0 110.655 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.03 132.15 47.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.65 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -134.38 152.56 51.87 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.612 0.72 . . . . 1.0 110.909 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.448 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 2.0 pm0 -138.03 136.07 36.5 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.497 0.665 . . . . 1.0 110.498 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -88.49 167.85 13.09 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -153.69 127.19 8.64 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.139 -0.624 . . . . 1.0 112.37 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.78 178.23 30.84 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.399 -1.081 . . . . 1.0 110.399 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 66' ' ' ILE . 79.2 m -148.51 154.03 39.25 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.997 -0.708 . . . . 1.0 111.24 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.408 ' N ' HG22 ' A' ' 65' ' ' THR . 32.1 mm -80.4 121.95 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.403 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -90.97 -44.54 9.28 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.426 0.631 . . . . 1.0 109.964 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -133.8 135.24 43.71 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.718 -0.475 . . . . 1.0 109.718 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -135.08 102.64 5.27 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.726 0.774 . . . . 1.0 111.516 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.46 ' O ' ' CH2' ' A' ' 21' ' ' TRP . 6.9 m120 -124.83 102.89 7.78 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.345 -0.613 . . . . 1.0 109.345 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -42.94 127.53 4.12 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.729 -0.668 . . . . 1.0 112.261 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 45.15 53.98 7.45 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.051 0.54 . . . . 1.0 112.352 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.7 t -160.05 -74.32 0.07 Allowed 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.782 -0.574 . . . . 1.0 112.027 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.5 mt -138.15 133.02 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.656 0.741 . . . . 1.0 111.374 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.1 tp -132.08 125.48 31.49 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.32 -0.855 . . . . 1.0 110.57 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.499 HE21 HG11 ' A' ' 95' ' ' VAL . 58.3 tt0 -135.13 136.71 42.12 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.452 0.644 . . . . 1.0 110.235 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -149.7 152.98 36.21 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.019 0.914 . . . . 1.0 112.0 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 p -86.94 151.07 23.62 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.152 -1.055 . . . . 1.0 108.152 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.413 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 15.2 t-80 -151.19 142.11 22.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.544 0.688 . . . . 1.0 111.939 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -144.91 148.65 34.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.048 -0.978 . . . . 1.0 110.351 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 74.8 m . . . . . 0 CA--C 1.548 0.903 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.63 179.699 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 66.9 t30 . . . . . 0 N--CA 1.465 0.284 0 N-CA-C 112.227 0.454 . . . . 1.0 112.227 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.59 173.2 12.94 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.616 0.722 . . . . 1.0 112.031 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -139.61 165.15 28.03 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 122.138 0.97 . . . . 1.0 111.19 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.499 HG11 HE21 ' A' ' 76' ' ' GLN . 59.2 t -107.28 128.9 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 114.829 -1.078 . . . . 1.0 109.657 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.0 t -92.82 134.13 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.919 -0.582 . . . . 1.0 111.14 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.9 t -132.03 124.78 29.97 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.51 0.671 . . . . 1.0 110.443 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.95 129.96 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.17 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.5 m -106.87 120.85 43.15 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.555 0.693 . . . . 1.0 109.831 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 mp -117.21 124.1 48.27 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.613 0.721 . . . . 1.0 110.816 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.7 p -131.02 134.08 46.35 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.824 0.821 . . . . 1.0 110.477 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.98 111.37 23.61 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.119 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.5 mt -77.76 -168.98 1.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.042 0.449 . . . . 1.0 110.464 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -64.47 -48.34 75.62 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.515 0.561 . . . . 1.0 112.515 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -137.48 38.5 2.46 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.407 0.683 . . . . 1.0 109.942 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.91 168.84 41.31 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.9 p -134.4 144.4 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.742 0.782 . . . . 1.0 110.776 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -120.27 143.03 48.54 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.698 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.0 m -129.91 149.98 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.643 0.735 . . . . 1.0 110.345 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -152.2 134.14 14.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.698 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.9 tt -119.98 131.05 55.04 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.365 0.603 . . . . 1.0 109.957 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 m -120.67 142.65 49.27 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.415 0.626 . . . . 1.0 111.265 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -145.52 136.63 24.77 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.462 -0.79 . . . . 1.0 110.046 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 10.9 p-10 -116.48 -171.09 1.94 Allowed 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.655 0.74 . . . . 1.0 112.341 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.0 t30 65.01 38.76 6.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.627 0.973 . . . . 1.0 113.627 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -84.91 116.65 23.46 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 107.638 -1.245 . . . . 1.0 107.638 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -58.87 -36.92 75.41 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 120.954 -1.092 . . . . 1.0 111.773 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.6 p -140.96 163.6 32.52 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.872 -0.518 . . . . 1.0 111.045 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.1 -34.59 77.92 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -57.9 -38.94 76.73 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.535 -0.542 . . . . 1.0 109.535 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.49 -35.04 70.66 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.87 -0.519 . . . . 1.0 110.21 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -62.16 -47.72 83.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.792 -0.818 . . . . 1.0 108.792 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -60.23 -42.46 95.28 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.827 -0.805 . . . . 1.0 108.827 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -61.0 -38.38 85.84 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.6 t -68.42 -53.46 23.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.638 -0.505 . . . . 1.0 109.638 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -55.41 -45.46 76.71 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.999 -0.371 . . . . 1.0 109.999 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -62.76 -40.2 96.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -66.74 -51.6 54.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.373 0.606 . . . . 1.0 110.136 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -61.26 -35.68 77.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.495 -0.557 . . . . 1.0 109.495 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -59.69 -40.4 87.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.569 -0.9 . . . . 1.0 108.569 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.7 m -63.77 -43.01 97.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.252 -0.647 . . . . 1.0 109.252 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 83.4 mmm -61.42 -50.34 73.22 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.52 -40.35 94.32 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -62.8 -44.25 96.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.91 -41.94 86.93 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.224 -1.15 . . . . 1.0 110.224 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.517 HD23 ' O ' ' A' ' 136' ' ' LEU . 2.4 tt -63.03 -50.41 70.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.691 0.758 . . . . 1.0 110.179 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.479 ' NZ ' HG23 ' A' ' 11' ' ' THR . 1.0 OUTLIER -62.54 -36.86 83.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.229 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.68 -35.1 54.74 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 122.378 -0.201 . . . . 1.0 110.761 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -65.48 -51.06 62.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.915 0.388 . . . . 1.0 110.423 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.75 -41.05 88.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.488 -0.324 . . . . 1.0 110.905 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -68.58 -18.08 64.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.249 0.547 . . . . 1.0 109.935 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -48.7 -30.87 6.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 1.0 110.721 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.3 pttt . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.722 0.296 . . . . 1.0 111.278 -179.709 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.1 pt . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 121.757 0.789 . . . . 1.0 110.928 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -77.26 -165.23 0.55 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.771 -0.581 . . . . 1.0 111.059 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 5' ' ' LEU . 9.3 mp -68.61 139.12 55.51 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.65 0.738 . . . . 1.0 111.306 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.5 mm -110.0 124.81 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.934 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.31 136.31 42.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.956 0.407 . . . . 1.0 110.637 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -131.92 119.84 21.71 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.079 0.466 . . . . 1.0 110.935 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.9 m -143.95 136.29 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 121.095 0.474 . . . . 1.0 110.609 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -150.66 149.97 30.52 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.989 0.423 . . . . 1.0 111.305 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 t -146.98 144.56 29.27 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.404 0.621 . . . . 1.0 111.136 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.1 t -85.27 113.34 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.262 0.553 . . . . 1.0 110.586 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mm -110.51 126.83 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.682 0.753 . . . . 1.0 110.512 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -92.51 94.95 9.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.21 0.529 . . . . 1.0 109.806 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' HB1' ' HD2' ' A' ' 16' ' ' PRO . . . -171.62 169.7 2.91 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.806 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD2' ' HB1' ' A' ' 15' ' ' ALA . 27.2 Cg_exo -61.52 148.13 93.74 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 122.286 1.991 . . . . 1.0 112.477 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 tp -68.41 -36.25 74.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.17 0.509 . . . . 1.0 111.336 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -66.29 -48.46 70.32 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.878 -0.514 . . . . 1.0 112.084 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.13 -42.72 99.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.916 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.2 t -68.26 -45.6 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -59.47 -41.59 90.1 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.086 -0.709 . . . . 1.0 109.086 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -56.3 -43.22 78.67 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 122.044 -0.41 . . . . 1.0 110.367 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.43 -31.81 66.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.336 . . . . 1.0 111.669 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.515 HD13 ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -66.42 -45.88 78.41 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.766 0.317 . . . . 1.0 111.643 -179.066 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 m -116.5 82.01 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.585 0.707 . . . . 1.0 110.78 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -160.2 113.78 1.42 Allowed Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.491 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.94 -12.65 28.58 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 121.635 1.556 . . . . 1.0 112.362 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -86.43 -46.24 10.41 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.647 0.26 . . . . 1.0 110.453 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.7 mt -71.75 -43.36 70.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.5 mt -59.66 -43.08 90.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.03 -0.73 . . . . 1.0 109.03 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -70.9 -29.28 65.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.997 0.427 . . . . 1.0 110.353 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -57.25 -40.93 78.66 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -70.08 -33.52 72.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 1.0 110.249 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.413 ' CE ' ' OG1' ' A' ' 37' ' ' THR . 64.7 mtp -87.81 154.85 20.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.602 0.715 . . . . 1.0 111.167 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -60.75 -43.7 97.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.696 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.26 49.82 0.14 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.966 -0.635 . . . . 1.0 111.919 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.413 ' OG1' ' CE ' ' A' ' 34' ' ' MET . 88.8 m -81.94 128.87 34.51 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.73 0.776 . . . . 1.0 110.761 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.4 m -91.29 91.83 8.35 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.755 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p -103.93 134.1 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.702 0.763 . . . . 1.0 110.383 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.6 t -126.41 134.54 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.671 0.748 . . . . 1.0 110.409 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.1 t -155.45 143.37 19.9 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.386 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -81.92 -19.53 40.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.84 0.829 . . . . 1.0 109.098 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.2 m0 69.42 48.11 0.65 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.523 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -157.46 168.47 27.23 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.428 0.633 . . . . 1.0 111.195 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -58.68 127.63 33.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.689 0.757 . . . . 1.0 112.294 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.23 -1.42 84.51 Favored Glycine 0 N--CA 1.47 0.934 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.994 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.2 m -67.59 133.2 48.98 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.235 -0.568 . . . . 1.0 111.805 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 64' ' ' GLY . 68.0 tp60 -83.24 145.88 28.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.821 -0.807 . . . . 1.0 108.821 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.0 tt -136.83 137.35 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.457 0.646 . . . . 1.0 111.134 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -143.46 149.73 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.696 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.511 ' CZ3' ' NE2' ' A' ' 79' ' ' HIS . 9.6 m0 -124.55 140.45 52.93 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.039 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -103.61 137.46 41.64 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.099 0.476 . . . . 1.0 109.798 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.95 176.35 40.73 Favored Glycine 0 N--CA 1.46 0.27 0 N-CA-C 111.041 -0.824 . . . . 1.0 111.041 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -127.09 138.65 53.24 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.802 0.811 . . . . 1.0 110.19 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -143.16 117.43 9.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.285 0.564 . . . . 1.0 110.293 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 54.56 34.85 22.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.581 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.85 -9.34 38.16 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -97.99 117.3 32.03 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.656 0.741 . . . . 1.0 110.147 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.38 129.06 38.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.301 0.572 . . . . 1.0 110.085 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -128.9 150.37 50.39 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.66 0.743 . . . . 1.0 110.803 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -136.58 133.72 36.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.493 0.663 . . . . 1.0 110.341 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -92.71 142.52 27.26 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -127.69 129.37 47.03 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.62 0.724 . . . . 1.0 112.517 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.469 ' O ' ' NE2' ' A' ' 48' ' ' GLN . . . -151.71 177.97 29.29 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.378 -1.089 . . . . 1.0 110.378 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 66' ' ' ILE . 71.5 m -149.96 156.06 41.06 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 122.047 -0.679 . . . . 1.0 111.193 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.421 ' N ' HG22 ' A' ' 65' ' ' THR . 38.4 mm -77.68 115.29 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.269 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.4 tp -73.3 -44.28 59.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.707 0.765 . . . . 1.0 110.154 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -150.15 147.87 28.26 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.63 -0.507 . . . . 1.0 109.63 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -132.04 110.05 10.45 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.97 0.89 . . . . 1.0 111.494 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -124.84 94.57 4.22 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.355 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -40.15 130.46 2.16 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.935 -0.575 . . . . 1.0 112.533 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 42.93 54.57 4.71 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.194 0.598 . . . . 1.0 112.432 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.0 t -163.46 -71.06 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.716 -0.615 . . . . 1.0 112.192 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 94.8 mt -138.0 136.31 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 121.511 0.672 . . . . 1.0 111.448 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.571 HD13 ' N ' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -135.83 120.28 18.08 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.429 -0.805 . . . . 1.0 110.328 178.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.571 ' N ' HD13 ' A' ' 75' ' ' LEU . 7.3 tt0 -133.37 138.75 46.45 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.474 0.654 . . . . 1.0 110.34 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -149.46 150.86 33.02 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.944 0.878 . . . . 1.0 111.922 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.2 p -85.33 152.29 23.39 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.511 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 45.8 t-80 -148.77 136.82 20.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.686 0.755 . . . . 1.0 111.986 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -138.04 144.31 40.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.918 -1.037 . . . . 1.0 110.31 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.476 0.84 0 CA-C-N 115.746 -0.661 . . . . 1.0 110.767 179.318 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.2 t30 . . . . . 0 N--CA 1.466 0.367 0 N-CA-C 112.587 0.588 . . . . 1.0 112.587 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -101.55 172.09 7.18 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.519 0.676 . . . . 1.0 112.0 -178.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -140.66 162.75 34.65 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.849 0.833 . . . . 1.0 111.342 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.2 p -106.62 131.23 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 115.057 -0.974 . . . . 1.0 109.677 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.1 t -96.51 131.41 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.238 0.542 . . . . 1.0 110.679 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.1 t -121.82 120.76 35.5 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.604 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.6 mm -110.3 131.77 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.591 -0.731 . . . . 1.0 110.414 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.406 ' C ' HD12 ' A' ' 100' ' ' LEU . 91.7 m -124.09 120.42 32.32 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.391 0.615 . . . . 1.0 110.288 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.406 HD12 ' C ' ' A' ' 99' ' ' THR . 9.6 mp -115.31 131.61 56.87 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 122.119 0.961 . . . . 1.0 110.772 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.42 ' OG1' ' CG ' ' A' ' 108' ' ' GLU . 32.0 p -133.45 128.83 36.3 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.076 -0.966 . . . . 1.0 110.337 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -84.57 108.82 17.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.13 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 106' ' ' GLY . 25.8 mt -91.79 170.76 9.63 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.072 0.463 . . . . 1.0 110.482 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -63.87 -39.03 93.25 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.452 0.538 . . . . 1.0 112.452 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -84.08 -33.35 24.41 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.298 0.571 . . . . 1.0 110.728 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 103' ' ' LEU . . . -175.86 -139.06 3.01 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.8 p -134.22 139.27 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.437 0.637 . . . . 1.0 110.79 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.42 ' CG ' ' OG1' ' A' ' 101' ' ' THR . 19.0 pt-20 -105.49 142.02 35.97 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.463 -0.789 . . . . 1.0 109.768 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -124.06 139.33 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.716 0.769 . . . . 1.0 110.408 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -135.76 132.08 36.33 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.349 0.595 . . . . 1.0 110.77 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 tt -128.41 134.73 48.86 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.073 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 75.6 p -131.29 150.57 52.09 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.654 0.74 . . . . 1.0 111.357 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -146.14 108.92 4.54 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.278 -0.874 . . . . 1.0 110.053 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -82.38 -170.19 2.81 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.646 0.736 . . . . 1.0 112.521 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.9 t30 62.25 36.71 14.6 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.737 1.014 . . . . 1.0 113.737 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -81.44 122.12 27.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.597 -1.261 . . . . 1.0 107.597 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -65.23 -36.25 83.58 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 120.999 -1.063 . . . . 1.0 111.839 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.418 HG23 ' H ' ' A' ' 121' ' ' GLU . 1.6 t -151.08 168.48 24.48 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.17 0.509 . . . . 1.0 111.042 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -57.53 -36.67 71.89 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -58.39 -41.9 85.86 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.418 ' H ' HG23 ' A' ' 118' ' ' THR . 78.6 tt0 -70.43 -39.72 74.21 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.932 -0.48 . . . . 1.0 110.213 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -64.01 -48.91 74.49 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.729 -0.841 . . . . 1.0 108.729 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -59.35 -46.84 87.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -57.81 -39.55 77.85 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.1 t -67.78 -56.09 10.55 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.647 -0.501 . . . . 1.0 109.647 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -54.29 -44.03 71.57 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.13 -39.22 91.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.008 0.432 . . . . 1.0 109.951 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -69.91 -51.28 34.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.188 0.518 . . . . 1.0 110.146 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -62.59 -39.18 92.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -57.71 -40.26 79.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.0 m -61.59 -39.51 91.43 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -65.81 -48.21 72.48 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 133' ' ' LEU . 4.2 mm? -61.0 -41.51 96.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.372 -0.603 . . . . 1.0 109.372 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -64.99 -41.39 95.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.78 -35.65 87.17 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 136' ' ' LEU . 0.2 OUTLIER -70.83 -48.32 54.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.199 0.523 . . . . 1.0 109.971 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -59.02 -43.91 91.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.931 -0.396 . . . . 1.0 109.931 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.99 -41.99 98.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.713 0.292 . . . . 1.0 110.775 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -71.66 -45.86 60.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.222 0.534 . . . . 1.0 110.755 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.528 ' O ' HD13 ' A' ' 140' ' ' LEU . 0.2 OUTLIER -65.09 -45.66 84.31 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.859 -179.328 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -73.45 -1.62 19.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.105 0.479 . . . . 1.0 109.767 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -61.41 -37.34 83.12 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.272 -0.268 . . . . 1.0 110.445 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.1 pttt . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.74 0.305 . . . . 1.0 111.291 -179.957 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 108.531 -0.914 . . . . 1.0 108.531 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -168.16 -164.2 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.743 0.306 . . . . 1.0 110.262 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt -55.38 145.63 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.704 0.764 . . . . 1.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -82.53 -161.65 0.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.738 -0.601 . . . . 1.0 111.108 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.7 mp -71.48 144.15 49.78 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.702 0.763 . . . . 1.0 111.399 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.87 129.36 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 121.451 0.643 . . . . 1.0 110.892 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.42 134.14 33.92 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.933 -0.479 . . . . 1.0 110.386 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -142.51 138.13 30.71 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.041 0.448 . . . . 1.0 110.684 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.4 m -140.8 156.13 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.147 0.499 . . . . 1.0 110.611 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -159.46 143.48 14.9 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 122.055 -0.403 . . . . 1.0 111.207 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 t -147.54 145.26 29.01 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.244 0.545 . . . . 1.0 111.361 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.6 t -84.05 112.35 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.318 0.58 . . . . 1.0 110.635 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.7 mm -115.07 130.14 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.822 0.82 . . . . 1.0 110.74 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -94.02 95.91 9.34 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.95 -0.469 . . . . 1.0 110.02 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.45 155.73 7.37 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.58 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -61.97 145.94 96.54 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.392 2.061 . . . . 1.0 112.212 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.403 HG23 ' N ' ' A' ' 18' ' ' GLU . 10.3 tp -62.8 -38.0 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.125 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.403 ' N ' HG23 ' A' ' 17' ' ' ILE . 79.8 mm-40 -54.48 -56.44 18.72 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.933 -0.479 . . . . 1.0 112.068 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -64.62 -41.78 95.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.935 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.3 t -65.6 -48.5 82.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -57.83 -42.61 84.73 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.29 -47.13 86.53 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 122.072 -0.392 . . . . 1.0 110.235 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.82 -28.74 66.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.636 0.255 . . . . 1.0 111.609 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.7 tp -72.97 -43.24 62.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 1.0 111.645 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.42 79.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 121.545 0.688 . . . . 1.0 110.992 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -160.72 113.41 1.34 Allowed Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.498 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.79 -15.26 36.89 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.885 1.723 . . . . 1.0 112.373 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -83.47 -49.79 8.93 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -69.16 -41.73 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 mm -59.66 -26.11 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -77.78 -30.89 51.57 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.062 -0.347 . . . . 1.0 110.062 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -56.44 -43.44 79.5 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.792 -0.447 . . . . 1.0 109.792 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -69.62 -33.91 73.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.964 0.412 . . . . 1.0 110.486 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.6 mmt -89.01 151.85 22.03 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.57 0.7 . . . . 1.0 111.123 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -61.53 -40.72 95.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.731 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.55 37.44 0.13 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.088 -0.577 . . . . 1.0 111.953 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.1 m -74.6 128.93 36.78 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.663 0.744 . . . . 1.0 110.82 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.1 m -94.46 93.5 7.69 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.731 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.5 t -92.59 128.74 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.402 0.62 . . . . 1.0 110.4 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.63 129.03 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 121.346 0.593 . . . . 1.0 110.456 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.545 ' HG ' ' HE1' ' A' ' 43' ' ' TRP . 38.4 p -155.21 157.94 38.11 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.222 -0.445 . . . . 1.0 111.306 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -97.35 -18.01 19.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.872 0.844 . . . . 1.0 108.78 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.545 ' HE1' ' HG ' ' A' ' 41' ' ' SER . 2.8 m0 67.27 44.91 1.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.24 0.616 . . . . 1.0 111.607 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -150.17 157.97 43.67 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.443 0.64 . . . . 1.0 111.433 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -52.71 130.23 31.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.8 0.81 . . . . 1.0 112.267 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.62 3.8 90.36 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 115.713 -0.676 . . . . 1.0 112.082 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.2 t -71.83 134.09 45.9 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.282 -0.54 . . . . 1.0 111.608 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -81.38 148.85 29.12 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.463 HD11 ' HE1' ' A' ' 51' ' ' TRP . 20.2 tt -134.62 133.8 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.547 0.689 . . . . 1.0 111.353 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.8 t -134.72 140.15 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.599 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.463 ' HE1' HD11 ' A' ' 49' ' ' ILE . 24.0 m0 -118.72 131.32 56.13 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.179 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -99.88 140.28 34.32 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.319 0.58 . . . . 1.0 109.738 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.23 178.78 42.24 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 110.989 -0.845 . . . . 1.0 110.989 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -128.66 134.32 48.49 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.914 0.864 . . . . 1.0 110.118 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -135.65 116.78 14.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.323 0.582 . . . . 1.0 110.375 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt 52.92 40.25 30.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.33 0.586 . . . . 1.0 110.659 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.6 -8.3 15.07 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.682 -0.967 . . . . 1.0 110.682 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -97.74 115.57 28.24 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.435 0.636 . . . . 1.0 110.407 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.61 133.0 47.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.078 0.466 . . . . 1.0 110.216 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -136.4 154.12 50.9 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.721 0.772 . . . . 1.0 110.963 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -138.21 132.77 32.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.826 -0.624 . . . . 1.0 110.53 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -88.27 167.48 13.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.244 -0.65 . . . . 1.0 109.244 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -156.23 133.85 10.95 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.702 0.763 . . . . 1.0 112.663 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.95 -176.86 34.48 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.359 -1.096 . . . . 1.0 110.359 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 66' ' ' ILE . 90.8 m -147.19 156.69 43.18 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.951 -0.735 . . . . 1.0 111.102 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.445 ' N ' HG22 ' A' ' 65' ' ' THR . 42.9 mm -73.94 115.4 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.555 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.415 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 46.0 tp -67.02 -41.84 85.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.611 0.72 . . . . 1.0 110.164 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -159.56 149.32 18.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.546 -0.538 . . . . 1.0 109.546 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -133.89 111.39 10.43 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.962 0.887 . . . . 1.0 111.54 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.402 ' HB2' ' H ' ' A' ' 74' ' ' ILE . 12.5 m120 -119.66 104.68 10.48 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.327 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -41.16 122.95 1.93 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.358 0.599 . . . . 1.0 112.247 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 41.35 55.1 3.44 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.09 0.556 . . . . 1.0 112.436 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.7 m -157.91 -68.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.723 -0.611 . . . . 1.0 112.107 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.402 ' H ' ' HB2' ' A' ' 70' ' ' ASN . 91.4 mt -141.68 138.16 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-O 121.647 0.737 . . . . 1.0 111.509 -178.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 tp -133.33 125.85 30.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.29 -0.868 . . . . 1.0 110.687 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -132.52 138.92 47.68 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.238 0.542 . . . . 1.0 110.203 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.415 ' HA ' ' H ' ' A' ' 67' ' ' LEU . 49.8 p90 -150.75 143.94 24.81 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.939 0.876 . . . . 1.0 112.077 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 93.1 p -85.99 153.76 21.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.008 -1.108 . . . . 1.0 108.008 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.407 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 42.4 t-80 -147.47 142.29 26.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.732 0.777 . . . . 1.0 111.96 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -142.01 134.65 28.34 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.876 -1.056 . . . . 1.0 110.457 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.1 t -111.84 119.37 44.69 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.666 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -71.91 -20.0 26.32 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 121.375 1.383 . . . . 1.0 112.271 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.6 mt -59.49 -12.08 5.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.897 0.379 . . . . 1.0 110.346 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.4 p -64.87 -34.99 79.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.557 -0.292 . . . . 1.0 110.659 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.6 29.76 33.06 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.836 -0.906 . . . . 1.0 110.836 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -90.27 153.29 46.48 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 120.914 -0.314 . . . . 1.0 111.351 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.64 149.5 24.47 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 121.666 1.577 . . . . 1.0 111.679 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -44.97 97.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.591 0.71 . . . . 1.0 111.969 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.486 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 7.0 tp -152.09 89.91 3.9 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 121.954 -0.466 . . . . 1.0 110.367 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.488 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 51.5 Cg_exo -51.28 -27.92 24.86 Favored 'Trans proline' 0 N--CA 1.502 2.019 0 C-N-CA 122.45 2.1 . . . . 1.0 112.516 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.0 mp0 -69.2 -1.85 8.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.169 0.509 . . . . 1.0 110.322 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 89' ' ' LEU . 29.5 p30 -70.14 -23.04 62.94 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.421 0.526 . . . . 1.0 112.421 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 90' ' ' PRO . 30.1 p90 -108.99 178.07 4.58 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.469 0.652 . . . . 1.0 112.019 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.496 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.3 OUTLIER -135.4 163.12 30.76 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.936 0.874 . . . . 1.0 111.277 -179.297 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.4 p -103.31 131.64 51.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.028 -0.987 . . . . 1.0 109.673 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -97.53 134.0 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.025 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 t -125.6 121.31 33.23 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.704 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.1 mm -108.0 129.84 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.452 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.8 m -114.78 121.63 43.89 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.444 0.64 . . . . 1.0 109.953 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 70.8 mt -123.77 128.85 50.15 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.549 0.69 . . . . 1.0 110.907 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 69.5 p -135.55 144.39 46.21 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.37 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -99.79 108.09 20.3 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.456 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 106' ' ' GLY . 55.1 mt -96.12 171.53 8.55 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.04 0.448 . . . . 1.0 110.697 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.95 -42.62 99.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.247 0.462 . . . . 1.0 112.247 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -81.78 -32.55 31.32 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.099 0.56 . . . . 1.0 110.672 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 103' ' ' LEU . . . -176.69 -141.53 3.98 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.579 -1.008 . . . . 1.0 110.579 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 m -133.94 130.27 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.566 0.222 . . . . 1.0 111.179 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -92.46 141.98 27.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.336 0.589 . . . . 1.0 109.904 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.73 151.26 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.513 0.673 . . . . 1.0 110.396 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -151.77 135.1 16.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.107 0.479 . . . . 1.0 110.686 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 tt -125.21 126.23 44.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.956 -0.566 . . . . 1.0 109.928 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 m -120.78 144.68 48.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.421 0.629 . . . . 1.0 111.477 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.496 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 39.4 tt0 -143.79 130.22 19.96 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.507 -0.769 . . . . 1.0 110.141 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.442 ' O ' ' ND1' ' A' ' 94' ' ' HIS . 0.7 OUTLIER -105.23 -170.42 1.75 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.476 0.655 . . . . 1.0 112.467 -179.321 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.3 t30 63.46 38.0 10.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.655 0.983 . . . . 1.0 113.655 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -82.88 128.96 34.91 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -67.38 -41.31 85.26 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.083 -1.011 . . . . 1.0 111.83 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.454 ' OG1' ' N ' ' A' ' 119' ' ' GLU . 1.3 t -150.9 175.97 11.53 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.109 0.48 . . . . 1.0 111.079 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.454 ' N ' ' OG1' ' A' ' 118' ' ' THR . 96.5 mt-10 -59.19 -37.57 77.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.406 ' N ' ' CD ' ' A' ' 120' ' ' LYS . 13.0 mptt -59.57 -42.41 92.41 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -71.76 -39.78 69.75 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.919 -0.488 . . . . 1.0 109.97 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -63.33 -44.89 93.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -63.92 -43.1 96.92 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -59.95 -40.37 88.77 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 78.3 p -72.96 -46.9 49.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -57.08 -47.91 79.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.7 -0.481 . . . . 1.0 109.7 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.67 -37.37 87.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.44 ' O ' ' SD ' ' A' ' 132' ' ' MET . 42.3 t30 -65.27 -54.01 35.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 1.0 110.044 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.445 ' NE1' ' OE1' ' A' ' 113' ' ' GLN . 83.4 m95 -59.41 -36.83 76.58 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -59.27 -36.53 75.69 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.525 -0.917 . . . . 1.0 108.525 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.6 m -64.29 -43.08 95.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.994 -0.743 . . . . 1.0 108.994 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.509 ' N ' ' SD ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -63.18 -48.84 76.68 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 133' ' ' LEU . 4.2 mm? -62.47 -39.99 95.2 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -66.74 -41.73 87.38 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.37 -36.99 93.88 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.003 -1.239 . . . . 1.0 110.003 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.21 -43.87 77.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.434 0.635 . . . . 1.0 110.114 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -65.44 -39.34 91.95 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.071 -0.393 . . . . 1.0 110.153 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.7 tptt -62.01 -39.34 91.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.011 0.434 . . . . 1.0 111.246 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -75.81 -46.57 29.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.128 0.489 . . . . 1.0 110.323 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -64.59 -42.62 95.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.06 0.457 . . . . 1.0 111.097 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -75.8 -1.36 24.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.242 0.544 . . . . 1.0 109.866 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -60.14 -33.08 71.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.411 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -46.12 -20.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.221 -0.3 . . . . 1.0 111.097 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.77 -36.77 75.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.692 0.282 . . . . 1.0 110.359 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.6 m -59.11 -41.63 88.61 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.125 -0.359 . . . . 1.0 110.36 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 117.95 -1.024 . . . . 1.0 110.442 179.882 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.4 mtm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.69 -42.98 90.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.56 -0.291 . . . . 1.0 110.754 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.1 pt -143.71 165.2 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.72 0.771 . . . . 1.0 111.028 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -77.61 -167.76 1.03 Allowed 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.698 -0.626 . . . . 1.0 111.216 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 5' ' ' LEU . 10.0 mp -75.09 143.79 43.24 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.605 0.717 . . . . 1.0 111.422 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.5 mt -114.43 128.81 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.4 0.619 . . . . 1.0 111.201 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.69 143.43 44.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.041 0.448 . . . . 1.0 110.604 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -133.54 123.41 25.12 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.228 0.537 . . . . 1.0 111.011 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.7 m -141.76 140.08 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.24 0.543 . . . . 1.0 110.438 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -152.96 139.14 18.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.559 0.695 . . . . 1.0 110.902 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.5 t -147.04 145.43 29.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.996 -0.547 . . . . 1.0 111.022 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.4 t -93.44 124.51 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.32 0.581 . . . . 1.0 110.445 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 78.2 mt -129.43 131.34 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 121.453 0.644 . . . . 1.0 110.625 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -90.57 99.73 12.7 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.148 0.499 . . . . 1.0 110.263 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -169.31 153.55 5.41 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 118.894 -0.574 . . . . 1.0 111.487 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.98 146.75 78.45 Favored 'Trans proline' 0 N--CA 1.502 2.003 0 C-N-CA 121.295 1.33 . . . . 1.0 112.591 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.402 HG21 ' NE ' ' A' ' 72' ' ' ARG . 9.8 tp -65.48 -36.68 78.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.845 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -61.44 -50.77 71.46 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.812 -0.555 . . . . 1.0 111.753 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.97 -41.0 97.68 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.87 0.322 . . . . 1.0 111.87 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.1 t -66.17 -46.43 87.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 40.1 t-105 -59.8 -41.88 92.17 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.806 0.813 . . . . 1.0 109.07 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.48 -45.45 93.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.489 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.99 -31.86 65.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.026 0.441 . . . . 1.0 111.698 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -71.72 -48.04 49.8 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.151 -0.343 . . . . 1.0 111.823 -179.113 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 m -112.07 77.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.871 0.843 . . . . 1.0 111.099 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -159.82 109.97 1.45 Allowed Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.49 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.431 ' HD3' ' HE1' ' A' ' 43' ' ' TRP . 53.7 Cg_endo -67.34 -14.95 44.53 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 120.934 1.09 . . . . 1.0 112.33 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -80.73 -50.9 9.29 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.358 -0.238 . . . . 1.0 110.358 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.79 -42.42 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.65 0.738 . . . . 1.0 109.209 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.8 mt -57.6 -41.93 80.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -64.53 -36.66 84.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 1.0 110.33 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -67.23 -32.07 72.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.94 0.4 . . . . 1.0 110.029 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -69.59 -34.18 73.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.947 0.403 . . . . 1.0 109.977 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.7 mmm -101.13 177.31 4.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.675 0.75 . . . . 1.0 110.941 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -64.43 -37.96 89.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.837 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.43 64.47 0.02 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.759 -0.536 . . . . 1.0 111.759 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -96.61 126.64 41.92 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.69 0.757 . . . . 1.0 110.704 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.8 p -78.34 92.5 4.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.86 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.2 t -95.52 131.56 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.275 0.56 . . . . 1.0 110.616 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.47 129.72 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 121.306 0.574 . . . . 1.0 110.419 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.561 ' HG ' ' HE1' ' A' ' 43' ' ' TRP . 60.3 p -153.54 150.94 29.22 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.314 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -94.38 -20.58 19.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.799 0.809 . . . . 1.0 109.018 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.561 ' HE1' ' HG ' ' A' ' 41' ' ' SER . 1.3 m0 68.76 46.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.896 -0.593 . . . . 1.0 111.363 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -148.86 156.33 42.17 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.562 0.696 . . . . 1.0 111.182 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -55.27 129.74 39.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.673 0.749 . . . . 1.0 112.184 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.2 -3.2 87.34 Favored Glycine 0 N--CA 1.469 0.841 0 CA-C-N 115.838 -0.619 . . . . 1.0 112.028 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.2 t -67.12 133.95 50.84 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.257 -0.555 . . . . 1.0 111.548 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -89.03 146.72 24.67 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.78 148.95 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.473 0.654 . . . . 1.0 111.328 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.57 155.16 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.461 -0.79 . . . . 1.0 110.7 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.538 ' CH2' ' NE2' ' A' ' 79' ' ' HIS . 14.7 m0 -128.54 123.17 32.79 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.234 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -89.93 140.48 29.58 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.68 173.82 42.06 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -121.76 128.41 51.72 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.752 0.787 . . . . 1.0 110.201 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 33.8 t90 -129.01 112.12 13.71 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.42 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 52.36 40.91 30.26 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.128 0.489 . . . . 1.0 110.655 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.63 -11.72 18.34 Favored Glycine 0 N--CA 1.468 0.793 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -96.41 116.93 29.85 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.208 0.527 . . . . 1.0 110.438 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.37 133.15 47.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.998 0.428 . . . . 1.0 110.251 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -132.57 152.91 51.45 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.615 0.721 . . . . 1.0 111.01 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -139.45 132.77 29.98 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.43 0.633 . . . . 1.0 110.592 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -87.67 168.11 13.29 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -153.64 129.37 10.1 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.677 0.751 . . . . 1.0 112.508 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.21 -179.48 31.28 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.24 -1.144 . . . . 1.0 110.24 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 66' ' ' ILE . 91.0 m -149.5 154.55 38.95 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.948 -0.737 . . . . 1.0 111.312 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.408 ' N ' HG22 ' A' ' 65' ' ' THR . 39.8 mm -77.71 122.58 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.59 0.71 . . . . 1.0 110.251 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 67' ' ' LEU . 3.8 mm? -86.13 -52.47 5.65 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.97 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -131.73 137.69 48.33 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.648 -0.501 . . . . 1.0 109.648 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -135.38 104.94 6.04 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.771 0.796 . . . . 1.0 111.482 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -124.46 93.59 3.95 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.25 122.04 3.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.852 -0.613 . . . . 1.0 112.049 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.402 ' NE ' HG21 ' A' ' 17' ' ' ILE . 67.8 ttt180 61.82 51.97 3.64 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.266 0.626 . . . . 1.0 111.784 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 t -169.62 -72.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.707 -0.621 . . . . 1.0 111.992 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 95.0 mt -137.04 133.8 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-O 121.626 0.727 . . . . 1.0 111.564 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.4 tp -136.16 124.99 24.0 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.353 -0.84 . . . . 1.0 110.296 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -135.24 141.87 45.86 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.184 0.516 . . . . 1.0 109.966 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -149.14 152.51 36.23 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.1 0.952 . . . . 1.0 112.144 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.8 p -94.32 150.92 19.83 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.538 ' NE2' ' CH2' ' A' ' 51' ' ' TRP . 1.2 m80 -152.42 144.99 24.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 122.0 0.905 . . . . 1.0 111.561 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -141.95 136.61 30.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.66 -1.155 . . . . 1.0 110.236 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.5 t -108.13 115.99 57.55 Favored Pre-proline 0 N--CA 1.476 0.849 0 CA-C-O 118.445 -0.788 . . . . 1.0 110.664 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.76 -18.22 28.67 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 120.991 1.127 . . . . 1.0 112.252 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.4 mt -72.07 -11.97 61.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.121 0.486 . . . . 1.0 110.355 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.7 m -65.01 -29.66 70.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.96 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.62 24.46 56.09 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -114.1 95.57 38.99 Favored Pre-proline 0 N--CA 1.475 0.806 0 CA-C-O 119.427 -0.321 . . . . 1.0 111.34 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 89' ' ' LEU . 73.8 Cg_exo -49.13 -178.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.93 1.754 . . . . 1.0 111.702 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -39.16 91.42 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.769 0.795 . . . . 1.0 112.233 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 87' ' ' PRO . 13.5 mt -136.15 89.09 20.54 Favored Pre-proline 0 N--CA 1.476 0.836 0 O-C-N 121.97 -0.457 . . . . 1.0 109.941 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.81 -18.18 12.0 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 C-N-CA 122.187 1.925 . . . . 1.0 112.427 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.476 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 80.9 mm-40 -87.06 -20.06 27.71 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.139 0.495 . . . . 1.0 110.47 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -76.19 -39.18 55.41 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.471 0.545 . . . . 1.0 112.471 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.58 172.28 8.02 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.641 0.734 . . . . 1.0 111.738 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.456 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.7 OUTLIER -145.69 169.42 18.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.619 0.723 . . . . 1.0 111.213 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.0 p -107.32 132.63 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.205 -0.907 . . . . 1.0 109.841 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.6 t -94.14 135.13 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.398 0.618 . . . . 1.0 110.961 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.0 t -126.7 123.79 38.31 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.515 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.6 mt -120.91 131.87 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.723 -0.672 . . . . 1.0 110.244 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 59.1 m -117.59 122.16 42.88 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.02 -0.536 . . . . 1.0 109.904 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.6 mt -115.93 124.84 51.58 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.463 0.649 . . . . 1.0 110.792 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 74.4 p -128.05 137.62 52.25 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.513 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -96.42 105.7 17.82 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.349 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.8 mt -92.15 170.21 10.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.11 0.481 . . . . 1.0 110.41 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -61.97 -41.3 97.85 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.442 0.534 . . . . 1.0 112.442 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -75.4 -40.21 58.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.417 0.627 . . . . 1.0 110.845 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.1 -140.33 3.13 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.7 p -125.18 134.17 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.445 0.64 . . . . 1.0 111.029 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -99.2 141.06 32.45 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.543 -0.753 . . . . 1.0 109.602 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.82 138.73 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 121.278 0.561 . . . . 1.0 110.521 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -142.93 131.73 22.73 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.447 0.641 . . . . 1.0 110.509 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tt -125.15 131.68 53.2 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.719 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.8 m -128.67 143.01 50.85 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.45 0.643 . . . . 1.0 111.235 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.456 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 33.7 tt0 -142.53 138.3 30.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.086 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 12.4 p-10 -111.99 -167.12 1.14 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.538 0.685 . . . . 1.0 112.32 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 91' ' ' GLU . 66.8 t30 60.73 37.52 18.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.758 1.021 . . . . 1.0 113.758 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -82.16 117.77 22.56 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.76 -1.2 . . . . 1.0 107.76 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -61.51 -39.87 92.57 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.011 -1.056 . . . . 1.0 111.866 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.6 p -144.78 168.31 20.51 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.923 -0.486 . . . . 1.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.46 -34.82 71.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.275 -0.639 . . . . 1.0 109.275 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.57 -40.88 93.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -69.44 -39.77 77.62 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.963 -0.461 . . . . 1.0 110.303 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -63.14 -47.82 81.12 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -59.93 -42.81 94.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -61.25 -39.05 88.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.333 -0.618 . . . . 1.0 109.333 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 62.4 m -68.03 -53.26 27.16 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.59 -44.91 73.43 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -62.55 -41.31 98.81 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -66.36 -54.0 29.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.02 0.438 . . . . 1.0 110.097 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.507 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 87.8 m95 -60.42 -39.42 87.34 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -59.44 -39.09 82.46 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.7 m -63.73 -41.98 97.96 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.507 ' SD ' ' CE3' ' A' ' 129' ' ' TRP . 79.0 mtp -64.93 -50.41 66.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.287 0.565 . . . . 1.0 109.617 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.02 -40.08 94.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -69.14 -39.46 78.81 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.078 -0.712 . . . . 1.0 109.078 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.36 -39.5 91.7 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 109.632 -1.387 . . . . 1.0 109.632 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.9 tt -65.9 -43.06 89.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.024 0.44 . . . . 1.0 110.033 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -61.69 -32.72 72.93 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -60.99 -37.99 84.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.982 0.42 . . . . 1.0 111.031 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -74.59 -49.93 19.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.422 0.63 . . . . 1.0 110.775 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.88 -42.66 99.85 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.785 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -75.37 -4.33 38.75 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.371 0.605 . . . . 1.0 110.253 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -62.12 -39.14 91.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.972 0.415 . . . . 1.0 110.449 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -61.69 -44.79 96.27 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.693 -0.231 . . . . 1.0 111.007 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.42 -44.02 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 120.8 0.333 . . . . 1.0 110.246 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.7 m -60.47 -41.1 93.49 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.032 -0.417 . . . . 1.0 110.359 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.572 0 CA-C-O 117.961 -1.019 . . . . 1.0 110.638 -179.923 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 tpt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -66.86 -36.61 82.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.499 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.642 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -143.37 175.51 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.465 0.65 . . . . 1.0 111.066 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -74.57 -156.3 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.479 0.657 . . . . 1.0 110.787 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.49 HD22 ' N ' ' A' ' 5' ' ' LEU . 3.9 mm? -75.47 142.18 42.97 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.867 0.842 . . . . 1.0 111.512 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.95 129.62 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.393 0.616 . . . . 1.0 111.035 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.78 136.57 36.02 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.034 -0.416 . . . . 1.0 110.648 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -145.13 145.05 31.24 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.226 0.536 . . . . 1.0 110.753 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.49 155.79 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.329 0.585 . . . . 1.0 110.429 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -154.37 134.06 12.87 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.252 0.548 . . . . 1.0 110.922 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 t -148.56 146.92 28.49 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.102 0.477 . . . . 1.0 111.256 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 m -99.06 131.36 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.378 0.608 . . . . 1.0 110.249 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.3 mt -130.68 132.16 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 121.875 0.845 . . . . 1.0 110.553 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -85.83 96.41 9.75 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.314 0.578 . . . . 1.0 110.224 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.95 157.93 4.27 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.622 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -61.36 144.44 98.4 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.257 1.971 . . . . 1.0 112.358 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.5 tp -64.84 -33.84 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.752 -0.658 . . . . 1.0 111.4 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -58.15 -50.26 74.13 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.901 -0.499 . . . . 1.0 111.914 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -65.21 -40.44 94.17 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.996 0.369 . . . . 1.0 111.996 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.3 t -66.33 -47.46 84.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -60.05 -43.43 95.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -58.26 -49.16 78.11 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.044 -0.41 . . . . 1.0 110.258 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.04 -32.77 64.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.752 0.279 . . . . 1.0 111.752 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.54 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.4 tt -67.7 -45.28 75.56 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.206 -0.309 . . . . 1.0 111.229 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 m -115.94 79.47 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.677 0.751 . . . . 1.0 111.383 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -156.98 117.12 2.06 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.201 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.457 ' HD3' ' HE1' ' A' ' 43' ' ' TRP . 70.8 Cg_endo -73.88 -5.3 16.81 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.344 1.363 . . . . 1.0 112.277 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -93.73 -52.39 4.47 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.209 -0.293 . . . . 1.0 110.209 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.88 -42.18 94.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.647 -0.872 . . . . 1.0 108.647 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.87 -40.18 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -66.14 -36.45 83.17 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.255 -0.278 . . . . 1.0 110.445 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -57.78 -36.64 72.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -68.91 -33.33 73.57 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.239 -0.282 . . . . 1.0 110.239 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 73.1 mmm -96.43 156.54 16.3 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.712 0.768 . . . . 1.0 110.906 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -61.58 -43.22 99.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.713 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.44 42.99 0.18 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 120.904 -0.665 . . . . 1.0 111.977 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.8 m -76.85 129.15 35.83 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.561 0.696 . . . . 1.0 110.58 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 48.7 m -93.05 92.07 7.64 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.693 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -99.03 132.64 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.441 0.639 . . . . 1.0 110.481 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.0 t -130.58 132.22 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.646 0.736 . . . . 1.0 110.264 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 m -156.09 166.68 32.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.565 . . . . 1.0 111.376 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -109.34 -19.67 13.2 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.98 0.895 . . . . 1.0 109.076 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.457 ' HE1' ' HD3' ' A' ' 27' ' ' PRO . 58.0 m95 58.23 56.32 4.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.795 -0.639 . . . . 1.0 111.76 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -152.4 156.83 40.29 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.418 0.628 . . . . 1.0 111.125 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.28 119.68 1.25 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.539 0.685 . . . . 1.0 112.422 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.04 11.2 84.72 Favored Glycine 0 N--CA 1.468 0.782 0 CA-C-N 115.918 -0.583 . . . . 1.0 112.065 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.1 t -72.26 130.46 40.85 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.3 -0.529 . . . . 1.0 111.523 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -87.45 150.47 23.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.747 -0.835 . . . . 1.0 108.747 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.9 pt -145.07 149.35 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.1 0.476 . . . . 1.0 111.107 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.6 m -143.51 154.53 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.782 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 10.3 m0 -129.2 131.72 47.16 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.34 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -91.57 139.69 30.45 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.45 172.71 39.45 Favored Glycine 0 N--CA 1.464 0.514 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -131.95 134.56 45.77 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.007 0.908 . . . . 1.0 110.231 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -138.3 118.04 13.16 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.374 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 52.92 37.1 23.49 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.112 0.482 . . . . 1.0 110.688 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.96 -6.06 44.29 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.932 -0.867 . . . . 1.0 110.932 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -97.15 112.51 24.26 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.346 0.593 . . . . 1.0 110.565 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.14 135.88 49.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.029 0.442 . . . . 1.0 110.239 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -141.26 155.89 45.95 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.642 0.734 . . . . 1.0 110.864 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 1.5 pm0 -136.27 133.83 37.39 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.388 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -86.91 144.5 26.94 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -133.88 128.13 33.99 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.502 0.668 . . . . 1.0 112.731 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.08 -177.24 30.01 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.293 -1.123 . . . . 1.0 110.293 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.414 HG22 ' N ' ' A' ' 66' ' ' ILE . 85.9 m -146.68 155.02 42.11 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.656 0.741 . . . . 1.0 111.056 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.414 ' N ' HG22 ' A' ' 65' ' ' THR . 50.7 mm -75.56 115.55 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.249 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.401 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 42.5 tp -69.93 -41.91 73.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.503 0.668 . . . . 1.0 110.111 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -152.07 147.8 26.92 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -132.52 104.08 6.5 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.989 0.899 . . . . 1.0 111.597 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -125.16 104.56 8.58 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -47.16 136.31 9.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.658 0.742 . . . . 1.0 111.98 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 36.91 53.72 1.14 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.666 -0.697 . . . . 1.0 112.552 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.5 t -161.12 -73.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.635 -0.666 . . . . 1.0 112.098 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.4 mt -136.89 131.82 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.464 0.65 . . . . 1.0 111.496 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.1 tp -136.98 124.97 22.77 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.525 -0.762 . . . . 1.0 110.333 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.02 144.53 32.32 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.409 0.623 . . . . 1.0 109.961 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.401 ' HA ' ' H ' ' A' ' 67' ' ' LEU . 46.6 p90 -150.04 154.88 38.91 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.816 0.817 . . . . 1.0 112.061 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.4 p -87.0 151.44 23.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.004 -1.11 . . . . 1.0 108.004 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.404 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 52.9 t-80 -146.08 144.37 29.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.925 0.869 . . . . 1.0 111.887 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -143.38 135.11 26.51 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.718 -1.128 . . . . 1.0 110.315 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.9 p -111.12 119.12 46.46 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-O 118.622 -0.704 . . . . 1.0 110.33 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.72 -17.84 29.13 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 120.999 1.133 . . . . 1.0 112.342 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 55.9 mt -60.33 -16.54 35.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.989 0.423 . . . . 1.0 110.321 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 49.3 p -65.43 -32.66 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.928 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.31 -6.82 49.66 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.819 -0.912 . . . . 1.0 110.819 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -91.83 152.57 43.22 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 119.26 -0.4 . . . . 1.0 111.363 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -49.39 144.24 18.55 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 121.037 1.158 . . . . 1.0 111.953 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -78.39 86.52 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.532 0.682 . . . . 1.0 111.643 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.4 mt -128.83 148.6 69.37 Favored Pre-proline 0 N--CA 1.479 0.988 0 O-C-N 121.944 -0.472 . . . . 1.0 111.104 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -46.28 -32.52 10.74 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 122.08 1.853 . . . . 1.0 112.845 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.77 -35.31 78.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.326 0.584 . . . . 1.0 110.572 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -69.66 -39.1 77.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.007 -0.542 . . . . 1.0 112.457 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 47.8 p90 -117.83 178.47 4.4 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.308 0.575 . . . . 1.0 112.246 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.19 167.25 21.01 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.058 0.932 . . . . 1.0 111.373 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 52.1 t -106.77 127.74 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 114.809 -1.087 . . . . 1.0 109.647 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.31 133.57 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.036 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.7 t -125.36 121.06 32.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.253 0.549 . . . . 1.0 110.657 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 75.7 mt -119.01 129.97 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.358 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 64.8 m -117.47 116.9 28.07 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.532 0.682 . . . . 1.0 109.957 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.3 mt -114.34 124.81 52.91 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.801 0.81 . . . . 1.0 110.812 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.5 m -138.31 143.36 39.93 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.325 -0.852 . . . . 1.0 110.49 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.03 123.98 38.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.266 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.8 mt -107.99 173.7 6.21 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.235 0.54 . . . . 1.0 110.332 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -61.7 -41.6 97.81 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.409 0.522 . . . . 1.0 112.409 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -74.2 -44.23 54.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.144 0.497 . . . . 1.0 110.779 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -172.55 -129.53 1.15 Allowed Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.892 -0.883 . . . . 1.0 110.892 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.3 t -128.81 133.9 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.539 0.685 . . . . 1.0 110.852 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -107.2 132.78 52.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.48 -0.782 . . . . 1.0 109.537 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.1 p -125.23 142.08 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.81 0.814 . . . . 1.0 110.25 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -140.03 135.12 32.34 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.567 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 tt -127.98 129.41 46.71 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.586 -0.733 . . . . 1.0 109.822 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.8 m -123.37 145.37 48.81 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.425 0.631 . . . . 1.0 111.379 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.419 ' OE1' ' NE1' ' A' ' 129' ' ' TRP . 37.6 tt0 -143.69 123.67 13.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.471 -0.786 . . . . 1.0 109.918 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -101.14 -167.62 1.45 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.392 0.615 . . . . 1.0 112.514 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.9 t30 59.58 38.38 22.23 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.455 0.909 . . . . 1.0 113.455 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -82.96 133.1 35.12 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.543 -1.28 . . . . 1.0 107.543 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -63.02 -43.34 98.99 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.045 -1.035 . . . . 1.0 111.977 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 119' ' ' GLU . 1.4 t -149.79 176.2 10.92 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.133 0.492 . . . . 1.0 110.884 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.422 ' N ' ' OG1' ' A' ' 118' ' ' THR . 95.1 mt-10 -58.81 -38.13 77.93 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -59.06 -40.09 84.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -70.42 -38.49 74.61 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.01 -0.431 . . . . 1.0 109.919 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -64.65 -47.06 79.88 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -61.81 -40.29 94.72 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.912 -0.773 . . . . 1.0 108.912 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -62.43 -39.95 94.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.44 -0.578 . . . . 1.0 109.44 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.7 m -71.69 -49.18 41.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 1.0 109.822 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -55.54 -47.36 76.45 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.28 -37.95 89.3 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.702 -0.481 . . . . 1.0 109.702 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -66.59 -54.55 22.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.135 0.493 . . . . 1.0 110.13 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.419 ' NE1' ' OE1' ' A' ' 113' ' ' GLN . 86.2 m95 -59.42 -37.37 77.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -56.78 -39.87 74.85 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.533 -0.914 . . . . 1.0 108.533 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.7 m -63.97 -41.17 97.62 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.73 -50.53 70.74 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.29 -38.63 90.09 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -67.35 -41.51 85.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.887 -0.783 . . . . 1.0 108.887 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.09 -40.57 98.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.026 -1.23 . . . . 1.0 110.026 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 64.9 tp -67.9 -42.63 80.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.372 0.606 . . . . 1.0 109.805 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.44 -44.25 95.06 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.102 -0.374 . . . . 1.0 110.477 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -61.3 -40.88 95.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.714 0.293 . . . . 1.0 110.728 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -66.38 -50.21 64.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.042 0.448 . . . . 1.0 110.637 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.502 ' O ' HD23 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -65.35 -42.44 92.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.547 -179.562 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -76.92 -0.41 24.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.269 0.557 . . . . 1.0 110.186 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -61.54 -36.5 80.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.59 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 27.1 pttm -59.85 -37.71 80.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.682 0.277 . . . . 1.0 111.124 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.28 -44.18 99.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 122.264 -0.273 . . . . 1.0 110.324 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.4 m -59.16 -41.82 89.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.771 0.319 . . . . 1.0 110.449 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 117.928 -1.034 . . . . 1.0 110.51 -179.915 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 mtt . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -167.4 124.76 1.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.319 0.58 . . . . 1.0 110.278 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.699 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -144.95 179.1 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.684 0.754 . . . . 1.0 110.849 -179.621 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -73.21 -160.96 0.09 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.363 0.602 . . . . 1.0 111.019 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.49 ' N ' HD12 ' A' ' 5' ' ' LEU . 9.8 mp -73.7 141.27 46.4 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.622 0.725 . . . . 1.0 111.583 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.2 mt -116.78 129.21 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.917 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.28 146.15 37.02 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.998 -0.438 . . . . 1.0 110.69 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -138.08 127.03 24.04 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.906 0.384 . . . . 1.0 110.952 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.7 m -140.53 139.13 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.05 0.453 . . . . 1.0 110.507 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -153.37 135.49 14.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.954 0.407 . . . . 1.0 111.023 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.8 t -146.44 145.01 30.07 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.251 0.548 . . . . 1.0 111.173 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 12' ' ' VAL . 14.9 p -91.22 129.89 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.207 0.527 . . . . 1.0 110.545 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 75.7 mt -132.63 131.92 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.554 0.693 . . . . 1.0 110.4 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -89.36 95.19 10.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.287 0.565 . . . . 1.0 109.73 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.65 159.14 3.09 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 120.759 -0.376 . . . . 1.0 110.942 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.79 146.09 96.81 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 122.146 1.897 . . . . 1.0 112.521 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.2 tt -68.66 -29.84 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.72 0.771 . . . . 1.0 111.529 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -63.53 -48.17 78.63 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.909 -0.494 . . . . 1.0 112.16 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.02 -45.85 90.38 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.809 0.3 . . . . 1.0 111.809 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.44 -45.31 85.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 23.5 t-105 -56.46 -41.62 76.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -58.97 -45.56 90.22 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.043 -0.41 . . . . 1.0 110.342 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.78 -34.62 62.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.598 -0.273 . . . . 1.0 111.359 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.527 HD13 ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -70.42 -48.28 56.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.033 0.445 . . . . 1.0 111.796 -179.184 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.7 m -107.39 74.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.437 0.637 . . . . 1.0 110.83 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -162.13 113.62 1.16 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 119.053 -0.499 . . . . 1.0 110.636 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HD3' ' HE1' ' A' ' 43' ' ' TRP . 57.4 Cg_endo -70.6 -18.38 33.09 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 121.812 1.675 . . . . 1.0 112.391 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -79.71 -46.93 16.17 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.645 0.259 . . . . 1.0 110.402 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -71.91 -42.13 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.938 -0.764 . . . . 1.0 108.938 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 mm -58.79 -41.51 82.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -69.43 -31.22 69.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.089 0.471 . . . . 1.0 110.181 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -60.86 -35.74 77.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.128 0.489 . . . . 1.0 110.043 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -69.1 -33.49 73.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.901 0.381 . . . . 1.0 110.034 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.8 mmm -98.05 162.62 13.13 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.824 0.821 . . . . 1.0 110.916 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -62.19 -41.21 98.13 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.749 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.85 42.27 0.14 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.106 -0.569 . . . . 1.0 111.924 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.7 m -70.16 128.37 36.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.378 0.609 . . . . 1.0 110.994 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.4 m -92.56 92.36 8.01 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.16 -0.337 . . . . 1.0 110.872 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.72 135.36 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 121.374 0.607 . . . . 1.0 110.483 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.2 p -126.96 137.45 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.27 0.557 . . . . 1.0 110.589 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.5 p -154.21 155.23 34.88 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.106 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -94.69 -20.04 19.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 122.121 0.962 . . . . 1.0 108.933 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.44 ' HE1' ' HD3' ' A' ' 27' ' ' PRO . 1.5 m0 72.16 45.56 0.38 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.422 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 pttt -153.34 153.44 32.6 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.768 -0.582 . . . . 1.0 111.447 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -50.38 132.01 24.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.736 0.779 . . . . 1.0 112.361 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.68 -6.44 83.44 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-N 115.873 -0.603 . . . . 1.0 112.034 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.1 m -65.14 137.11 57.43 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.188 -0.595 . . . . 1.0 111.885 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -88.77 150.25 23.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.7 pt -138.65 147.91 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-O 121.34 0.591 . . . . 1.0 111.355 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.3 t -143.77 141.32 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.617 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.451 ' CZ3' ' NE2' ' A' ' 79' ' ' HIS . 18.4 m0 -118.11 137.63 52.81 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.081 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -100.98 134.4 44.03 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.09 0.471 . . . . 1.0 109.968 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.12 173.71 37.6 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -125.99 134.56 51.44 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.636 0.731 . . . . 1.0 110.193 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -138.24 115.29 10.9 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.48 0.657 . . . . 1.0 110.302 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt 52.71 38.07 25.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.62 -9.02 38.23 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 110.451 -1.06 . . . . 1.0 110.451 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -98.41 116.32 30.39 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.372 0.606 . . . . 1.0 110.749 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.3 129.08 38.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.253 0.549 . . . . 1.0 110.32 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -128.56 150.99 49.96 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.724 0.773 . . . . 1.0 110.944 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.437 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 1.2 pm0 -135.7 126.37 27.18 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.387 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -86.86 134.87 33.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.978 -0.749 . . . . 1.0 108.978 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -120.12 129.12 54.02 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.725 0.774 . . . . 1.0 112.53 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.14 175.52 30.03 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.35 -1.1 . . . . 1.0 110.35 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.1 m -144.41 151.99 40.03 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 122.07 -0.665 . . . . 1.0 111.33 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.7 mm -73.72 113.79 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.468 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -66.98 -51.25 57.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.612 0.72 . . . . 1.0 110.243 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -150.01 147.88 28.37 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.433 -0.581 . . . . 1.0 109.433 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -126.06 110.76 13.91 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.74 0.781 . . . . 1.0 111.351 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.4 ' HB3' ' H ' ' A' ' 74' ' ' ILE . 39.0 t-20 -126.25 91.47 3.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.295 -0.631 . . . . 1.0 109.295 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -36.73 128.84 0.83 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.189 0.518 . . . . 1.0 112.241 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 41.92 57.12 3.28 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.681 0.623 . . . . 1.0 112.681 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.5 t -165.1 -71.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.7 -0.625 . . . . 1.0 111.886 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.4 ' H ' ' HB3' ' A' ' 70' ' ' ASN . 91.2 mt -138.07 131.25 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.573 0.701 . . . . 1.0 111.629 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.1 tp -133.95 123.22 24.27 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.371 -0.831 . . . . 1.0 110.634 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -138.93 142.96 38.45 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.192 0.52 . . . . 1.0 110.113 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -152.84 155.7 37.61 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.678 0.751 . . . . 1.0 112.15 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.6 p -86.7 151.19 23.62 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.451 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 16.5 t-80 -146.56 138.44 24.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.869 0.843 . . . . 1.0 111.846 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.49 ' CD2' ' NZ ' ' A' ' 86' ' ' LYS . 37.3 t80 -138.1 127.55 24.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.813 -1.085 . . . . 1.0 110.529 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.5 t -139.95 125.13 11.44 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 118.913 -0.565 . . . . 1.0 110.64 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.45 -20.91 30.96 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 121.411 1.408 . . . . 1.0 112.212 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.7 mt -76.21 -3.38 36.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.121 0.486 . . . . 1.0 110.452 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.7 m -64.33 -22.37 66.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.787 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.33 -21.11 6.9 Favored Glycine 0 N--CA 1.473 1.16 0 N-CA-C 110.812 -0.915 . . . . 1.0 110.812 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.49 ' NZ ' ' CD2' ' A' ' 80' ' ' PHE . 56.3 pttt -76.9 147.12 76.94 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 121.093 -0.243 . . . . 1.0 111.432 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.9 -86.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.709 1.606 . . . . 1.0 111.837 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -145.57 80.18 1.59 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.794 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.2 tp -152.89 116.29 2.83 Favored Pre-proline 0 CA--C 1.552 1.023 0 O-C-N 121.888 -0.508 . . . . 1.0 110.772 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.536 ' O ' ' CD1' ' A' ' 93' ' ' TYR . 58.1 Cg_endo -73.8 -6.01 17.95 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 122.154 1.903 . . . . 1.0 112.381 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -81.74 -12.57 58.53 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.362 0.601 . . . . 1.0 110.598 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -92.66 10.49 30.37 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.016 -0.538 . . . . 1.0 112.272 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.536 ' CD1' ' O ' ' A' ' 90' ' ' PRO . 0.1 OUTLIER -101.55 175.5 5.54 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.493 0.663 . . . . 1.0 112.145 -179.494 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.563 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.3 OUTLIER -142.54 161.01 39.17 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.953 0.882 . . . . 1.0 111.172 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.0 t -106.24 114.08 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 115.025 -0.989 . . . . 1.0 109.455 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.4 m -82.69 139.92 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.097 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 t -130.2 129.8 43.85 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.303 0.573 . . . . 1.0 110.917 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.86 130.08 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.542 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 59.4 m -117.8 118.13 31.21 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.446 0.641 . . . . 1.0 109.989 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.0 mt -114.15 130.85 56.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.401 0.62 . . . . 1.0 110.894 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.438 ' OG1' ' CG ' ' A' ' 108' ' ' GLU . 30.0 p -135.07 128.34 32.07 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.639 -0.709 . . . . 1.0 110.587 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -88.67 111.83 22.4 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.03 0.443 . . . . 1.0 110.139 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 25.3 mt -96.35 175.74 6.31 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.297 0.57 . . . . 1.0 110.485 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.54 -40.71 96.1 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.384 0.512 . . . . 1.0 112.384 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -79.57 -40.77 28.68 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.003 0.521 . . . . 1.0 110.875 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -171.55 -143.18 3.94 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.8 p -129.13 132.77 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.039 0.447 . . . . 1.0 111.225 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.438 ' CG ' ' OG1' ' A' ' 101' ' ' THR . 12.4 pt-20 -98.62 144.59 27.74 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.65 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.59 135.37 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.242 0.544 . . . . 1.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -141.24 129.48 22.26 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.091 0.472 . . . . 1.0 110.592 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -124.63 140.72 52.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.142 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.1 m -132.54 144.39 50.39 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.501 0.667 . . . . 1.0 111.428 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.563 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 40.3 tt0 -143.43 139.36 29.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.872 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -114.41 -162.65 0.82 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.399 0.619 . . . . 1.0 112.309 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.403 ' HA ' HD21 ' A' ' 115' ' ' ASN . 1.1 t-20 58.54 35.56 24.67 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.641 0.978 . . . . 1.0 113.641 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -82.23 122.17 27.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.681 -1.229 . . . . 1.0 107.681 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.48 -40.44 93.14 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.01 -1.056 . . . . 1.0 111.79 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.1 p -145.58 171.58 14.49 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.839 -0.538 . . . . 1.0 111.065 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -57.17 -38.51 73.69 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -58.69 -41.21 85.71 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -69.84 -39.67 76.29 Favored 'General case' 0 C--N 1.33 -0.283 0 O-C-N 121.937 -0.477 . . . . 1.0 110.15 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -64.7 -45.14 87.87 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -62.73 -44.77 95.34 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.068 -0.716 . . . . 1.0 109.068 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -58.63 -40.12 82.46 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.7 m -72.14 -47.85 47.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.201 0.524 . . . . 1.0 109.67 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -55.68 -48.51 74.96 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -64.55 -37.37 87.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.036 0.446 . . . . 1.0 109.81 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -65.52 -56.5 12.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.943 0.401 . . . . 1.0 110.138 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.477 ' NE1' ' OE1' ' A' ' 113' ' ' GLN . 86.6 m95 -58.6 -39.23 79.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -54.68 -41.03 69.71 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.0 m -63.6 -41.56 98.32 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.624 0.726 . . . . 1.0 109.211 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.9 tpt -64.42 -51.51 62.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 133' ' ' LEU . 4.4 mm? -59.56 -41.24 89.68 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -68.16 -36.64 79.96 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.57 -41.57 99.6 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.011 -1.236 . . . . 1.0 110.011 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.47 -42.42 83.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.323 0.582 . . . . 1.0 110.099 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.4 -37.6 86.41 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.049 -0.407 . . . . 1.0 110.266 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -59.76 -38.51 82.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.975 0.417 . . . . 1.0 111.095 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -76.32 -44.91 34.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.282 0.563 . . . . 1.0 110.473 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 65.0 mt -64.8 -41.98 95.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.044 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.74 0.05 21.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.048 0.452 . . . . 1.0 109.838 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.35 -39.01 93.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.91 0.386 . . . . 1.0 110.604 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -61.1 -56.91 15.35 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.23 -0.294 . . . . 1.0 110.947 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.9 p -65.07 -38.43 82.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.751 0.31 . . . . 1.0 110.611 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.5 t -62.65 -42.73 99.77 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.144 -0.348 . . . . 1.0 110.403 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.043 -0.979 . . . . 1.0 110.334 -179.857 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttp . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.0 155.63 16.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.014 0.435 . . . . 1.0 110.149 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.493 HD13 ' N ' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -63.82 168.71 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.376 0.608 . . . . 1.0 111.034 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -77.38 -161.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.68 -0.638 . . . . 1.0 111.046 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 5' ' ' LEU . 10.3 mp -73.76 139.66 45.38 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.652 0.739 . . . . 1.0 111.376 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.1 mt -113.7 129.34 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.328 0.585 . . . . 1.0 111.009 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.68 141.33 39.44 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.062 0.458 . . . . 1.0 110.736 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -138.5 117.98 12.93 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.189 0.518 . . . . 1.0 110.976 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.78 155.91 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.072 0.463 . . . . 1.0 110.627 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -174.18 151.04 1.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.199 0.523 . . . . 1.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 t -145.6 145.43 30.97 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.364 0.602 . . . . 1.0 111.162 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.69 124.59 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.277 0.56 . . . . 1.0 110.542 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.4 mt -130.27 132.69 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 121.669 0.747 . . . . 1.0 110.541 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -87.86 96.49 10.49 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.402 0.62 . . . . 1.0 110.188 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.31 155.86 2.81 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 119.139 -0.458 . . . . 1.0 111.051 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.56 147.57 94.06 Favored 'Trans proline' 0 N--CA 1.506 2.217 0 C-N-CA 121.599 1.533 . . . . 1.0 112.528 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.2 tt -68.09 -26.34 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.187 0.518 . . . . 1.0 111.185 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -59.48 -49.89 76.03 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.885 -0.509 . . . . 1.0 111.604 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.436 ' N ' ' CD ' ' A' ' 19' ' ' LYS . 3.9 mptp? -65.48 -41.51 93.22 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.709 0.263 . . . . 1.0 111.709 -178.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.48 -48.25 81.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -57.45 -43.14 83.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.627 0.727 . . . . 1.0 109.224 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -58.28 -45.8 87.25 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.877 -0.515 . . . . 1.0 110.436 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.17 -35.43 64.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.957 0.408 . . . . 1.0 111.856 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -66.84 -46.0 76.45 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.1 -0.375 . . . . 1.0 111.652 -179.21 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 m -112.98 79.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.794 0.807 . . . . 1.0 111.014 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -159.75 111.32 1.46 Allowed Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.416 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.41 -1.7 10.11 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.195 1.263 . . . . 1.0 112.503 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -96.86 -48.51 5.42 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 110.172 -0.307 . . . . 1.0 110.172 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -68.25 -43.03 84.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.223 -0.658 . . . . 1.0 109.223 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mm -61.03 -42.16 92.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -69.22 -31.13 69.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.046 0.45 . . . . 1.0 110.271 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -58.32 -42.99 87.96 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.812 -0.44 . . . . 1.0 109.812 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -69.37 -33.55 73.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.759 0.314 . . . . 1.0 110.163 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 66.6 mtt -89.12 152.01 21.88 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.684 0.754 . . . . 1.0 111.053 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -59.47 -46.97 87.26 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.697 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.9 48.92 0.22 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.064 -0.589 . . . . 1.0 111.975 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.6 m -82.33 111.26 18.23 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.77 0.795 . . . . 1.0 110.776 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.7 m -77.79 91.94 4.16 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.909 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -102.79 135.12 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.987 0.899 . . . . 1.0 110.5 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 m -128.27 138.75 53.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.55 0.691 . . . . 1.0 110.508 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.455 ' OG ' ' NE1' ' A' ' 43' ' ' TRP . 33.2 p -155.53 158.35 38.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.966 -0.561 . . . . 1.0 111.153 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 50.9 t0 -97.14 -23.63 16.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.89 0.852 . . . . 1.0 108.995 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.455 ' NE1' ' OG ' ' A' ' 41' ' ' SER . 1.5 m0 71.17 47.83 0.39 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.465 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.56 152.54 27.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.645 0.736 . . . . 1.0 111.206 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -48.91 131.35 18.64 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.746 0.784 . . . . 1.0 112.373 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.67 4.7 85.07 Favored Glycine 0 N--CA 1.47 0.956 0 CA-C-N 115.721 -0.672 . . . . 1.0 112.105 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.3 t -76.89 134.8 38.87 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.214 -0.58 . . . . 1.0 111.539 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 64' ' ' GLY . 66.0 tp60 -81.11 146.2 30.7 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.76 -0.83 . . . . 1.0 108.76 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.02 134.58 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.577 0.703 . . . . 1.0 111.348 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 p -140.21 150.25 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.399 -0.819 . . . . 1.0 110.395 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -128.45 137.2 51.71 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.085 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -104.47 129.87 52.43 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.304 0.573 . . . . 1.0 109.693 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.66 -179.32 29.81 Favored Glycine 0 N--CA 1.464 0.519 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -134.34 134.59 41.95 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.835 0.826 . . . . 1.0 110.117 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 35.0 t90 -140.71 124.46 17.1 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.252 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm 52.5 36.18 19.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.179 0.514 . . . . 1.0 110.704 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.53 -6.06 26.02 Favored Glycine 0 N--CA 1.464 0.535 0 N-CA-C 110.746 -0.942 . . . . 1.0 110.746 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -98.88 115.63 29.29 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.346 0.593 . . . . 1.0 110.4 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.25 133.59 47.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.09 0.471 . . . . 1.0 110.197 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -136.69 154.2 50.68 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.543 0.687 . . . . 1.0 110.851 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -136.46 133.57 36.75 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.437 0.637 . . . . 1.0 110.695 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -90.6 167.65 12.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -158.07 133.77 9.05 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.459 0.647 . . . . 1.0 112.369 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 48' ' ' GLN . . . -160.43 -174.68 30.54 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.41 -1.076 . . . . 1.0 110.41 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 66' ' ' ILE . 35.2 m -146.36 155.98 43.0 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.961 -0.729 . . . . 1.0 111.194 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.416 ' N ' HG22 ' A' ' 65' ' ' THR . 38.8 mm -75.89 119.78 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.336 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 tp -77.25 -48.94 16.18 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.621 0.724 . . . . 1.0 110.224 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -140.76 151.21 44.27 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.729 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -146.46 99.97 3.29 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.509 0.671 . . . . 1.0 111.367 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -125.46 106.88 10.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -38.27 133.17 0.98 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.531 0.681 . . . . 1.0 112.417 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 37.19 53.76 1.25 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.759 -0.655 . . . . 1.0 112.524 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.3 m -152.92 -66.87 0.16 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.793 -0.567 . . . . 1.0 111.862 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 74' ' ' ILE . 7.1 tt -150.47 138.73 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.11 0.481 . . . . 1.0 111.517 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.561 HD13 ' N ' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -130.25 122.24 27.66 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.827 -0.624 . . . . 1.0 109.705 178.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.561 ' N ' HD13 ' A' ' 75' ' ' LEU . 74.6 mt-30 -133.61 136.68 45.01 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.961 0.41 . . . . 1.0 110.271 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.441 ' CD1' ' ND1' ' A' ' 79' ' ' HIS . 19.9 p90 -148.06 156.85 43.1 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.056 0.931 . . . . 1.0 111.994 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 92.4 p -101.25 151.43 21.87 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.488 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.9 m80 -153.19 153.16 32.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.698 0.761 . . . . 1.0 111.736 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -143.32 133.18 23.99 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.873 -1.058 . . . . 1.0 110.4 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.2 t -105.43 116.61 59.95 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-O 118.741 -0.647 . . . . 1.0 110.512 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.88 -18.07 24.89 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 120.985 1.123 . . . . 1.0 112.234 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.4 mt -62.9 -7.42 5.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.013 0.435 . . . . 1.0 110.319 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.0 p -65.32 -32.32 73.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.84 12.97 68.6 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -91.34 150.29 41.11 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 121.203 -0.199 . . . . 1.0 111.296 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.07 -179.72 2.34 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 121.87 1.713 . . . . 1.0 111.5 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.1 p-10 -53.82 88.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.763 0.792 . . . . 1.0 112.028 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.7 mt -133.03 88.61 36.28 Favored Pre-proline 0 N--CA 1.475 0.78 0 O-C-N 121.955 -0.466 . . . . 1.0 109.933 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.08 -34.57 68.71 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 122.365 2.044 . . . . 1.0 112.644 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.34 -4.09 13.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.286 0.565 . . . . 1.0 110.431 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -68.59 -37.33 79.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.482 . . . . 1.0 112.095 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 33.9 p90 -100.1 177.16 5.16 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.686 0.755 . . . . 1.0 112.011 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.491 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.1 OUTLIER -132.18 160.76 35.14 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.277 1.037 . . . . 1.0 111.089 -179.331 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.7 t -102.6 114.6 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 114.709 -1.132 . . . . 1.0 109.613 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.38 135.64 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.956 -0.565 . . . . 1.0 111.118 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 t -126.22 122.42 35.53 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.335 0.588 . . . . 1.0 110.773 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.1 mm -105.56 128.19 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.453 -0.794 . . . . 1.0 110.243 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.3 m -117.46 126.52 52.76 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.014 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.6 mt -129.13 125.58 37.43 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.649 0.738 . . . . 1.0 110.778 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 64.5 p -129.7 129.45 44.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.47 -0.786 . . . . 1.0 110.506 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -91.59 107.96 19.57 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.156 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.1 mt -96.94 172.81 7.63 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.183 0.516 . . . . 1.0 110.441 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -61.7 -40.0 93.47 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.255 0.465 . . . . 1.0 112.255 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -77.03 -42.15 39.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.22 0.534 . . . . 1.0 110.882 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.75 -141.99 3.75 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.7 p -129.6 134.07 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.361 0.6 . . . . 1.0 111.205 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -99.18 144.62 28.11 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.813 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -131.74 141.35 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.867 0.841 . . . . 1.0 110.501 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -146.95 134.08 20.46 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.562 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -121.7 128.88 52.3 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.873 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.9 m -119.74 141.49 49.38 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.525 0.679 . . . . 1.0 111.243 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.491 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 39.4 tt0 -143.08 126.25 16.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.953 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.425 ' O ' ' ND1' ' A' ' 94' ' ' HIS . 7.7 p-10 -103.03 -170.14 1.75 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.705 0.764 . . . . 1.0 112.257 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.1 t30 62.59 37.78 12.81 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.604 0.964 . . . . 1.0 113.604 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -82.37 121.67 27.0 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.641 -1.244 . . . . 1.0 107.641 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -63.56 -41.82 98.4 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.933 -1.104 . . . . 1.0 111.902 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.4 p -144.71 172.28 13.22 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.874 -0.516 . . . . 1.0 110.854 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.72 -38.8 86.32 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.26 -0.644 . . . . 1.0 109.26 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -58.11 -40.84 82.25 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -70.34 -38.32 74.82 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.991 -0.443 . . . . 1.0 110.211 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -64.22 -47.57 79.18 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.72 -0.844 . . . . 1.0 108.72 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -60.53 -42.2 95.99 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -59.22 -38.66 80.49 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.7 t -71.39 -52.73 17.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -55.57 -47.06 77.04 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.933 -0.395 . . . . 1.0 109.933 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.48 -38.2 88.92 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -69.11 -52.84 24.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.278 0.561 . . . . 1.0 110.244 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -61.74 -38.01 86.37 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -58.06 -39.75 79.28 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.347 -0.983 . . . . 1.0 108.347 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.0 m -62.87 -38.36 90.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.906 -0.775 . . . . 1.0 108.906 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 40.9 tpp -67.62 -50.39 58.34 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.43 -41.7 97.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -69.1 -42.6 75.91 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.59 -37.29 94.51 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.012 -1.235 . . . . 1.0 110.012 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.2 tp -66.68 -41.63 87.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.298 0.57 . . . . 1.0 109.704 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -60.58 -36.24 78.05 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.053 -0.404 . . . . 1.0 109.952 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -61.51 -39.23 90.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.853 0.358 . . . . 1.0 110.784 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -73.2 -49.96 25.11 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.066 0.46 . . . . 1.0 110.788 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.13 -41.89 97.04 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.89 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -76.68 -1.51 28.17 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.128 0.489 . . . . 1.0 110.063 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -61.0 -38.74 87.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.768 0.318 . . . . 1.0 110.394 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -56.76 -39.96 74.95 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 122.3 -0.25 . . . . 1.0 110.849 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.56 -46.69 94.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.36 -0.237 . . . . 1.0 110.36 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.6 t -62.14 -42.58 99.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.847 0.356 . . . . 1.0 110.547 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.904 -1.046 . . . . 1.0 110.556 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 2' ' ' GLU . 67.0 mtt . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 1' ' ' MET . 75.4 mt-10 57.32 152.24 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.248 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.489 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -56.34 -179.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.59 0.71 . . . . 1.0 110.724 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -73.23 -168.79 0.55 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.756 -0.59 . . . . 1.0 110.712 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.0 mp -73.94 139.57 44.98 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.809 0.814 . . . . 1.0 111.187 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 75.5 mt -112.47 128.39 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.843 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.95 145.03 48.69 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.005 -0.434 . . . . 1.0 110.69 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -138.63 123.39 18.71 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.115 0.483 . . . . 1.0 111.026 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -141.72 152.15 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 121.172 0.51 . . . . 1.0 110.462 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -166.96 143.11 4.4 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.99 -0.444 . . . . 1.0 111.101 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.426 HG23 ' HZ1' ' A' ' 137' ' ' LYS . 1.3 t -147.1 146.11 29.84 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.641 0.734 . . . . 1.0 111.343 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p -107.27 132.63 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 115.89 -0.596 . . . . 1.0 110.798 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 tp -142.67 150.69 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.467 0.651 . . . . 1.0 110.759 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -87.04 95.3 9.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.521 0.677 . . . . 1.0 109.856 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.62 149.78 5.37 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.12 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.75 147.74 92.35 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 121.769 1.646 . . . . 1.0 112.484 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.75 -29.74 44.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.818 -0.628 . . . . 1.0 111.38 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.402 ' HG2' ' HE ' ' A' ' 72' ' ' ARG . 95.4 mt-10 -55.37 -53.2 59.15 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.972 -0.455 . . . . 1.0 111.726 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' CD ' ' N ' ' A' ' 19' ' ' LYS . 3.9 mptp? -67.48 -40.45 85.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 1.0 111.686 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.0 t -66.77 -48.71 79.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -55.95 -42.1 75.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.876 0.846 . . . . 1.0 109.208 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -58.76 -45.79 88.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.486 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.58 -29.12 67.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.726 0.298 . . . . 1.0 111.755 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.522 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.2 tt -67.55 -44.65 77.79 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.344 -0.222 . . . . 1.0 111.222 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.4 m -118.3 79.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 121.87 0.843 . . . . 1.0 111.476 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -157.09 115.99 2.0 Allowed Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.717 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.415 ' HD3' ' HE1' ' A' ' 43' ' ' TRP . 73.9 Cg_endo -73.27 -5.71 17.62 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 121.176 1.251 . . . . 1.0 112.349 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -94.12 -45.86 7.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.61 -0.268 . . . . 1.0 110.345 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 64.6 mt -72.53 -42.21 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.7 mt -60.6 -42.38 91.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.22 -29.36 70.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 1.0 110.327 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -55.22 -43.4 74.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -69.98 -33.67 72.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.365 . . . . 1.0 110.337 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 76.2 mmm -85.61 152.22 23.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.65 0.738 . . . . 1.0 110.888 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.65 -42.34 98.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.745 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.85 46.81 0.13 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.821 -0.704 . . . . 1.0 111.908 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.2 m -86.12 125.95 33.86 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.762 0.791 . . . . 1.0 110.768 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.3 m -87.55 95.86 10.19 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.717 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.9 t -92.84 127.6 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.174 0.511 . . . . 1.0 110.656 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 40' ' ' VAL . 13.4 p -127.26 125.53 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.304 0.573 . . . . 1.0 110.466 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.6 t -158.24 153.42 25.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.508 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -97.15 -12.82 22.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.785 0.802 . . . . 1.0 108.928 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.415 ' HE1' ' HD3' ' A' ' 27' ' ' PRO . 64.0 m95 54.22 62.46 2.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.872 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.46 157.77 34.53 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.541 0.686 . . . . 1.0 110.988 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.83 117.33 4.88 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.129 0.49 . . . . 1.0 112.086 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.27 -13.01 55.2 Favored Glycine 0 N--CA 1.469 0.865 0 CA-C-N 116.304 -0.407 . . . . 1.0 112.163 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.3 m -76.42 138.54 40.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.391 0.615 . . . . 1.0 111.218 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -93.06 158.45 15.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.291 -0.868 . . . . 1.0 108.794 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.2 pt -144.77 149.51 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.512 0.672 . . . . 1.0 110.884 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.3 m -143.05 154.74 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.58 -0.737 . . . . 1.0 110.507 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 18.3 m0 -127.17 112.77 15.51 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.148 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.63 137.38 32.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.78 -171.51 31.11 Favored Glycine 0 N--CA 1.464 0.51 0 N-CA-C 111.088 -0.805 . . . . 1.0 111.088 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -126.12 131.87 51.99 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.854 0.835 . . . . 1.0 110.189 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -138.14 117.09 12.43 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.405 0.621 . . . . 1.0 110.263 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 54.37 38.37 29.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.587 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.34 -8.3 19.23 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 110.853 -0.899 . . . . 1.0 110.853 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -101.73 118.18 36.4 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.286 0.565 . . . . 1.0 110.556 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.99 129.98 41.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.11 0.481 . . . . 1.0 110.258 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -128.09 151.62 48.97 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.806 0.813 . . . . 1.0 110.811 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -135.11 129.71 34.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.698 0.761 . . . . 1.0 110.46 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -85.24 168.84 14.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.277 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -155.6 126.16 6.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.482 0.658 . . . . 1.0 112.358 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.17 178.37 32.73 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.401 -1.08 . . . . 1.0 110.401 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 90.3 m -145.48 154.24 42.01 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 122.029 -0.689 . . . . 1.0 111.282 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.83 114.45 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.294 0.569 . . . . 1.0 110.068 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.7 mt -77.26 -44.34 30.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.401 0.619 . . . . 1.0 110.086 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -151.24 149.39 29.36 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -138.63 112.63 8.52 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.602 0.715 . . . . 1.0 111.448 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.423 ' HB3' ' H ' ' A' ' 74' ' ' ILE . 47.6 t-20 -126.37 103.45 7.64 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.441 -0.577 . . . . 1.0 109.441 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.456 ' OE2' ' NH1' ' A' ' 72' ' ' ARG . 79.2 tt0 -46.43 129.69 10.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.493 0.663 . . . . 1.0 112.14 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.456 ' NH1' ' OE2' ' A' ' 71' ' ' GLU . 85.6 mtt85 42.58 55.91 4.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.852 -0.613 . . . . 1.0 112.549 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.7 t -167.2 -70.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.797 -0.565 . . . . 1.0 111.925 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.423 ' H ' ' HB3' ' A' ' 70' ' ' ASN . 87.8 mt -135.27 130.74 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.654 0.74 . . . . 1.0 111.497 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.8 tp -140.27 120.95 14.31 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.287 -0.87 . . . . 1.0 110.382 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -141.0 146.54 37.4 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.181 0.515 . . . . 1.0 110.259 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -151.68 158.17 43.07 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.884 0.849 . . . . 1.0 112.215 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 p -82.23 148.61 28.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -142.52 133.75 26.12 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.707 0.765 . . . . 1.0 111.84 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -144.42 133.41 22.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.013 -0.994 . . . . 1.0 110.548 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.4 p -142.52 131.54 11.88 Favored Pre-proline 0 N--CA 1.475 0.78 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.555 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 84' ' ' THR . 65.1 Cg_endo -71.86 -21.57 24.57 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 121.132 1.221 . . . . 1.0 112.317 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 64.6 mt -62.26 -1.58 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.092 0.473 . . . . 1.0 110.607 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 82' ' ' PRO . 21.7 p -67.16 -16.53 64.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.09 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.86 13.97 82.52 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.851 -0.9 . . . . 1.0 110.851 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.43 ' C ' ' H ' ' A' ' 88' ' ' ASP . 25.3 mtpp -144.91 81.29 10.8 Favored Pre-proline 0 N--CA 1.471 0.622 0 CA-C-O 119.104 -0.474 . . . . 1.0 111.113 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.77 21.91 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.589 1.526 . . . . 1.0 111.819 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 86' ' ' LYS . 96.9 m-20 -59.93 -179.71 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.945 0.878 . . . . 1.0 111.298 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.7 mt -42.7 149.69 0.47 Allowed Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 123.211 0.604 . . . . 1.0 111.337 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.431 ' C ' ' N ' ' A' ' 92' ' ' ASN . 59.3 Cg_exo -48.87 -36.53 34.21 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 121.35 1.367 . . . . 1.0 112.878 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -47.49 -17.29 0.08 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.532 0.682 . . . . 1.0 110.631 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.431 ' N ' ' C ' ' A' ' 90' ' ' PRO . 11.5 t-20 -70.6 -7.72 46.25 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.927 -0.579 . . . . 1.0 112.409 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -99.61 176.83 5.34 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.271 0.558 . . . . 1.0 112.039 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -141.0 161.43 37.87 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 122.006 0.907 . . . . 1.0 111.199 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -106.94 130.17 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 114.943 -1.026 . . . . 1.0 109.62 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.41 131.85 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.747 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -124.3 121.89 36.24 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.341 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 60.8 mt -121.26 132.99 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.286 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.2 m -129.1 118.0 21.76 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.195 0.521 . . . . 1.0 110.451 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.3 mp -105.19 135.26 46.88 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.922 0.868 . . . . 1.0 110.598 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 74.0 p -129.79 131.21 46.13 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.19 -0.914 . . . . 1.0 110.575 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.01 108.34 20.41 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.175 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -96.19 166.79 11.57 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.12 0.486 . . . . 1.0 110.47 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -59.48 -40.47 87.07 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.313 0.486 . . . . 1.0 112.313 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -75.47 -39.83 58.15 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.058 0.543 . . . . 1.0 110.93 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.67 -140.1 3.11 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 p -133.09 138.92 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.63 0.728 . . . . 1.0 110.935 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -115.74 143.78 44.9 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.377 -0.829 . . . . 1.0 109.812 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.43 154.06 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.994 0.902 . . . . 1.0 110.229 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -145.07 134.78 23.46 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.676 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -131.58 146.4 52.19 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.928 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.5 p -142.63 151.91 41.94 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.577 0.703 . . . . 1.0 111.356 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -142.22 112.57 7.11 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.445 -0.798 . . . . 1.0 110.063 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -84.59 -169.71 2.76 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.457 0.646 . . . . 1.0 112.514 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.85 39.42 29.55 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.561 0.948 . . . . 1.0 113.561 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -82.76 120.6 25.81 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.793 -1.188 . . . . 1.0 107.793 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -62.39 -38.03 88.05 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.869 -1.144 . . . . 1.0 111.873 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.7 t -149.3 168.96 21.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.272 0.558 . . . . 1.0 110.911 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -57.6 -37.65 73.59 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -57.4 -40.66 78.73 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.524 -0.547 . . . . 1.0 109.524 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -70.53 -39.14 74.22 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 121.906 -0.496 . . . . 1.0 110.043 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -64.53 -45.98 84.87 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.566 -0.902 . . . . 1.0 108.566 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -62.57 -41.48 98.96 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.102 -0.703 . . . . 1.0 109.102 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -60.28 -41.42 93.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.9 m -73.62 -48.17 34.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.13 0.49 . . . . 1.0 109.756 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -55.68 -50.48 70.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -62.47 -38.05 88.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -65.36 -51.98 56.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.074 0.464 . . . . 1.0 110.198 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.512 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 80.7 m95 -61.12 -39.78 91.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.539 -0.541 . . . . 1.0 109.539 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -58.18 -39.04 77.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.7 m -64.62 -42.31 95.59 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.512 ' SD ' ' CE3' ' A' ' 129' ' ' TRP . 81.5 mtp -64.2 -49.99 69.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.7 -40.47 95.14 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -62.17 -44.45 96.57 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.99 -0.744 . . . . 1.0 108.99 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.59 -34.01 82.71 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.295 -1.122 . . . . 1.0 110.295 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.47 ' O ' HD23 ' A' ' 136' ' ' LEU . 1.7 tt -66.86 -52.95 37.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.653 0.74 . . . . 1.0 109.906 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.426 ' HZ1' HG23 ' A' ' 11' ' ' THR . 45.6 mmtm -62.06 -36.82 82.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.433 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -59.94 -37.98 81.09 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.424 -0.173 . . . . 1.0 110.558 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -63.72 -48.85 75.4 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.183 -0.323 . . . . 1.0 110.541 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 140' ' ' LEU . 11.0 mp -66.73 -40.14 88.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.683 0.277 . . . . 1.0 110.546 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -70.24 -1.54 10.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.038 0.447 . . . . 1.0 110.128 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -66.35 -37.15 84.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.033 0.444 . . . . 1.0 110.663 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -62.15 -54.35 42.43 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.23 -0.294 . . . . 1.0 111.356 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.1 p -66.07 -38.1 81.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.79 0.328 . . . . 1.0 110.411 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.0 m -60.05 -41.23 91.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.814 0.34 . . . . 1.0 110.462 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.975 -1.012 . . . . 1.0 110.52 179.947 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.184 -0.673 . . . . 1.0 109.184 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -66.33 -38.93 88.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.53 -0.305 . . . . 1.0 110.557 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.531 ' O ' HD12 ' A' ' 3' ' ' ILE . 1.2 pp -137.39 165.92 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 122.226 1.012 . . . . 1.0 110.911 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -80.52 -172.57 3.65 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.706 0.765 . . . . 1.0 110.585 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.478 ' N ' HD12 ' A' ' 5' ' ' LEU . 10.4 mp -70.17 141.56 52.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.982 0.896 . . . . 1.0 111.444 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.0 mt -114.64 130.62 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 115.648 -0.706 . . . . 1.0 110.91 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.37 142.94 47.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.06 0.457 . . . . 1.0 110.645 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -135.97 115.76 13.05 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.875 0.369 . . . . 1.0 110.971 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.91 137.14 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 120.98 0.419 . . . . 1.0 110.612 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -155.39 144.09 20.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.996 0.427 . . . . 1.0 111.164 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 t -146.81 143.49 28.66 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.233 0.539 . . . . 1.0 111.401 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.2 t -85.18 126.56 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.334 0.588 . . . . 1.0 110.631 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.7 mt -130.18 133.36 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.63 0.729 . . . . 1.0 110.49 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -90.5 95.85 10.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.39 0.614 . . . . 1.0 109.813 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.45 156.25 2.26 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.926 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.06 146.95 92.55 Favored 'Trans proline' 0 N--CA 1.506 2.238 0 C-N-CA 122.018 1.812 . . . . 1.0 112.621 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.1 tt -68.47 -27.47 36.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.446 0.641 . . . . 1.0 111.466 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.44 ' OE2' ' NE ' ' A' ' 72' ' ' ARG . 71.4 mm-40 -62.03 -47.26 85.55 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.88 -0.513 . . . . 1.0 112.286 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -62.77 -46.31 88.63 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.993 0.368 . . . . 1.0 111.993 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 21' ' ' TRP . 19.0 m -69.18 -46.47 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.833 -0.803 . . . . 1.0 108.833 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.429 ' N ' HG23 ' A' ' 20' ' ' VAL . 58.1 t-105 -55.2 -50.51 69.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -60.74 -44.8 96.23 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.018 -0.426 . . . . 1.0 110.357 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.75 -21.48 28.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.468 -0.333 . . . . 1.0 111.755 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.03 -41.46 15.77 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.061 0.458 . . . . 1.0 111.555 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 m -108.14 75.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.308 0.575 . . . . 1.0 110.69 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.405 ' O ' ' CG1' ' A' ' 30' ' ' ILE . 0.2 OUTLIER -159.4 124.64 2.26 Favored Pre-proline 0 CA--C 1.548 0.867 0 CA-C-O 119.184 -0.436 . . . . 1.0 110.783 178.536 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.52 -11.62 20.55 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 121.805 1.67 . . . . 1.0 112.34 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -91.03 -47.74 7.38 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 110.269 -0.271 . . . . 1.0 110.269 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.91 -42.69 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.919 -0.771 . . . . 1.0 108.919 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.405 ' CG1' ' O ' ' A' ' 26' ' ' ASN . 5.4 mm -60.34 -42.14 89.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.271 -0.64 . . . . 1.0 109.271 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -64.5 -31.26 72.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.686 0.279 . . . . 1.0 110.357 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -65.24 -45.98 82.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -72.04 -34.07 68.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.089 0.471 . . . . 1.0 110.589 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.549 ' O ' ' N ' ' A' ' 36' ' ' GLY . 68.6 mmm -93.94 59.82 2.79 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.554 0.692 . . . . 1.0 111.098 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 38.03 -84.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.135 -0.484 . . . . 1.0 112.2 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 34' ' ' MET . . . -146.34 48.26 0.68 Allowed Glycine 0 N--CA 1.469 0.865 0 O-C-N 121.948 -0.47 . . . . 1.0 112.021 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.7 m -93.48 117.57 30.25 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.675 0.75 . . . . 1.0 110.712 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 51.9 m -83.19 124.72 30.8 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.708 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.88 145.05 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.374 0.607 . . . . 1.0 110.631 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.5 t -120.74 130.65 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.41 0.624 . . . . 1.0 110.428 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.6 t -152.34 131.28 12.55 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.085 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.408 ' OD2' ' NZ ' ' A' ' 44' ' ' LYS . 93.9 m-20 -75.68 -19.08 59.39 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.119 0.961 . . . . 1.0 109.387 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.1 m0 68.16 45.47 1.27 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.65 -0.705 . . . . 1.0 111.488 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.408 ' NZ ' ' OD2' ' A' ' 42' ' ' ASP . 25.0 pttm -148.44 156.43 42.47 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.46 0.647 . . . . 1.0 111.369 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -48.19 127.69 12.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.687 0.756 . . . . 1.0 112.385 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.79 1.97 89.78 Favored Glycine 0 N--CA 1.465 0.609 0 CA-C-N 115.722 -0.672 . . . . 1.0 112.044 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.0 t -64.89 132.58 49.78 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.301 -0.529 . . . . 1.0 111.75 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -83.02 143.69 30.45 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.2 mt -134.1 136.08 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.791 0.805 . . . . 1.0 110.944 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.7 t -128.58 142.1 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.213 -0.903 . . . . 1.0 110.632 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 20.8 m-90 -117.18 123.26 46.25 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.014 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -97.0 126.63 42.27 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.25 178.26 34.59 Favored Glycine 0 N--CA 1.461 0.32 0 N-CA-C 110.997 -0.841 . . . . 1.0 110.997 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -128.68 136.59 50.82 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.571 0.701 . . . . 1.0 110.163 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -138.53 117.7 12.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.038 0.447 . . . . 1.0 110.466 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? 53.57 38.71 28.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.348 0.594 . . . . 1.0 110.747 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.7 -8.37 21.36 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.516 -1.034 . . . . 1.0 110.516 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -98.83 116.56 31.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.107 0.479 . . . . 1.0 110.664 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.09 128.44 36.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.251 0.548 . . . . 1.0 110.247 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -129.96 150.45 51.23 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.618 0.723 . . . . 1.0 110.971 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -135.77 131.66 35.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.437 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -89.54 162.6 15.6 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -141.18 126.99 19.16 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.558 0.694 . . . . 1.0 112.424 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.66 170.56 31.16 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.333 -1.107 . . . . 1.0 110.333 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.7 m -146.51 153.73 40.74 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 122.054 -0.674 . . . . 1.0 111.243 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.4 mm -77.9 116.49 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.37 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.4 tp -76.13 -44.9 36.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.653 0.74 . . . . 1.0 110.065 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -145.4 148.44 33.34 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -136.3 105.51 6.0 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.843 0.83 . . . . 1.0 111.439 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -125.45 107.95 11.16 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.25 -0.648 . . . . 1.0 109.25 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.464 ' H ' ' CD ' ' A' ' 71' ' ' GLU . 56.3 mp0 -46.69 134.54 9.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.546 0.688 . . . . 1.0 111.969 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.44 ' NE ' ' OE2' ' A' ' 18' ' ' GLU . 14.4 ptp180 36.76 53.46 1.09 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.78 -0.645 . . . . 1.0 112.445 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 m -157.59 -69.9 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.822 -0.549 . . . . 1.0 111.618 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.6 mt -142.4 134.87 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-O 121.588 0.708 . . . . 1.0 111.535 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.6 tp -132.0 119.52 21.18 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.317 -0.856 . . . . 1.0 110.792 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -133.54 138.3 46.0 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.257 0.551 . . . . 1.0 110.299 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -151.06 153.26 34.75 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.975 0.893 . . . . 1.0 112.073 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.8 p -84.59 151.79 24.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.253 -1.017 . . . . 1.0 108.253 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -149.84 137.32 19.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.632 0.73 . . . . 1.0 112.105 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -150.67 150.09 30.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.001 -0.999 . . . . 1.0 110.655 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.5 t -143.39 139.58 16.65 Favored Pre-proline 0 CA--C 1.549 0.91 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.612 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 84' ' ' THR . 48.6 Cg_endo -70.05 -20.63 33.22 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 121.603 1.535 . . . . 1.0 112.149 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.1 mt -58.21 -6.85 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.002 0.429 . . . . 1.0 110.332 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 82' ' ' PRO . 26.1 p -66.01 -18.62 65.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.958 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.4 22.77 72.34 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.535 -1.026 . . . . 1.0 110.535 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -145.16 149.93 43.49 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.462 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.52 153.46 77.09 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.863 1.708 . . . . 1.0 111.646 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.7 p-10 -50.97 105.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.359 0.6 . . . . 1.0 111.788 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 19.9 mt -138.75 150.95 67.53 Favored Pre-proline 0 N--CA 1.473 0.722 0 O-C-N 121.854 -0.529 . . . . 1.0 110.893 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.33 -22.87 59.59 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.693 2.262 . . . . 1.0 112.226 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -89.07 -9.39 51.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.278 0.561 . . . . 1.0 110.563 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -100.35 11.45 39.39 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.078 -0.51 . . . . 1.0 112.313 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.428 ' C ' ' CD1' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -151.26 170.58 19.16 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.405 0.621 . . . . 1.0 111.722 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.492 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.3 OUTLIER -144.68 160.67 40.82 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.761 0.791 . . . . 1.0 111.318 179.354 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -104.5 129.19 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 115.171 -0.922 . . . . 1.0 109.458 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.8 t -96.26 132.79 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.987 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -123.18 121.63 36.42 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.378 0.609 . . . . 1.0 110.612 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.1 mm -107.15 131.76 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.468 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.1 m -118.89 114.36 22.48 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.356 0.598 . . . . 1.0 110.115 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.4 mt -122.94 122.94 39.81 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.641 0.734 . . . . 1.0 110.829 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 m -131.29 132.39 44.51 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.491 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -85.28 123.42 30.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.043 0.449 . . . . 1.0 110.38 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.6 mt -93.21 -152.56 0.33 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.007 0.432 . . . . 1.0 110.508 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.555 ' CD ' ' H ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -77.7 -48.73 16.0 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.187 0.44 . . . . 1.0 112.187 -178.802 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -136.95 35.47 2.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.81 0.844 . . . . 1.0 110.001 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 179.21 169.14 39.3 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.915 -0.874 . . . . 1.0 110.915 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.8 p -127.07 133.08 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.04 0.448 . . . . 1.0 111.302 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -88.72 139.87 30.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.589 . . . . 1.0 109.741 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.77 138.7 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.536 0.684 . . . . 1.0 110.248 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -150.33 136.37 18.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.307 0.575 . . . . 1.0 110.513 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 tt -122.12 132.59 54.55 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.982 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.2 m -124.2 143.38 50.55 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.491 0.662 . . . . 1.0 111.419 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.492 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 43.1 tt0 -145.4 135.5 23.82 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.419 -0.81 . . . . 1.0 109.947 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -110.24 -165.25 0.98 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.474 0.654 . . . . 1.0 112.407 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.0 t30 60.01 37.16 21.39 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.751 1.019 . . . . 1.0 113.751 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -83.63 113.15 20.64 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.663 -1.236 . . . . 1.0 107.663 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -62.58 -35.77 80.55 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.006 -1.058 . . . . 1.0 111.584 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.0 p -143.89 164.91 29.21 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.877 -0.514 . . . . 1.0 111.067 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -58.66 -35.65 72.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.57 0.7 . . . . 1.0 109.23 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -58.66 -41.14 85.43 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.443 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -68.28 -41.45 80.99 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.981 -0.45 . . . . 1.0 110.084 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -64.16 -47.64 79.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -59.26 -42.93 92.3 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -63.32 -37.78 88.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 71.0 m -67.95 -54.51 18.1 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -52.6 -43.95 65.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.34 -0.391 . . . . 1.0 109.963 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -62.97 -39.44 94.7 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.758 -0.46 . . . . 1.0 109.758 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -67.39 -51.69 48.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.045 0.45 . . . . 1.0 110.175 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -64.05 -42.25 97.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -58.39 -39.79 80.6 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.628 -0.878 . . . . 1.0 108.628 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.2 m -63.94 -40.93 97.56 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.919 -0.771 . . . . 1.0 108.919 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 39.5 ttm -65.8 -50.39 64.82 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.7 -40.7 95.93 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -66.23 -44.21 84.45 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.16 -37.25 91.26 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.106 -1.198 . . . . 1.0 110.106 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 49.0 tp -71.44 -44.78 64.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.4 0.619 . . . . 1.0 110.072 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -60.87 -43.93 97.74 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.108 -0.37 . . . . 1.0 110.461 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.67 -36.29 76.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.69 0.281 . . . . 1.0 110.847 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -62.02 -48.5 80.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.215 0.531 . . . . 1.0 110.399 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.31 -37.18 84.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.653 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.88 -0.54 13.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.296 0.569 . . . . 1.0 110.152 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -62.41 -35.96 80.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.665 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -61.69 -54.05 47.82 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 122.388 -0.195 . . . . 1.0 110.864 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.21 -31.03 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 1.0 110.564 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.5 t -59.64 -44.13 93.62 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.152 -0.343 . . . . 1.0 110.446 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.579 0 CA-C-O 118.018 -0.991 . . . . 1.0 110.329 179.933 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.529 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -163.08 147.56 11.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.166 0.508 . . . . 1.0 109.946 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.663 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -144.07 -179.22 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-O 121.44 0.638 . . . . 1.0 110.951 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -75.8 -153.82 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.21 0.528 . . . . 1.0 110.805 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 5' ' ' LEU . 3.3 mm? -79.0 141.6 37.34 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.618 0.723 . . . . 1.0 111.57 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.9 mt -117.92 128.64 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.0 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.17 138.99 33.42 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.991 -0.443 . . . . 1.0 110.651 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -136.35 126.5 26.27 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.265 0.555 . . . . 1.0 111.01 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.52 156.15 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.053 0.454 . . . . 1.0 110.626 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -170.75 144.59 2.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.018 0.437 . . . . 1.0 111.013 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 t -147.09 145.15 29.52 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.365 0.602 . . . . 1.0 111.034 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 12' ' ' VAL . 13.5 p -90.03 128.6 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.245 0.545 . . . . 1.0 110.439 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.5 mt -131.77 135.37 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.724 0.773 . . . . 1.0 110.613 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -88.01 94.4 9.78 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.476 0.655 . . . . 1.0 110.052 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.68 156.65 2.19 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.683 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.93 149.64 90.14 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.208 1.939 . . . . 1.0 112.401 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.9 tt -68.93 -29.01 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.91 -0.586 . . . . 1.0 111.263 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.44 -54.23 43.56 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.953 -0.467 . . . . 1.0 111.859 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.46 -40.06 89.17 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.97 0.359 . . . . 1.0 111.97 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.7 t -66.11 -46.93 86.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 30.2 t-105 -58.08 -41.53 83.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.727 0.775 . . . . 1.0 109.01 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -60.67 -44.13 96.85 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.993 -0.442 . . . . 1.0 110.38 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.2 69.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.578 -0.283 . . . . 1.0 111.687 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.55 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.1 tt -70.2 -41.74 73.29 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.231 -0.293 . . . . 1.0 111.469 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 m -121.21 79.06 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 121.749 0.785 . . . . 1.0 111.149 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -160.75 103.19 1.31 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.228 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -54.08 -27.33 45.47 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.064 1.843 . . . . 1.0 112.791 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -70.12 -53.44 17.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.147 0.499 . . . . 1.0 110.533 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.04 -42.19 88.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.401 0.619 . . . . 1.0 109.334 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.1 mm -59.43 -42.49 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.003 -0.74 . . . . 1.0 109.003 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -69.93 -31.76 69.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.016 0.436 . . . . 1.0 110.4 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -57.39 -41.98 81.29 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -70.27 -34.1 72.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.848 0.356 . . . . 1.0 110.37 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.2 mmt -85.07 148.25 26.25 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.582 0.706 . . . . 1.0 111.052 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -60.67 -43.68 97.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.633 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.41 41.58 0.24 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.106 -0.569 . . . . 1.0 112.061 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.7 m -85.27 126.96 34.12 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.448 0.642 . . . . 1.0 110.675 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.1 m -92.71 106.33 18.32 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.954 0.407 . . . . 1.0 110.599 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.0 t -106.19 135.32 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.659 0.743 . . . . 1.0 110.484 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.2 m -129.73 130.96 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.512 0.672 . . . . 1.0 110.549 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.2 t -155.78 154.18 31.0 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.535 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -92.75 -18.77 22.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.854 0.835 . . . . 1.0 108.948 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 2.2 m0 66.68 46.84 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 1.0 111.409 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -149.76 157.19 42.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.576 0.703 . . . . 1.0 111.334 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -52.22 129.55 28.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.865 0.84 . . . . 1.0 112.296 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.04 1.68 90.37 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.648 -0.706 . . . . 1.0 112.172 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.0 t -68.17 133.41 48.85 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 122.305 -0.527 . . . . 1.0 111.589 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -79.46 144.58 33.9 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.9 tt -138.25 136.93 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.608 0.718 . . . . 1.0 111.205 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.2 m -140.56 151.58 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.542 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -124.36 131.54 53.51 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.238 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -94.16 137.17 33.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.515 0.674 . . . . 1.0 109.694 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.78 169.9 37.34 Favored Glycine 0 C--N 1.33 0.239 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.55 122.78 40.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.816 0.817 . . . . 1.0 110.017 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' A' ' 58' ' ' LYS . 43.1 t-105 -117.58 115.87 25.96 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.576 0.703 . . . . 1.0 109.913 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.432 ' HG2' ' CD1' ' A' ' 55' ' ' TRP . 9.5 ptmm? 40.07 46.33 1.8 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.89 -0.596 . . . . 1.0 111.548 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.15 -17.77 9.19 Favored Glycine 0 N--CA 1.472 1.045 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 55' ' ' TRP . 37.5 ttmt -91.22 114.78 27.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.404 0.621 . . . . 1.0 110.299 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.37 136.59 46.16 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.108 -0.37 . . . . 1.0 110.33 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -138.61 155.82 47.99 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.558 0.695 . . . . 1.0 110.948 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.446 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 1.5 pm0 -138.73 131.78 29.72 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.542 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -87.09 136.81 32.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -120.52 127.74 52.46 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.56 0.695 . . . . 1.0 112.478 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.95 178.79 33.18 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.362 -1.095 . . . . 1.0 110.362 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 66' ' ' ILE . 58.1 m -148.12 157.9 43.77 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.86 -0.788 . . . . 1.0 111.132 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.454 ' N ' HG22 ' A' ' 65' ' ' THR . 31.8 mm -73.39 115.54 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.506 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.402 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 38.3 tp -69.73 -44.34 70.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.363 0.602 . . . . 1.0 110.137 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -155.97 147.53 22.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -131.06 110.17 11.02 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.649 0.738 . . . . 1.0 111.597 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -125.39 95.36 4.44 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.338 -0.615 . . . . 1.0 109.338 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -40.78 131.76 2.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.388 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.6 mtm-85 40.38 55.04 2.86 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.5 m -163.37 -70.65 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.757 -0.589 . . . . 1.0 111.976 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.1 mt -140.88 133.97 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 121.491 0.662 . . . . 1.0 111.408 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 tp -136.19 126.31 26.23 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.377 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -142.97 146.43 33.92 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.114 0.483 . . . . 1.0 110.226 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.402 ' HA ' ' H ' ' A' ' 67' ' ' LEU . 29.5 p90 -150.26 155.03 38.94 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.142 0.973 . . . . 1.0 112.204 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 93.8 p -95.18 152.68 18.15 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.469 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -152.06 151.42 31.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.844 0.83 . . . . 1.0 111.554 -179.482 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -142.35 134.72 27.81 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.752 -1.113 . . . . 1.0 110.463 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.0 m -104.49 114.19 64.35 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-O 118.686 -0.673 . . . . 1.0 110.546 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.17 -18.25 23.85 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 120.945 1.097 . . . . 1.0 112.137 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.9 mt -60.51 -14.29 18.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.979 0.419 . . . . 1.0 110.379 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.2 p -65.35 -34.58 78.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.015 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.02 29.31 27.65 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.972 -0.851 . . . . 1.0 110.972 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -90.69 153.89 45.73 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 120.791 -0.363 . . . . 1.0 111.249 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.94 148.16 23.9 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 121.124 1.216 . . . . 1.0 111.964 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -45.13 101.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.693 0.758 . . . . 1.0 111.981 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.1 tp -152.38 91.42 3.6 Favored Pre-proline 0 CA--C 1.544 0.741 0 O-C-N 121.994 -0.441 . . . . 1.0 110.293 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.412 ' O ' ' CD1' ' A' ' 93' ' ' TYR . 65.4 Cg_exo -51.03 -32.98 40.91 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.064 1.843 . . . . 1.0 112.738 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.4 -3.77 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.267 0.556 . . . . 1.0 110.493 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.48 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 43.7 t30 -68.77 -35.45 77.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 1.0 112.292 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.469 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 39.5 p90 -101.38 177.65 4.87 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.626 0.726 . . . . 1.0 112.053 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -134.96 162.5 32.27 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.892 0.853 . . . . 1.0 111.416 -179.316 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.6 p -101.3 129.86 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.012 -0.995 . . . . 1.0 109.8 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 t -94.76 133.5 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.9 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.4 t -128.75 121.96 29.56 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.494 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.15 132.4 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.35 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.3 m -111.88 124.63 52.79 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.421 0.629 . . . . 1.0 109.999 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 74.9 mt -125.51 117.67 24.12 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.428 0.632 . . . . 1.0 110.794 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.9 m -133.25 134.67 44.28 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.431 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -85.7 126.3 33.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.296 0.57 . . . . 1.0 110.29 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 47.7 mt -110.14 172.24 6.98 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.167 0.508 . . . . 1.0 110.589 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -64.54 -40.28 95.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.47 0.545 . . . . 1.0 112.47 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -83.73 -34.98 24.76 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.276 0.56 . . . . 1.0 110.875 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.25 -146.58 5.86 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.909 -0.876 . . . . 1.0 110.909 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.2 p -125.44 128.64 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.248 0.547 . . . . 1.0 111.016 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -95.81 142.15 28.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.611 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.3 m -130.14 148.7 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.622 0.725 . . . . 1.0 110.558 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -151.1 133.07 15.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.152 0.501 . . . . 1.0 110.514 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.6 tt -124.6 131.82 53.46 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.806 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.8 m -123.28 143.34 50.13 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.648 0.737 . . . . 1.0 111.142 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.438 ' OE1' ' ND2' ' A' ' 116' ' ' ASN . 0.9 OUTLIER -142.32 136.74 30.01 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.309 -0.86 . . . . 1.0 110.034 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 0.7 OUTLIER -114.23 -164.67 0.95 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.631 0.729 . . . . 1.0 112.334 -179.04 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 92' ' ' ASN . 64.4 t30 59.03 35.39 23.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.469 0.915 . . . . 1.0 113.469 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.438 ' ND2' ' OE1' ' A' ' 113' ' ' GLN . 83.5 m-20 -83.64 133.75 34.82 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.557 -1.275 . . . . 1.0 107.557 177.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -64.07 -46.17 85.49 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.028 -1.045 . . . . 1.0 112.066 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 62.0 p -147.79 179.71 7.51 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.843 -0.535 . . . . 1.0 110.835 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -60.39 -37.07 79.63 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -61.34 -43.96 98.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -71.32 -41.69 69.54 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.967 -0.458 . . . . 1.0 110.075 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -63.24 -44.89 93.92 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -62.8 -42.82 99.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.698 -0.852 . . . . 1.0 108.698 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -59.57 -39.94 85.75 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 16.8 t -69.73 -44.75 69.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -56.01 -47.73 77.23 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.98 -39.15 91.21 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.787 -0.449 . . . . 1.0 109.787 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -64.28 -53.11 54.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 1.0 110.068 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.506 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 86.5 m95 -60.61 -39.18 87.21 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -59.08 -39.89 83.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.396 -0.965 . . . . 1.0 108.396 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.4 m -63.5 -43.13 98.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.506 ' SD ' ' CE3' ' A' ' 129' ' ' TRP . 77.2 mtp -62.7 -50.7 70.07 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.497 -0.556 . . . . 1.0 109.497 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.54 -38.8 88.76 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.41 ' HA ' ' HZ3' ' A' ' 137' ' ' LYS . 78.8 tt0 -65.66 -34.04 77.28 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.68 -32.34 33.78 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.155 -1.178 . . . . 1.0 110.155 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.453 ' O ' HD23 ' A' ' 136' ' ' LEU . 1.7 tt -68.56 -54.13 18.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.641 0.734 . . . . 1.0 109.871 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.41 ' HZ3' ' HA ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -61.84 -27.0 68.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.534 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -56.36 -32.18 64.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.891 0.377 . . . . 1.0 110.613 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -79.22 -41.95 27.11 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.036 0.446 . . . . 1.0 110.7 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 140' ' ' LEU . 4.1 mm? -63.24 -41.87 99.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.838 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -75.74 -1.98 27.52 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.338 0.59 . . . . 1.0 110.231 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -63.5 -41.2 98.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.661 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -60.39 -56.47 21.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.748 0.308 . . . . 1.0 110.902 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.48 -43.52 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 110.155 -0.313 . . . . 1.0 110.155 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.9 m -60.51 -41.29 94.06 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.152 -0.343 . . . . 1.0 110.211 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.966 -1.016 . . . . 1.0 110.372 -179.961 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.439 ' O ' ' N ' ' A' ' 3' ' ' ILE . 79.1 mtp . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.41 ' N ' ' CD ' ' A' ' 2' ' ' GLU . 23.7 mp0 51.94 -88.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.549 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 1' ' ' MET . 39.1 pt -140.73 168.38 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.903 0.859 . . . . 1.0 110.931 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -74.9 -175.8 2.67 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.7 -0.625 . . . . 1.0 110.971 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.7 mp -68.2 140.2 56.08 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.03 0.919 . . . . 1.0 111.182 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.1 mp -112.21 124.33 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.687 -0.688 . . . . 1.0 111.099 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.08 134.21 36.75 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.029 -0.42 . . . . 1.0 110.372 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -133.7 122.36 23.27 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.976 0.417 . . . . 1.0 110.804 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.3 m -139.89 135.59 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.099 0.476 . . . . 1.0 110.576 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -152.64 150.69 29.75 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.089 0.471 . . . . 1.0 111.033 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.479 HG23 ' NZ ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -145.87 142.39 28.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.541 0.686 . . . . 1.0 111.143 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 t -85.62 114.51 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.416 0.627 . . . . 1.0 110.715 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.9 mm -127.84 138.77 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 122.183 0.992 . . . . 1.0 110.733 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -98.04 105.93 18.15 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.397 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' A' ' 16' ' ' PRO . . . -173.24 160.6 3.46 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 120.977 -0.289 . . . . 1.0 110.416 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.436 ' HD2' ' HB1' ' A' ' 15' ' ' ALA . 26.0 Cg_endo -59.85 140.5 93.45 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.341 2.027 . . . . 1.0 112.135 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.1 tp -68.21 -32.87 57.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.649 0.738 . . . . 1.0 111.221 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -57.4 -52.39 65.58 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.886 -0.508 . . . . 1.0 111.859 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' CD ' ' N ' ' A' ' 19' ' ' LYS . 12.2 mptt -64.49 -42.91 95.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.52 -47.54 91.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.46 ' CH2' ' O ' ' A' ' 70' ' ' ASN . 62.3 t-105 -60.23 -42.42 95.19 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -58.99 -47.39 85.34 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.977 -0.452 . . . . 1.0 110.206 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.79 -28.82 69.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.647 0.261 . . . . 1.0 111.702 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -70.56 -41.73 72.07 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.237 -0.289 . . . . 1.0 111.489 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 m -120.27 78.89 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 121.759 0.79 . . . . 1.0 111.226 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -158.63 113.22 1.66 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.56 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.99 -11.34 31.59 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.237 1.291 . . . . 1.0 112.649 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -86.28 -47.66 9.21 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.804 0.335 . . . . 1.0 110.332 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.18 -41.46 66.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.295 -0.632 . . . . 1.0 109.295 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.31 -42.3 86.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -65.46 -31.26 72.24 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.292 -0.262 . . . . 1.0 110.292 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -56.6 -42.77 79.28 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.824 -0.435 . . . . 1.0 109.824 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -69.81 -33.8 72.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.942 0.401 . . . . 1.0 110.389 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 79.8 mmm -85.22 153.72 22.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.66 0.743 . . . . 1.0 110.816 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -62.56 -35.83 80.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.63 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.28 42.62 0.07 OUTLIER Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.017 -0.611 . . . . 1.0 111.943 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.2 m -85.8 125.73 33.48 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.601 0.715 . . . . 1.0 110.74 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.0 p -88.95 102.42 15.05 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.636 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.53 130.64 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.471 0.653 . . . . 1.0 110.419 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.05 128.42 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.408 0.623 . . . . 1.0 110.264 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.507 ' HG ' ' HD1' ' A' ' 43' ' ' TRP . 31.5 t -155.6 153.42 30.07 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.125 -0.488 . . . . 1.0 111.384 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 8.1 t0 -92.77 -20.61 20.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.945 0.879 . . . . 1.0 108.958 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.507 ' HD1' ' HG ' ' A' ' 41' ' ' SER . 2.6 m0 67.8 49.75 0.91 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.828 -0.624 . . . . 1.0 111.559 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -151.77 155.18 37.73 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.519 0.676 . . . . 1.0 111.186 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -49.64 127.41 15.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.794 0.807 . . . . 1.0 112.176 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.4 0.75 90.2 Favored Glycine 0 N--CA 1.468 0.833 0 CA-C-N 115.678 -0.692 . . . . 1.0 112.115 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.0 t -66.31 135.9 55.06 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.232 -0.57 . . . . 1.0 111.694 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -84.67 147.01 27.16 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.44 HD11 ' HE1' ' A' ' 51' ' ' TRP . 19.8 tt -136.91 136.15 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.539 0.685 . . . . 1.0 111.338 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -138.66 142.47 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 115.505 -0.77 . . . . 1.0 110.556 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.44 ' HE1' HD11 ' A' ' 49' ' ' ILE . 14.1 m0 -119.67 136.64 54.32 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.052 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -101.97 143.53 31.71 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.332 0.587 . . . . 1.0 109.578 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.41 175.41 43.68 Favored Glycine 0 C--N 1.329 0.167 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -125.53 127.01 45.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.97 0.89 . . . . 1.0 109.791 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.587 ' O ' ' N ' ' A' ' 58' ' ' LYS . 36.2 t-105 -120.34 119.17 32.33 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.384 0.612 . . . . 1.0 109.645 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.415 ' HG2' ' CD1' ' A' ' 55' ' ' TRP . 9.9 ptmm? 39.66 42.02 0.88 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.346 0.594 . . . . 1.0 111.7 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.02 -18.01 19.12 Favored Glycine 0 N--CA 1.476 1.316 0 N-CA-C 110.768 -0.933 . . . . 1.0 110.768 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.587 ' N ' ' O ' ' A' ' 55' ' ' TRP . 74.4 mmtt -91.36 110.5 21.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.98 0.895 . . . . 1.0 110.655 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.03 132.15 47.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.65 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -134.38 152.56 51.87 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.612 0.72 . . . . 1.0 110.909 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.448 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 2.0 pm0 -138.03 136.07 36.5 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.497 0.665 . . . . 1.0 110.498 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -88.49 167.85 13.09 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -153.69 127.19 8.64 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.139 -0.624 . . . . 1.0 112.37 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.78 178.23 30.84 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.399 -1.081 . . . . 1.0 110.399 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 66' ' ' ILE . 79.2 m -148.51 154.03 39.25 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.997 -0.708 . . . . 1.0 111.24 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.408 ' N ' HG22 ' A' ' 65' ' ' THR . 32.1 mm -80.4 121.95 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.403 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -90.97 -44.54 9.28 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.426 0.631 . . . . 1.0 109.964 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -133.8 135.24 43.71 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.718 -0.475 . . . . 1.0 109.718 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -135.08 102.64 5.27 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.726 0.774 . . . . 1.0 111.516 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.46 ' O ' ' CH2' ' A' ' 21' ' ' TRP . 6.9 m120 -124.83 102.89 7.78 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.345 -0.613 . . . . 1.0 109.345 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -42.94 127.53 4.12 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.729 -0.668 . . . . 1.0 112.261 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 45.15 53.98 7.45 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.051 0.54 . . . . 1.0 112.352 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.7 t -160.05 -74.32 0.07 Allowed 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.782 -0.574 . . . . 1.0 112.027 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.5 mt -138.15 133.02 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.656 0.741 . . . . 1.0 111.374 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.1 tp -132.08 125.48 31.49 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.32 -0.855 . . . . 1.0 110.57 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.499 HE21 HG11 ' A' ' 95' ' ' VAL . 58.3 tt0 -135.13 136.71 42.12 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.452 0.644 . . . . 1.0 110.235 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -149.7 152.98 36.21 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.019 0.914 . . . . 1.0 112.0 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 p -86.94 151.07 23.62 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.152 -1.055 . . . . 1.0 108.152 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.413 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 15.2 t-80 -151.19 142.11 22.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.544 0.688 . . . . 1.0 111.939 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -144.91 148.65 34.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.048 -0.978 . . . . 1.0 110.351 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 74.8 m -122.25 118.85 28.8 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.63 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.58 -16.82 26.92 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 121.008 1.139 . . . . 1.0 112.354 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.2 mt -65.2 -12.19 48.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.948 0.404 . . . . 1.0 110.35 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.6 p -64.61 -33.04 74.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.791 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.1 3.8 32.22 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.648 -0.981 . . . . 1.0 110.648 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -88.25 150.11 46.35 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-O 119.352 -0.356 . . . . 1.0 111.398 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.34 141.45 18.85 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 121.163 1.242 . . . . 1.0 111.708 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -79.52 77.82 6.09 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.364 0.602 . . . . 1.0 111.642 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.427 ' H ' ' HB2' ' A' ' 92' ' ' ASN . 4.7 mp -115.79 161.27 31.45 Favored Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.936 -0.477 . . . . 1.0 110.778 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.29 -31.74 38.53 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 122.465 2.11 . . . . 1.0 112.626 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.442 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 80.9 mm-40 -86.47 -7.2 58.61 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.223 0.535 . . . . 1.0 110.44 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.427 ' HB2' ' H ' ' A' ' 89' ' ' LEU . 66.9 t30 -77.22 -10.14 59.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 1.0 112.227 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.59 173.2 12.94 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.616 0.722 . . . . 1.0 112.031 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -139.61 165.15 28.03 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 122.138 0.97 . . . . 1.0 111.19 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.499 HG11 HE21 ' A' ' 76' ' ' GLN . 59.2 t -107.28 128.9 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 114.829 -1.078 . . . . 1.0 109.657 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.0 t -92.82 134.13 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.919 -0.582 . . . . 1.0 111.14 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.9 t -132.03 124.78 29.97 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.51 0.671 . . . . 1.0 110.443 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.95 129.96 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.17 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.5 m -106.87 120.85 43.15 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.555 0.693 . . . . 1.0 109.831 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 mp -117.21 124.1 48.27 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.613 0.721 . . . . 1.0 110.816 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.7 p -131.02 134.08 46.35 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.824 0.821 . . . . 1.0 110.477 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.98 111.37 23.61 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.119 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.5 mt -77.76 -168.98 1.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.042 0.449 . . . . 1.0 110.464 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -64.47 -48.34 75.62 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.515 0.561 . . . . 1.0 112.515 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -137.48 38.5 2.46 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.407 0.683 . . . . 1.0 109.942 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.91 168.84 41.31 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.9 p -134.4 144.4 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.742 0.782 . . . . 1.0 110.776 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -120.27 143.03 48.54 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.698 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.0 m -129.91 149.98 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.643 0.735 . . . . 1.0 110.345 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -152.2 134.14 14.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.698 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.9 tt -119.98 131.05 55.04 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.365 0.603 . . . . 1.0 109.957 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 m -120.67 142.65 49.27 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.415 0.626 . . . . 1.0 111.265 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -145.52 136.63 24.77 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.462 -0.79 . . . . 1.0 110.046 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 10.9 p-10 -116.48 -171.09 1.94 Allowed 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.655 0.74 . . . . 1.0 112.341 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 91' ' ' GLU . 67.0 t30 65.01 38.76 6.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.627 0.973 . . . . 1.0 113.627 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -84.91 116.65 23.46 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 107.638 -1.245 . . . . 1.0 107.638 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -58.87 -36.92 75.41 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 120.954 -1.092 . . . . 1.0 111.773 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.6 p -140.96 163.6 32.52 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.872 -0.518 . . . . 1.0 111.045 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.1 -34.59 77.92 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -57.9 -38.94 76.73 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.535 -0.542 . . . . 1.0 109.535 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.49 -35.04 70.66 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.87 -0.519 . . . . 1.0 110.21 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -62.16 -47.72 83.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.792 -0.818 . . . . 1.0 108.792 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -60.23 -42.46 95.28 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.827 -0.805 . . . . 1.0 108.827 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -61.0 -38.38 85.84 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.6 t -68.42 -53.46 23.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.638 -0.505 . . . . 1.0 109.638 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -55.41 -45.46 76.71 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.999 -0.371 . . . . 1.0 109.999 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -62.76 -40.2 96.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -66.74 -51.6 54.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.373 0.606 . . . . 1.0 110.136 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -61.26 -35.68 77.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.495 -0.557 . . . . 1.0 109.495 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -59.69 -40.4 87.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.569 -0.9 . . . . 1.0 108.569 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.7 m -63.77 -43.01 97.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.252 -0.647 . . . . 1.0 109.252 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 83.4 mmm -61.42 -50.34 73.22 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.52 -40.35 94.32 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -62.8 -44.25 96.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.91 -41.94 86.93 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.224 -1.15 . . . . 1.0 110.224 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.517 ' O ' HD23 ' A' ' 136' ' ' LEU . 2.4 tt -63.03 -50.41 70.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.691 0.758 . . . . 1.0 110.179 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.479 ' NZ ' HG23 ' A' ' 11' ' ' THR . 1.0 OUTLIER -62.54 -36.86 83.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.229 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.68 -35.1 54.74 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 122.378 -0.201 . . . . 1.0 110.761 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -65.48 -51.06 62.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.915 0.388 . . . . 1.0 110.423 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.75 -41.05 88.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.488 -0.324 . . . . 1.0 110.905 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -68.58 -18.08 64.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.249 0.547 . . . . 1.0 109.935 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -48.7 -30.87 6.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 1.0 110.721 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -45.71 -25.29 0.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.722 0.296 . . . . 1.0 111.278 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 145' ' ' SER . 12.1 p -60.25 -42.44 90.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 O-C-N 122.255 -0.278 . . . . 1.0 110.454 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.455 ' N ' HG13 ' A' ' 144' ' ' VAL . 78.1 p -61.79 -35.0 76.89 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 122.117 -0.365 . . . . 1.0 110.419 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.969 -1.015 . . . . 1.0 110.488 -179.968 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.9 ttp . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.7 mp0 -66.23 -45.53 80.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.51 -0.314 . . . . 1.0 110.749 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.1 pt -138.45 148.84 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.757 0.789 . . . . 1.0 110.928 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -77.26 -165.23 0.55 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.771 -0.581 . . . . 1.0 111.059 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.3 mp -68.61 139.12 55.51 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.65 0.738 . . . . 1.0 111.306 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.5 mm -110.0 124.81 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.934 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.31 136.31 42.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.956 0.407 . . . . 1.0 110.637 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -131.92 119.84 21.71 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.079 0.466 . . . . 1.0 110.935 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.9 m -143.95 136.29 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 121.095 0.474 . . . . 1.0 110.609 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -150.66 149.97 30.52 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.989 0.423 . . . . 1.0 111.305 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 t -146.98 144.56 29.27 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.404 0.621 . . . . 1.0 111.136 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.1 t -85.27 113.34 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.262 0.553 . . . . 1.0 110.586 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mm -110.51 126.83 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.682 0.753 . . . . 1.0 110.512 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -92.51 94.95 9.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.21 0.529 . . . . 1.0 109.806 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' HB1' ' HD2' ' A' ' 16' ' ' PRO . . . -171.62 169.7 2.91 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.806 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD2' ' HB1' ' A' ' 15' ' ' ALA . 27.2 Cg_exo -61.52 148.13 93.74 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 122.286 1.991 . . . . 1.0 112.477 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 tp -68.41 -36.25 74.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.17 0.509 . . . . 1.0 111.336 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -66.29 -48.46 70.32 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.878 -0.514 . . . . 1.0 112.084 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.13 -42.72 99.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.916 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.2 t -68.26 -45.6 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -59.47 -41.59 90.1 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.086 -0.709 . . . . 1.0 109.086 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -56.3 -43.22 78.67 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 122.044 -0.41 . . . . 1.0 110.367 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.43 -31.81 66.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.336 . . . . 1.0 111.669 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.515 ' O ' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -66.42 -45.88 78.41 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.766 0.317 . . . . 1.0 111.643 -179.066 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 m -116.5 82.01 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.585 0.707 . . . . 1.0 110.78 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -160.2 113.78 1.42 Allowed Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.491 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.94 -12.65 28.58 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 121.635 1.556 . . . . 1.0 112.362 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -86.43 -46.24 10.41 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.647 0.26 . . . . 1.0 110.453 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.7 mt -71.75 -43.36 70.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.5 mt -59.66 -43.08 90.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.03 -0.73 . . . . 1.0 109.03 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -70.9 -29.28 65.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.997 0.427 . . . . 1.0 110.353 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -57.25 -40.93 78.66 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -70.08 -33.52 72.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 1.0 110.249 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.413 ' CE ' ' OG1' ' A' ' 37' ' ' THR . 64.7 mtp -87.81 154.85 20.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.602 0.715 . . . . 1.0 111.167 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -60.75 -43.7 97.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.696 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.26 49.82 0.14 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.966 -0.635 . . . . 1.0 111.919 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.413 ' OG1' ' CE ' ' A' ' 34' ' ' MET . 88.8 m -81.94 128.87 34.51 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.73 0.776 . . . . 1.0 110.761 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.4 m -91.29 91.83 8.35 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.755 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p -103.93 134.1 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.702 0.763 . . . . 1.0 110.383 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.6 t -126.41 134.54 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.671 0.748 . . . . 1.0 110.409 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.1 t -155.45 143.37 19.9 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.386 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -81.92 -19.53 40.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.84 0.829 . . . . 1.0 109.098 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.2 m0 69.42 48.11 0.65 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.523 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -157.46 168.47 27.23 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.428 0.633 . . . . 1.0 111.195 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -58.68 127.63 33.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.689 0.757 . . . . 1.0 112.294 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.23 -1.42 84.51 Favored Glycine 0 N--CA 1.47 0.934 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.994 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.2 m -67.59 133.2 48.98 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.235 -0.568 . . . . 1.0 111.805 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 64' ' ' GLY . 68.0 tp60 -83.24 145.88 28.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.821 -0.807 . . . . 1.0 108.821 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.0 tt -136.83 137.35 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.457 0.646 . . . . 1.0 111.134 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -143.46 149.73 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.696 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.511 ' CZ3' ' NE2' ' A' ' 79' ' ' HIS . 9.6 m0 -124.55 140.45 52.93 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.039 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -103.61 137.46 41.64 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.099 0.476 . . . . 1.0 109.798 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.95 176.35 40.73 Favored Glycine 0 N--CA 1.46 0.27 0 N-CA-C 111.041 -0.824 . . . . 1.0 111.041 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -127.09 138.65 53.24 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.802 0.811 . . . . 1.0 110.19 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -143.16 117.43 9.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.285 0.564 . . . . 1.0 110.293 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 54.56 34.85 22.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.581 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.85 -9.34 38.16 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -97.99 117.3 32.03 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.656 0.741 . . . . 1.0 110.147 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.38 129.06 38.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.301 0.572 . . . . 1.0 110.085 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -128.9 150.37 50.39 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.66 0.743 . . . . 1.0 110.803 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -136.58 133.72 36.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.493 0.663 . . . . 1.0 110.341 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -92.71 142.52 27.26 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -127.69 129.37 47.03 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.62 0.724 . . . . 1.0 112.517 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.469 ' O ' ' NE2' ' A' ' 48' ' ' GLN . . . -151.71 177.97 29.29 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.378 -1.089 . . . . 1.0 110.378 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 66' ' ' ILE . 71.5 m -149.96 156.06 41.06 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 122.047 -0.679 . . . . 1.0 111.193 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.421 ' N ' HG22 ' A' ' 65' ' ' THR . 38.4 mm -77.68 115.29 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.269 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.4 tp -73.3 -44.28 59.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.707 0.765 . . . . 1.0 110.154 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -150.15 147.87 28.26 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.63 -0.507 . . . . 1.0 109.63 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -132.04 110.05 10.45 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.97 0.89 . . . . 1.0 111.494 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -124.84 94.57 4.22 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.355 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -40.15 130.46 2.16 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.935 -0.575 . . . . 1.0 112.533 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 42.93 54.57 4.71 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.194 0.598 . . . . 1.0 112.432 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.0 t -163.46 -71.06 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.716 -0.615 . . . . 1.0 112.192 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 94.8 mt -138.0 136.31 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 121.511 0.672 . . . . 1.0 111.448 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.571 HD13 ' N ' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -135.83 120.28 18.08 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.429 -0.805 . . . . 1.0 110.328 178.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.571 ' N ' HD13 ' A' ' 75' ' ' LEU . 7.3 tt0 -133.37 138.75 46.45 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.474 0.654 . . . . 1.0 110.34 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -149.46 150.86 33.02 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.944 0.878 . . . . 1.0 111.922 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.2 p -85.33 152.29 23.39 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.511 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 45.8 t-80 -148.77 136.82 20.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.686 0.755 . . . . 1.0 111.986 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -138.04 144.31 40.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.918 -1.037 . . . . 1.0 110.31 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.9 t -134.69 129.67 19.46 Favored Pre-proline 0 N--CA 1.476 0.84 0 CA-C-N 115.746 -0.661 . . . . 1.0 110.767 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 84' ' ' THR . 56.1 Cg_endo -71.38 -22.14 25.47 Favored 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 121.356 1.371 . . . . 1.0 112.29 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.4 mt -56.04 -6.53 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.448 . . . . 1.0 110.523 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 82' ' ' PRO . 3.6 t -64.4 -35.87 82.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.692 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 73.3 -1.02 44.71 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -98.7 146.1 31.05 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 119.273 -0.394 . . . . 1.0 111.451 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -46.97 160.09 0.28 Allowed 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 121.426 1.417 . . . . 1.0 112.016 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -76.74 86.37 3.36 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.721 0.772 . . . . 1.0 111.474 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.3 mt -117.01 146.05 37.05 Favored Pre-proline 0 N--CA 1.48 1.073 0 O-C-N 121.874 -0.516 . . . . 1.0 110.957 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.51 -20.28 60.67 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 122.216 1.944 . . . . 1.0 112.481 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.502 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 98.0 mt-10 -87.07 -16.42 35.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.936 0.398 . . . . 1.0 110.31 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -71.36 -39.56 71.18 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.587 0.588 . . . . 1.0 112.587 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -101.55 172.09 7.18 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.519 0.676 . . . . 1.0 112.0 -178.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -140.66 162.75 34.65 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.849 0.833 . . . . 1.0 111.342 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.2 p -106.62 131.23 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 115.057 -0.974 . . . . 1.0 109.677 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.1 t -96.51 131.41 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.238 0.542 . . . . 1.0 110.679 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.1 t -121.82 120.76 35.5 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.604 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.6 mm -110.3 131.77 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.591 -0.731 . . . . 1.0 110.414 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.406 ' C ' HD12 ' A' ' 100' ' ' LEU . 91.7 m -124.09 120.42 32.32 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.391 0.615 . . . . 1.0 110.288 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.406 HD12 ' C ' ' A' ' 99' ' ' THR . 9.6 mp -115.31 131.61 56.87 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 122.119 0.961 . . . . 1.0 110.772 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.42 ' OG1' ' CG ' ' A' ' 108' ' ' GLU . 32.0 p -133.45 128.83 36.3 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.076 -0.966 . . . . 1.0 110.337 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -84.57 108.82 17.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.13 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 106' ' ' GLY . 25.8 mt -91.79 170.76 9.63 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.072 0.463 . . . . 1.0 110.482 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -63.87 -39.03 93.25 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.452 0.538 . . . . 1.0 112.452 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -84.08 -33.35 24.41 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.298 0.571 . . . . 1.0 110.728 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 103' ' ' LEU . . . -175.86 -139.06 3.01 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.8 p -134.22 139.27 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.437 0.637 . . . . 1.0 110.79 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.42 ' CG ' ' OG1' ' A' ' 101' ' ' THR . 19.0 pt-20 -105.49 142.02 35.97 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.463 -0.789 . . . . 1.0 109.768 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -124.06 139.33 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.716 0.769 . . . . 1.0 110.408 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -135.76 132.08 36.33 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.349 0.595 . . . . 1.0 110.77 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 tt -128.41 134.73 48.86 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.073 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 75.6 p -131.29 150.57 52.09 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.654 0.74 . . . . 1.0 111.357 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -146.14 108.92 4.54 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.278 -0.874 . . . . 1.0 110.053 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -82.38 -170.19 2.81 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.646 0.736 . . . . 1.0 112.521 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.502 ' ND2' ' O ' ' A' ' 91' ' ' GLU . 65.9 t30 62.25 36.71 14.6 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.737 1.014 . . . . 1.0 113.737 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -81.44 122.12 27.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.597 -1.261 . . . . 1.0 107.597 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -65.23 -36.25 83.58 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 120.999 -1.063 . . . . 1.0 111.839 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.418 HG23 ' H ' ' A' ' 121' ' ' GLU . 1.6 t -151.08 168.48 24.48 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.17 0.509 . . . . 1.0 111.042 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -57.53 -36.67 71.89 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -58.39 -41.9 85.86 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.418 ' H ' HG23 ' A' ' 118' ' ' THR . 78.6 tt0 -70.43 -39.72 74.21 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.932 -0.48 . . . . 1.0 110.213 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -64.01 -48.91 74.49 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.729 -0.841 . . . . 1.0 108.729 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -59.35 -46.84 87.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -57.81 -39.55 77.85 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.1 t -67.78 -56.09 10.55 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.647 -0.501 . . . . 1.0 109.647 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -54.29 -44.03 71.57 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.13 -39.22 91.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.008 0.432 . . . . 1.0 109.951 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -69.91 -51.28 34.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.188 0.518 . . . . 1.0 110.146 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -62.59 -39.18 92.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -57.71 -40.26 79.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.0 m -61.59 -39.51 91.43 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -65.81 -48.21 72.48 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 133' ' ' LEU . 4.2 mm? -61.0 -41.51 96.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.372 -0.603 . . . . 1.0 109.372 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -64.99 -41.39 95.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.78 -35.65 87.17 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.472 ' O ' HD13 ' A' ' 136' ' ' LEU . 0.2 OUTLIER -70.83 -48.32 54.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.199 0.523 . . . . 1.0 109.971 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -59.02 -43.91 91.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.931 -0.396 . . . . 1.0 109.931 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.99 -41.99 98.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.713 0.292 . . . . 1.0 110.775 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -71.66 -45.86 60.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.222 0.534 . . . . 1.0 110.755 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.528 HD13 ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -65.09 -45.66 84.31 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.859 -179.328 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -73.45 -1.62 19.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.105 0.479 . . . . 1.0 109.767 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 144' ' ' VAL . 15.1 t-20 -61.41 -37.34 83.12 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.272 -0.268 . . . . 1.0 110.445 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -46.55 -15.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.74 0.305 . . . . 1.0 111.291 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 145' ' ' SER . 12.1 p -60.35 -40.9 85.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 O-C-N 122.309 -0.244 . . . . 1.0 110.387 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.431 ' N ' HG13 ' A' ' 144' ' ' VAL . 44.1 m -58.72 -40.68 84.46 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 122.239 -0.288 . . . . 1.0 110.354 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.985 -1.007 . . . . 1.0 110.441 179.923 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 121.704 0.764 . . . . 1.0 110.886 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -82.53 -161.65 0.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.738 -0.601 . . . . 1.0 111.108 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.7 mp -71.48 144.15 49.78 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.702 0.763 . . . . 1.0 111.399 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.87 129.36 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 121.451 0.643 . . . . 1.0 110.892 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.42 134.14 33.92 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.933 -0.479 . . . . 1.0 110.386 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -142.51 138.13 30.71 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.041 0.448 . . . . 1.0 110.684 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.4 m -140.8 156.13 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.147 0.499 . . . . 1.0 110.611 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -159.46 143.48 14.9 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 122.055 -0.403 . . . . 1.0 111.207 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 t -147.54 145.26 29.01 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.244 0.545 . . . . 1.0 111.361 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.6 t -84.05 112.35 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.318 0.58 . . . . 1.0 110.635 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.7 mm -115.07 130.14 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.822 0.82 . . . . 1.0 110.74 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -94.02 95.91 9.34 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.95 -0.469 . . . . 1.0 110.02 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.45 155.73 7.37 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.58 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -61.97 145.94 96.54 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.392 2.061 . . . . 1.0 112.212 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.403 HG23 ' N ' ' A' ' 18' ' ' GLU . 10.3 tp -62.8 -38.0 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.125 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.403 ' N ' HG23 ' A' ' 17' ' ' ILE . 79.8 mm-40 -54.48 -56.44 18.72 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.933 -0.479 . . . . 1.0 112.068 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -64.62 -41.78 95.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.935 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.3 t -65.6 -48.5 82.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -57.83 -42.61 84.73 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.29 -47.13 86.53 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 122.072 -0.392 . . . . 1.0 110.235 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.82 -28.74 66.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.636 0.255 . . . . 1.0 111.609 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.7 tp -72.97 -43.24 62.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 1.0 111.645 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.42 79.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 121.545 0.688 . . . . 1.0 110.992 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.748 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -160.72 113.41 1.34 Allowed Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.498 178.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.575 ' N ' HD22 ' A' ' 26' ' ' ASN . 55.5 Cg_endo -69.79 -15.26 36.89 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.885 1.723 . . . . 1.0 112.373 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.748 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 44.9 tp10 -83.47 -49.79 8.93 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -69.16 -41.73 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 mm -59.66 -26.11 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -77.78 -30.89 51.57 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.062 -0.347 . . . . 1.0 110.062 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -56.44 -43.44 79.5 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.792 -0.447 . . . . 1.0 109.792 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -69.62 -33.91 73.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.964 0.412 . . . . 1.0 110.486 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.6 mmt -89.01 151.85 22.03 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.57 0.7 . . . . 1.0 111.123 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -61.53 -40.72 95.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.731 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.55 37.44 0.13 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.088 -0.577 . . . . 1.0 111.953 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.1 m -74.6 128.93 36.78 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.663 0.744 . . . . 1.0 110.82 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.1 m -94.46 93.5 7.69 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.731 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.5 t -92.59 128.74 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.402 0.62 . . . . 1.0 110.4 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.63 129.03 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 121.346 0.593 . . . . 1.0 110.456 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.545 ' HG ' ' HE1' ' A' ' 43' ' ' TRP . 38.4 p -155.21 157.94 38.11 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.222 -0.445 . . . . 1.0 111.306 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -97.35 -18.01 19.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.872 0.844 . . . . 1.0 108.78 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.545 ' HE1' ' HG ' ' A' ' 41' ' ' SER . 2.8 m0 67.27 44.91 1.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.24 0.616 . . . . 1.0 111.607 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -150.17 157.97 43.67 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.443 0.64 . . . . 1.0 111.433 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -52.71 130.23 31.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.8 0.81 . . . . 1.0 112.267 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.62 3.8 90.36 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 115.713 -0.676 . . . . 1.0 112.082 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.2 t -71.83 134.09 45.9 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.282 -0.54 . . . . 1.0 111.608 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -81.38 148.85 29.12 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.463 HD11 ' HE1' ' A' ' 51' ' ' TRP . 20.2 tt -134.62 133.8 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.547 0.689 . . . . 1.0 111.353 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.8 t -134.72 140.15 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.599 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.463 ' HE1' HD11 ' A' ' 49' ' ' ILE . 24.0 m0 -118.72 131.32 56.13 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.179 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -99.88 140.28 34.32 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.319 0.58 . . . . 1.0 109.738 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.23 178.78 42.24 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 110.989 -0.845 . . . . 1.0 110.989 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -128.66 134.32 48.49 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.914 0.864 . . . . 1.0 110.118 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -135.65 116.78 14.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.323 0.582 . . . . 1.0 110.375 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt 52.92 40.25 30.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.33 0.586 . . . . 1.0 110.659 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.6 -8.3 15.07 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.682 -0.967 . . . . 1.0 110.682 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -97.74 115.57 28.24 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.435 0.636 . . . . 1.0 110.407 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.61 133.0 47.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.078 0.466 . . . . 1.0 110.216 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -136.4 154.12 50.9 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.721 0.772 . . . . 1.0 110.963 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -138.21 132.77 32.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.826 -0.624 . . . . 1.0 110.53 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -88.27 167.48 13.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.244 -0.65 . . . . 1.0 109.244 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -156.23 133.85 10.95 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.702 0.763 . . . . 1.0 112.663 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.95 -176.86 34.48 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.359 -1.096 . . . . 1.0 110.359 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 66' ' ' ILE . 90.8 m -147.19 156.69 43.18 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.951 -0.735 . . . . 1.0 111.102 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.445 ' N ' HG22 ' A' ' 65' ' ' THR . 42.9 mm -73.94 115.4 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.555 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.415 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 46.0 tp -67.02 -41.84 85.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.611 0.72 . . . . 1.0 110.164 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.499 HE21 HD21 ' A' ' 70' ' ' ASN . 64.7 tt0 -159.56 149.32 18.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.546 -0.538 . . . . 1.0 109.546 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -133.89 111.39 10.43 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.962 0.887 . . . . 1.0 111.54 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.499 HD21 HE21 ' A' ' 68' ' ' GLN . 12.5 m120 -119.66 104.68 10.48 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.327 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -41.16 122.95 1.93 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.358 0.599 . . . . 1.0 112.247 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 41.35 55.1 3.44 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.09 0.556 . . . . 1.0 112.436 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.7 m -157.91 -68.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.723 -0.611 . . . . 1.0 112.107 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.402 ' H ' ' HB2' ' A' ' 70' ' ' ASN . 91.4 mt -141.68 138.16 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-O 121.647 0.737 . . . . 1.0 111.509 -178.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 tp -133.33 125.85 30.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.29 -0.868 . . . . 1.0 110.687 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -132.52 138.92 47.68 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.238 0.542 . . . . 1.0 110.203 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.415 ' HA ' ' H ' ' A' ' 67' ' ' LEU . 49.8 p90 -150.75 143.94 24.81 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.939 0.876 . . . . 1.0 112.077 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 93.1 p -85.99 153.76 21.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.008 -1.108 . . . . 1.0 108.008 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.407 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 42.4 t-80 -147.47 142.29 26.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.732 0.777 . . . . 1.0 111.96 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -142.01 134.65 28.34 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.876 -1.056 . . . . 1.0 110.457 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 CA--C 1.55 0.952 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.666 179.429 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.48 ' OD1' ' N ' ' A' ' 93' ' ' TYR . 29.5 p30 . . . . . 0 N--CA 1.465 0.302 0 N-CA-C 112.421 0.526 . . . . 1.0 112.421 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.48 ' N ' ' OD1' ' A' ' 92' ' ' ASN . 30.1 p90 -108.99 178.07 4.58 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.469 0.652 . . . . 1.0 112.019 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.496 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.3 OUTLIER -135.4 163.12 30.76 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.936 0.874 . . . . 1.0 111.277 -179.297 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.4 p -103.31 131.64 51.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.028 -0.987 . . . . 1.0 109.673 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -97.53 134.0 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.025 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 t -125.6 121.31 33.23 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.704 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.1 mm -108.0 129.84 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.452 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.8 m -114.78 121.63 43.89 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.444 0.64 . . . . 1.0 109.953 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 70.8 mt -123.77 128.85 50.15 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.549 0.69 . . . . 1.0 110.907 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 69.5 p -135.55 144.39 46.21 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.37 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -99.79 108.09 20.3 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.456 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 106' ' ' GLY . 55.1 mt -96.12 171.53 8.55 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.04 0.448 . . . . 1.0 110.697 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.95 -42.62 99.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.247 0.462 . . . . 1.0 112.247 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -81.78 -32.55 31.32 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.099 0.56 . . . . 1.0 110.672 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 103' ' ' LEU . . . -176.69 -141.53 3.98 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.579 -1.008 . . . . 1.0 110.579 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 m -133.94 130.27 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.566 0.222 . . . . 1.0 111.179 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -92.46 141.98 27.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.336 0.589 . . . . 1.0 109.904 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.73 151.26 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.513 0.673 . . . . 1.0 110.396 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -151.77 135.1 16.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.107 0.479 . . . . 1.0 110.686 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 tt -125.21 126.23 44.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.956 -0.566 . . . . 1.0 109.928 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 m -120.78 144.68 48.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.421 0.629 . . . . 1.0 111.477 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.496 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 39.4 tt0 -143.79 130.22 19.96 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.507 -0.769 . . . . 1.0 110.141 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.442 ' O ' ' ND1' ' A' ' 94' ' ' HIS . 0.7 OUTLIER -105.23 -170.42 1.75 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.476 0.655 . . . . 1.0 112.467 -179.321 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.3 t30 63.46 38.0 10.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.655 0.983 . . . . 1.0 113.655 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -82.88 128.96 34.91 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -67.38 -41.31 85.26 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.083 -1.011 . . . . 1.0 111.83 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.454 ' OG1' ' N ' ' A' ' 119' ' ' GLU . 1.3 t -150.9 175.97 11.53 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.109 0.48 . . . . 1.0 111.079 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.454 ' N ' ' OG1' ' A' ' 118' ' ' THR . 96.5 mt-10 -59.19 -37.57 77.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.406 ' N ' ' CD ' ' A' ' 120' ' ' LYS . 13.0 mptt -59.57 -42.41 92.41 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -71.76 -39.78 69.75 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.919 -0.488 . . . . 1.0 109.97 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -63.33 -44.89 93.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -63.92 -43.1 96.92 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -59.95 -40.37 88.77 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 78.3 p -72.96 -46.9 49.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -57.08 -47.91 79.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.7 -0.481 . . . . 1.0 109.7 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.67 -37.37 87.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.44 ' O ' ' SD ' ' A' ' 132' ' ' MET . 42.3 t30 -65.27 -54.01 35.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 1.0 110.044 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.445 ' NE1' ' OE1' ' A' ' 113' ' ' GLN . 83.4 m95 -59.41 -36.83 76.58 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -59.27 -36.53 75.69 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.525 -0.917 . . . . 1.0 108.525 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.6 m -64.29 -43.08 95.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.994 -0.743 . . . . 1.0 108.994 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.509 ' N ' ' SD ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -63.18 -48.84 76.68 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 133' ' ' LEU . 4.2 mm? -62.47 -39.99 95.2 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -66.74 -41.73 87.38 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.37 -36.99 93.88 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.003 -1.239 . . . . 1.0 110.003 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.21 -43.87 77.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.434 0.635 . . . . 1.0 110.114 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -65.44 -39.34 91.95 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.071 -0.393 . . . . 1.0 110.153 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.7 tptt -62.01 -39.34 91.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.011 0.434 . . . . 1.0 111.246 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -75.81 -46.57 29.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.128 0.489 . . . . 1.0 110.323 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -64.59 -42.62 95.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.06 0.457 . . . . 1.0 111.097 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -75.8 -1.36 24.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.242 0.544 . . . . 1.0 109.866 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -60.14 -33.08 71.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.411 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.0 pttt . . . . . 0 C--N 1.329 -0.32 0 O-C-N 122.221 -0.3 . . . . 1.0 111.097 -179.681 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.1 pt . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 121.72 0.771 . . . . 1.0 111.028 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -77.61 -167.76 1.03 Allowed 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.698 -0.626 . . . . 1.0 111.216 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 5' ' ' LEU . 10.0 mp -75.09 143.79 43.24 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.605 0.717 . . . . 1.0 111.422 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.549 ' C ' HE21 ' A' ' 122' ' ' GLN . 93.5 mt -114.43 128.81 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.4 0.619 . . . . 1.0 111.201 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.69 143.43 44.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.041 0.448 . . . . 1.0 110.604 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -133.54 123.41 25.12 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.228 0.537 . . . . 1.0 111.011 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.7 m -141.76 140.08 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.24 0.543 . . . . 1.0 110.438 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -152.96 139.14 18.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.559 0.695 . . . . 1.0 110.902 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.5 t -147.04 145.43 29.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.996 -0.547 . . . . 1.0 111.022 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.4 t -93.44 124.51 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.32 0.581 . . . . 1.0 110.445 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 78.2 mt -129.43 131.34 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 121.453 0.644 . . . . 1.0 110.625 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -90.57 99.73 12.7 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.148 0.499 . . . . 1.0 110.263 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -169.31 153.55 5.41 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 118.894 -0.574 . . . . 1.0 111.487 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.98 146.75 78.45 Favored 'Trans proline' 0 N--CA 1.502 2.003 0 C-N-CA 121.295 1.33 . . . . 1.0 112.591 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.402 HG21 ' NE ' ' A' ' 72' ' ' ARG . 9.8 tp -65.48 -36.68 78.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.845 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -61.44 -50.77 71.46 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.812 -0.555 . . . . 1.0 111.753 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.97 -41.0 97.68 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.87 0.322 . . . . 1.0 111.87 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.1 t -66.17 -46.43 87.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 40.1 t-105 -59.8 -41.88 92.17 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.806 0.813 . . . . 1.0 109.07 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.48 -45.45 93.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.489 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.99 -31.86 65.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.026 0.441 . . . . 1.0 111.698 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -71.72 -48.04 49.8 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.151 -0.343 . . . . 1.0 111.823 -179.113 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 m -112.07 77.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.871 0.843 . . . . 1.0 111.099 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.742 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -159.82 109.97 1.45 Allowed Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.49 179.203 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.518 ' N ' HD22 ' A' ' 26' ' ' ASN . 53.7 Cg_endo -67.34 -14.95 44.53 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 120.934 1.09 . . . . 1.0 112.33 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.742 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 83.1 tt0 -80.73 -50.9 9.29 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.358 -0.238 . . . . 1.0 110.358 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.79 -42.42 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.65 0.738 . . . . 1.0 109.209 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.8 mt -57.6 -41.93 80.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -64.53 -36.66 84.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 1.0 110.33 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -67.23 -32.07 72.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.94 0.4 . . . . 1.0 110.029 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -69.59 -34.18 73.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.947 0.403 . . . . 1.0 109.977 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.7 mmm -101.13 177.31 4.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.675 0.75 . . . . 1.0 110.941 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -64.43 -37.96 89.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.837 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.43 64.47 0.02 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.759 -0.536 . . . . 1.0 111.759 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -96.61 126.64 41.92 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.69 0.757 . . . . 1.0 110.704 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.8 p -78.34 92.5 4.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.86 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.2 t -95.52 131.56 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.275 0.56 . . . . 1.0 110.616 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.47 129.72 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 121.306 0.574 . . . . 1.0 110.419 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.561 ' HG ' ' HE1' ' A' ' 43' ' ' TRP . 60.3 p -153.54 150.94 29.22 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.314 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -94.38 -20.58 19.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.799 0.809 . . . . 1.0 109.018 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.561 ' HE1' ' HG ' ' A' ' 41' ' ' SER . 1.3 m0 68.76 46.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.896 -0.593 . . . . 1.0 111.363 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -148.86 156.33 42.17 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.562 0.696 . . . . 1.0 111.182 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -55.27 129.74 39.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.673 0.749 . . . . 1.0 112.184 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.2 -3.2 87.34 Favored Glycine 0 N--CA 1.469 0.841 0 CA-C-N 115.838 -0.619 . . . . 1.0 112.028 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.2 t -67.12 133.95 50.84 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.257 -0.555 . . . . 1.0 111.548 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -89.03 146.72 24.67 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.78 148.95 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.473 0.654 . . . . 1.0 111.328 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.57 155.16 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.461 -0.79 . . . . 1.0 110.7 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.538 ' CH2' ' NE2' ' A' ' 79' ' ' HIS . 14.7 m0 -128.54 123.17 32.79 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.234 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -89.93 140.48 29.58 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.68 173.82 42.06 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -121.76 128.41 51.72 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.752 0.787 . . . . 1.0 110.201 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 33.8 t90 -129.01 112.12 13.71 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.42 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 52.36 40.91 30.26 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.128 0.489 . . . . 1.0 110.655 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.63 -11.72 18.34 Favored Glycine 0 N--CA 1.468 0.793 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -96.41 116.93 29.85 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.208 0.527 . . . . 1.0 110.438 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.37 133.15 47.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.998 0.428 . . . . 1.0 110.251 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -132.57 152.91 51.45 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.615 0.721 . . . . 1.0 111.01 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -139.45 132.77 29.98 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.43 0.633 . . . . 1.0 110.592 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -87.67 168.11 13.29 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -153.64 129.37 10.1 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.677 0.751 . . . . 1.0 112.508 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.21 -179.48 31.28 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.24 -1.144 . . . . 1.0 110.24 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 66' ' ' ILE . 91.0 m -149.5 154.55 38.95 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.948 -0.737 . . . . 1.0 111.312 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.408 ' N ' HG22 ' A' ' 65' ' ' THR . 39.8 mm -77.71 122.58 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.59 0.71 . . . . 1.0 110.251 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 67' ' ' LEU . 3.8 mm? -86.13 -52.47 5.65 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.97 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -131.73 137.69 48.33 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.648 -0.501 . . . . 1.0 109.648 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -135.38 104.94 6.04 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.771 0.796 . . . . 1.0 111.482 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -124.46 93.59 3.95 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.25 122.04 3.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.852 -0.613 . . . . 1.0 112.049 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.402 ' NE ' HG21 ' A' ' 17' ' ' ILE . 67.8 ttt180 61.82 51.97 3.64 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.266 0.626 . . . . 1.0 111.784 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 t -169.62 -72.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.707 -0.621 . . . . 1.0 111.992 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 95.0 mt -137.04 133.8 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-O 121.626 0.727 . . . . 1.0 111.564 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.4 tp -136.16 124.99 24.0 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.353 -0.84 . . . . 1.0 110.296 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -135.24 141.87 45.86 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.184 0.516 . . . . 1.0 109.966 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -149.14 152.51 36.23 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.1 0.952 . . . . 1.0 112.144 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.8 p -94.32 150.92 19.83 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.538 ' NE2' ' CH2' ' A' ' 51' ' ' TRP . 1.2 m80 -152.42 144.99 24.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 122.0 0.905 . . . . 1.0 111.561 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -141.95 136.61 30.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.66 -1.155 . . . . 1.0 110.236 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 118.445 -0.788 . . . . 1.0 110.664 179.838 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 112.471 0.545 . . . . 1.0 112.471 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.58 172.28 8.02 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.641 0.734 . . . . 1.0 111.738 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.456 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.7 OUTLIER -145.69 169.42 18.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.619 0.723 . . . . 1.0 111.213 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.0 p -107.32 132.63 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.205 -0.907 . . . . 1.0 109.841 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.6 t -94.14 135.13 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.398 0.618 . . . . 1.0 110.961 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.0 t -126.7 123.79 38.31 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.515 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.6 mt -120.91 131.87 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.723 -0.672 . . . . 1.0 110.244 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 59.1 m -117.59 122.16 42.88 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.02 -0.536 . . . . 1.0 109.904 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.6 mt -115.93 124.84 51.58 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.463 0.649 . . . . 1.0 110.792 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 74.4 p -128.05 137.62 52.25 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.513 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -96.42 105.7 17.82 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.349 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.8 mt -92.15 170.21 10.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.11 0.481 . . . . 1.0 110.41 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -61.97 -41.3 97.85 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.442 0.534 . . . . 1.0 112.442 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -75.4 -40.21 58.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.417 0.627 . . . . 1.0 110.845 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.1 -140.33 3.13 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.7 p -125.18 134.17 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.445 0.64 . . . . 1.0 111.029 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -99.2 141.06 32.45 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.543 -0.753 . . . . 1.0 109.602 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.82 138.73 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 121.278 0.561 . . . . 1.0 110.521 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -142.93 131.73 22.73 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.447 0.641 . . . . 1.0 110.509 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tt -125.15 131.68 53.2 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.719 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.8 m -128.67 143.01 50.85 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.45 0.643 . . . . 1.0 111.235 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.456 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 33.7 tt0 -142.53 138.3 30.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.086 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 12.4 p-10 -111.99 -167.12 1.14 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.538 0.685 . . . . 1.0 112.32 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.8 t30 60.73 37.52 18.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.758 1.021 . . . . 1.0 113.758 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -82.16 117.77 22.56 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.76 -1.2 . . . . 1.0 107.76 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -61.51 -39.87 92.57 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.011 -1.056 . . . . 1.0 111.866 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.6 p -144.78 168.31 20.51 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.923 -0.486 . . . . 1.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.46 -34.82 71.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.275 -0.639 . . . . 1.0 109.275 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.57 -40.88 93.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -69.44 -39.77 77.62 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.963 -0.461 . . . . 1.0 110.303 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.549 HE21 ' C ' ' A' ' 6' ' ' ILE . 50.6 tt0 -63.14 -47.82 81.12 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -59.93 -42.81 94.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -61.25 -39.05 88.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.333 -0.618 . . . . 1.0 109.333 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 62.4 m -68.03 -53.26 27.16 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.59 -44.91 73.43 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -62.55 -41.31 98.81 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -66.36 -54.0 29.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.02 0.438 . . . . 1.0 110.097 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.507 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 87.8 m95 -60.42 -39.42 87.34 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -59.44 -39.09 82.46 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.7 m -63.73 -41.98 97.96 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.507 ' SD ' ' CE3' ' A' ' 129' ' ' TRP . 79.0 mtp -64.93 -50.41 66.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.287 0.565 . . . . 1.0 109.617 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.02 -40.08 94.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -69.14 -39.46 78.81 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.078 -0.712 . . . . 1.0 109.078 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.36 -39.5 91.7 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 109.632 -1.387 . . . . 1.0 109.632 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.9 tt -65.9 -43.06 89.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.024 0.44 . . . . 1.0 110.033 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -61.69 -32.72 72.93 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -60.99 -37.99 84.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.982 0.42 . . . . 1.0 111.031 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -74.59 -49.93 19.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.422 0.63 . . . . 1.0 110.775 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.88 -42.66 99.85 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.785 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -75.37 -4.33 38.75 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.371 0.605 . . . . 1.0 110.253 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -62.12 -39.14 91.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.972 0.415 . . . . 1.0 110.449 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? . . . . . 0 N--CA 1.449 -0.5 0 CA-C-N 116.693 -0.231 . . . . 1.0 111.007 -179.683 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.478 HD13 ' N ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 121.465 0.65 . . . . 1.0 111.066 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -74.57 -156.3 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.479 0.657 . . . . 1.0 110.787 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.49 HD22 ' N ' ' A' ' 5' ' ' LEU . 3.9 mm? -75.47 142.18 42.97 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.867 0.842 . . . . 1.0 111.512 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.95 129.62 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.393 0.616 . . . . 1.0 111.035 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.78 136.57 36.02 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.034 -0.416 . . . . 1.0 110.648 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -145.13 145.05 31.24 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.226 0.536 . . . . 1.0 110.753 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.49 155.79 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.329 0.585 . . . . 1.0 110.429 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -154.37 134.06 12.87 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.252 0.548 . . . . 1.0 110.922 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 t -148.56 146.92 28.49 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.102 0.477 . . . . 1.0 111.256 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 m -99.06 131.36 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.378 0.608 . . . . 1.0 110.249 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.3 mt -130.68 132.16 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 121.875 0.845 . . . . 1.0 110.553 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -85.83 96.41 9.75 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.314 0.578 . . . . 1.0 110.224 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.95 157.93 4.27 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.622 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -61.36 144.44 98.4 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.257 1.971 . . . . 1.0 112.358 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.5 tp -64.84 -33.84 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.752 -0.658 . . . . 1.0 111.4 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -58.15 -50.26 74.13 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.901 -0.499 . . . . 1.0 111.914 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -65.21 -40.44 94.17 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.996 0.369 . . . . 1.0 111.996 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.3 t -66.33 -47.46 84.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -60.05 -43.43 95.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -58.26 -49.16 78.11 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.044 -0.41 . . . . 1.0 110.258 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.04 -32.77 64.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.752 0.279 . . . . 1.0 111.752 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.54 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.4 tt -67.7 -45.28 75.56 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.206 -0.309 . . . . 1.0 111.229 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 m -115.94 79.47 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.677 0.751 . . . . 1.0 111.383 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.772 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.2 OUTLIER -156.98 117.12 2.06 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.201 179.148 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.564 ' N ' HD22 ' A' ' 26' ' ' ASN . 70.8 Cg_endo -73.88 -5.3 16.81 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.344 1.363 . . . . 1.0 112.277 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.772 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 10.2 tm-20 -93.73 -52.39 4.47 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.209 -0.293 . . . . 1.0 110.209 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.88 -42.18 94.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.647 -0.872 . . . . 1.0 108.647 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.87 -40.18 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -66.14 -36.45 83.17 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.255 -0.278 . . . . 1.0 110.445 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -57.78 -36.64 72.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -68.91 -33.33 73.57 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.239 -0.282 . . . . 1.0 110.239 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 73.1 mmm -96.43 156.54 16.3 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.712 0.768 . . . . 1.0 110.906 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -61.58 -43.22 99.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.713 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.44 42.99 0.18 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 120.904 -0.665 . . . . 1.0 111.977 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.8 m -76.85 129.15 35.83 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.561 0.696 . . . . 1.0 110.58 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 48.7 m -93.05 92.07 7.64 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.693 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -99.03 132.64 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.441 0.639 . . . . 1.0 110.481 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.0 t -130.58 132.22 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.646 0.736 . . . . 1.0 110.264 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 m -156.09 166.68 32.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.565 . . . . 1.0 111.376 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -109.34 -19.67 13.2 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.98 0.895 . . . . 1.0 109.076 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.457 ' HE1' ' HD3' ' A' ' 27' ' ' PRO . 58.0 m95 58.23 56.32 4.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.795 -0.639 . . . . 1.0 111.76 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -152.4 156.83 40.29 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.418 0.628 . . . . 1.0 111.125 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.28 119.68 1.25 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.539 0.685 . . . . 1.0 112.422 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.04 11.2 84.72 Favored Glycine 0 N--CA 1.468 0.782 0 CA-C-N 115.918 -0.583 . . . . 1.0 112.065 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.1 t -72.26 130.46 40.85 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.3 -0.529 . . . . 1.0 111.523 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -87.45 150.47 23.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.747 -0.835 . . . . 1.0 108.747 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.9 pt -145.07 149.35 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.1 0.476 . . . . 1.0 111.107 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.6 m -143.51 154.53 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.782 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 10.3 m0 -129.2 131.72 47.16 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.34 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -91.57 139.69 30.45 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.45 172.71 39.45 Favored Glycine 0 N--CA 1.464 0.514 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -131.95 134.56 45.77 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.007 0.908 . . . . 1.0 110.231 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -138.3 118.04 13.16 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.374 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 52.92 37.1 23.49 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.112 0.482 . . . . 1.0 110.688 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.96 -6.06 44.29 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.932 -0.867 . . . . 1.0 110.932 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -97.15 112.51 24.26 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.346 0.593 . . . . 1.0 110.565 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.14 135.88 49.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.029 0.442 . . . . 1.0 110.239 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -141.26 155.89 45.95 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.642 0.734 . . . . 1.0 110.864 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 1.5 pm0 -136.27 133.83 37.39 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.388 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -86.91 144.5 26.94 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -133.88 128.13 33.99 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.502 0.668 . . . . 1.0 112.731 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.08 -177.24 30.01 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.293 -1.123 . . . . 1.0 110.293 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.414 HG22 ' N ' ' A' ' 66' ' ' ILE . 85.9 m -146.68 155.02 42.11 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.656 0.741 . . . . 1.0 111.056 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.414 ' N ' HG22 ' A' ' 65' ' ' THR . 50.7 mm -75.56 115.55 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.249 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.401 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 42.5 tp -69.93 -41.91 73.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.503 0.668 . . . . 1.0 110.111 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -152.07 147.8 26.92 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -132.52 104.08 6.5 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.989 0.899 . . . . 1.0 111.597 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -125.16 104.56 8.58 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -47.16 136.31 9.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.658 0.742 . . . . 1.0 111.98 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 36.91 53.72 1.14 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.666 -0.697 . . . . 1.0 112.552 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.5 t -161.12 -73.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.635 -0.666 . . . . 1.0 112.098 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.4 mt -136.89 131.82 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.464 0.65 . . . . 1.0 111.496 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.1 tp -136.98 124.97 22.77 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.525 -0.762 . . . . 1.0 110.333 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.02 144.53 32.32 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.409 0.623 . . . . 1.0 109.961 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.401 ' HA ' ' H ' ' A' ' 67' ' ' LEU . 46.6 p90 -150.04 154.88 38.91 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.816 0.817 . . . . 1.0 112.061 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.4 p -87.0 151.44 23.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.004 -1.11 . . . . 1.0 108.004 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.404 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 52.9 t-80 -146.08 144.37 29.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.925 0.869 . . . . 1.0 111.887 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -143.38 135.11 26.51 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.718 -1.128 . . . . 1.0 110.315 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.9 p . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 118.622 -0.704 . . . . 1.0 110.33 179.409 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 56.2 t30 . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 112.457 0.539 . . . . 1.0 112.457 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 47.8 p90 -117.83 178.47 4.4 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.308 0.575 . . . . 1.0 112.246 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.19 167.25 21.01 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.058 0.932 . . . . 1.0 111.373 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 52.1 t -106.77 127.74 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 114.809 -1.087 . . . . 1.0 109.647 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.31 133.57 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.036 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.7 t -125.36 121.06 32.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.253 0.549 . . . . 1.0 110.657 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 75.7 mt -119.01 129.97 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.358 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 64.8 m -117.47 116.9 28.07 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.532 0.682 . . . . 1.0 109.957 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.3 mt -114.34 124.81 52.91 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.801 0.81 . . . . 1.0 110.812 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.5 m -138.31 143.36 39.93 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.325 -0.852 . . . . 1.0 110.49 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.03 123.98 38.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.266 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.8 mt -107.99 173.7 6.21 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.235 0.54 . . . . 1.0 110.332 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -61.7 -41.6 97.81 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.409 0.522 . . . . 1.0 112.409 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -74.2 -44.23 54.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.144 0.497 . . . . 1.0 110.779 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -172.55 -129.53 1.15 Allowed Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.892 -0.883 . . . . 1.0 110.892 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.3 t -128.81 133.9 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.539 0.685 . . . . 1.0 110.852 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -107.2 132.78 52.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.48 -0.782 . . . . 1.0 109.537 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.1 p -125.23 142.08 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.81 0.814 . . . . 1.0 110.25 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -140.03 135.12 32.34 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.567 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 tt -127.98 129.41 46.71 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.586 -0.733 . . . . 1.0 109.822 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.8 m -123.37 145.37 48.81 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.425 0.631 . . . . 1.0 111.379 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.419 ' OE1' ' NE1' ' A' ' 129' ' ' TRP . 37.6 tt0 -143.69 123.67 13.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.471 -0.786 . . . . 1.0 109.918 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -101.14 -167.62 1.45 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.392 0.615 . . . . 1.0 112.514 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.9 t30 59.58 38.38 22.23 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.455 0.909 . . . . 1.0 113.455 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -82.96 133.1 35.12 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.543 -1.28 . . . . 1.0 107.543 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -63.02 -43.34 98.99 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.045 -1.035 . . . . 1.0 111.977 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 119' ' ' GLU . 1.4 t -149.79 176.2 10.92 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.133 0.492 . . . . 1.0 110.884 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.422 ' N ' ' OG1' ' A' ' 118' ' ' THR . 95.1 mt-10 -58.81 -38.13 77.93 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -59.06 -40.09 84.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -70.42 -38.49 74.61 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.01 -0.431 . . . . 1.0 109.919 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -64.65 -47.06 79.88 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -61.81 -40.29 94.72 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.912 -0.773 . . . . 1.0 108.912 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -62.43 -39.95 94.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.44 -0.578 . . . . 1.0 109.44 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.7 m -71.69 -49.18 41.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 1.0 109.822 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -55.54 -47.36 76.45 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.28 -37.95 89.3 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.702 -0.481 . . . . 1.0 109.702 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -66.59 -54.55 22.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.135 0.493 . . . . 1.0 110.13 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.419 ' NE1' ' OE1' ' A' ' 113' ' ' GLN . 86.2 m95 -59.42 -37.37 77.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -56.78 -39.87 74.85 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.533 -0.914 . . . . 1.0 108.533 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.7 m -63.97 -41.17 97.62 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.73 -50.53 70.74 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.29 -38.63 90.09 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -67.35 -41.51 85.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.887 -0.783 . . . . 1.0 108.887 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.09 -40.57 98.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.026 -1.23 . . . . 1.0 110.026 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 64.9 tp -67.9 -42.63 80.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.372 0.606 . . . . 1.0 109.805 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.44 -44.25 95.06 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.102 -0.374 . . . . 1.0 110.477 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -61.3 -40.88 95.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.714 0.293 . . . . 1.0 110.728 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -66.38 -50.21 64.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.042 0.448 . . . . 1.0 110.637 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.502 ' O ' HD23 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -65.35 -42.44 92.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.547 -179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -76.92 -0.41 24.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.269 0.557 . . . . 1.0 110.186 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -61.54 -36.5 80.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.59 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 27.1 pttm . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.682 0.277 . . . . 1.0 111.124 -179.719 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.533 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 121.684 0.754 . . . . 1.0 110.849 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -73.21 -160.96 0.09 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.363 0.602 . . . . 1.0 111.019 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.8 mp -73.7 141.27 46.4 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.622 0.725 . . . . 1.0 111.583 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.565 ' C ' HE21 ' A' ' 122' ' ' GLN . 80.2 mt -116.78 129.21 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.917 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.28 146.15 37.02 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.998 -0.438 . . . . 1.0 110.69 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -138.08 127.03 24.04 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.906 0.384 . . . . 1.0 110.952 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.7 m -140.53 139.13 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.05 0.453 . . . . 1.0 110.507 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -153.37 135.49 14.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.954 0.407 . . . . 1.0 111.023 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.8 t -146.44 145.01 30.07 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.251 0.548 . . . . 1.0 111.173 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 12' ' ' VAL . 14.9 p -91.22 129.89 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.207 0.527 . . . . 1.0 110.545 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 75.7 mt -132.63 131.92 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.554 0.693 . . . . 1.0 110.4 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -89.36 95.19 10.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.287 0.565 . . . . 1.0 109.73 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.65 159.14 3.09 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 120.759 -0.376 . . . . 1.0 110.942 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.79 146.09 96.81 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 122.146 1.897 . . . . 1.0 112.521 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.2 tt -68.66 -29.84 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.72 0.771 . . . . 1.0 111.529 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -63.53 -48.17 78.63 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.909 -0.494 . . . . 1.0 112.16 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.02 -45.85 90.38 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.809 0.3 . . . . 1.0 111.809 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.44 -45.31 85.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 23.5 t-105 -56.46 -41.62 76.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -58.97 -45.56 90.22 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.043 -0.41 . . . . 1.0 110.342 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.78 -34.62 62.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.598 -0.273 . . . . 1.0 111.359 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.527 ' O ' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -70.42 -48.28 56.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.033 0.445 . . . . 1.0 111.796 -179.184 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.7 m -107.39 74.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.437 0.637 . . . . 1.0 110.83 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.752 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -162.13 113.62 1.16 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 119.053 -0.499 . . . . 1.0 110.636 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.602 ' N ' HD22 ' A' ' 26' ' ' ASN . 57.4 Cg_endo -70.6 -18.38 33.09 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 121.812 1.675 . . . . 1.0 112.391 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.752 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 78.0 mm-40 -79.71 -46.93 16.17 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.645 0.259 . . . . 1.0 110.402 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -71.91 -42.13 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.938 -0.764 . . . . 1.0 108.938 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 mm -58.79 -41.51 82.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -69.43 -31.22 69.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.089 0.471 . . . . 1.0 110.181 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -60.86 -35.74 77.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.128 0.489 . . . . 1.0 110.043 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -69.1 -33.49 73.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.901 0.381 . . . . 1.0 110.034 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.8 mmm -98.05 162.62 13.13 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.824 0.821 . . . . 1.0 110.916 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -62.19 -41.21 98.13 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.749 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.85 42.27 0.14 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.106 -0.569 . . . . 1.0 111.924 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.7 m -70.16 128.37 36.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.378 0.609 . . . . 1.0 110.994 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.4 m -92.56 92.36 8.01 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.16 -0.337 . . . . 1.0 110.872 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.72 135.36 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 121.374 0.607 . . . . 1.0 110.483 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.2 p -126.96 137.45 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.27 0.557 . . . . 1.0 110.589 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.5 p -154.21 155.23 34.88 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.106 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -94.69 -20.04 19.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 122.121 0.962 . . . . 1.0 108.933 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.44 ' HE1' ' HD3' ' A' ' 27' ' ' PRO . 1.5 m0 72.16 45.56 0.38 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.422 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 pttt -153.34 153.44 32.6 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.768 -0.582 . . . . 1.0 111.447 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -50.38 132.01 24.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.736 0.779 . . . . 1.0 112.361 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.68 -6.44 83.44 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-N 115.873 -0.603 . . . . 1.0 112.034 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.1 m -65.14 137.11 57.43 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.188 -0.595 . . . . 1.0 111.885 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -88.77 150.25 23.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.7 pt -138.65 147.91 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-O 121.34 0.591 . . . . 1.0 111.355 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.3 t -143.77 141.32 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.617 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.451 ' CZ3' ' NE2' ' A' ' 79' ' ' HIS . 18.4 m0 -118.11 137.63 52.81 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.081 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -100.98 134.4 44.03 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.09 0.471 . . . . 1.0 109.968 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.12 173.71 37.6 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -125.99 134.56 51.44 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.636 0.731 . . . . 1.0 110.193 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -138.24 115.29 10.9 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.48 0.657 . . . . 1.0 110.302 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt 52.71 38.07 25.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.62 -9.02 38.23 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 110.451 -1.06 . . . . 1.0 110.451 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -98.41 116.32 30.39 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.372 0.606 . . . . 1.0 110.749 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.3 129.08 38.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.253 0.549 . . . . 1.0 110.32 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -128.56 150.99 49.96 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.724 0.773 . . . . 1.0 110.944 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.437 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 1.2 pm0 -135.7 126.37 27.18 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.387 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -86.86 134.87 33.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.978 -0.749 . . . . 1.0 108.978 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -120.12 129.12 54.02 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.725 0.774 . . . . 1.0 112.53 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.14 175.52 30.03 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.35 -1.1 . . . . 1.0 110.35 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.1 m -144.41 151.99 40.03 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 122.07 -0.665 . . . . 1.0 111.33 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.7 mm -73.72 113.79 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.468 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.474 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -66.98 -51.25 57.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.612 0.72 . . . . 1.0 110.243 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -150.01 147.88 28.37 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.433 -0.581 . . . . 1.0 109.433 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -126.06 110.76 13.91 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.74 0.781 . . . . 1.0 111.351 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.403 ' C ' HD22 ' A' ' 70' ' ' ASN . 0.3 OUTLIER -126.25 91.47 3.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.295 -0.631 . . . . 1.0 109.295 179.08 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -36.73 128.84 0.83 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.189 0.518 . . . . 1.0 112.241 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 41.92 57.12 3.28 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.681 0.623 . . . . 1.0 112.681 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.5 t -165.1 -71.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.7 -0.625 . . . . 1.0 111.886 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.4 ' H ' ' HB3' ' A' ' 70' ' ' ASN . 91.2 mt -138.07 131.25 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.573 0.701 . . . . 1.0 111.629 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.1 tp -133.95 123.22 24.27 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.371 -0.831 . . . . 1.0 110.634 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -138.93 142.96 38.45 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.192 0.52 . . . . 1.0 110.113 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -152.84 155.7 37.61 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.678 0.751 . . . . 1.0 112.15 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.6 p -86.7 151.19 23.62 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.451 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 16.5 t-80 -146.56 138.44 24.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.869 0.843 . . . . 1.0 111.846 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -138.1 127.55 24.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.813 -1.085 . . . . 1.0 110.529 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.5 t . . . . . 0 CA--C 1.547 0.854 0 CA-C-O 118.913 -0.565 . . . . 1.0 110.64 179.11 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.417 ' C ' ' ND2' ' A' ' 115' ' ' ASN . 12.0 m120 . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 112.272 0.471 . . . . 1.0 112.272 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -101.55 175.5 5.54 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.493 0.663 . . . . 1.0 112.145 -179.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.563 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.3 OUTLIER -142.54 161.01 39.17 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.953 0.882 . . . . 1.0 111.172 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.0 t -106.24 114.08 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 115.025 -0.989 . . . . 1.0 109.455 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.4 m -82.69 139.92 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.097 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 t -130.2 129.8 43.85 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.303 0.573 . . . . 1.0 110.917 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.86 130.08 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.542 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 59.4 m -117.8 118.13 31.21 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.446 0.641 . . . . 1.0 109.989 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.0 mt -114.15 130.85 56.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.401 0.62 . . . . 1.0 110.894 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.438 ' OG1' ' CG ' ' A' ' 108' ' ' GLU . 30.0 p -135.07 128.34 32.07 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.639 -0.709 . . . . 1.0 110.587 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -88.67 111.83 22.4 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.03 0.443 . . . . 1.0 110.139 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 25.3 mt -96.35 175.74 6.31 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.297 0.57 . . . . 1.0 110.485 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.54 -40.71 96.1 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.384 0.512 . . . . 1.0 112.384 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -79.57 -40.77 28.68 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.003 0.521 . . . . 1.0 110.875 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -171.55 -143.18 3.94 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.8 p -129.13 132.77 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.039 0.447 . . . . 1.0 111.225 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.438 ' CG ' ' OG1' ' A' ' 101' ' ' THR . 12.4 pt-20 -98.62 144.59 27.74 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.65 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.59 135.37 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.242 0.544 . . . . 1.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -141.24 129.48 22.26 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.091 0.472 . . . . 1.0 110.592 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -124.63 140.72 52.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.142 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.1 m -132.54 144.39 50.39 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.501 0.667 . . . . 1.0 111.428 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.563 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 40.3 tt0 -143.43 139.36 29.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.872 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -114.41 -162.65 0.82 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.399 0.619 . . . . 1.0 112.309 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.417 ' ND2' ' C ' ' A' ' 92' ' ' ASN . 49.8 t30 58.54 35.56 24.67 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.641 0.978 . . . . 1.0 113.641 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -82.23 122.17 27.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.681 -1.229 . . . . 1.0 107.681 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.48 -40.44 93.14 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.01 -1.056 . . . . 1.0 111.79 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.1 p -145.58 171.58 14.49 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.839 -0.538 . . . . 1.0 111.065 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -57.17 -38.51 73.69 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -58.69 -41.21 85.71 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -69.84 -39.67 76.29 Favored 'General case' 0 C--N 1.33 -0.283 0 O-C-N 121.937 -0.477 . . . . 1.0 110.15 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.565 HE21 ' C ' ' A' ' 6' ' ' ILE . 50.2 tt0 -64.7 -45.14 87.87 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -62.73 -44.77 95.34 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.068 -0.716 . . . . 1.0 109.068 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -58.63 -40.12 82.46 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.7 m -72.14 -47.85 47.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.201 0.524 . . . . 1.0 109.67 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -55.68 -48.51 74.96 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -64.55 -37.37 87.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.036 0.446 . . . . 1.0 109.81 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -65.52 -56.5 12.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.943 0.401 . . . . 1.0 110.138 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.477 ' NE1' ' OE1' ' A' ' 113' ' ' GLN . 86.6 m95 -58.6 -39.23 79.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -54.68 -41.03 69.71 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.0 m -63.6 -41.56 98.32 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.624 0.726 . . . . 1.0 109.211 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.9 tpt -64.42 -51.51 62.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 133' ' ' LEU . 4.4 mm? -59.56 -41.24 89.68 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -68.16 -36.64 79.96 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.57 -41.57 99.6 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.011 -1.236 . . . . 1.0 110.011 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.47 -42.42 83.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.323 0.582 . . . . 1.0 110.099 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.4 -37.6 86.41 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.049 -0.407 . . . . 1.0 110.266 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -59.76 -38.51 82.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.975 0.417 . . . . 1.0 111.095 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -76.32 -44.91 34.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.282 0.563 . . . . 1.0 110.473 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 65.0 mt -64.8 -41.98 95.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.044 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.74 0.05 21.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.048 0.452 . . . . 1.0 109.838 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.35 -39.01 93.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.91 0.386 . . . . 1.0 110.604 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt . . . . . 0 N--CA 1.452 -0.347 0 O-C-N 122.23 -0.294 . . . . 1.0 110.947 -179.506 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.493 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 121.376 0.608 . . . . 1.0 111.034 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -77.38 -161.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.68 -0.638 . . . . 1.0 111.046 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.3 mp -73.76 139.66 45.38 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.652 0.739 . . . . 1.0 111.376 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.53 ' C ' HE21 ' A' ' 122' ' ' GLN . 83.1 mt -113.7 129.34 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.328 0.585 . . . . 1.0 111.009 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.68 141.33 39.44 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.062 0.458 . . . . 1.0 110.736 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -138.5 117.98 12.93 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.189 0.518 . . . . 1.0 110.976 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.78 155.91 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.072 0.463 . . . . 1.0 110.627 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -174.18 151.04 1.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.199 0.523 . . . . 1.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 t -145.6 145.43 30.97 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.364 0.602 . . . . 1.0 111.162 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.69 124.59 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.277 0.56 . . . . 1.0 110.542 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.4 mt -130.27 132.69 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 121.669 0.747 . . . . 1.0 110.541 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -87.86 96.49 10.49 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.402 0.62 . . . . 1.0 110.188 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.31 155.86 2.81 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 119.139 -0.458 . . . . 1.0 111.051 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.56 147.57 94.06 Favored 'Trans proline' 0 N--CA 1.506 2.217 0 C-N-CA 121.599 1.533 . . . . 1.0 112.528 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.2 tt -68.09 -26.34 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.187 0.518 . . . . 1.0 111.185 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -59.48 -49.89 76.03 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.885 -0.509 . . . . 1.0 111.604 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.436 ' CD ' ' N ' ' A' ' 19' ' ' LYS . 3.9 mptp? -65.48 -41.51 93.22 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.709 0.263 . . . . 1.0 111.709 -178.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.48 -48.25 81.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -57.45 -43.14 83.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.627 0.727 . . . . 1.0 109.224 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -58.28 -45.8 87.25 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.877 -0.515 . . . . 1.0 110.436 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.17 -35.43 64.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.957 0.408 . . . . 1.0 111.856 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.504 ' O ' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -66.84 -46.0 76.45 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.1 -0.375 . . . . 1.0 111.652 -179.21 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 m -112.98 79.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.794 0.807 . . . . 1.0 111.014 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.728 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -159.75 111.32 1.46 Allowed Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.416 179.152 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.525 ' N ' HD22 ' A' ' 26' ' ' ASN . 61.1 Cg_endo -71.41 -1.7 10.11 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.195 1.263 . . . . 1.0 112.503 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.728 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 81.3 mm-40 -96.86 -48.51 5.42 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 110.172 -0.307 . . . . 1.0 110.172 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -68.25 -43.03 84.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.223 -0.658 . . . . 1.0 109.223 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mm -61.03 -42.16 92.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -69.22 -31.13 69.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.046 0.45 . . . . 1.0 110.271 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -58.32 -42.99 87.96 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.812 -0.44 . . . . 1.0 109.812 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -69.37 -33.55 73.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.759 0.314 . . . . 1.0 110.163 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 66.6 mtt -89.12 152.01 21.88 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.684 0.754 . . . . 1.0 111.053 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -59.47 -46.97 87.26 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.697 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.9 48.92 0.22 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.064 -0.589 . . . . 1.0 111.975 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.6 m -82.33 111.26 18.23 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.77 0.795 . . . . 1.0 110.776 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.7 m -77.79 91.94 4.16 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.909 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -102.79 135.12 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.987 0.899 . . . . 1.0 110.5 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 m -128.27 138.75 53.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.55 0.691 . . . . 1.0 110.508 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.455 ' OG ' ' NE1' ' A' ' 43' ' ' TRP . 33.2 p -155.53 158.35 38.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.966 -0.561 . . . . 1.0 111.153 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 50.9 t0 -97.14 -23.63 16.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.89 0.852 . . . . 1.0 108.995 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.455 ' NE1' ' OG ' ' A' ' 41' ' ' SER . 1.5 m0 71.17 47.83 0.39 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.465 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.56 152.54 27.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.645 0.736 . . . . 1.0 111.206 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -48.91 131.35 18.64 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.746 0.784 . . . . 1.0 112.373 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.67 4.7 85.07 Favored Glycine 0 N--CA 1.47 0.956 0 CA-C-N 115.721 -0.672 . . . . 1.0 112.105 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.3 t -76.89 134.8 38.87 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.214 -0.58 . . . . 1.0 111.539 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 64' ' ' GLY . 66.0 tp60 -81.11 146.2 30.7 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.76 -0.83 . . . . 1.0 108.76 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.02 134.58 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.577 0.703 . . . . 1.0 111.348 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 p -140.21 150.25 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.399 -0.819 . . . . 1.0 110.395 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -128.45 137.2 51.71 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.085 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -104.47 129.87 52.43 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.304 0.573 . . . . 1.0 109.693 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.66 -179.32 29.81 Favored Glycine 0 N--CA 1.464 0.519 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -134.34 134.59 41.95 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.835 0.826 . . . . 1.0 110.117 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 35.0 t90 -140.71 124.46 17.1 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.252 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm 52.5 36.18 19.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.179 0.514 . . . . 1.0 110.704 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.53 -6.06 26.02 Favored Glycine 0 N--CA 1.464 0.535 0 N-CA-C 110.746 -0.942 . . . . 1.0 110.746 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -98.88 115.63 29.29 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.346 0.593 . . . . 1.0 110.4 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.25 133.59 47.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.09 0.471 . . . . 1.0 110.197 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -136.69 154.2 50.68 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.543 0.687 . . . . 1.0 110.851 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -136.46 133.57 36.75 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.437 0.637 . . . . 1.0 110.695 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -90.6 167.65 12.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -158.07 133.77 9.05 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.459 0.647 . . . . 1.0 112.369 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 48' ' ' GLN . . . -160.43 -174.68 30.54 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.41 -1.076 . . . . 1.0 110.41 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 66' ' ' ILE . 35.2 m -146.36 155.98 43.0 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.961 -0.729 . . . . 1.0 111.194 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.416 ' N ' HG22 ' A' ' 65' ' ' THR . 38.8 mm -75.89 119.78 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.336 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 tp -77.25 -48.94 16.18 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.621 0.724 . . . . 1.0 110.224 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -140.76 151.21 44.27 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.729 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -146.46 99.97 3.29 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.509 0.671 . . . . 1.0 111.367 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -125.46 106.88 10.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -38.27 133.17 0.98 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.531 0.681 . . . . 1.0 112.417 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 37.19 53.76 1.25 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.759 -0.655 . . . . 1.0 112.524 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.3 m -152.92 -66.87 0.16 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.793 -0.567 . . . . 1.0 111.862 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 74' ' ' ILE . 7.1 tt -150.47 138.73 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.11 0.481 . . . . 1.0 111.517 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.561 HD13 ' N ' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -130.25 122.24 27.66 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.827 -0.624 . . . . 1.0 109.705 178.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.561 ' N ' HD13 ' A' ' 75' ' ' LEU . 74.6 mt-30 -133.61 136.68 45.01 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.961 0.41 . . . . 1.0 110.271 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.441 ' CD1' ' ND1' ' A' ' 79' ' ' HIS . 19.9 p90 -148.06 156.85 43.1 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.056 0.931 . . . . 1.0 111.994 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 92.4 p -101.25 151.43 21.87 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.488 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.9 m80 -153.19 153.16 32.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.698 0.761 . . . . 1.0 111.736 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -143.32 133.18 23.99 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.873 -1.058 . . . . 1.0 110.4 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.2 t . . . . . 0 CA--C 1.546 0.793 0 CA-C-O 118.741 -0.647 . . . . 1.0 110.512 179.684 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 112.095 0.406 . . . . 1.0 112.095 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 33.9 p90 -100.1 177.16 5.16 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.686 0.755 . . . . 1.0 112.011 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.491 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.1 OUTLIER -132.18 160.76 35.14 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.277 1.037 . . . . 1.0 111.089 -179.331 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.7 t -102.6 114.6 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 114.709 -1.132 . . . . 1.0 109.613 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.38 135.64 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.956 -0.565 . . . . 1.0 111.118 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 t -126.22 122.42 35.53 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.335 0.588 . . . . 1.0 110.773 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.1 mm -105.56 128.19 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.453 -0.794 . . . . 1.0 110.243 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.3 m -117.46 126.52 52.76 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.014 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.6 mt -129.13 125.58 37.43 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.649 0.738 . . . . 1.0 110.778 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 64.5 p -129.7 129.45 44.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.47 -0.786 . . . . 1.0 110.506 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -91.59 107.96 19.57 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.156 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.1 mt -96.94 172.81 7.63 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.183 0.516 . . . . 1.0 110.441 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -61.7 -40.0 93.47 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.255 0.465 . . . . 1.0 112.255 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -77.03 -42.15 39.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.22 0.534 . . . . 1.0 110.882 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.75 -141.99 3.75 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.7 p -129.6 134.07 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.361 0.6 . . . . 1.0 111.205 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -99.18 144.62 28.11 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.813 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -131.74 141.35 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.867 0.841 . . . . 1.0 110.501 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -146.95 134.08 20.46 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.562 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -121.7 128.88 52.3 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.873 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.9 m -119.74 141.49 49.38 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.525 0.679 . . . . 1.0 111.243 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.491 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 39.4 tt0 -143.08 126.25 16.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.953 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.425 ' O ' ' ND1' ' A' ' 94' ' ' HIS . 7.7 p-10 -103.03 -170.14 1.75 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.705 0.764 . . . . 1.0 112.257 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.1 t30 62.59 37.78 12.81 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.604 0.964 . . . . 1.0 113.604 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -82.37 121.67 27.0 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.641 -1.244 . . . . 1.0 107.641 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -63.56 -41.82 98.4 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.933 -1.104 . . . . 1.0 111.902 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.4 p -144.71 172.28 13.22 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.874 -0.516 . . . . 1.0 110.854 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.72 -38.8 86.32 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.26 -0.644 . . . . 1.0 109.26 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -58.11 -40.84 82.25 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -70.34 -38.32 74.82 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.991 -0.443 . . . . 1.0 110.211 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.53 HE21 ' C ' ' A' ' 6' ' ' ILE . 51.8 tt0 -64.22 -47.57 79.18 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.72 -0.844 . . . . 1.0 108.72 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -60.53 -42.2 95.99 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -59.22 -38.66 80.49 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.7 t -71.39 -52.73 17.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -55.57 -47.06 77.04 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.933 -0.395 . . . . 1.0 109.933 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.48 -38.2 88.92 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -69.11 -52.84 24.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.278 0.561 . . . . 1.0 110.244 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -61.74 -38.01 86.37 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -58.06 -39.75 79.28 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.347 -0.983 . . . . 1.0 108.347 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.0 m -62.87 -38.36 90.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.906 -0.775 . . . . 1.0 108.906 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 40.9 tpp -67.62 -50.39 58.34 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.43 -41.7 97.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -69.1 -42.6 75.91 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.59 -37.29 94.51 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.012 -1.235 . . . . 1.0 110.012 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.2 tp -66.68 -41.63 87.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.298 0.57 . . . . 1.0 109.704 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -60.58 -36.24 78.05 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.053 -0.404 . . . . 1.0 109.952 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -61.51 -39.23 90.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.853 0.358 . . . . 1.0 110.784 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -73.2 -49.96 25.11 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.066 0.46 . . . . 1.0 110.788 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.13 -41.89 97.04 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.89 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -76.68 -1.51 28.17 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.128 0.489 . . . . 1.0 110.063 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -61.0 -38.74 87.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.768 0.318 . . . . 1.0 110.394 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.3 pttt . . . . . 0 N--CA 1.451 -0.387 0 O-C-N 122.3 -0.25 . . . . 1.0 110.849 -179.706 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.489 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 121.59 0.71 . . . . 1.0 110.724 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -73.23 -168.79 0.55 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.756 -0.59 . . . . 1.0 110.712 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.0 mp -73.94 139.57 44.98 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.809 0.814 . . . . 1.0 111.187 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.533 ' C ' HE21 ' A' ' 122' ' ' GLN . 75.5 mt -112.47 128.39 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.843 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.95 145.03 48.69 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.005 -0.434 . . . . 1.0 110.69 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -138.63 123.39 18.71 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.115 0.483 . . . . 1.0 111.026 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -141.72 152.15 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 121.172 0.51 . . . . 1.0 110.462 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -166.96 143.11 4.4 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.99 -0.444 . . . . 1.0 111.101 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.426 HG23 ' HZ1' ' A' ' 137' ' ' LYS . 1.3 t -147.1 146.11 29.84 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.641 0.734 . . . . 1.0 111.343 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p -107.27 132.63 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 115.89 -0.596 . . . . 1.0 110.798 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 tp -142.67 150.69 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.467 0.651 . . . . 1.0 110.759 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -87.04 95.3 9.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.521 0.677 . . . . 1.0 109.856 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.62 149.78 5.37 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.12 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.75 147.74 92.35 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 121.769 1.646 . . . . 1.0 112.484 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.75 -29.74 44.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.818 -0.628 . . . . 1.0 111.38 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.402 ' HG2' ' HE ' ' A' ' 72' ' ' ARG . 95.4 mt-10 -55.37 -53.2 59.15 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.972 -0.455 . . . . 1.0 111.726 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' CD ' ' N ' ' A' ' 19' ' ' LYS . 3.9 mptp? -67.48 -40.45 85.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 1.0 111.686 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.0 t -66.77 -48.71 79.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -55.95 -42.1 75.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.876 0.846 . . . . 1.0 109.208 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -58.76 -45.79 88.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.486 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.58 -29.12 67.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.726 0.298 . . . . 1.0 111.755 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.522 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.2 tt -67.55 -44.65 77.79 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.344 -0.222 . . . . 1.0 111.222 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.4 m -118.3 79.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 121.87 0.843 . . . . 1.0 111.476 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.737 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.2 OUTLIER -157.09 115.99 2.0 Allowed Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.717 179.253 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.552 ' N ' HD22 ' A' ' 26' ' ' ASN . 73.9 Cg_endo -73.27 -5.71 17.62 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 121.176 1.251 . . . . 1.0 112.349 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.737 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 80.6 mm-40 -94.12 -45.86 7.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.61 -0.268 . . . . 1.0 110.345 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 64.6 mt -72.53 -42.21 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.7 mt -60.6 -42.38 91.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.22 -29.36 70.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 1.0 110.327 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -55.22 -43.4 74.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -69.98 -33.67 72.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.365 . . . . 1.0 110.337 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 76.2 mmm -85.61 152.22 23.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.65 0.738 . . . . 1.0 110.888 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.65 -42.34 98.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.745 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.85 46.81 0.13 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.821 -0.704 . . . . 1.0 111.908 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.2 m -86.12 125.95 33.86 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.762 0.791 . . . . 1.0 110.768 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.3 m -87.55 95.86 10.19 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.717 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.9 t -92.84 127.6 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.174 0.511 . . . . 1.0 110.656 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 40' ' ' VAL . 13.4 p -127.26 125.53 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.304 0.573 . . . . 1.0 110.466 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.6 t -158.24 153.42 25.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.508 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -97.15 -12.82 22.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.785 0.802 . . . . 1.0 108.928 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.415 ' HE1' ' HD3' ' A' ' 27' ' ' PRO . 64.0 m95 54.22 62.46 2.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.872 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.46 157.77 34.53 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.541 0.686 . . . . 1.0 110.988 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.83 117.33 4.88 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.129 0.49 . . . . 1.0 112.086 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.27 -13.01 55.2 Favored Glycine 0 N--CA 1.469 0.865 0 CA-C-N 116.304 -0.407 . . . . 1.0 112.163 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.3 m -76.42 138.54 40.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.391 0.615 . . . . 1.0 111.218 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -93.06 158.45 15.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.291 -0.868 . . . . 1.0 108.794 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.2 pt -144.77 149.51 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.512 0.672 . . . . 1.0 110.884 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.3 m -143.05 154.74 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.58 -0.737 . . . . 1.0 110.507 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 18.3 m0 -127.17 112.77 15.51 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.148 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.63 137.38 32.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.78 -171.51 31.11 Favored Glycine 0 N--CA 1.464 0.51 0 N-CA-C 111.088 -0.805 . . . . 1.0 111.088 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -126.12 131.87 51.99 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.854 0.835 . . . . 1.0 110.189 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -138.14 117.09 12.43 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.405 0.621 . . . . 1.0 110.263 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 54.37 38.37 29.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.587 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.34 -8.3 19.23 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 110.853 -0.899 . . . . 1.0 110.853 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -101.73 118.18 36.4 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.286 0.565 . . . . 1.0 110.556 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.99 129.98 41.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.11 0.481 . . . . 1.0 110.258 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -128.09 151.62 48.97 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.806 0.813 . . . . 1.0 110.811 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -135.11 129.71 34.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.698 0.761 . . . . 1.0 110.46 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -85.24 168.84 14.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.277 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -155.6 126.16 6.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.482 0.658 . . . . 1.0 112.358 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.17 178.37 32.73 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.401 -1.08 . . . . 1.0 110.401 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 90.3 m -145.48 154.24 42.01 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 122.029 -0.689 . . . . 1.0 111.282 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.83 114.45 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.294 0.569 . . . . 1.0 110.068 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.7 mt -77.26 -44.34 30.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.401 0.619 . . . . 1.0 110.086 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -151.24 149.39 29.36 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -138.63 112.63 8.52 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.602 0.715 . . . . 1.0 111.448 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.423 ' HB3' ' H ' ' A' ' 74' ' ' ILE . 47.6 t-20 -126.37 103.45 7.64 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.441 -0.577 . . . . 1.0 109.441 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.456 ' OE2' ' NH1' ' A' ' 72' ' ' ARG . 79.2 tt0 -46.43 129.69 10.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.493 0.663 . . . . 1.0 112.14 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.456 ' NH1' ' OE2' ' A' ' 71' ' ' GLU . 85.6 mtt85 42.58 55.91 4.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.852 -0.613 . . . . 1.0 112.549 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.7 t -167.2 -70.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.797 -0.565 . . . . 1.0 111.925 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.423 ' H ' ' HB3' ' A' ' 70' ' ' ASN . 87.8 mt -135.27 130.74 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.654 0.74 . . . . 1.0 111.497 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.8 tp -140.27 120.95 14.31 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.287 -0.87 . . . . 1.0 110.382 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -141.0 146.54 37.4 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.181 0.515 . . . . 1.0 110.259 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -151.68 158.17 43.07 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.884 0.849 . . . . 1.0 112.215 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 p -82.23 148.61 28.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -142.52 133.75 26.12 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.707 0.765 . . . . 1.0 111.84 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -144.42 133.41 22.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.013 -0.994 . . . . 1.0 110.548 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.4 p . . . . . 0 N--CA 1.475 0.78 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.555 179.691 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.465 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 52.9 t30 . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 112.409 0.522 . . . . 1.0 112.409 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -99.61 176.83 5.34 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.271 0.558 . . . . 1.0 112.039 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -141.0 161.43 37.87 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 122.006 0.907 . . . . 1.0 111.199 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -106.94 130.17 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 114.943 -1.026 . . . . 1.0 109.62 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.41 131.85 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.747 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -124.3 121.89 36.24 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.341 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 60.8 mt -121.26 132.99 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.286 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.2 m -129.1 118.0 21.76 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.195 0.521 . . . . 1.0 110.451 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.3 mp -105.19 135.26 46.88 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.922 0.868 . . . . 1.0 110.598 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 74.0 p -129.79 131.21 46.13 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.19 -0.914 . . . . 1.0 110.575 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.01 108.34 20.41 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.175 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -96.19 166.79 11.57 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.12 0.486 . . . . 1.0 110.47 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -59.48 -40.47 87.07 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.313 0.486 . . . . 1.0 112.313 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -75.47 -39.83 58.15 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.058 0.543 . . . . 1.0 110.93 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.67 -140.1 3.11 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 p -133.09 138.92 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.63 0.728 . . . . 1.0 110.935 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -115.74 143.78 44.9 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.377 -0.829 . . . . 1.0 109.812 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.43 154.06 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.994 0.902 . . . . 1.0 110.229 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -145.07 134.78 23.46 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.676 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -131.58 146.4 52.19 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.928 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.5 p -142.63 151.91 41.94 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.577 0.703 . . . . 1.0 111.356 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -142.22 112.57 7.11 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.445 -0.798 . . . . 1.0 110.063 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -84.59 -169.71 2.76 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.457 0.646 . . . . 1.0 112.514 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 92' ' ' ASN . 43.2 t-20 56.85 39.42 29.55 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.561 0.948 . . . . 1.0 113.561 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -82.76 120.6 25.81 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.793 -1.188 . . . . 1.0 107.793 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -62.39 -38.03 88.05 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.869 -1.144 . . . . 1.0 111.873 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.7 t -149.3 168.96 21.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.272 0.558 . . . . 1.0 110.911 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -57.6 -37.65 73.59 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -57.4 -40.66 78.73 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.524 -0.547 . . . . 1.0 109.524 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -70.53 -39.14 74.22 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 121.906 -0.496 . . . . 1.0 110.043 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.533 HE21 ' C ' ' A' ' 6' ' ' ILE . 52.3 tt0 -64.53 -45.98 84.87 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.566 -0.902 . . . . 1.0 108.566 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -62.57 -41.48 98.96 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.102 -0.703 . . . . 1.0 109.102 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -60.28 -41.42 93.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.9 m -73.62 -48.17 34.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.13 0.49 . . . . 1.0 109.756 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -55.68 -50.48 70.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -62.47 -38.05 88.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -65.36 -51.98 56.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.074 0.464 . . . . 1.0 110.198 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.512 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 80.7 m95 -61.12 -39.78 91.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.539 -0.541 . . . . 1.0 109.539 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -58.18 -39.04 77.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.7 m -64.62 -42.31 95.59 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.512 ' SD ' ' CE3' ' A' ' 129' ' ' TRP . 81.5 mtp -64.2 -49.99 69.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.7 -40.47 95.14 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -62.17 -44.45 96.57 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.99 -0.744 . . . . 1.0 108.99 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.59 -34.01 82.71 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.295 -1.122 . . . . 1.0 110.295 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.47 ' O ' HD23 ' A' ' 136' ' ' LEU . 1.7 tt -66.86 -52.95 37.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.653 0.74 . . . . 1.0 109.906 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.426 ' HZ1' HG23 ' A' ' 11' ' ' THR . 45.6 mmtm -62.06 -36.82 82.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.433 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -59.94 -37.98 81.09 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.424 -0.173 . . . . 1.0 110.558 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -63.72 -48.85 75.4 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.183 -0.323 . . . . 1.0 110.541 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 140' ' ' LEU . 11.0 mp -66.73 -40.14 88.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.683 0.277 . . . . 1.0 110.546 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -70.24 -1.54 10.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.038 0.447 . . . . 1.0 110.128 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -66.35 -37.15 84.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.033 0.444 . . . . 1.0 110.663 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt . . . . . 0 C--N 1.328 -0.333 0 O-C-N 122.23 -0.294 . . . . 1.0 111.356 -179.312 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.531 ' O ' HD12 ' A' ' 3' ' ' ILE . 1.2 pp . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 122.226 1.012 . . . . 1.0 110.911 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -80.52 -172.57 3.65 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.706 0.765 . . . . 1.0 110.585 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.478 ' N ' HD12 ' A' ' 5' ' ' LEU . 10.4 mp -70.17 141.56 52.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.982 0.896 . . . . 1.0 111.444 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.0 mt -114.64 130.62 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 115.648 -0.706 . . . . 1.0 110.91 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.37 142.94 47.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.06 0.457 . . . . 1.0 110.645 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -135.97 115.76 13.05 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.875 0.369 . . . . 1.0 110.971 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.91 137.14 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 120.98 0.419 . . . . 1.0 110.612 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -155.39 144.09 20.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.996 0.427 . . . . 1.0 111.164 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 t -146.81 143.49 28.66 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.233 0.539 . . . . 1.0 111.401 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.2 t -85.18 126.56 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.334 0.588 . . . . 1.0 110.631 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.7 mt -130.18 133.36 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.63 0.729 . . . . 1.0 110.49 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -90.5 95.85 10.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.39 0.614 . . . . 1.0 109.813 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.45 156.25 2.26 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.926 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.06 146.95 92.55 Favored 'Trans proline' 0 N--CA 1.506 2.238 0 C-N-CA 122.018 1.812 . . . . 1.0 112.621 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.1 tt -68.47 -27.47 36.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.446 0.641 . . . . 1.0 111.466 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.44 ' OE2' ' NE ' ' A' ' 72' ' ' ARG . 71.4 mm-40 -62.03 -47.26 85.55 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.88 -0.513 . . . . 1.0 112.286 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -62.77 -46.31 88.63 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.993 0.368 . . . . 1.0 111.993 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 21' ' ' TRP . 19.0 m -69.18 -46.47 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.833 -0.803 . . . . 1.0 108.833 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.429 ' N ' HG23 ' A' ' 20' ' ' VAL . 58.1 t-105 -55.2 -50.51 69.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -60.74 -44.8 96.23 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.018 -0.426 . . . . 1.0 110.357 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.75 -21.48 28.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.468 -0.333 . . . . 1.0 111.755 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.03 -41.46 15.77 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.061 0.458 . . . . 1.0 111.555 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 m -108.14 75.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.308 0.575 . . . . 1.0 110.69 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.405 ' O ' ' CG1' ' A' ' 30' ' ' ILE . 0.2 OUTLIER -159.4 124.64 2.26 Favored Pre-proline 0 CA--C 1.548 0.867 0 CA-C-O 119.184 -0.436 . . . . 1.0 110.783 178.536 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.52 -11.62 20.55 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 121.805 1.67 . . . . 1.0 112.34 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -91.03 -47.74 7.38 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 110.269 -0.271 . . . . 1.0 110.269 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.91 -42.69 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.919 -0.771 . . . . 1.0 108.919 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.405 ' CG1' ' O ' ' A' ' 26' ' ' ASN . 5.4 mm -60.34 -42.14 89.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.271 -0.64 . . . . 1.0 109.271 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -64.5 -31.26 72.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.686 0.279 . . . . 1.0 110.357 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -65.24 -45.98 82.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -72.04 -34.07 68.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.089 0.471 . . . . 1.0 110.589 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.549 ' O ' ' N ' ' A' ' 36' ' ' GLY . 68.6 mmm -93.94 59.82 2.79 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.554 0.692 . . . . 1.0 111.098 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 38.03 -84.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.135 -0.484 . . . . 1.0 112.2 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 34' ' ' MET . . . -146.34 48.26 0.68 Allowed Glycine 0 N--CA 1.469 0.865 0 O-C-N 121.948 -0.47 . . . . 1.0 112.021 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.7 m -93.48 117.57 30.25 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.675 0.75 . . . . 1.0 110.712 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 51.9 m -83.19 124.72 30.8 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.708 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.88 145.05 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.374 0.607 . . . . 1.0 110.631 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.5 t -120.74 130.65 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.41 0.624 . . . . 1.0 110.428 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.6 t -152.34 131.28 12.55 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.085 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.408 ' OD2' ' NZ ' ' A' ' 44' ' ' LYS . 93.9 m-20 -75.68 -19.08 59.39 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.119 0.961 . . . . 1.0 109.387 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.1 m0 68.16 45.47 1.27 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.65 -0.705 . . . . 1.0 111.488 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.408 ' NZ ' ' OD2' ' A' ' 42' ' ' ASP . 25.0 pttm -148.44 156.43 42.47 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.46 0.647 . . . . 1.0 111.369 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -48.19 127.69 12.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.687 0.756 . . . . 1.0 112.385 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.79 1.97 89.78 Favored Glycine 0 N--CA 1.465 0.609 0 CA-C-N 115.722 -0.672 . . . . 1.0 112.044 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.0 t -64.89 132.58 49.78 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.301 -0.529 . . . . 1.0 111.75 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -83.02 143.69 30.45 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.2 mt -134.1 136.08 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.791 0.805 . . . . 1.0 110.944 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.7 t -128.58 142.1 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.213 -0.903 . . . . 1.0 110.632 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 20.8 m-90 -117.18 123.26 46.25 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.014 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -97.0 126.63 42.27 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.25 178.26 34.59 Favored Glycine 0 N--CA 1.461 0.32 0 N-CA-C 110.997 -0.841 . . . . 1.0 110.997 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -128.68 136.59 50.82 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.571 0.701 . . . . 1.0 110.163 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -138.53 117.7 12.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.038 0.447 . . . . 1.0 110.466 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? 53.57 38.71 28.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.348 0.594 . . . . 1.0 110.747 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.7 -8.37 21.36 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.516 -1.034 . . . . 1.0 110.516 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -98.83 116.56 31.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.107 0.479 . . . . 1.0 110.664 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.09 128.44 36.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.251 0.548 . . . . 1.0 110.247 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -129.96 150.45 51.23 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.618 0.723 . . . . 1.0 110.971 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -135.77 131.66 35.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.437 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -89.54 162.6 15.6 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -141.18 126.99 19.16 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.558 0.694 . . . . 1.0 112.424 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.66 170.56 31.16 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.333 -1.107 . . . . 1.0 110.333 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.7 m -146.51 153.73 40.74 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 122.054 -0.674 . . . . 1.0 111.243 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.4 mm -77.9 116.49 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.37 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.4 tp -76.13 -44.9 36.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.653 0.74 . . . . 1.0 110.065 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -145.4 148.44 33.34 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -136.3 105.51 6.0 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.843 0.83 . . . . 1.0 111.439 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -125.45 107.95 11.16 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.25 -0.648 . . . . 1.0 109.25 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.464 ' H ' ' CD ' ' A' ' 71' ' ' GLU . 56.3 mp0 -46.69 134.54 9.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.546 0.688 . . . . 1.0 111.969 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.44 ' NE ' ' OE2' ' A' ' 18' ' ' GLU . 14.4 ptp180 36.76 53.46 1.09 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.78 -0.645 . . . . 1.0 112.445 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 m -157.59 -69.9 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.822 -0.549 . . . . 1.0 111.618 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.6 mt -142.4 134.87 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-O 121.588 0.708 . . . . 1.0 111.535 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.6 tp -132.0 119.52 21.18 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.317 -0.856 . . . . 1.0 110.792 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.493 HE21 HG11 ' A' ' 95' ' ' VAL . 58.4 tt0 -133.54 138.3 46.0 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.257 0.551 . . . . 1.0 110.299 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -151.06 153.26 34.75 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.975 0.893 . . . . 1.0 112.073 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.8 p -84.59 151.79 24.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.253 -1.017 . . . . 1.0 108.253 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -149.84 137.32 19.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.632 0.73 . . . . 1.0 112.105 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -150.67 150.09 30.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.001 -0.999 . . . . 1.0 110.655 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.5 t . . . . . 0 CA--C 1.549 0.91 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.612 179.236 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 112.313 0.486 . . . . 1.0 112.313 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.428 ' C ' ' CD1' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -151.26 170.58 19.16 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.405 0.621 . . . . 1.0 111.722 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.492 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.3 OUTLIER -144.68 160.67 40.82 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.761 0.791 . . . . 1.0 111.318 179.354 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.493 HG11 HE21 ' A' ' 76' ' ' GLN . 61.5 t -104.5 129.19 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 115.171 -0.922 . . . . 1.0 109.458 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.8 t -96.26 132.79 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.987 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -123.18 121.63 36.42 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.378 0.609 . . . . 1.0 110.612 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.1 mm -107.15 131.76 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.468 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.1 m -118.89 114.36 22.48 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.356 0.598 . . . . 1.0 110.115 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.4 mt -122.94 122.94 39.81 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.641 0.734 . . . . 1.0 110.829 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 m -131.29 132.39 44.51 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.491 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -85.28 123.42 30.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.043 0.449 . . . . 1.0 110.38 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.6 mt -93.21 -152.56 0.33 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.007 0.432 . . . . 1.0 110.508 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.555 ' CD ' ' H ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -77.7 -48.73 16.0 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.187 0.44 . . . . 1.0 112.187 -178.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -136.95 35.47 2.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.81 0.844 . . . . 1.0 110.001 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 179.21 169.14 39.3 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.915 -0.874 . . . . 1.0 110.915 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.8 p -127.07 133.08 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.04 0.448 . . . . 1.0 111.302 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -88.72 139.87 30.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.589 . . . . 1.0 109.741 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.77 138.7 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.536 0.684 . . . . 1.0 110.248 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -150.33 136.37 18.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.307 0.575 . . . . 1.0 110.513 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 tt -122.12 132.59 54.55 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.982 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.2 m -124.2 143.38 50.55 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.491 0.662 . . . . 1.0 111.419 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.492 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 43.1 tt0 -145.4 135.5 23.82 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.419 -0.81 . . . . 1.0 109.947 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -110.24 -165.25 0.98 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.474 0.654 . . . . 1.0 112.407 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.0 t30 60.01 37.16 21.39 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.751 1.019 . . . . 1.0 113.751 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -83.63 113.15 20.64 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.663 -1.236 . . . . 1.0 107.663 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -62.58 -35.77 80.55 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.006 -1.058 . . . . 1.0 111.584 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.0 p -143.89 164.91 29.21 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.877 -0.514 . . . . 1.0 111.067 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -58.66 -35.65 72.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.57 0.7 . . . . 1.0 109.23 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -58.66 -41.14 85.43 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.443 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -68.28 -41.45 80.99 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.981 -0.45 . . . . 1.0 110.084 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -64.16 -47.64 79.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -59.26 -42.93 92.3 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -63.32 -37.78 88.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 71.0 m -67.95 -54.51 18.1 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -52.6 -43.95 65.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.34 -0.391 . . . . 1.0 109.963 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -62.97 -39.44 94.7 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.758 -0.46 . . . . 1.0 109.758 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -67.39 -51.69 48.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.045 0.45 . . . . 1.0 110.175 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -64.05 -42.25 97.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -58.39 -39.79 80.6 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.628 -0.878 . . . . 1.0 108.628 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.2 m -63.94 -40.93 97.56 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.919 -0.771 . . . . 1.0 108.919 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 39.5 ttm -65.8 -50.39 64.82 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.7 -40.7 95.93 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -66.23 -44.21 84.45 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.16 -37.25 91.26 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.106 -1.198 . . . . 1.0 110.106 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 49.0 tp -71.44 -44.78 64.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.4 0.619 . . . . 1.0 110.072 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -60.87 -43.93 97.74 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.108 -0.37 . . . . 1.0 110.461 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.67 -36.29 76.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.69 0.281 . . . . 1.0 110.847 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -62.02 -48.5 80.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.215 0.531 . . . . 1.0 110.399 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.31 -37.18 84.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.653 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.88 -0.54 13.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.296 0.569 . . . . 1.0 110.152 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -62.41 -35.96 80.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.665 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt . . . . . 0 C--N 1.329 -0.287 0 O-C-N 122.388 -0.195 . . . . 1.0 110.864 -179.278 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.509 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 121.44 0.638 . . . . 1.0 110.951 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -75.8 -153.82 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.21 0.528 . . . . 1.0 110.805 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 5' ' ' LEU . 3.3 mm? -79.0 141.6 37.34 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.618 0.723 . . . . 1.0 111.57 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.9 mt -117.92 128.64 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.0 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.17 138.99 33.42 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.991 -0.443 . . . . 1.0 110.651 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -136.35 126.5 26.27 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.265 0.555 . . . . 1.0 111.01 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.52 156.15 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.053 0.454 . . . . 1.0 110.626 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -170.75 144.59 2.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.018 0.437 . . . . 1.0 111.013 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 t -147.09 145.15 29.52 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.365 0.602 . . . . 1.0 111.034 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 12' ' ' VAL . 13.5 p -90.03 128.6 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.245 0.545 . . . . 1.0 110.439 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.5 mt -131.77 135.37 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.724 0.773 . . . . 1.0 110.613 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -88.01 94.4 9.78 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.476 0.655 . . . . 1.0 110.052 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.68 156.65 2.19 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.683 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.93 149.64 90.14 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.208 1.939 . . . . 1.0 112.401 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.9 tt -68.93 -29.01 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.91 -0.586 . . . . 1.0 111.263 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.44 -54.23 43.56 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.953 -0.467 . . . . 1.0 111.859 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.46 -40.06 89.17 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.97 0.359 . . . . 1.0 111.97 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.7 t -66.11 -46.93 86.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 30.2 t-105 -58.08 -41.53 83.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.727 0.775 . . . . 1.0 109.01 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -60.67 -44.13 96.85 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.993 -0.442 . . . . 1.0 110.38 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.2 69.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.578 -0.283 . . . . 1.0 111.687 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.55 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.1 tt -70.2 -41.74 73.29 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.231 -0.293 . . . . 1.0 111.469 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 m -121.21 79.06 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 121.749 0.785 . . . . 1.0 111.149 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.66 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -160.75 103.19 1.31 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.228 179.138 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.439 ' N ' HD22 ' A' ' 26' ' ' ASN . 47.2 Cg_exo -54.08 -27.33 45.47 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.064 1.843 . . . . 1.0 112.791 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.66 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 96.2 mt-10 -70.12 -53.44 17.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.147 0.499 . . . . 1.0 110.533 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.04 -42.19 88.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.401 0.619 . . . . 1.0 109.334 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.1 mm -59.43 -42.49 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.003 -0.74 . . . . 1.0 109.003 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -69.93 -31.76 69.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.016 0.436 . . . . 1.0 110.4 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -57.39 -41.98 81.29 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -70.27 -34.1 72.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.848 0.356 . . . . 1.0 110.37 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.2 mmt -85.07 148.25 26.25 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.582 0.706 . . . . 1.0 111.052 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -60.67 -43.68 97.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.633 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.41 41.58 0.24 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.106 -0.569 . . . . 1.0 112.061 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.7 m -85.27 126.96 34.12 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.448 0.642 . . . . 1.0 110.675 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.1 m -92.71 106.33 18.32 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.954 0.407 . . . . 1.0 110.599 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.0 t -106.19 135.32 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.659 0.743 . . . . 1.0 110.484 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.2 m -129.73 130.96 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.512 0.672 . . . . 1.0 110.549 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.2 t -155.78 154.18 31.0 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.535 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -92.75 -18.77 22.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.854 0.835 . . . . 1.0 108.948 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 2.2 m0 66.68 46.84 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 1.0 111.409 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -149.76 157.19 42.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.576 0.703 . . . . 1.0 111.334 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -52.22 129.55 28.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.865 0.84 . . . . 1.0 112.296 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.04 1.68 90.37 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.648 -0.706 . . . . 1.0 112.172 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.0 t -68.17 133.41 48.85 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 122.305 -0.527 . . . . 1.0 111.589 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -79.46 144.58 33.9 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.9 tt -138.25 136.93 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.608 0.718 . . . . 1.0 111.205 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.2 m -140.56 151.58 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.542 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -124.36 131.54 53.51 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.238 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -94.16 137.17 33.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.515 0.674 . . . . 1.0 109.694 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.78 169.9 37.34 Favored Glycine 0 C--N 1.33 0.239 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.55 122.78 40.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.816 0.817 . . . . 1.0 110.017 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' A' ' 58' ' ' LYS . 43.1 t-105 -117.58 115.87 25.96 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.576 0.703 . . . . 1.0 109.913 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.432 ' HG2' ' CD1' ' A' ' 55' ' ' TRP . 9.5 ptmm? 40.07 46.33 1.8 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.89 -0.596 . . . . 1.0 111.548 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.15 -17.77 9.19 Favored Glycine 0 N--CA 1.472 1.045 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 55' ' ' TRP . 37.5 ttmt -91.22 114.78 27.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.404 0.621 . . . . 1.0 110.299 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.37 136.59 46.16 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.108 -0.37 . . . . 1.0 110.33 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -138.61 155.82 47.99 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.558 0.695 . . . . 1.0 110.948 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.446 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 1.5 pm0 -138.73 131.78 29.72 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.542 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -87.09 136.81 32.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -120.52 127.74 52.46 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.56 0.695 . . . . 1.0 112.478 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.95 178.79 33.18 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.362 -1.095 . . . . 1.0 110.362 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 66' ' ' ILE . 58.1 m -148.12 157.9 43.77 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.86 -0.788 . . . . 1.0 111.132 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.454 ' N ' HG22 ' A' ' 65' ' ' THR . 31.8 mm -73.39 115.54 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.506 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.402 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 38.3 tp -69.73 -44.34 70.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.363 0.602 . . . . 1.0 110.137 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -155.97 147.53 22.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -131.06 110.17 11.02 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.649 0.738 . . . . 1.0 111.597 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.39 95.36 4.44 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.338 -0.615 . . . . 1.0 109.338 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -40.78 131.76 2.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.388 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.6 mtm-85 40.38 55.04 2.86 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.5 m -163.37 -70.65 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.757 -0.589 . . . . 1.0 111.976 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.1 mt -140.88 133.97 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 121.491 0.662 . . . . 1.0 111.408 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 tp -136.19 126.31 26.23 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.377 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -142.97 146.43 33.92 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.114 0.483 . . . . 1.0 110.226 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.402 ' HA ' ' H ' ' A' ' 67' ' ' LEU . 29.5 p90 -150.26 155.03 38.94 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.142 0.973 . . . . 1.0 112.204 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 93.8 p -95.18 152.68 18.15 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.469 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -152.06 151.42 31.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.844 0.83 . . . . 1.0 111.554 -179.482 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -142.35 134.72 27.81 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.752 -1.113 . . . . 1.0 110.463 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.0 m . . . . . 0 CA--C 1.545 0.775 0 CA-C-O 118.686 -0.673 . . . . 1.0 110.546 179.797 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.48 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 43.7 t30 . . . . . 0 CA--C 1.529 0.144 0 N-CA-C 112.292 0.479 . . . . 1.0 112.292 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.469 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 39.5 p90 -101.38 177.65 4.87 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.626 0.726 . . . . 1.0 112.053 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -134.96 162.5 32.27 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.892 0.853 . . . . 1.0 111.416 -179.316 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.6 p -101.3 129.86 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.012 -0.995 . . . . 1.0 109.8 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 t -94.76 133.5 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.9 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.4 t -128.75 121.96 29.56 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.494 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.15 132.4 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.35 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.3 m -111.88 124.63 52.79 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.421 0.629 . . . . 1.0 109.999 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 74.9 mt -125.51 117.67 24.12 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.428 0.632 . . . . 1.0 110.794 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.9 m -133.25 134.67 44.28 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.431 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -85.7 126.3 33.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.296 0.57 . . . . 1.0 110.29 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 47.7 mt -110.14 172.24 6.98 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.167 0.508 . . . . 1.0 110.589 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -64.54 -40.28 95.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.47 0.545 . . . . 1.0 112.47 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -83.73 -34.98 24.76 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.276 0.56 . . . . 1.0 110.875 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.25 -146.58 5.86 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.909 -0.876 . . . . 1.0 110.909 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.2 p -125.44 128.64 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.248 0.547 . . . . 1.0 111.016 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -95.81 142.15 28.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.611 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.3 m -130.14 148.7 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.622 0.725 . . . . 1.0 110.558 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -151.1 133.07 15.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.152 0.501 . . . . 1.0 110.514 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.6 tt -124.6 131.82 53.46 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.806 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.8 m -123.28 143.34 50.13 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.648 0.737 . . . . 1.0 111.142 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.438 ' OE1' ' ND2' ' A' ' 116' ' ' ASN . 0.9 OUTLIER -142.32 136.74 30.01 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.309 -0.86 . . . . 1.0 110.034 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 0.7 OUTLIER -114.23 -164.67 0.95 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.631 0.729 . . . . 1.0 112.334 -179.04 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 92' ' ' ASN . 64.4 t30 59.03 35.39 23.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.469 0.915 . . . . 1.0 113.469 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.438 ' ND2' ' OE1' ' A' ' 113' ' ' GLN . 83.5 m-20 -83.64 133.75 34.82 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.557 -1.275 . . . . 1.0 107.557 177.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -64.07 -46.17 85.49 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.028 -1.045 . . . . 1.0 112.066 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 62.0 p -147.79 179.71 7.51 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.843 -0.535 . . . . 1.0 110.835 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -60.39 -37.07 79.63 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -61.34 -43.96 98.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -71.32 -41.69 69.54 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.967 -0.458 . . . . 1.0 110.075 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.8 tm0? -63.24 -44.89 93.92 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -62.8 -42.82 99.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.698 -0.852 . . . . 1.0 108.698 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -59.57 -39.94 85.75 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 16.8 t -69.73 -44.75 69.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -56.01 -47.73 77.23 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.98 -39.15 91.21 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.787 -0.449 . . . . 1.0 109.787 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -64.28 -53.11 54.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 1.0 110.068 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.506 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 86.5 m95 -60.61 -39.18 87.21 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -59.08 -39.89 83.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.396 -0.965 . . . . 1.0 108.396 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.4 m -63.5 -43.13 98.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.506 ' SD ' ' CE3' ' A' ' 129' ' ' TRP . 77.2 mtp -62.7 -50.7 70.07 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.497 -0.556 . . . . 1.0 109.497 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.54 -38.8 88.76 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.41 ' HA ' ' HZ3' ' A' ' 137' ' ' LYS . 78.8 tt0 -65.66 -34.04 77.28 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.68 -32.34 33.78 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.155 -1.178 . . . . 1.0 110.155 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.453 ' O ' HD23 ' A' ' 136' ' ' LEU . 1.7 tt -68.56 -54.13 18.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.641 0.734 . . . . 1.0 109.871 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.41 ' HZ3' ' HA ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -61.84 -27.0 68.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.534 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -56.36 -32.18 64.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.891 0.377 . . . . 1.0 110.613 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -79.22 -41.95 27.11 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.036 0.446 . . . . 1.0 110.7 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 140' ' ' LEU . 4.1 mm? -63.24 -41.87 99.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.838 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -75.74 -1.98 27.52 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.338 0.59 . . . . 1.0 110.231 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -63.5 -41.2 98.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.661 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.748 0.308 . . . . 1.0 110.902 -179.753 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.1 pt . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 121.903 0.859 . . . . 1.0 110.931 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -74.9 -175.8 2.67 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.7 -0.625 . . . . 1.0 110.971 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.7 mp -68.2 140.2 56.08 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.03 0.919 . . . . 1.0 111.182 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.563 ' C ' HE21 ' A' ' 122' ' ' GLN . 5.1 mp -112.21 124.33 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.687 -0.688 . . . . 1.0 111.099 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.08 134.21 36.75 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.029 -0.42 . . . . 1.0 110.372 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -133.7 122.36 23.27 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.976 0.417 . . . . 1.0 110.804 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.3 m -139.89 135.59 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.099 0.476 . . . . 1.0 110.576 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -152.64 150.69 29.75 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.089 0.471 . . . . 1.0 111.033 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.479 HG23 ' NZ ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -145.87 142.39 28.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.541 0.686 . . . . 1.0 111.143 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 t -85.62 114.51 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.416 0.627 . . . . 1.0 110.715 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.9 mm -127.84 138.77 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 122.183 0.992 . . . . 1.0 110.733 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -98.04 105.93 18.15 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.397 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' A' ' 16' ' ' PRO . . . -173.24 160.6 3.46 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 120.977 -0.289 . . . . 1.0 110.416 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.436 ' HD2' ' HB1' ' A' ' 15' ' ' ALA . 26.0 Cg_endo -59.85 140.5 93.45 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.341 2.027 . . . . 1.0 112.135 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.1 tp -68.21 -32.87 57.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.649 0.738 . . . . 1.0 111.221 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -57.4 -52.39 65.58 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.886 -0.508 . . . . 1.0 111.859 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.451 ' CD ' ' N ' ' A' ' 19' ' ' LYS . 12.2 mptt -64.49 -42.91 95.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.52 -47.54 91.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.46 ' CH2' ' O ' ' A' ' 70' ' ' ASN . 62.3 t-105 -60.23 -42.42 95.19 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -58.99 -47.39 85.34 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.977 -0.452 . . . . 1.0 110.206 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.79 -28.82 69.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.647 0.261 . . . . 1.0 111.702 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -70.56 -41.73 72.07 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.237 -0.289 . . . . 1.0 111.489 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 m -120.27 78.89 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 121.759 0.79 . . . . 1.0 111.226 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.773 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -158.63 113.22 1.66 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.56 179.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.578 ' N ' HD22 ' A' ' 26' ' ' ASN . 57.0 Cg_endo -68.99 -11.34 31.59 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.237 1.291 . . . . 1.0 112.649 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.773 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 45.6 mt-10 -86.28 -47.66 9.21 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.804 0.335 . . . . 1.0 110.332 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.18 -41.46 66.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.295 -0.632 . . . . 1.0 109.295 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.31 -42.3 86.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -65.46 -31.26 72.24 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.292 -0.262 . . . . 1.0 110.292 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -56.6 -42.77 79.28 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.824 -0.435 . . . . 1.0 109.824 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -69.81 -33.8 72.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.942 0.401 . . . . 1.0 110.389 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 79.8 mmm -85.22 153.72 22.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.66 0.743 . . . . 1.0 110.816 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -62.56 -35.83 80.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.63 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.28 42.62 0.07 OUTLIER Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.017 -0.611 . . . . 1.0 111.943 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.2 m -85.8 125.73 33.48 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.601 0.715 . . . . 1.0 110.74 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.0 p -88.95 102.42 15.05 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.636 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.53 130.64 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.471 0.653 . . . . 1.0 110.419 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.05 128.42 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.408 0.623 . . . . 1.0 110.264 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.507 ' HG ' ' HD1' ' A' ' 43' ' ' TRP . 31.5 t -155.6 153.42 30.07 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.125 -0.488 . . . . 1.0 111.384 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 8.1 t0 -92.77 -20.61 20.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.945 0.879 . . . . 1.0 108.958 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.507 ' HD1' ' HG ' ' A' ' 41' ' ' SER . 2.6 m0 67.8 49.75 0.91 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.828 -0.624 . . . . 1.0 111.559 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -151.77 155.18 37.73 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.519 0.676 . . . . 1.0 111.186 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -49.64 127.41 15.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.794 0.807 . . . . 1.0 112.176 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.4 0.75 90.2 Favored Glycine 0 N--CA 1.468 0.833 0 CA-C-N 115.678 -0.692 . . . . 1.0 112.115 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.0 t -66.31 135.9 55.06 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.232 -0.57 . . . . 1.0 111.694 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 64' ' ' GLY . 68.0 tp60 -84.67 147.01 27.16 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.44 HD11 ' HE1' ' A' ' 51' ' ' TRP . 19.8 tt -136.91 136.15 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.539 0.685 . . . . 1.0 111.338 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -138.66 142.47 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 115.505 -0.77 . . . . 1.0 110.556 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.44 ' HE1' HD11 ' A' ' 49' ' ' ILE . 14.1 m0 -119.67 136.64 54.32 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.052 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -101.97 143.53 31.71 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.332 0.587 . . . . 1.0 109.578 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.41 175.41 43.68 Favored Glycine 0 C--N 1.329 0.167 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -125.53 127.01 45.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.97 0.89 . . . . 1.0 109.791 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.587 ' O ' ' N ' ' A' ' 58' ' ' LYS . 36.2 t-105 -120.34 119.17 32.33 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.384 0.612 . . . . 1.0 109.645 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.415 ' HG2' ' CD1' ' A' ' 55' ' ' TRP . 9.9 ptmm? 39.66 42.02 0.88 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.346 0.594 . . . . 1.0 111.7 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.02 -18.01 19.12 Favored Glycine 0 N--CA 1.476 1.316 0 N-CA-C 110.768 -0.933 . . . . 1.0 110.768 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.587 ' N ' ' O ' ' A' ' 55' ' ' TRP . 74.4 mmtt -91.36 110.5 21.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.98 0.895 . . . . 1.0 110.655 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.03 132.15 47.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.65 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -134.38 152.56 51.87 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.612 0.72 . . . . 1.0 110.909 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.448 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 2.0 pm0 -138.03 136.07 36.5 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.497 0.665 . . . . 1.0 110.498 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -88.49 167.85 13.09 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -153.69 127.19 8.64 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.139 -0.624 . . . . 1.0 112.37 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.429 ' O ' ' NE2' ' A' ' 48' ' ' GLN . . . -153.78 178.23 30.84 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.399 -1.081 . . . . 1.0 110.399 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 66' ' ' ILE . 79.2 m -148.51 154.03 39.25 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.997 -0.708 . . . . 1.0 111.24 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.408 ' N ' HG22 ' A' ' 65' ' ' THR . 32.1 mm -80.4 121.95 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.403 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -90.97 -44.54 9.28 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.426 0.631 . . . . 1.0 109.964 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.672 HE21 ' ND2' ' A' ' 70' ' ' ASN . 58.5 tt0 -133.8 135.24 43.71 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.718 -0.475 . . . . 1.0 109.718 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -135.08 102.64 5.27 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.726 0.774 . . . . 1.0 111.516 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.672 ' ND2' HE21 ' A' ' 68' ' ' GLN . 82.6 m-20 -124.83 102.89 7.78 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.345 -0.613 . . . . 1.0 109.345 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -42.94 127.53 4.12 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.729 -0.668 . . . . 1.0 112.261 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 45.15 53.98 7.45 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.051 0.54 . . . . 1.0 112.352 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.7 t -160.05 -74.32 0.07 Allowed 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.782 -0.574 . . . . 1.0 112.027 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.5 mt -138.15 133.02 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.656 0.741 . . . . 1.0 111.374 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.1 tp -132.08 125.48 31.49 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.32 -0.855 . . . . 1.0 110.57 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.499 HE21 HG11 ' A' ' 95' ' ' VAL . 58.3 tt0 -135.13 136.71 42.12 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.452 0.644 . . . . 1.0 110.235 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -149.7 152.98 36.21 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.019 0.914 . . . . 1.0 112.0 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 p -86.94 151.07 23.62 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.152 -1.055 . . . . 1.0 108.152 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.413 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 15.2 t-80 -151.19 142.11 22.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.544 0.688 . . . . 1.0 111.939 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -144.91 148.65 34.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.048 -0.978 . . . . 1.0 110.351 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 74.8 m . . . . . 0 CA--C 1.548 0.903 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.63 179.699 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 66.9 t30 . . . . . 0 N--CA 1.465 0.284 0 N-CA-C 112.227 0.454 . . . . 1.0 112.227 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.59 173.2 12.94 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.616 0.722 . . . . 1.0 112.031 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -139.61 165.15 28.03 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 122.138 0.97 . . . . 1.0 111.19 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.499 HG11 HE21 ' A' ' 76' ' ' GLN . 59.2 t -107.28 128.9 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 114.829 -1.078 . . . . 1.0 109.657 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.0 t -92.82 134.13 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.919 -0.582 . . . . 1.0 111.14 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.9 t -132.03 124.78 29.97 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.51 0.671 . . . . 1.0 110.443 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.95 129.96 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.17 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.5 m -106.87 120.85 43.15 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.555 0.693 . . . . 1.0 109.831 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 mp -117.21 124.1 48.27 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.613 0.721 . . . . 1.0 110.816 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.7 p -131.02 134.08 46.35 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.824 0.821 . . . . 1.0 110.477 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.98 111.37 23.61 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.119 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.5 mt -77.76 -168.98 1.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.042 0.449 . . . . 1.0 110.464 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -64.47 -48.34 75.62 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.515 0.561 . . . . 1.0 112.515 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -137.48 38.5 2.46 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.407 0.683 . . . . 1.0 109.942 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.91 168.84 41.31 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.9 p -134.4 144.4 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.742 0.782 . . . . 1.0 110.776 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -120.27 143.03 48.54 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.698 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.0 m -129.91 149.98 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.643 0.735 . . . . 1.0 110.345 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -152.2 134.14 14.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.698 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.9 tt -119.98 131.05 55.04 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.365 0.603 . . . . 1.0 109.957 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 m -120.67 142.65 49.27 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.415 0.626 . . . . 1.0 111.265 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -145.52 136.63 24.77 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.462 -0.79 . . . . 1.0 110.046 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 10.9 p-10 -116.48 -171.09 1.94 Allowed 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.655 0.74 . . . . 1.0 112.341 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.0 t30 65.01 38.76 6.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.627 0.973 . . . . 1.0 113.627 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -84.91 116.65 23.46 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 107.638 -1.245 . . . . 1.0 107.638 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -58.87 -36.92 75.41 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 120.954 -1.092 . . . . 1.0 111.773 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.6 p -140.96 163.6 32.52 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.872 -0.518 . . . . 1.0 111.045 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.1 -34.59 77.92 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -57.9 -38.94 76.73 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.535 -0.542 . . . . 1.0 109.535 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.49 -35.04 70.66 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.87 -0.519 . . . . 1.0 110.21 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.563 HE21 ' C ' ' A' ' 6' ' ' ILE . 54.9 tt0 -62.16 -47.72 83.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.792 -0.818 . . . . 1.0 108.792 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -60.23 -42.46 95.28 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.827 -0.805 . . . . 1.0 108.827 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -61.0 -38.38 85.84 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.6 t -68.42 -53.46 23.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.638 -0.505 . . . . 1.0 109.638 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -55.41 -45.46 76.71 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.999 -0.371 . . . . 1.0 109.999 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -62.76 -40.2 96.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -66.74 -51.6 54.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.373 0.606 . . . . 1.0 110.136 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -61.26 -35.68 77.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.495 -0.557 . . . . 1.0 109.495 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -59.69 -40.4 87.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.569 -0.9 . . . . 1.0 108.569 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.7 m -63.77 -43.01 97.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.252 -0.647 . . . . 1.0 109.252 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 83.4 mmm -61.42 -50.34 73.22 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.52 -40.35 94.32 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -62.8 -44.25 96.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.91 -41.94 86.93 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.224 -1.15 . . . . 1.0 110.224 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.517 ' O ' HD23 ' A' ' 136' ' ' LEU . 2.4 tt -63.03 -50.41 70.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.691 0.758 . . . . 1.0 110.179 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.479 ' NZ ' HG23 ' A' ' 11' ' ' THR . 1.0 OUTLIER -62.54 -36.86 83.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.229 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.68 -35.1 54.74 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 122.378 -0.201 . . . . 1.0 110.761 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -65.48 -51.06 62.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.915 0.388 . . . . 1.0 110.423 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.75 -41.05 88.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.488 -0.324 . . . . 1.0 110.905 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -68.58 -18.08 64.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.249 0.547 . . . . 1.0 109.935 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -48.7 -30.87 6.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 1.0 110.721 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.3 pttt . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.722 0.296 . . . . 1.0 111.278 -179.709 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.1 pt . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 121.757 0.789 . . . . 1.0 110.928 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -77.26 -165.23 0.55 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.771 -0.581 . . . . 1.0 111.059 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.3 mp -68.61 139.12 55.51 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.65 0.738 . . . . 1.0 111.306 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.482 ' C ' HE21 ' A' ' 122' ' ' GLN . 28.5 mm -110.0 124.81 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.934 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.31 136.31 42.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.956 0.407 . . . . 1.0 110.637 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -131.92 119.84 21.71 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.079 0.466 . . . . 1.0 110.935 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.9 m -143.95 136.29 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 121.095 0.474 . . . . 1.0 110.609 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -150.66 149.97 30.52 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.989 0.423 . . . . 1.0 111.305 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 t -146.98 144.56 29.27 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.404 0.621 . . . . 1.0 111.136 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.1 t -85.27 113.34 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.262 0.553 . . . . 1.0 110.586 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mm -110.51 126.83 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.682 0.753 . . . . 1.0 110.512 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -92.51 94.95 9.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.21 0.529 . . . . 1.0 109.806 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' HB1' ' HD2' ' A' ' 16' ' ' PRO . . . -171.62 169.7 2.91 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.806 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD2' ' HB1' ' A' ' 15' ' ' ALA . 27.2 Cg_exo -61.52 148.13 93.74 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 122.286 1.991 . . . . 1.0 112.477 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 tp -68.41 -36.25 74.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.17 0.509 . . . . 1.0 111.336 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -66.29 -48.46 70.32 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.878 -0.514 . . . . 1.0 112.084 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.13 -42.72 99.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.916 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.2 t -68.26 -45.6 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -59.47 -41.59 90.1 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.086 -0.709 . . . . 1.0 109.086 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -56.3 -43.22 78.67 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 122.044 -0.41 . . . . 1.0 110.367 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.43 -31.81 66.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.336 . . . . 1.0 111.669 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.515 ' O ' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -66.42 -45.88 78.41 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.766 0.317 . . . . 1.0 111.643 -179.066 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 m -116.5 82.01 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.585 0.707 . . . . 1.0 110.78 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.724 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -160.2 113.78 1.42 Allowed Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.491 179.15 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.556 ' N ' HD22 ' A' ' 26' ' ' ASN . 61.3 Cg_endo -71.94 -12.65 28.58 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 121.635 1.556 . . . . 1.0 112.362 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.724 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 50.0 mt-10 -86.43 -46.24 10.41 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.647 0.26 . . . . 1.0 110.453 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.7 mt -71.75 -43.36 70.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.5 mt -59.66 -43.08 90.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.03 -0.73 . . . . 1.0 109.03 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -70.9 -29.28 65.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.997 0.427 . . . . 1.0 110.353 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -57.25 -40.93 78.66 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -70.08 -33.52 72.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 1.0 110.249 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.413 ' CE ' ' OG1' ' A' ' 37' ' ' THR . 64.7 mtp -87.81 154.85 20.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.602 0.715 . . . . 1.0 111.167 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -60.75 -43.7 97.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.696 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.26 49.82 0.14 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.966 -0.635 . . . . 1.0 111.919 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.413 ' OG1' ' CE ' ' A' ' 34' ' ' MET . 88.8 m -81.94 128.87 34.51 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.73 0.776 . . . . 1.0 110.761 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.4 m -91.29 91.83 8.35 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.755 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p -103.93 134.1 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.702 0.763 . . . . 1.0 110.383 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.6 t -126.41 134.54 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.671 0.748 . . . . 1.0 110.409 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.1 t -155.45 143.37 19.9 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.386 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -81.92 -19.53 40.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.84 0.829 . . . . 1.0 109.098 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.2 m0 69.42 48.11 0.65 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.523 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -157.46 168.47 27.23 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.428 0.633 . . . . 1.0 111.195 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -58.68 127.63 33.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.689 0.757 . . . . 1.0 112.294 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.23 -1.42 84.51 Favored Glycine 0 N--CA 1.47 0.934 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.994 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.2 m -67.59 133.2 48.98 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.235 -0.568 . . . . 1.0 111.805 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 64' ' ' GLY . 68.0 tp60 -83.24 145.88 28.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.821 -0.807 . . . . 1.0 108.821 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.0 tt -136.83 137.35 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.457 0.646 . . . . 1.0 111.134 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -143.46 149.73 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.696 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.511 ' CZ3' ' NE2' ' A' ' 79' ' ' HIS . 9.6 m0 -124.55 140.45 52.93 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.039 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -103.61 137.46 41.64 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.099 0.476 . . . . 1.0 109.798 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.95 176.35 40.73 Favored Glycine 0 N--CA 1.46 0.27 0 N-CA-C 111.041 -0.824 . . . . 1.0 111.041 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -127.09 138.65 53.24 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.802 0.811 . . . . 1.0 110.19 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -143.16 117.43 9.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.285 0.564 . . . . 1.0 110.293 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 54.56 34.85 22.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.581 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.85 -9.34 38.16 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -97.99 117.3 32.03 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.656 0.741 . . . . 1.0 110.147 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.38 129.06 38.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.301 0.572 . . . . 1.0 110.085 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -128.9 150.37 50.39 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.66 0.743 . . . . 1.0 110.803 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -136.58 133.72 36.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.493 0.663 . . . . 1.0 110.341 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -92.71 142.52 27.26 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -127.69 129.37 47.03 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.62 0.724 . . . . 1.0 112.517 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.469 ' O ' ' NE2' ' A' ' 48' ' ' GLN . . . -151.71 177.97 29.29 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.378 -1.089 . . . . 1.0 110.378 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 66' ' ' ILE . 71.5 m -149.96 156.06 41.06 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 122.047 -0.679 . . . . 1.0 111.193 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.421 ' N ' HG22 ' A' ' 65' ' ' THR . 38.4 mm -77.68 115.29 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.269 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.4 tp -73.3 -44.28 59.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.707 0.765 . . . . 1.0 110.154 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -150.15 147.87 28.26 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.63 -0.507 . . . . 1.0 109.63 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -132.04 110.05 10.45 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.97 0.89 . . . . 1.0 111.494 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -124.84 94.57 4.22 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.355 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -40.15 130.46 2.16 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.935 -0.575 . . . . 1.0 112.533 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 42.93 54.57 4.71 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.194 0.598 . . . . 1.0 112.432 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.0 t -163.46 -71.06 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.716 -0.615 . . . . 1.0 112.192 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 94.8 mt -138.0 136.31 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 121.511 0.672 . . . . 1.0 111.448 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.571 HD13 ' N ' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -135.83 120.28 18.08 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.429 -0.805 . . . . 1.0 110.328 178.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.571 ' N ' HD13 ' A' ' 75' ' ' LEU . 7.3 tt0 -133.37 138.75 46.45 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.474 0.654 . . . . 1.0 110.34 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -149.46 150.86 33.02 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.944 0.878 . . . . 1.0 111.922 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.2 p -85.33 152.29 23.39 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.511 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 45.8 t-80 -148.77 136.82 20.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.686 0.755 . . . . 1.0 111.986 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -138.04 144.31 40.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.918 -1.037 . . . . 1.0 110.31 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.476 0.84 0 CA-C-N 115.746 -0.661 . . . . 1.0 110.767 179.318 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.2 t30 . . . . . 0 N--CA 1.466 0.367 0 N-CA-C 112.587 0.588 . . . . 1.0 112.587 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -101.55 172.09 7.18 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.519 0.676 . . . . 1.0 112.0 -178.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -140.66 162.75 34.65 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.849 0.833 . . . . 1.0 111.342 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.2 p -106.62 131.23 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 115.057 -0.974 . . . . 1.0 109.677 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.1 t -96.51 131.41 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.238 0.542 . . . . 1.0 110.679 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.1 t -121.82 120.76 35.5 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.604 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.6 mm -110.3 131.77 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.591 -0.731 . . . . 1.0 110.414 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.406 ' C ' HD12 ' A' ' 100' ' ' LEU . 91.7 m -124.09 120.42 32.32 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.391 0.615 . . . . 1.0 110.288 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.406 HD12 ' C ' ' A' ' 99' ' ' THR . 9.6 mp -115.31 131.61 56.87 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 122.119 0.961 . . . . 1.0 110.772 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.42 ' OG1' ' CG ' ' A' ' 108' ' ' GLU . 32.0 p -133.45 128.83 36.3 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.076 -0.966 . . . . 1.0 110.337 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -84.57 108.82 17.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.13 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 106' ' ' GLY . 25.8 mt -91.79 170.76 9.63 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.072 0.463 . . . . 1.0 110.482 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -63.87 -39.03 93.25 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.452 0.538 . . . . 1.0 112.452 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -84.08 -33.35 24.41 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.298 0.571 . . . . 1.0 110.728 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 103' ' ' LEU . . . -175.86 -139.06 3.01 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.8 p -134.22 139.27 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.437 0.637 . . . . 1.0 110.79 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.42 ' CG ' ' OG1' ' A' ' 101' ' ' THR . 19.0 pt-20 -105.49 142.02 35.97 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.463 -0.789 . . . . 1.0 109.768 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -124.06 139.33 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.716 0.769 . . . . 1.0 110.408 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -135.76 132.08 36.33 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.349 0.595 . . . . 1.0 110.77 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 tt -128.41 134.73 48.86 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.073 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 75.6 p -131.29 150.57 52.09 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.654 0.74 . . . . 1.0 111.357 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -146.14 108.92 4.54 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.278 -0.874 . . . . 1.0 110.053 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -82.38 -170.19 2.81 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.646 0.736 . . . . 1.0 112.521 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.9 t30 62.25 36.71 14.6 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.737 1.014 . . . . 1.0 113.737 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -81.44 122.12 27.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.597 -1.261 . . . . 1.0 107.597 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -65.23 -36.25 83.58 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 120.999 -1.063 . . . . 1.0 111.839 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.418 HG23 ' H ' ' A' ' 121' ' ' GLU . 1.6 t -151.08 168.48 24.48 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.17 0.509 . . . . 1.0 111.042 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -57.53 -36.67 71.89 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -58.39 -41.9 85.86 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.418 ' H ' HG23 ' A' ' 118' ' ' THR . 78.6 tt0 -70.43 -39.72 74.21 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.932 -0.48 . . . . 1.0 110.213 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.482 HE21 ' C ' ' A' ' 6' ' ' ILE . 53.2 tt0 -64.01 -48.91 74.49 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.729 -0.841 . . . . 1.0 108.729 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -59.35 -46.84 87.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -57.81 -39.55 77.85 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.1 t -67.78 -56.09 10.55 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.647 -0.501 . . . . 1.0 109.647 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -54.29 -44.03 71.57 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.13 -39.22 91.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.008 0.432 . . . . 1.0 109.951 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -69.91 -51.28 34.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.188 0.518 . . . . 1.0 110.146 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -62.59 -39.18 92.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -57.71 -40.26 79.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.0 m -61.59 -39.51 91.43 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -65.81 -48.21 72.48 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 133' ' ' LEU . 4.2 mm? -61.0 -41.51 96.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.372 -0.603 . . . . 1.0 109.372 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -64.99 -41.39 95.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.78 -35.65 87.17 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.472 ' O ' HD13 ' A' ' 136' ' ' LEU . 0.2 OUTLIER -70.83 -48.32 54.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.199 0.523 . . . . 1.0 109.971 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -59.02 -43.91 91.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.931 -0.396 . . . . 1.0 109.931 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.99 -41.99 98.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.713 0.292 . . . . 1.0 110.775 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -71.66 -45.86 60.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.222 0.534 . . . . 1.0 110.755 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.528 HD13 ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -65.09 -45.66 84.31 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.859 -179.328 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -73.45 -1.62 19.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.105 0.479 . . . . 1.0 109.767 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -61.41 -37.34 83.12 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.272 -0.268 . . . . 1.0 110.445 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.1 pttt . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.74 0.305 . . . . 1.0 111.291 -179.957 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 108.531 -0.914 . . . . 1.0 108.531 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -168.16 -164.2 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.743 0.306 . . . . 1.0 110.262 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt -55.38 145.63 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.704 0.764 . . . . 1.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -82.53 -161.65 0.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.738 -0.601 . . . . 1.0 111.108 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.7 mp -71.48 144.15 49.78 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.702 0.763 . . . . 1.0 111.399 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.87 129.36 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 121.451 0.643 . . . . 1.0 110.892 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.42 134.14 33.92 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.933 -0.479 . . . . 1.0 110.386 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -142.51 138.13 30.71 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.041 0.448 . . . . 1.0 110.684 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.4 m -140.8 156.13 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.147 0.499 . . . . 1.0 110.611 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -159.46 143.48 14.9 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 122.055 -0.403 . . . . 1.0 111.207 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 t -147.54 145.26 29.01 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.244 0.545 . . . . 1.0 111.361 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.6 t -84.05 112.35 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.318 0.58 . . . . 1.0 110.635 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.7 mm -115.07 130.14 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.822 0.82 . . . . 1.0 110.74 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -94.02 95.91 9.34 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.95 -0.469 . . . . 1.0 110.02 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.45 155.73 7.37 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.58 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -61.97 145.94 96.54 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.392 2.061 . . . . 1.0 112.212 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.403 HG23 ' N ' ' A' ' 18' ' ' GLU . 10.3 tp -62.8 -38.0 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.125 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.403 ' N ' HG23 ' A' ' 17' ' ' ILE . 79.8 mm-40 -54.48 -56.44 18.72 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.933 -0.479 . . . . 1.0 112.068 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -64.62 -41.78 95.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.935 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.3 t -65.6 -48.5 82.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -57.83 -42.61 84.73 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.29 -47.13 86.53 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 122.072 -0.392 . . . . 1.0 110.235 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.82 -28.74 66.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.636 0.255 . . . . 1.0 111.609 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.7 tp -72.97 -43.24 62.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 1.0 111.645 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.42 79.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 121.545 0.688 . . . . 1.0 110.992 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.748 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -160.72 113.41 1.34 Allowed Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.498 178.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.575 ' N ' HD22 ' A' ' 26' ' ' ASN . 55.5 Cg_endo -69.79 -15.26 36.89 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.885 1.723 . . . . 1.0 112.373 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.748 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 44.9 tp10 -83.47 -49.79 8.93 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -69.16 -41.73 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 mm -59.66 -26.11 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -77.78 -30.89 51.57 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.062 -0.347 . . . . 1.0 110.062 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -56.44 -43.44 79.5 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.792 -0.447 . . . . 1.0 109.792 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -69.62 -33.91 73.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.964 0.412 . . . . 1.0 110.486 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.6 mmt -89.01 151.85 22.03 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.57 0.7 . . . . 1.0 111.123 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -61.53 -40.72 95.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.731 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.55 37.44 0.13 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.088 -0.577 . . . . 1.0 111.953 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.1 m -74.6 128.93 36.78 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.663 0.744 . . . . 1.0 110.82 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.1 m -94.46 93.5 7.69 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.731 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.5 t -92.59 128.74 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.402 0.62 . . . . 1.0 110.4 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.63 129.03 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 121.346 0.593 . . . . 1.0 110.456 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.545 ' HG ' ' HE1' ' A' ' 43' ' ' TRP . 38.4 p -155.21 157.94 38.11 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.222 -0.445 . . . . 1.0 111.306 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -97.35 -18.01 19.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.872 0.844 . . . . 1.0 108.78 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.545 ' HE1' ' HG ' ' A' ' 41' ' ' SER . 2.8 m0 67.27 44.91 1.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.24 0.616 . . . . 1.0 111.607 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -150.17 157.97 43.67 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.443 0.64 . . . . 1.0 111.433 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -52.71 130.23 31.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.8 0.81 . . . . 1.0 112.267 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.62 3.8 90.36 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 115.713 -0.676 . . . . 1.0 112.082 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.2 t -71.83 134.09 45.9 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.282 -0.54 . . . . 1.0 111.608 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -81.38 148.85 29.12 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.463 HD11 ' HE1' ' A' ' 51' ' ' TRP . 20.2 tt -134.62 133.8 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.547 0.689 . . . . 1.0 111.353 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.8 t -134.72 140.15 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.599 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.463 ' HE1' HD11 ' A' ' 49' ' ' ILE . 24.0 m0 -118.72 131.32 56.13 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.179 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -99.88 140.28 34.32 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.319 0.58 . . . . 1.0 109.738 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.23 178.78 42.24 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 110.989 -0.845 . . . . 1.0 110.989 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -128.66 134.32 48.49 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.914 0.864 . . . . 1.0 110.118 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -135.65 116.78 14.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.323 0.582 . . . . 1.0 110.375 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt 52.92 40.25 30.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.33 0.586 . . . . 1.0 110.659 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.6 -8.3 15.07 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.682 -0.967 . . . . 1.0 110.682 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -97.74 115.57 28.24 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.435 0.636 . . . . 1.0 110.407 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.61 133.0 47.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.078 0.466 . . . . 1.0 110.216 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -136.4 154.12 50.9 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.721 0.772 . . . . 1.0 110.963 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -138.21 132.77 32.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.826 -0.624 . . . . 1.0 110.53 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -88.27 167.48 13.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.244 -0.65 . . . . 1.0 109.244 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -156.23 133.85 10.95 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.702 0.763 . . . . 1.0 112.663 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.95 -176.86 34.48 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.359 -1.096 . . . . 1.0 110.359 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 66' ' ' ILE . 90.8 m -147.19 156.69 43.18 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.951 -0.735 . . . . 1.0 111.102 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.445 ' N ' HG22 ' A' ' 65' ' ' THR . 42.9 mm -73.94 115.4 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.555 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.415 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 46.0 tp -67.02 -41.84 85.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.611 0.72 . . . . 1.0 110.164 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.499 HE21 HD21 ' A' ' 70' ' ' ASN . 64.7 tt0 -159.56 149.32 18.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.546 -0.538 . . . . 1.0 109.546 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -133.89 111.39 10.43 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.962 0.887 . . . . 1.0 111.54 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.499 HD21 HE21 ' A' ' 68' ' ' GLN . 12.5 m120 -119.66 104.68 10.48 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.327 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -41.16 122.95 1.93 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.358 0.599 . . . . 1.0 112.247 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 41.35 55.1 3.44 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.09 0.556 . . . . 1.0 112.436 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.7 m -157.91 -68.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.723 -0.611 . . . . 1.0 112.107 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.402 ' H ' ' HB2' ' A' ' 70' ' ' ASN . 91.4 mt -141.68 138.16 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-O 121.647 0.737 . . . . 1.0 111.509 -178.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 tp -133.33 125.85 30.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.29 -0.868 . . . . 1.0 110.687 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -132.52 138.92 47.68 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.238 0.542 . . . . 1.0 110.203 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.415 ' HA ' ' H ' ' A' ' 67' ' ' LEU . 49.8 p90 -150.75 143.94 24.81 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.939 0.876 . . . . 1.0 112.077 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 93.1 p -85.99 153.76 21.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.008 -1.108 . . . . 1.0 108.008 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.407 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 42.4 t-80 -147.47 142.29 26.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.732 0.777 . . . . 1.0 111.96 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -142.01 134.65 28.34 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.876 -1.056 . . . . 1.0 110.457 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.1 t -111.84 119.37 44.69 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.666 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -71.91 -20.0 26.32 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 121.375 1.383 . . . . 1.0 112.271 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.6 mt -59.49 -12.08 5.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.897 0.379 . . . . 1.0 110.346 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.4 p -64.87 -34.99 79.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.557 -0.292 . . . . 1.0 110.659 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.6 29.76 33.06 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.836 -0.906 . . . . 1.0 110.836 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -90.27 153.29 46.48 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 120.914 -0.314 . . . . 1.0 111.351 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.64 149.5 24.47 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 121.666 1.577 . . . . 1.0 111.679 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -44.97 97.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.591 0.71 . . . . 1.0 111.969 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.486 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 7.0 tp -152.09 89.91 3.9 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 121.954 -0.466 . . . . 1.0 110.367 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.488 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 51.5 Cg_exo -51.28 -27.92 24.86 Favored 'Trans proline' 0 N--CA 1.502 2.019 0 C-N-CA 122.45 2.1 . . . . 1.0 112.516 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.0 mp0 -69.2 -1.85 8.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.169 0.509 . . . . 1.0 110.322 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 89' ' ' LEU . 29.5 p30 -70.14 -23.04 62.94 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.421 0.526 . . . . 1.0 112.421 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 90' ' ' PRO . 30.1 p90 -108.99 178.07 4.58 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.469 0.652 . . . . 1.0 112.019 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.496 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.3 OUTLIER -135.4 163.12 30.76 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.936 0.874 . . . . 1.0 111.277 -179.297 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.4 p -103.31 131.64 51.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.028 -0.987 . . . . 1.0 109.673 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -97.53 134.0 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.025 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 t -125.6 121.31 33.23 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.704 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.1 mm -108.0 129.84 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.452 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.8 m -114.78 121.63 43.89 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.444 0.64 . . . . 1.0 109.953 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 70.8 mt -123.77 128.85 50.15 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.549 0.69 . . . . 1.0 110.907 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 69.5 p -135.55 144.39 46.21 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.37 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -99.79 108.09 20.3 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.456 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 106' ' ' GLY . 55.1 mt -96.12 171.53 8.55 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.04 0.448 . . . . 1.0 110.697 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.95 -42.62 99.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.247 0.462 . . . . 1.0 112.247 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -81.78 -32.55 31.32 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.099 0.56 . . . . 1.0 110.672 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 103' ' ' LEU . . . -176.69 -141.53 3.98 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.579 -1.008 . . . . 1.0 110.579 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 m -133.94 130.27 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.566 0.222 . . . . 1.0 111.179 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -92.46 141.98 27.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.336 0.589 . . . . 1.0 109.904 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.73 151.26 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.513 0.673 . . . . 1.0 110.396 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -151.77 135.1 16.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.107 0.479 . . . . 1.0 110.686 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 tt -125.21 126.23 44.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.956 -0.566 . . . . 1.0 109.928 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 m -120.78 144.68 48.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.421 0.629 . . . . 1.0 111.477 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.496 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 39.4 tt0 -143.79 130.22 19.96 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.507 -0.769 . . . . 1.0 110.141 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.442 ' O ' ' ND1' ' A' ' 94' ' ' HIS . 0.7 OUTLIER -105.23 -170.42 1.75 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.476 0.655 . . . . 1.0 112.467 -179.321 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.3 t30 63.46 38.0 10.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.655 0.983 . . . . 1.0 113.655 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -82.88 128.96 34.91 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -67.38 -41.31 85.26 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.083 -1.011 . . . . 1.0 111.83 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.454 ' OG1' ' N ' ' A' ' 119' ' ' GLU . 1.3 t -150.9 175.97 11.53 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.109 0.48 . . . . 1.0 111.079 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.454 ' N ' ' OG1' ' A' ' 118' ' ' THR . 96.5 mt-10 -59.19 -37.57 77.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.406 ' N ' ' CD ' ' A' ' 120' ' ' LYS . 13.0 mptt -59.57 -42.41 92.41 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -71.76 -39.78 69.75 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.919 -0.488 . . . . 1.0 109.97 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -63.33 -44.89 93.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -63.92 -43.1 96.92 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -59.95 -40.37 88.77 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 78.3 p -72.96 -46.9 49.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -57.08 -47.91 79.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.7 -0.481 . . . . 1.0 109.7 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.67 -37.37 87.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.44 ' O ' ' SD ' ' A' ' 132' ' ' MET . 42.3 t30 -65.27 -54.01 35.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 1.0 110.044 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.445 ' NE1' ' OE1' ' A' ' 113' ' ' GLN . 83.4 m95 -59.41 -36.83 76.58 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -59.27 -36.53 75.69 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.525 -0.917 . . . . 1.0 108.525 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.6 m -64.29 -43.08 95.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.994 -0.743 . . . . 1.0 108.994 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.509 ' N ' ' SD ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -63.18 -48.84 76.68 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.012 -0.736 . . . . 1.0 109.012 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 133' ' ' LEU . 4.2 mm? -62.47 -39.99 95.2 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -66.74 -41.73 87.38 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.37 -36.99 93.88 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.003 -1.239 . . . . 1.0 110.003 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.21 -43.87 77.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.434 0.635 . . . . 1.0 110.114 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -65.44 -39.34 91.95 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.071 -0.393 . . . . 1.0 110.153 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.7 tptt -62.01 -39.34 91.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.011 0.434 . . . . 1.0 111.246 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -75.81 -46.57 29.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.128 0.489 . . . . 1.0 110.323 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -64.59 -42.62 95.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.06 0.457 . . . . 1.0 111.097 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -75.8 -1.36 24.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.242 0.544 . . . . 1.0 109.866 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -60.14 -33.08 71.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.411 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -46.12 -20.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.221 -0.3 . . . . 1.0 111.097 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.77 -36.77 75.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.692 0.282 . . . . 1.0 110.359 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.6 m -59.11 -41.63 88.61 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.125 -0.359 . . . . 1.0 110.36 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 117.95 -1.024 . . . . 1.0 110.442 179.882 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.4 mtm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.69 -42.98 90.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.56 -0.291 . . . . 1.0 110.754 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.1 pt -143.71 165.2 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.72 0.771 . . . . 1.0 111.028 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -77.61 -167.76 1.03 Allowed 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.698 -0.626 . . . . 1.0 111.216 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.0 mp -75.09 143.79 43.24 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.605 0.717 . . . . 1.0 111.422 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.549 ' C ' HE21 ' A' ' 122' ' ' GLN . 93.5 mt -114.43 128.81 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.4 0.619 . . . . 1.0 111.201 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.69 143.43 44.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.041 0.448 . . . . 1.0 110.604 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -133.54 123.41 25.12 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.228 0.537 . . . . 1.0 111.011 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.7 m -141.76 140.08 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.24 0.543 . . . . 1.0 110.438 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -152.96 139.14 18.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.559 0.695 . . . . 1.0 110.902 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.5 t -147.04 145.43 29.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.996 -0.547 . . . . 1.0 111.022 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.4 t -93.44 124.51 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.32 0.581 . . . . 1.0 110.445 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 78.2 mt -129.43 131.34 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 121.453 0.644 . . . . 1.0 110.625 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -90.57 99.73 12.7 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.148 0.499 . . . . 1.0 110.263 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -169.31 153.55 5.41 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 118.894 -0.574 . . . . 1.0 111.487 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.98 146.75 78.45 Favored 'Trans proline' 0 N--CA 1.502 2.003 0 C-N-CA 121.295 1.33 . . . . 1.0 112.591 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.402 HG21 ' NE ' ' A' ' 72' ' ' ARG . 9.8 tp -65.48 -36.68 78.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.845 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -61.44 -50.77 71.46 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.812 -0.555 . . . . 1.0 111.753 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.97 -41.0 97.68 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.87 0.322 . . . . 1.0 111.87 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.1 t -66.17 -46.43 87.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 40.1 t-105 -59.8 -41.88 92.17 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.806 0.813 . . . . 1.0 109.07 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.48 -45.45 93.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.489 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.99 -31.86 65.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.026 0.441 . . . . 1.0 111.698 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.476 ' O ' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -71.72 -48.04 49.8 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.151 -0.343 . . . . 1.0 111.823 -179.113 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 m -112.07 77.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.871 0.843 . . . . 1.0 111.099 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.742 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -159.82 109.97 1.45 Allowed Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.49 179.203 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.518 ' N ' HD22 ' A' ' 26' ' ' ASN . 53.7 Cg_endo -67.34 -14.95 44.53 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 120.934 1.09 . . . . 1.0 112.33 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.742 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 83.1 tt0 -80.73 -50.9 9.29 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.358 -0.238 . . . . 1.0 110.358 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.79 -42.42 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.65 0.738 . . . . 1.0 109.209 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.8 mt -57.6 -41.93 80.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -64.53 -36.66 84.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 1.0 110.33 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -67.23 -32.07 72.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.94 0.4 . . . . 1.0 110.029 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -69.59 -34.18 73.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.947 0.403 . . . . 1.0 109.977 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.7 mmm -101.13 177.31 4.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.675 0.75 . . . . 1.0 110.941 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -64.43 -37.96 89.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.837 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.43 64.47 0.02 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.759 -0.536 . . . . 1.0 111.759 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -96.61 126.64 41.92 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.69 0.757 . . . . 1.0 110.704 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.8 p -78.34 92.5 4.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.86 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.2 t -95.52 131.56 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.275 0.56 . . . . 1.0 110.616 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -124.47 129.72 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 121.306 0.574 . . . . 1.0 110.419 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.561 ' HG ' ' HE1' ' A' ' 43' ' ' TRP . 60.3 p -153.54 150.94 29.22 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.314 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -94.38 -20.58 19.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.799 0.809 . . . . 1.0 109.018 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.561 ' HE1' ' HG ' ' A' ' 41' ' ' SER . 1.3 m0 68.76 46.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.896 -0.593 . . . . 1.0 111.363 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -148.86 156.33 42.17 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.562 0.696 . . . . 1.0 111.182 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -55.27 129.74 39.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.673 0.749 . . . . 1.0 112.184 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.2 -3.2 87.34 Favored Glycine 0 N--CA 1.469 0.841 0 CA-C-N 115.838 -0.619 . . . . 1.0 112.028 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.2 t -67.12 133.95 50.84 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.257 -0.555 . . . . 1.0 111.548 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -89.03 146.72 24.67 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.78 148.95 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.473 0.654 . . . . 1.0 111.328 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.57 155.16 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.461 -0.79 . . . . 1.0 110.7 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.538 ' CH2' ' NE2' ' A' ' 79' ' ' HIS . 14.7 m0 -128.54 123.17 32.79 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.234 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -89.93 140.48 29.58 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.865 -0.42 . . . . 1.0 109.865 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.68 173.82 42.06 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -121.76 128.41 51.72 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.752 0.787 . . . . 1.0 110.201 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 33.8 t90 -129.01 112.12 13.71 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.42 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 52.36 40.91 30.26 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.128 0.489 . . . . 1.0 110.655 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.63 -11.72 18.34 Favored Glycine 0 N--CA 1.468 0.793 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -96.41 116.93 29.85 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.208 0.527 . . . . 1.0 110.438 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.37 133.15 47.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.998 0.428 . . . . 1.0 110.251 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -132.57 152.91 51.45 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.615 0.721 . . . . 1.0 111.01 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -139.45 132.77 29.98 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.43 0.633 . . . . 1.0 110.592 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -87.67 168.11 13.29 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -153.64 129.37 10.1 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.677 0.751 . . . . 1.0 112.508 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.21 -179.48 31.28 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.24 -1.144 . . . . 1.0 110.24 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 66' ' ' ILE . 91.0 m -149.5 154.55 38.95 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.948 -0.737 . . . . 1.0 111.312 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.408 ' N ' HG22 ' A' ' 65' ' ' THR . 39.8 mm -77.71 122.58 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.59 0.71 . . . . 1.0 110.251 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 67' ' ' LEU . 3.8 mm? -86.13 -52.47 5.65 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.939 -0.573 . . . . 1.0 109.97 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -131.73 137.69 48.33 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.648 -0.501 . . . . 1.0 109.648 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -135.38 104.94 6.04 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.771 0.796 . . . . 1.0 111.482 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -124.46 93.59 3.95 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.25 122.04 3.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.852 -0.613 . . . . 1.0 112.049 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.402 ' NE ' HG21 ' A' ' 17' ' ' ILE . 67.8 ttt180 61.82 51.97 3.64 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.266 0.626 . . . . 1.0 111.784 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 t -169.62 -72.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.707 -0.621 . . . . 1.0 111.992 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 95.0 mt -137.04 133.8 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-O 121.626 0.727 . . . . 1.0 111.564 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.4 tp -136.16 124.99 24.0 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.353 -0.84 . . . . 1.0 110.296 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -135.24 141.87 45.86 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.184 0.516 . . . . 1.0 109.966 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -149.14 152.51 36.23 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.1 0.952 . . . . 1.0 112.144 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.8 p -94.32 150.92 19.83 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.538 ' NE2' ' CH2' ' A' ' 51' ' ' TRP . 1.2 m80 -152.42 144.99 24.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 122.0 0.905 . . . . 1.0 111.561 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -141.95 136.61 30.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.66 -1.155 . . . . 1.0 110.236 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.5 t -108.13 115.99 57.55 Favored Pre-proline 0 N--CA 1.476 0.849 0 CA-C-O 118.445 -0.788 . . . . 1.0 110.664 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.76 -18.22 28.67 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 120.991 1.127 . . . . 1.0 112.252 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.4 mt -72.07 -11.97 61.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.121 0.486 . . . . 1.0 110.355 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.7 m -65.01 -29.66 70.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.96 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.62 24.46 56.09 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -114.1 95.57 38.99 Favored Pre-proline 0 N--CA 1.475 0.806 0 CA-C-O 119.427 -0.321 . . . . 1.0 111.34 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 89' ' ' LEU . 73.8 Cg_exo -49.13 -178.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 121.93 1.754 . . . . 1.0 111.702 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -39.16 91.42 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.769 0.795 . . . . 1.0 112.233 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 87' ' ' PRO . 13.5 mt -136.15 89.09 20.54 Favored Pre-proline 0 N--CA 1.476 0.836 0 O-C-N 121.97 -0.457 . . . . 1.0 109.941 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.81 -18.18 12.0 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 C-N-CA 122.187 1.925 . . . . 1.0 112.427 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.476 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 80.9 mm-40 -87.06 -20.06 27.71 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.139 0.495 . . . . 1.0 110.47 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -76.19 -39.18 55.41 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.471 0.545 . . . . 1.0 112.471 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.58 172.28 8.02 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.641 0.734 . . . . 1.0 111.738 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.456 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.7 OUTLIER -145.69 169.42 18.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.619 0.723 . . . . 1.0 111.213 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.0 p -107.32 132.63 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.205 -0.907 . . . . 1.0 109.841 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.6 t -94.14 135.13 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.398 0.618 . . . . 1.0 110.961 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.0 t -126.7 123.79 38.31 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.515 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.6 mt -120.91 131.87 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.723 -0.672 . . . . 1.0 110.244 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 59.1 m -117.59 122.16 42.88 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.02 -0.536 . . . . 1.0 109.904 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.6 mt -115.93 124.84 51.58 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.463 0.649 . . . . 1.0 110.792 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 74.4 p -128.05 137.62 52.25 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.513 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -96.42 105.7 17.82 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.349 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.8 mt -92.15 170.21 10.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.11 0.481 . . . . 1.0 110.41 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -61.97 -41.3 97.85 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.442 0.534 . . . . 1.0 112.442 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -75.4 -40.21 58.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.417 0.627 . . . . 1.0 110.845 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.1 -140.33 3.13 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.7 p -125.18 134.17 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.445 0.64 . . . . 1.0 111.029 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -99.2 141.06 32.45 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.543 -0.753 . . . . 1.0 109.602 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.82 138.73 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 121.278 0.561 . . . . 1.0 110.521 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -142.93 131.73 22.73 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.447 0.641 . . . . 1.0 110.509 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tt -125.15 131.68 53.2 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.719 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.8 m -128.67 143.01 50.85 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.45 0.643 . . . . 1.0 111.235 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.456 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 33.7 tt0 -142.53 138.3 30.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.086 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 12.4 p-10 -111.99 -167.12 1.14 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.538 0.685 . . . . 1.0 112.32 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 91' ' ' GLU . 66.8 t30 60.73 37.52 18.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.758 1.021 . . . . 1.0 113.758 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -82.16 117.77 22.56 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.76 -1.2 . . . . 1.0 107.76 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -61.51 -39.87 92.57 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.011 -1.056 . . . . 1.0 111.866 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.6 p -144.78 168.31 20.51 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.923 -0.486 . . . . 1.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.46 -34.82 71.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.275 -0.639 . . . . 1.0 109.275 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.57 -40.88 93.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -69.44 -39.77 77.62 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.963 -0.461 . . . . 1.0 110.303 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.549 HE21 ' C ' ' A' ' 6' ' ' ILE . 50.6 tt0 -63.14 -47.82 81.12 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -59.93 -42.81 94.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -61.25 -39.05 88.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.333 -0.618 . . . . 1.0 109.333 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 62.4 m -68.03 -53.26 27.16 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.59 -44.91 73.43 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -62.55 -41.31 98.81 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -66.36 -54.0 29.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.02 0.438 . . . . 1.0 110.097 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.507 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 87.8 m95 -60.42 -39.42 87.34 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -59.44 -39.09 82.46 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.7 m -63.73 -41.98 97.96 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.507 ' SD ' ' CE3' ' A' ' 129' ' ' TRP . 79.0 mtp -64.93 -50.41 66.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.287 0.565 . . . . 1.0 109.617 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.02 -40.08 94.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -69.14 -39.46 78.81 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.078 -0.712 . . . . 1.0 109.078 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.36 -39.5 91.7 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 109.632 -1.387 . . . . 1.0 109.632 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.9 tt -65.9 -43.06 89.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.024 0.44 . . . . 1.0 110.033 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -61.69 -32.72 72.93 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -60.99 -37.99 84.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.982 0.42 . . . . 1.0 111.031 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -74.59 -49.93 19.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.422 0.63 . . . . 1.0 110.775 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.88 -42.66 99.85 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.785 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -75.37 -4.33 38.75 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.371 0.605 . . . . 1.0 110.253 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -62.12 -39.14 91.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.972 0.415 . . . . 1.0 110.449 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -61.69 -44.79 96.27 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.693 -0.231 . . . . 1.0 111.007 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.42 -44.02 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 120.8 0.333 . . . . 1.0 110.246 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.7 m -60.47 -41.1 93.49 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.032 -0.417 . . . . 1.0 110.359 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.572 0 CA-C-O 117.961 -1.019 . . . . 1.0 110.638 -179.923 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 tpt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -66.86 -36.61 82.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.499 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.642 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -143.37 175.51 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.465 0.65 . . . . 1.0 111.066 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -74.57 -156.3 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.479 0.657 . . . . 1.0 110.787 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.49 HD22 ' N ' ' A' ' 5' ' ' LEU . 3.9 mm? -75.47 142.18 42.97 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.867 0.842 . . . . 1.0 111.512 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.95 129.62 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.393 0.616 . . . . 1.0 111.035 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.78 136.57 36.02 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.034 -0.416 . . . . 1.0 110.648 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -145.13 145.05 31.24 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.226 0.536 . . . . 1.0 110.753 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.49 155.79 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.329 0.585 . . . . 1.0 110.429 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -154.37 134.06 12.87 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.252 0.548 . . . . 1.0 110.922 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 t -148.56 146.92 28.49 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.102 0.477 . . . . 1.0 111.256 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 m -99.06 131.36 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.378 0.608 . . . . 1.0 110.249 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.3 mt -130.68 132.16 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 121.875 0.845 . . . . 1.0 110.553 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -85.83 96.41 9.75 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.314 0.578 . . . . 1.0 110.224 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.95 157.93 4.27 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.622 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -61.36 144.44 98.4 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.257 1.971 . . . . 1.0 112.358 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.5 tp -64.84 -33.84 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.752 -0.658 . . . . 1.0 111.4 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -58.15 -50.26 74.13 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.901 -0.499 . . . . 1.0 111.914 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -65.21 -40.44 94.17 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.996 0.369 . . . . 1.0 111.996 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.3 t -66.33 -47.46 84.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -60.05 -43.43 95.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -58.26 -49.16 78.11 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.044 -0.41 . . . . 1.0 110.258 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.04 -32.77 64.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.752 0.279 . . . . 1.0 111.752 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.54 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.4 tt -67.7 -45.28 75.56 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.206 -0.309 . . . . 1.0 111.229 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 m -115.94 79.47 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.677 0.751 . . . . 1.0 111.383 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.772 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.2 OUTLIER -156.98 117.12 2.06 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.201 179.148 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.564 ' N ' HD22 ' A' ' 26' ' ' ASN . 70.8 Cg_endo -73.88 -5.3 16.81 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.344 1.363 . . . . 1.0 112.277 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.772 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 10.2 tm-20 -93.73 -52.39 4.47 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.209 -0.293 . . . . 1.0 110.209 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.88 -42.18 94.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.647 -0.872 . . . . 1.0 108.647 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.87 -40.18 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -66.14 -36.45 83.17 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.255 -0.278 . . . . 1.0 110.445 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -57.78 -36.64 72.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -68.91 -33.33 73.57 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.239 -0.282 . . . . 1.0 110.239 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 73.1 mmm -96.43 156.54 16.3 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.712 0.768 . . . . 1.0 110.906 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -61.58 -43.22 99.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.713 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.44 42.99 0.18 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 120.904 -0.665 . . . . 1.0 111.977 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.8 m -76.85 129.15 35.83 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.561 0.696 . . . . 1.0 110.58 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 48.7 m -93.05 92.07 7.64 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.693 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -99.03 132.64 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.441 0.639 . . . . 1.0 110.481 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.0 t -130.58 132.22 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.646 0.736 . . . . 1.0 110.264 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 m -156.09 166.68 32.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.565 . . . . 1.0 111.376 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -109.34 -19.67 13.2 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.98 0.895 . . . . 1.0 109.076 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.457 ' HE1' ' HD3' ' A' ' 27' ' ' PRO . 58.0 m95 58.23 56.32 4.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.795 -0.639 . . . . 1.0 111.76 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -152.4 156.83 40.29 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.418 0.628 . . . . 1.0 111.125 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -41.28 119.68 1.25 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.539 0.685 . . . . 1.0 112.422 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.04 11.2 84.72 Favored Glycine 0 N--CA 1.468 0.782 0 CA-C-N 115.918 -0.583 . . . . 1.0 112.065 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.1 t -72.26 130.46 40.85 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.3 -0.529 . . . . 1.0 111.523 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -87.45 150.47 23.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.747 -0.835 . . . . 1.0 108.747 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.9 pt -145.07 149.35 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.1 0.476 . . . . 1.0 111.107 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.6 m -143.51 154.53 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.782 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 10.3 m0 -129.2 131.72 47.16 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.34 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -91.57 139.69 30.45 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.45 172.71 39.45 Favored Glycine 0 N--CA 1.464 0.514 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -131.95 134.56 45.77 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.007 0.908 . . . . 1.0 110.231 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -138.3 118.04 13.16 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.374 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 52.92 37.1 23.49 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.112 0.482 . . . . 1.0 110.688 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.96 -6.06 44.29 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.932 -0.867 . . . . 1.0 110.932 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -97.15 112.51 24.26 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.346 0.593 . . . . 1.0 110.565 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.14 135.88 49.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.029 0.442 . . . . 1.0 110.239 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -141.26 155.89 45.95 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.642 0.734 . . . . 1.0 110.864 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 1.5 pm0 -136.27 133.83 37.39 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.388 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -86.91 144.5 26.94 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -133.88 128.13 33.99 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.502 0.668 . . . . 1.0 112.731 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.08 -177.24 30.01 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.293 -1.123 . . . . 1.0 110.293 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.414 HG22 ' N ' ' A' ' 66' ' ' ILE . 85.9 m -146.68 155.02 42.11 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.656 0.741 . . . . 1.0 111.056 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.414 ' N ' HG22 ' A' ' 65' ' ' THR . 50.7 mm -75.56 115.55 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.249 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.401 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 42.5 tp -69.93 -41.91 73.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.503 0.668 . . . . 1.0 110.111 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -152.07 147.8 26.92 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -132.52 104.08 6.5 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.989 0.899 . . . . 1.0 111.597 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -125.16 104.56 8.58 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -47.16 136.31 9.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.658 0.742 . . . . 1.0 111.98 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 36.91 53.72 1.14 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.666 -0.697 . . . . 1.0 112.552 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.5 t -161.12 -73.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.635 -0.666 . . . . 1.0 112.098 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.4 mt -136.89 131.82 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.464 0.65 . . . . 1.0 111.496 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.1 tp -136.98 124.97 22.77 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.525 -0.762 . . . . 1.0 110.333 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.02 144.53 32.32 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.409 0.623 . . . . 1.0 109.961 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.401 ' HA ' ' H ' ' A' ' 67' ' ' LEU . 46.6 p90 -150.04 154.88 38.91 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.816 0.817 . . . . 1.0 112.061 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.4 p -87.0 151.44 23.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.004 -1.11 . . . . 1.0 108.004 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.404 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 52.9 t-80 -146.08 144.37 29.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.925 0.869 . . . . 1.0 111.887 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -143.38 135.11 26.51 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.718 -1.128 . . . . 1.0 110.315 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.9 p -111.12 119.12 46.46 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-O 118.622 -0.704 . . . . 1.0 110.33 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.72 -17.84 29.13 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 120.999 1.133 . . . . 1.0 112.342 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 55.9 mt -60.33 -16.54 35.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.989 0.423 . . . . 1.0 110.321 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 49.3 p -65.43 -32.66 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.928 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.31 -6.82 49.66 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.819 -0.912 . . . . 1.0 110.819 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -91.83 152.57 43.22 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 119.26 -0.4 . . . . 1.0 111.363 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -49.39 144.24 18.55 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 121.037 1.158 . . . . 1.0 111.953 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -78.39 86.52 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.532 0.682 . . . . 1.0 111.643 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.4 mt -128.83 148.6 69.37 Favored Pre-proline 0 N--CA 1.479 0.988 0 O-C-N 121.944 -0.472 . . . . 1.0 111.104 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -46.28 -32.52 10.74 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 122.08 1.853 . . . . 1.0 112.845 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.77 -35.31 78.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.326 0.584 . . . . 1.0 110.572 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -69.66 -39.1 77.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.007 -0.542 . . . . 1.0 112.457 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 47.8 p90 -117.83 178.47 4.4 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.308 0.575 . . . . 1.0 112.246 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.19 167.25 21.01 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.058 0.932 . . . . 1.0 111.373 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 52.1 t -106.77 127.74 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 114.809 -1.087 . . . . 1.0 109.647 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.31 133.57 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.036 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.7 t -125.36 121.06 32.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.253 0.549 . . . . 1.0 110.657 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 75.7 mt -119.01 129.97 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.358 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 64.8 m -117.47 116.9 28.07 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.532 0.682 . . . . 1.0 109.957 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.3 mt -114.34 124.81 52.91 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.801 0.81 . . . . 1.0 110.812 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.5 m -138.31 143.36 39.93 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.325 -0.852 . . . . 1.0 110.49 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.03 123.98 38.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.266 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.8 mt -107.99 173.7 6.21 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.235 0.54 . . . . 1.0 110.332 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -61.7 -41.6 97.81 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.409 0.522 . . . . 1.0 112.409 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -74.2 -44.23 54.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.144 0.497 . . . . 1.0 110.779 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -172.55 -129.53 1.15 Allowed Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.892 -0.883 . . . . 1.0 110.892 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.3 t -128.81 133.9 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.539 0.685 . . . . 1.0 110.852 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -107.2 132.78 52.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.48 -0.782 . . . . 1.0 109.537 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.1 p -125.23 142.08 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.81 0.814 . . . . 1.0 110.25 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -140.03 135.12 32.34 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.567 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 tt -127.98 129.41 46.71 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.586 -0.733 . . . . 1.0 109.822 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.8 m -123.37 145.37 48.81 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.425 0.631 . . . . 1.0 111.379 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.419 ' OE1' ' NE1' ' A' ' 129' ' ' TRP . 37.6 tt0 -143.69 123.67 13.57 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.471 -0.786 . . . . 1.0 109.918 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -101.14 -167.62 1.45 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.392 0.615 . . . . 1.0 112.514 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.9 t30 59.58 38.38 22.23 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.455 0.909 . . . . 1.0 113.455 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -82.96 133.1 35.12 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.543 -1.28 . . . . 1.0 107.543 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -63.02 -43.34 98.99 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.045 -1.035 . . . . 1.0 111.977 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 119' ' ' GLU . 1.4 t -149.79 176.2 10.92 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.133 0.492 . . . . 1.0 110.884 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.422 ' N ' ' OG1' ' A' ' 118' ' ' THR . 95.1 mt-10 -58.81 -38.13 77.93 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -59.06 -40.09 84.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -70.42 -38.49 74.61 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.01 -0.431 . . . . 1.0 109.919 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -64.65 -47.06 79.88 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -61.81 -40.29 94.72 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.912 -0.773 . . . . 1.0 108.912 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -62.43 -39.95 94.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.44 -0.578 . . . . 1.0 109.44 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.7 m -71.69 -49.18 41.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 1.0 109.822 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -55.54 -47.36 76.45 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.28 -37.95 89.3 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.702 -0.481 . . . . 1.0 109.702 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -66.59 -54.55 22.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.135 0.493 . . . . 1.0 110.13 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.419 ' NE1' ' OE1' ' A' ' 113' ' ' GLN . 86.2 m95 -59.42 -37.37 77.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -56.78 -39.87 74.85 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.533 -0.914 . . . . 1.0 108.533 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.7 m -63.97 -41.17 97.62 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.73 -50.53 70.74 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.29 -38.63 90.09 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -67.35 -41.51 85.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.887 -0.783 . . . . 1.0 108.887 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.09 -40.57 98.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.026 -1.23 . . . . 1.0 110.026 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 64.9 tp -67.9 -42.63 80.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.372 0.606 . . . . 1.0 109.805 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.44 -44.25 95.06 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.102 -0.374 . . . . 1.0 110.477 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -61.3 -40.88 95.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.714 0.293 . . . . 1.0 110.728 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -66.38 -50.21 64.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.042 0.448 . . . . 1.0 110.637 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.502 ' O ' HD23 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -65.35 -42.44 92.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.547 -179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -76.92 -0.41 24.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.269 0.557 . . . . 1.0 110.186 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -61.54 -36.5 80.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.59 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 27.1 pttm -59.85 -37.71 80.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.682 0.277 . . . . 1.0 111.124 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.28 -44.18 99.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 122.264 -0.273 . . . . 1.0 110.324 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.4 m -59.16 -41.82 89.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.771 0.319 . . . . 1.0 110.449 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 117.928 -1.034 . . . . 1.0 110.51 -179.915 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 mtt . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -167.4 124.76 1.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.319 0.58 . . . . 1.0 110.278 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.699 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -144.95 179.1 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.684 0.754 . . . . 1.0 110.849 -179.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -73.21 -160.96 0.09 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.363 0.602 . . . . 1.0 111.019 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.8 mp -73.7 141.27 46.4 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.622 0.725 . . . . 1.0 111.583 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.565 ' C ' HE21 ' A' ' 122' ' ' GLN . 80.2 mt -116.78 129.21 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.917 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.28 146.15 37.02 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.998 -0.438 . . . . 1.0 110.69 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -138.08 127.03 24.04 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.906 0.384 . . . . 1.0 110.952 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.7 m -140.53 139.13 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.05 0.453 . . . . 1.0 110.507 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -153.37 135.49 14.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.954 0.407 . . . . 1.0 111.023 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.8 t -146.44 145.01 30.07 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.251 0.548 . . . . 1.0 111.173 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 12' ' ' VAL . 14.9 p -91.22 129.89 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.207 0.527 . . . . 1.0 110.545 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 75.7 mt -132.63 131.92 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.554 0.693 . . . . 1.0 110.4 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -89.36 95.19 10.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.287 0.565 . . . . 1.0 109.73 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.65 159.14 3.09 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 120.759 -0.376 . . . . 1.0 110.942 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.79 146.09 96.81 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 122.146 1.897 . . . . 1.0 112.521 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.2 tt -68.66 -29.84 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.72 0.771 . . . . 1.0 111.529 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -63.53 -48.17 78.63 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.909 -0.494 . . . . 1.0 112.16 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.02 -45.85 90.38 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.809 0.3 . . . . 1.0 111.809 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.44 -45.31 85.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 23.5 t-105 -56.46 -41.62 76.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -58.97 -45.56 90.22 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.043 -0.41 . . . . 1.0 110.342 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.78 -34.62 62.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.598 -0.273 . . . . 1.0 111.359 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.527 ' O ' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -70.42 -48.28 56.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.033 0.445 . . . . 1.0 111.796 -179.184 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.7 m -107.39 74.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.437 0.637 . . . . 1.0 110.83 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.752 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -162.13 113.62 1.16 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 119.053 -0.499 . . . . 1.0 110.636 179.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.602 ' N ' HD22 ' A' ' 26' ' ' ASN . 57.4 Cg_endo -70.6 -18.38 33.09 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 121.812 1.675 . . . . 1.0 112.391 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.752 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 78.0 mm-40 -79.71 -46.93 16.17 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.645 0.259 . . . . 1.0 110.402 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -71.91 -42.13 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.938 -0.764 . . . . 1.0 108.938 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 mm -58.79 -41.51 82.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -69.43 -31.22 69.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.089 0.471 . . . . 1.0 110.181 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -60.86 -35.74 77.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.128 0.489 . . . . 1.0 110.043 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -69.1 -33.49 73.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.901 0.381 . . . . 1.0 110.034 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.8 mmm -98.05 162.62 13.13 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.824 0.821 . . . . 1.0 110.916 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -62.19 -41.21 98.13 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.749 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.85 42.27 0.14 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.106 -0.569 . . . . 1.0 111.924 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.7 m -70.16 128.37 36.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.378 0.609 . . . . 1.0 110.994 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.4 m -92.56 92.36 8.01 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.16 -0.337 . . . . 1.0 110.872 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.72 135.36 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 121.374 0.607 . . . . 1.0 110.483 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.2 p -126.96 137.45 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.27 0.557 . . . . 1.0 110.589 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.5 p -154.21 155.23 34.88 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.106 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -94.69 -20.04 19.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 122.121 0.962 . . . . 1.0 108.933 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.44 ' HE1' ' HD3' ' A' ' 27' ' ' PRO . 1.5 m0 72.16 45.56 0.38 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.422 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 pttt -153.34 153.44 32.6 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.768 -0.582 . . . . 1.0 111.447 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -50.38 132.01 24.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.736 0.779 . . . . 1.0 112.361 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.68 -6.44 83.44 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-N 115.873 -0.603 . . . . 1.0 112.034 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.1 m -65.14 137.11 57.43 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.188 -0.595 . . . . 1.0 111.885 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -88.77 150.25 23.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.7 pt -138.65 147.91 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-O 121.34 0.591 . . . . 1.0 111.355 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.3 t -143.77 141.32 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.617 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.451 ' CZ3' ' NE2' ' A' ' 79' ' ' HIS . 18.4 m0 -118.11 137.63 52.81 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.081 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -100.98 134.4 44.03 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.09 0.471 . . . . 1.0 109.968 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.12 173.71 37.6 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -125.99 134.56 51.44 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.636 0.731 . . . . 1.0 110.193 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -138.24 115.29 10.9 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.48 0.657 . . . . 1.0 110.302 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt 52.71 38.07 25.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.62 -9.02 38.23 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 110.451 -1.06 . . . . 1.0 110.451 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -98.41 116.32 30.39 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.372 0.606 . . . . 1.0 110.749 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.3 129.08 38.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.253 0.549 . . . . 1.0 110.32 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -128.56 150.99 49.96 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.724 0.773 . . . . 1.0 110.944 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.437 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 1.2 pm0 -135.7 126.37 27.18 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.387 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -86.86 134.87 33.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.978 -0.749 . . . . 1.0 108.978 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -120.12 129.12 54.02 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.725 0.774 . . . . 1.0 112.53 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.14 175.52 30.03 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.35 -1.1 . . . . 1.0 110.35 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.1 m -144.41 151.99 40.03 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 122.07 -0.665 . . . . 1.0 111.33 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.7 mm -73.72 113.79 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.468 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.474 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -66.98 -51.25 57.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.612 0.72 . . . . 1.0 110.243 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -150.01 147.88 28.37 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.433 -0.581 . . . . 1.0 109.433 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -126.06 110.76 13.91 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.74 0.781 . . . . 1.0 111.351 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.403 ' C ' HD22 ' A' ' 70' ' ' ASN . 0.3 OUTLIER -126.25 91.47 3.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.295 -0.631 . . . . 1.0 109.295 179.08 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -36.73 128.84 0.83 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.189 0.518 . . . . 1.0 112.241 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 41.92 57.12 3.28 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.681 0.623 . . . . 1.0 112.681 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.5 t -165.1 -71.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.7 -0.625 . . . . 1.0 111.886 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.4 ' H ' ' HB3' ' A' ' 70' ' ' ASN . 91.2 mt -138.07 131.25 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.573 0.701 . . . . 1.0 111.629 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.1 tp -133.95 123.22 24.27 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.371 -0.831 . . . . 1.0 110.634 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -138.93 142.96 38.45 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.192 0.52 . . . . 1.0 110.113 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -152.84 155.7 37.61 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.678 0.751 . . . . 1.0 112.15 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.6 p -86.7 151.19 23.62 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.451 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 16.5 t-80 -146.56 138.44 24.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.869 0.843 . . . . 1.0 111.846 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.49 ' CD2' ' NZ ' ' A' ' 86' ' ' LYS . 37.3 t80 -138.1 127.55 24.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.813 -1.085 . . . . 1.0 110.529 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.5 t -139.95 125.13 11.44 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 118.913 -0.565 . . . . 1.0 110.64 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.45 -20.91 30.96 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 121.411 1.408 . . . . 1.0 112.212 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.7 mt -76.21 -3.38 36.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.121 0.486 . . . . 1.0 110.452 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.7 m -64.33 -22.37 66.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.787 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.33 -21.11 6.9 Favored Glycine 0 N--CA 1.473 1.16 0 N-CA-C 110.812 -0.915 . . . . 1.0 110.812 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.49 ' NZ ' ' CD2' ' A' ' 80' ' ' PHE . 56.3 pttt -76.9 147.12 76.94 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 121.093 -0.243 . . . . 1.0 111.432 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.9 -86.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.709 1.606 . . . . 1.0 111.837 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -145.57 80.18 1.59 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.794 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.2 tp -152.89 116.29 2.83 Favored Pre-proline 0 CA--C 1.552 1.023 0 O-C-N 121.888 -0.508 . . . . 1.0 110.772 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.536 ' O ' ' CD1' ' A' ' 93' ' ' TYR . 58.1 Cg_endo -73.8 -6.01 17.95 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 122.154 1.903 . . . . 1.0 112.381 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -81.74 -12.57 58.53 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.362 0.601 . . . . 1.0 110.598 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.417 ' C ' ' ND2' ' A' ' 115' ' ' ASN . 12.0 m120 -92.66 10.49 30.37 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.016 -0.538 . . . . 1.0 112.272 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.536 ' CD1' ' O ' ' A' ' 90' ' ' PRO . 0.1 OUTLIER -101.55 175.5 5.54 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.493 0.663 . . . . 1.0 112.145 -179.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.563 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.3 OUTLIER -142.54 161.01 39.17 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.953 0.882 . . . . 1.0 111.172 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.0 t -106.24 114.08 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 115.025 -0.989 . . . . 1.0 109.455 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.4 m -82.69 139.92 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.097 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 t -130.2 129.8 43.85 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.303 0.573 . . . . 1.0 110.917 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.86 130.08 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.542 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 59.4 m -117.8 118.13 31.21 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.446 0.641 . . . . 1.0 109.989 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.0 mt -114.15 130.85 56.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.401 0.62 . . . . 1.0 110.894 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.438 ' OG1' ' CG ' ' A' ' 108' ' ' GLU . 30.0 p -135.07 128.34 32.07 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.639 -0.709 . . . . 1.0 110.587 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -88.67 111.83 22.4 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.03 0.443 . . . . 1.0 110.139 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 25.3 mt -96.35 175.74 6.31 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.297 0.57 . . . . 1.0 110.485 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.54 -40.71 96.1 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.384 0.512 . . . . 1.0 112.384 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -79.57 -40.77 28.68 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.003 0.521 . . . . 1.0 110.875 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -171.55 -143.18 3.94 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.8 p -129.13 132.77 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.039 0.447 . . . . 1.0 111.225 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.438 ' CG ' ' OG1' ' A' ' 101' ' ' THR . 12.4 pt-20 -98.62 144.59 27.74 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.65 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.59 135.37 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.242 0.544 . . . . 1.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -141.24 129.48 22.26 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.091 0.472 . . . . 1.0 110.592 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -124.63 140.72 52.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.142 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.1 m -132.54 144.39 50.39 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.501 0.667 . . . . 1.0 111.428 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.563 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 40.3 tt0 -143.43 139.36 29.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.872 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -114.41 -162.65 0.82 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.399 0.619 . . . . 1.0 112.309 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.417 ' ND2' ' C ' ' A' ' 92' ' ' ASN . 49.8 t30 58.54 35.56 24.67 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.641 0.978 . . . . 1.0 113.641 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -82.23 122.17 27.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.681 -1.229 . . . . 1.0 107.681 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.48 -40.44 93.14 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.01 -1.056 . . . . 1.0 111.79 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.1 p -145.58 171.58 14.49 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.839 -0.538 . . . . 1.0 111.065 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -57.17 -38.51 73.69 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -58.69 -41.21 85.71 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -69.84 -39.67 76.29 Favored 'General case' 0 C--N 1.33 -0.283 0 O-C-N 121.937 -0.477 . . . . 1.0 110.15 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.565 HE21 ' C ' ' A' ' 6' ' ' ILE . 50.2 tt0 -64.7 -45.14 87.87 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -62.73 -44.77 95.34 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.068 -0.716 . . . . 1.0 109.068 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -58.63 -40.12 82.46 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.7 m -72.14 -47.85 47.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.201 0.524 . . . . 1.0 109.67 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -55.68 -48.51 74.96 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -64.55 -37.37 87.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.036 0.446 . . . . 1.0 109.81 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -65.52 -56.5 12.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.943 0.401 . . . . 1.0 110.138 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.477 ' NE1' ' OE1' ' A' ' 113' ' ' GLN . 86.6 m95 -58.6 -39.23 79.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -54.68 -41.03 69.71 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.0 m -63.6 -41.56 98.32 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.624 0.726 . . . . 1.0 109.211 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.9 tpt -64.42 -51.51 62.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 133' ' ' LEU . 4.4 mm? -59.56 -41.24 89.68 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -68.16 -36.64 79.96 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.57 -41.57 99.6 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.011 -1.236 . . . . 1.0 110.011 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.47 -42.42 83.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.323 0.582 . . . . 1.0 110.099 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.4 -37.6 86.41 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.049 -0.407 . . . . 1.0 110.266 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -59.76 -38.51 82.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.975 0.417 . . . . 1.0 111.095 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -76.32 -44.91 34.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.282 0.563 . . . . 1.0 110.473 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 65.0 mt -64.8 -41.98 95.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.044 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.74 0.05 21.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.048 0.452 . . . . 1.0 109.838 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.35 -39.01 93.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.91 0.386 . . . . 1.0 110.604 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -61.1 -56.91 15.35 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.23 -0.294 . . . . 1.0 110.947 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.9 p -65.07 -38.43 82.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.751 0.31 . . . . 1.0 110.611 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.5 t -62.65 -42.73 99.77 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.144 -0.348 . . . . 1.0 110.403 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.043 -0.979 . . . . 1.0 110.334 -179.857 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttp . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.0 155.63 16.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.014 0.435 . . . . 1.0 110.149 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.493 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -63.82 168.71 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.376 0.608 . . . . 1.0 111.034 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -77.38 -161.86 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.68 -0.638 . . . . 1.0 111.046 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.3 mp -73.76 139.66 45.38 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.652 0.739 . . . . 1.0 111.376 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.53 ' C ' HE21 ' A' ' 122' ' ' GLN . 83.1 mt -113.7 129.34 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.328 0.585 . . . . 1.0 111.009 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.68 141.33 39.44 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.062 0.458 . . . . 1.0 110.736 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -138.5 117.98 12.93 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.189 0.518 . . . . 1.0 110.976 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.78 155.91 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.072 0.463 . . . . 1.0 110.627 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -174.18 151.04 1.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.199 0.523 . . . . 1.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 t -145.6 145.43 30.97 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.364 0.602 . . . . 1.0 111.162 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.69 124.59 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.277 0.56 . . . . 1.0 110.542 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.4 mt -130.27 132.69 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 121.669 0.747 . . . . 1.0 110.541 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -87.86 96.49 10.49 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.402 0.62 . . . . 1.0 110.188 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.31 155.86 2.81 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 119.139 -0.458 . . . . 1.0 111.051 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.56 147.57 94.06 Favored 'Trans proline' 0 N--CA 1.506 2.217 0 C-N-CA 121.599 1.533 . . . . 1.0 112.528 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.2 tt -68.09 -26.34 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.187 0.518 . . . . 1.0 111.185 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -59.48 -49.89 76.03 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.885 -0.509 . . . . 1.0 111.604 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.436 ' CD ' ' N ' ' A' ' 19' ' ' LYS . 3.9 mptp? -65.48 -41.51 93.22 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.709 0.263 . . . . 1.0 111.709 -178.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.48 -48.25 81.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -57.45 -43.14 83.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.627 0.727 . . . . 1.0 109.224 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -58.28 -45.8 87.25 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.877 -0.515 . . . . 1.0 110.436 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.17 -35.43 64.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.957 0.408 . . . . 1.0 111.856 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.504 ' O ' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -66.84 -46.0 76.45 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.1 -0.375 . . . . 1.0 111.652 -179.21 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 m -112.98 79.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.794 0.807 . . . . 1.0 111.014 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.728 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -159.75 111.32 1.46 Allowed Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.416 179.152 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.525 ' N ' HD22 ' A' ' 26' ' ' ASN . 61.1 Cg_endo -71.41 -1.7 10.11 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.195 1.263 . . . . 1.0 112.503 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.728 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 81.3 mm-40 -96.86 -48.51 5.42 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 110.172 -0.307 . . . . 1.0 110.172 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -68.25 -43.03 84.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.223 -0.658 . . . . 1.0 109.223 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mm -61.03 -42.16 92.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -69.22 -31.13 69.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.046 0.45 . . . . 1.0 110.271 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -58.32 -42.99 87.96 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.812 -0.44 . . . . 1.0 109.812 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -69.37 -33.55 73.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.759 0.314 . . . . 1.0 110.163 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 66.6 mtt -89.12 152.01 21.88 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.684 0.754 . . . . 1.0 111.053 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -59.47 -46.97 87.26 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.697 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.9 48.92 0.22 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.064 -0.589 . . . . 1.0 111.975 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.6 m -82.33 111.26 18.23 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.77 0.795 . . . . 1.0 110.776 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.7 m -77.79 91.94 4.16 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.909 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -102.79 135.12 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.987 0.899 . . . . 1.0 110.5 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 m -128.27 138.75 53.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.55 0.691 . . . . 1.0 110.508 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.455 ' OG ' ' NE1' ' A' ' 43' ' ' TRP . 33.2 p -155.53 158.35 38.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.966 -0.561 . . . . 1.0 111.153 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 50.9 t0 -97.14 -23.63 16.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.89 0.852 . . . . 1.0 108.995 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.455 ' NE1' ' OG ' ' A' ' 41' ' ' SER . 1.5 m0 71.17 47.83 0.39 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.465 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.56 152.54 27.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.645 0.736 . . . . 1.0 111.206 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -48.91 131.35 18.64 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.746 0.784 . . . . 1.0 112.373 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.67 4.7 85.07 Favored Glycine 0 N--CA 1.47 0.956 0 CA-C-N 115.721 -0.672 . . . . 1.0 112.105 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.3 t -76.89 134.8 38.87 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.214 -0.58 . . . . 1.0 111.539 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 64' ' ' GLY . 66.0 tp60 -81.11 146.2 30.7 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.76 -0.83 . . . . 1.0 108.76 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.02 134.58 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.577 0.703 . . . . 1.0 111.348 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 p -140.21 150.25 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.399 -0.819 . . . . 1.0 110.395 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -128.45 137.2 51.71 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.085 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -104.47 129.87 52.43 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.304 0.573 . . . . 1.0 109.693 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.66 -179.32 29.81 Favored Glycine 0 N--CA 1.464 0.519 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -134.34 134.59 41.95 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.835 0.826 . . . . 1.0 110.117 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 35.0 t90 -140.71 124.46 17.1 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.252 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm 52.5 36.18 19.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.179 0.514 . . . . 1.0 110.704 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.53 -6.06 26.02 Favored Glycine 0 N--CA 1.464 0.535 0 N-CA-C 110.746 -0.942 . . . . 1.0 110.746 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -98.88 115.63 29.29 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.346 0.593 . . . . 1.0 110.4 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.25 133.59 47.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.09 0.471 . . . . 1.0 110.197 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -136.69 154.2 50.68 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.543 0.687 . . . . 1.0 110.851 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -136.46 133.57 36.75 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.437 0.637 . . . . 1.0 110.695 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -90.6 167.65 12.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -158.07 133.77 9.05 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.459 0.647 . . . . 1.0 112.369 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 48' ' ' GLN . . . -160.43 -174.68 30.54 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.41 -1.076 . . . . 1.0 110.41 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 66' ' ' ILE . 35.2 m -146.36 155.98 43.0 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.961 -0.729 . . . . 1.0 111.194 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.416 ' N ' HG22 ' A' ' 65' ' ' THR . 38.8 mm -75.89 119.78 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.336 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 tp -77.25 -48.94 16.18 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.621 0.724 . . . . 1.0 110.224 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -140.76 151.21 44.27 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.729 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -146.46 99.97 3.29 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.509 0.671 . . . . 1.0 111.367 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -125.46 106.88 10.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -38.27 133.17 0.98 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.531 0.681 . . . . 1.0 112.417 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 37.19 53.76 1.25 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.759 -0.655 . . . . 1.0 112.524 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.3 m -152.92 -66.87 0.16 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.793 -0.567 . . . . 1.0 111.862 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 74' ' ' ILE . 7.1 tt -150.47 138.73 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.11 0.481 . . . . 1.0 111.517 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.561 HD13 ' N ' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -130.25 122.24 27.66 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.827 -0.624 . . . . 1.0 109.705 178.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.561 ' N ' HD13 ' A' ' 75' ' ' LEU . 74.6 mt-30 -133.61 136.68 45.01 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.961 0.41 . . . . 1.0 110.271 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.441 ' CD1' ' ND1' ' A' ' 79' ' ' HIS . 19.9 p90 -148.06 156.85 43.1 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.056 0.931 . . . . 1.0 111.994 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 92.4 p -101.25 151.43 21.87 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.488 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.9 m80 -153.19 153.16 32.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.698 0.761 . . . . 1.0 111.736 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -143.32 133.18 23.99 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.873 -1.058 . . . . 1.0 110.4 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.2 t -105.43 116.61 59.95 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-O 118.741 -0.647 . . . . 1.0 110.512 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.88 -18.07 24.89 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 120.985 1.123 . . . . 1.0 112.234 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.4 mt -62.9 -7.42 5.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.013 0.435 . . . . 1.0 110.319 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.0 p -65.32 -32.32 73.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.84 12.97 68.6 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -91.34 150.29 41.11 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 121.203 -0.199 . . . . 1.0 111.296 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.07 -179.72 2.34 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 121.87 1.713 . . . . 1.0 111.5 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.1 p-10 -53.82 88.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.763 0.792 . . . . 1.0 112.028 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.7 mt -133.03 88.61 36.28 Favored Pre-proline 0 N--CA 1.475 0.78 0 O-C-N 121.955 -0.466 . . . . 1.0 109.933 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.08 -34.57 68.71 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 122.365 2.044 . . . . 1.0 112.644 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.34 -4.09 13.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.286 0.565 . . . . 1.0 110.431 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -68.59 -37.33 79.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.482 . . . . 1.0 112.095 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 33.9 p90 -100.1 177.16 5.16 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.686 0.755 . . . . 1.0 112.011 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.491 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.1 OUTLIER -132.18 160.76 35.14 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.277 1.037 . . . . 1.0 111.089 -179.331 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.7 t -102.6 114.6 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 114.709 -1.132 . . . . 1.0 109.613 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.38 135.64 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.956 -0.565 . . . . 1.0 111.118 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 t -126.22 122.42 35.53 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.335 0.588 . . . . 1.0 110.773 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.1 mm -105.56 128.19 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.453 -0.794 . . . . 1.0 110.243 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.3 m -117.46 126.52 52.76 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.014 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.6 mt -129.13 125.58 37.43 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.649 0.738 . . . . 1.0 110.778 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 64.5 p -129.7 129.45 44.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.47 -0.786 . . . . 1.0 110.506 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -91.59 107.96 19.57 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.156 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.1 mt -96.94 172.81 7.63 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.183 0.516 . . . . 1.0 110.441 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -61.7 -40.0 93.47 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.255 0.465 . . . . 1.0 112.255 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -77.03 -42.15 39.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.22 0.534 . . . . 1.0 110.882 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.75 -141.99 3.75 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.7 p -129.6 134.07 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.361 0.6 . . . . 1.0 111.205 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -99.18 144.62 28.11 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.813 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -131.74 141.35 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.867 0.841 . . . . 1.0 110.501 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -146.95 134.08 20.46 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.562 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -121.7 128.88 52.3 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.873 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.9 m -119.74 141.49 49.38 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.525 0.679 . . . . 1.0 111.243 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.491 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 39.4 tt0 -143.08 126.25 16.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.953 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.425 ' O ' ' ND1' ' A' ' 94' ' ' HIS . 7.7 p-10 -103.03 -170.14 1.75 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.705 0.764 . . . . 1.0 112.257 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.1 t30 62.59 37.78 12.81 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.604 0.964 . . . . 1.0 113.604 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -82.37 121.67 27.0 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.641 -1.244 . . . . 1.0 107.641 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -63.56 -41.82 98.4 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.933 -1.104 . . . . 1.0 111.902 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.4 p -144.71 172.28 13.22 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.874 -0.516 . . . . 1.0 110.854 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.72 -38.8 86.32 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.26 -0.644 . . . . 1.0 109.26 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -58.11 -40.84 82.25 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -70.34 -38.32 74.82 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.991 -0.443 . . . . 1.0 110.211 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.53 HE21 ' C ' ' A' ' 6' ' ' ILE . 51.8 tt0 -64.22 -47.57 79.18 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.72 -0.844 . . . . 1.0 108.72 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -60.53 -42.2 95.99 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -59.22 -38.66 80.49 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.7 t -71.39 -52.73 17.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -55.57 -47.06 77.04 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.933 -0.395 . . . . 1.0 109.933 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.48 -38.2 88.92 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -69.11 -52.84 24.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.278 0.561 . . . . 1.0 110.244 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -61.74 -38.01 86.37 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -58.06 -39.75 79.28 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.347 -0.983 . . . . 1.0 108.347 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.0 m -62.87 -38.36 90.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.906 -0.775 . . . . 1.0 108.906 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 40.9 tpp -67.62 -50.39 58.34 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.43 -41.7 97.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -69.1 -42.6 75.91 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.59 -37.29 94.51 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.012 -1.235 . . . . 1.0 110.012 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.2 tp -66.68 -41.63 87.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.298 0.57 . . . . 1.0 109.704 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -60.58 -36.24 78.05 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.053 -0.404 . . . . 1.0 109.952 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -61.51 -39.23 90.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.853 0.358 . . . . 1.0 110.784 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -73.2 -49.96 25.11 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.066 0.46 . . . . 1.0 110.788 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.13 -41.89 97.04 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.89 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -76.68 -1.51 28.17 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.128 0.489 . . . . 1.0 110.063 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -61.0 -38.74 87.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.768 0.318 . . . . 1.0 110.394 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -56.76 -39.96 74.95 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 122.3 -0.25 . . . . 1.0 110.849 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.56 -46.69 94.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.36 -0.237 . . . . 1.0 110.36 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.6 t -62.14 -42.58 99.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.847 0.356 . . . . 1.0 110.547 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.904 -1.046 . . . . 1.0 110.556 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 2' ' ' GLU . 67.0 mtt . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 1' ' ' MET . 75.4 mt-10 57.32 152.24 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.248 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.489 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -56.34 -179.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.59 0.71 . . . . 1.0 110.724 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -73.23 -168.79 0.55 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.756 -0.59 . . . . 1.0 110.712 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.0 mp -73.94 139.57 44.98 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.809 0.814 . . . . 1.0 111.187 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.533 ' C ' HE21 ' A' ' 122' ' ' GLN . 75.5 mt -112.47 128.39 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.843 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.95 145.03 48.69 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.005 -0.434 . . . . 1.0 110.69 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -138.63 123.39 18.71 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.115 0.483 . . . . 1.0 111.026 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 m -141.72 152.15 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 121.172 0.51 . . . . 1.0 110.462 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -166.96 143.11 4.4 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.99 -0.444 . . . . 1.0 111.101 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.426 HG23 ' HZ1' ' A' ' 137' ' ' LYS . 1.3 t -147.1 146.11 29.84 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.641 0.734 . . . . 1.0 111.343 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p -107.27 132.63 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 115.89 -0.596 . . . . 1.0 110.798 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 tp -142.67 150.69 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.467 0.651 . . . . 1.0 110.759 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -87.04 95.3 9.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.521 0.677 . . . . 1.0 109.856 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.62 149.78 5.37 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.12 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.75 147.74 92.35 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 121.769 1.646 . . . . 1.0 112.484 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.75 -29.74 44.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.818 -0.628 . . . . 1.0 111.38 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.402 ' HG2' ' HE ' ' A' ' 72' ' ' ARG . 95.4 mt-10 -55.37 -53.2 59.15 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.972 -0.455 . . . . 1.0 111.726 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' CD ' ' N ' ' A' ' 19' ' ' LYS . 3.9 mptp? -67.48 -40.45 85.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 1.0 111.686 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.0 t -66.77 -48.71 79.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.706 -0.85 . . . . 1.0 108.706 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -55.95 -42.1 75.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.876 0.846 . . . . 1.0 109.208 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -58.76 -45.79 88.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.486 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.58 -29.12 67.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.726 0.298 . . . . 1.0 111.755 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.522 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.2 tt -67.55 -44.65 77.79 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.344 -0.222 . . . . 1.0 111.222 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.4 m -118.3 79.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 121.87 0.843 . . . . 1.0 111.476 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.737 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.2 OUTLIER -157.09 115.99 2.0 Allowed Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.717 179.253 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.552 ' N ' HD22 ' A' ' 26' ' ' ASN . 73.9 Cg_endo -73.27 -5.71 17.62 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 121.176 1.251 . . . . 1.0 112.349 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.737 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 80.6 mm-40 -94.12 -45.86 7.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.61 -0.268 . . . . 1.0 110.345 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 64.6 mt -72.53 -42.21 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.7 mt -60.6 -42.38 91.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.22 -29.36 70.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 1.0 110.327 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -55.22 -43.4 74.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -69.98 -33.67 72.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.365 . . . . 1.0 110.337 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 76.2 mmm -85.61 152.22 23.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.65 0.738 . . . . 1.0 110.888 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.65 -42.34 98.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.745 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.85 46.81 0.13 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.821 -0.704 . . . . 1.0 111.908 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.2 m -86.12 125.95 33.86 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.762 0.791 . . . . 1.0 110.768 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.3 m -87.55 95.86 10.19 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.717 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.9 t -92.84 127.6 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-O 121.174 0.511 . . . . 1.0 110.656 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 40' ' ' VAL . 13.4 p -127.26 125.53 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.304 0.573 . . . . 1.0 110.466 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.6 t -158.24 153.42 25.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.508 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -97.15 -12.82 22.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.785 0.802 . . . . 1.0 108.928 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.415 ' HE1' ' HD3' ' A' ' 27' ' ' PRO . 64.0 m95 54.22 62.46 2.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.872 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.46 157.77 34.53 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.541 0.686 . . . . 1.0 110.988 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.83 117.33 4.88 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.129 0.49 . . . . 1.0 112.086 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.27 -13.01 55.2 Favored Glycine 0 N--CA 1.469 0.865 0 CA-C-N 116.304 -0.407 . . . . 1.0 112.163 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.3 m -76.42 138.54 40.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.391 0.615 . . . . 1.0 111.218 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -93.06 158.45 15.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.291 -0.868 . . . . 1.0 108.794 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.2 pt -144.77 149.51 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.512 0.672 . . . . 1.0 110.884 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.3 m -143.05 154.74 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.58 -0.737 . . . . 1.0 110.507 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 18.3 m0 -127.17 112.77 15.51 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.148 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.63 137.38 32.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.78 -171.51 31.11 Favored Glycine 0 N--CA 1.464 0.51 0 N-CA-C 111.088 -0.805 . . . . 1.0 111.088 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -126.12 131.87 51.99 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.854 0.835 . . . . 1.0 110.189 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -138.14 117.09 12.43 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.405 0.621 . . . . 1.0 110.263 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 54.37 38.37 29.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.587 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.34 -8.3 19.23 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 110.853 -0.899 . . . . 1.0 110.853 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -101.73 118.18 36.4 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.286 0.565 . . . . 1.0 110.556 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.99 129.98 41.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.11 0.481 . . . . 1.0 110.258 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -128.09 151.62 48.97 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.806 0.813 . . . . 1.0 110.811 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -135.11 129.71 34.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.698 0.761 . . . . 1.0 110.46 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -85.24 168.84 14.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.277 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -155.6 126.16 6.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.482 0.658 . . . . 1.0 112.358 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.17 178.37 32.73 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.401 -1.08 . . . . 1.0 110.401 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 90.3 m -145.48 154.24 42.01 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 122.029 -0.689 . . . . 1.0 111.282 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.83 114.45 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.294 0.569 . . . . 1.0 110.068 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.7 mt -77.26 -44.34 30.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.401 0.619 . . . . 1.0 110.086 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -151.24 149.39 29.36 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -138.63 112.63 8.52 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.602 0.715 . . . . 1.0 111.448 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.423 ' HB3' ' H ' ' A' ' 74' ' ' ILE . 47.6 t-20 -126.37 103.45 7.64 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.441 -0.577 . . . . 1.0 109.441 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.456 ' OE2' ' NH1' ' A' ' 72' ' ' ARG . 79.2 tt0 -46.43 129.69 10.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.493 0.663 . . . . 1.0 112.14 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.456 ' NH1' ' OE2' ' A' ' 71' ' ' GLU . 85.6 mtt85 42.58 55.91 4.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.852 -0.613 . . . . 1.0 112.549 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.7 t -167.2 -70.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.797 -0.565 . . . . 1.0 111.925 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.423 ' H ' ' HB3' ' A' ' 70' ' ' ASN . 87.8 mt -135.27 130.74 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.654 0.74 . . . . 1.0 111.497 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.8 tp -140.27 120.95 14.31 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.287 -0.87 . . . . 1.0 110.382 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -141.0 146.54 37.4 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.181 0.515 . . . . 1.0 110.259 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -151.68 158.17 43.07 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.884 0.849 . . . . 1.0 112.215 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 p -82.23 148.61 28.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -142.52 133.75 26.12 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.707 0.765 . . . . 1.0 111.84 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -144.42 133.41 22.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.013 -0.994 . . . . 1.0 110.548 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.4 p -142.52 131.54 11.88 Favored Pre-proline 0 N--CA 1.475 0.78 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.555 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 84' ' ' THR . 65.1 Cg_endo -71.86 -21.57 24.57 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 121.132 1.221 . . . . 1.0 112.317 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 64.6 mt -62.26 -1.58 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.092 0.473 . . . . 1.0 110.607 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 82' ' ' PRO . 21.7 p -67.16 -16.53 64.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.09 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.86 13.97 82.52 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.851 -0.9 . . . . 1.0 110.851 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.43 ' C ' ' H ' ' A' ' 88' ' ' ASP . 25.3 mtpp -144.91 81.29 10.8 Favored Pre-proline 0 N--CA 1.471 0.622 0 CA-C-O 119.104 -0.474 . . . . 1.0 111.113 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.77 21.91 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.589 1.526 . . . . 1.0 111.819 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 86' ' ' LYS . 96.9 m-20 -59.93 -179.71 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.945 0.878 . . . . 1.0 111.298 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.7 mt -42.7 149.69 0.47 Allowed Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 123.211 0.604 . . . . 1.0 111.337 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.431 ' C ' ' N ' ' A' ' 92' ' ' ASN . 59.3 Cg_exo -48.87 -36.53 34.21 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 121.35 1.367 . . . . 1.0 112.878 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -47.49 -17.29 0.08 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.532 0.682 . . . . 1.0 110.631 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.465 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 52.9 t30 -70.6 -7.72 46.25 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.927 -0.579 . . . . 1.0 112.409 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -99.61 176.83 5.34 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.271 0.558 . . . . 1.0 112.039 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -141.0 161.43 37.87 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 122.006 0.907 . . . . 1.0 111.199 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -106.94 130.17 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 114.943 -1.026 . . . . 1.0 109.62 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.41 131.85 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.747 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -124.3 121.89 36.24 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.341 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 60.8 mt -121.26 132.99 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.286 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.2 m -129.1 118.0 21.76 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.195 0.521 . . . . 1.0 110.451 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.3 mp -105.19 135.26 46.88 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.922 0.868 . . . . 1.0 110.598 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 74.0 p -129.79 131.21 46.13 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.19 -0.914 . . . . 1.0 110.575 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.01 108.34 20.41 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.175 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -96.19 166.79 11.57 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.12 0.486 . . . . 1.0 110.47 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -59.48 -40.47 87.07 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.313 0.486 . . . . 1.0 112.313 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -75.47 -39.83 58.15 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.058 0.543 . . . . 1.0 110.93 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.67 -140.1 3.11 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 p -133.09 138.92 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.63 0.728 . . . . 1.0 110.935 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -115.74 143.78 44.9 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.377 -0.829 . . . . 1.0 109.812 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.43 154.06 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.994 0.902 . . . . 1.0 110.229 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -145.07 134.78 23.46 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.676 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -131.58 146.4 52.19 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.928 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.5 p -142.63 151.91 41.94 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.577 0.703 . . . . 1.0 111.356 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -142.22 112.57 7.11 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.445 -0.798 . . . . 1.0 110.063 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -84.59 -169.71 2.76 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.457 0.646 . . . . 1.0 112.514 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 92' ' ' ASN . 43.2 t-20 56.85 39.42 29.55 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.561 0.948 . . . . 1.0 113.561 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -82.76 120.6 25.81 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.793 -1.188 . . . . 1.0 107.793 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -62.39 -38.03 88.05 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.869 -1.144 . . . . 1.0 111.873 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.7 t -149.3 168.96 21.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.272 0.558 . . . . 1.0 110.911 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -57.6 -37.65 73.59 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -57.4 -40.66 78.73 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.524 -0.547 . . . . 1.0 109.524 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -70.53 -39.14 74.22 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 121.906 -0.496 . . . . 1.0 110.043 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.533 HE21 ' C ' ' A' ' 6' ' ' ILE . 52.3 tt0 -64.53 -45.98 84.87 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.566 -0.902 . . . . 1.0 108.566 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -62.57 -41.48 98.96 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.102 -0.703 . . . . 1.0 109.102 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -60.28 -41.42 93.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.9 m -73.62 -48.17 34.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.13 0.49 . . . . 1.0 109.756 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -55.68 -50.48 70.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -62.47 -38.05 88.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -65.36 -51.98 56.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.074 0.464 . . . . 1.0 110.198 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.512 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 80.7 m95 -61.12 -39.78 91.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.539 -0.541 . . . . 1.0 109.539 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -58.18 -39.04 77.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.7 m -64.62 -42.31 95.59 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.512 ' SD ' ' CE3' ' A' ' 129' ' ' TRP . 81.5 mtp -64.2 -49.99 69.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.7 -40.47 95.14 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -62.17 -44.45 96.57 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.99 -0.744 . . . . 1.0 108.99 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.59 -34.01 82.71 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.295 -1.122 . . . . 1.0 110.295 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.47 ' O ' HD23 ' A' ' 136' ' ' LEU . 1.7 tt -66.86 -52.95 37.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.653 0.74 . . . . 1.0 109.906 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.426 ' HZ1' HG23 ' A' ' 11' ' ' THR . 45.6 mmtm -62.06 -36.82 82.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.433 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -59.94 -37.98 81.09 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.424 -0.173 . . . . 1.0 110.558 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -63.72 -48.85 75.4 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.183 -0.323 . . . . 1.0 110.541 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 140' ' ' LEU . 11.0 mp -66.73 -40.14 88.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.683 0.277 . . . . 1.0 110.546 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -70.24 -1.54 10.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.038 0.447 . . . . 1.0 110.128 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -66.35 -37.15 84.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.033 0.444 . . . . 1.0 110.663 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -62.15 -54.35 42.43 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.23 -0.294 . . . . 1.0 111.356 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.1 p -66.07 -38.1 81.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.79 0.328 . . . . 1.0 110.411 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.0 m -60.05 -41.23 91.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.814 0.34 . . . . 1.0 110.462 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.975 -1.012 . . . . 1.0 110.52 179.947 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.184 -0.673 . . . . 1.0 109.184 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -66.33 -38.93 88.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.53 -0.305 . . . . 1.0 110.557 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.531 ' O ' HD12 ' A' ' 3' ' ' ILE . 1.2 pp -137.39 165.92 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 122.226 1.012 . . . . 1.0 110.911 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -80.52 -172.57 3.65 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.706 0.765 . . . . 1.0 110.585 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.478 ' N ' HD12 ' A' ' 5' ' ' LEU . 10.4 mp -70.17 141.56 52.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.982 0.896 . . . . 1.0 111.444 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.0 mt -114.64 130.62 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 115.648 -0.706 . . . . 1.0 110.91 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.37 142.94 47.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.06 0.457 . . . . 1.0 110.645 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -135.97 115.76 13.05 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.875 0.369 . . . . 1.0 110.971 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.91 137.14 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 120.98 0.419 . . . . 1.0 110.612 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -155.39 144.09 20.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.996 0.427 . . . . 1.0 111.164 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 t -146.81 143.49 28.66 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.233 0.539 . . . . 1.0 111.401 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.2 t -85.18 126.56 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.334 0.588 . . . . 1.0 110.631 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.7 mt -130.18 133.36 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.63 0.729 . . . . 1.0 110.49 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -90.5 95.85 10.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.39 0.614 . . . . 1.0 109.813 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.45 156.25 2.26 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.926 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.06 146.95 92.55 Favored 'Trans proline' 0 N--CA 1.506 2.238 0 C-N-CA 122.018 1.812 . . . . 1.0 112.621 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.1 tt -68.47 -27.47 36.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.446 0.641 . . . . 1.0 111.466 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.44 ' OE2' ' NE ' ' A' ' 72' ' ' ARG . 71.4 mm-40 -62.03 -47.26 85.55 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.88 -0.513 . . . . 1.0 112.286 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -62.77 -46.31 88.63 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.993 0.368 . . . . 1.0 111.993 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 21' ' ' TRP . 19.0 m -69.18 -46.47 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.833 -0.803 . . . . 1.0 108.833 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.429 ' N ' HG23 ' A' ' 20' ' ' VAL . 58.1 t-105 -55.2 -50.51 69.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -60.74 -44.8 96.23 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.018 -0.426 . . . . 1.0 110.357 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.75 -21.48 28.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.468 -0.333 . . . . 1.0 111.755 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.03 -41.46 15.77 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.061 0.458 . . . . 1.0 111.555 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 m -108.14 75.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.308 0.575 . . . . 1.0 110.69 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.405 ' O ' ' CG1' ' A' ' 30' ' ' ILE . 0.2 OUTLIER -159.4 124.64 2.26 Favored Pre-proline 0 CA--C 1.548 0.867 0 CA-C-O 119.184 -0.436 . . . . 1.0 110.783 178.536 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.52 -11.62 20.55 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 121.805 1.67 . . . . 1.0 112.34 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -91.03 -47.74 7.38 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 110.269 -0.271 . . . . 1.0 110.269 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.91 -42.69 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.919 -0.771 . . . . 1.0 108.919 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.405 ' CG1' ' O ' ' A' ' 26' ' ' ASN . 5.4 mm -60.34 -42.14 89.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.271 -0.64 . . . . 1.0 109.271 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -64.5 -31.26 72.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.686 0.279 . . . . 1.0 110.357 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -65.24 -45.98 82.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -72.04 -34.07 68.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.089 0.471 . . . . 1.0 110.589 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.549 ' O ' ' N ' ' A' ' 36' ' ' GLY . 68.6 mmm -93.94 59.82 2.79 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.554 0.692 . . . . 1.0 111.098 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 38.03 -84.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.135 -0.484 . . . . 1.0 112.2 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 34' ' ' MET . . . -146.34 48.26 0.68 Allowed Glycine 0 N--CA 1.469 0.865 0 O-C-N 121.948 -0.47 . . . . 1.0 112.021 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.7 m -93.48 117.57 30.25 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.675 0.75 . . . . 1.0 110.712 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 51.9 m -83.19 124.72 30.8 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.708 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.88 145.05 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.374 0.607 . . . . 1.0 110.631 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.5 t -120.74 130.65 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.41 0.624 . . . . 1.0 110.428 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.6 t -152.34 131.28 12.55 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.085 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.408 ' OD2' ' NZ ' ' A' ' 44' ' ' LYS . 93.9 m-20 -75.68 -19.08 59.39 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.119 0.961 . . . . 1.0 109.387 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.1 m0 68.16 45.47 1.27 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.65 -0.705 . . . . 1.0 111.488 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.408 ' NZ ' ' OD2' ' A' ' 42' ' ' ASP . 25.0 pttm -148.44 156.43 42.47 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.46 0.647 . . . . 1.0 111.369 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -48.19 127.69 12.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.687 0.756 . . . . 1.0 112.385 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.79 1.97 89.78 Favored Glycine 0 N--CA 1.465 0.609 0 CA-C-N 115.722 -0.672 . . . . 1.0 112.044 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.0 t -64.89 132.58 49.78 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.301 -0.529 . . . . 1.0 111.75 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -83.02 143.69 30.45 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.2 mt -134.1 136.08 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.791 0.805 . . . . 1.0 110.944 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.7 t -128.58 142.1 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.213 -0.903 . . . . 1.0 110.632 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 20.8 m-90 -117.18 123.26 46.25 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.014 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -97.0 126.63 42.27 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.25 178.26 34.59 Favored Glycine 0 N--CA 1.461 0.32 0 N-CA-C 110.997 -0.841 . . . . 1.0 110.997 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -128.68 136.59 50.82 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.571 0.701 . . . . 1.0 110.163 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -138.53 117.7 12.65 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.038 0.447 . . . . 1.0 110.466 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? 53.57 38.71 28.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.348 0.594 . . . . 1.0 110.747 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.7 -8.37 21.36 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.516 -1.034 . . . . 1.0 110.516 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -98.83 116.56 31.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.107 0.479 . . . . 1.0 110.664 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.09 128.44 36.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.251 0.548 . . . . 1.0 110.247 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -129.96 150.45 51.23 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.618 0.723 . . . . 1.0 110.971 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -135.77 131.66 35.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.437 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -89.54 162.6 15.6 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -141.18 126.99 19.16 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.558 0.694 . . . . 1.0 112.424 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.66 170.56 31.16 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.333 -1.107 . . . . 1.0 110.333 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.7 m -146.51 153.73 40.74 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 122.054 -0.674 . . . . 1.0 111.243 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.4 mm -77.9 116.49 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.37 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.4 tp -76.13 -44.9 36.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.653 0.74 . . . . 1.0 110.065 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -145.4 148.44 33.34 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -136.3 105.51 6.0 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.843 0.83 . . . . 1.0 111.439 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -125.45 107.95 11.16 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.25 -0.648 . . . . 1.0 109.25 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.464 ' H ' ' CD ' ' A' ' 71' ' ' GLU . 56.3 mp0 -46.69 134.54 9.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.546 0.688 . . . . 1.0 111.969 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.44 ' NE ' ' OE2' ' A' ' 18' ' ' GLU . 14.4 ptp180 36.76 53.46 1.09 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.78 -0.645 . . . . 1.0 112.445 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 m -157.59 -69.9 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.822 -0.549 . . . . 1.0 111.618 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.6 mt -142.4 134.87 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-O 121.588 0.708 . . . . 1.0 111.535 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.6 tp -132.0 119.52 21.18 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.317 -0.856 . . . . 1.0 110.792 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.493 HE21 HG11 ' A' ' 95' ' ' VAL . 58.4 tt0 -133.54 138.3 46.0 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.257 0.551 . . . . 1.0 110.299 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -151.06 153.26 34.75 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.975 0.893 . . . . 1.0 112.073 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.8 p -84.59 151.79 24.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.253 -1.017 . . . . 1.0 108.253 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -149.84 137.32 19.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.632 0.73 . . . . 1.0 112.105 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -150.67 150.09 30.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.001 -0.999 . . . . 1.0 110.655 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.5 t -143.39 139.58 16.65 Favored Pre-proline 0 CA--C 1.549 0.91 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.612 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 84' ' ' THR . 48.6 Cg_endo -70.05 -20.63 33.22 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 121.603 1.535 . . . . 1.0 112.149 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.1 mt -58.21 -6.85 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.002 0.429 . . . . 1.0 110.332 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 82' ' ' PRO . 26.1 p -66.01 -18.62 65.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.958 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.4 22.77 72.34 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.535 -1.026 . . . . 1.0 110.535 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -145.16 149.93 43.49 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.462 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.52 153.46 77.09 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.863 1.708 . . . . 1.0 111.646 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.7 p-10 -50.97 105.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.359 0.6 . . . . 1.0 111.788 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 19.9 mt -138.75 150.95 67.53 Favored Pre-proline 0 N--CA 1.473 0.722 0 O-C-N 121.854 -0.529 . . . . 1.0 110.893 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.33 -22.87 59.59 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.693 2.262 . . . . 1.0 112.226 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -89.07 -9.39 51.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.278 0.561 . . . . 1.0 110.563 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -100.35 11.45 39.39 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.078 -0.51 . . . . 1.0 112.313 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.428 ' C ' ' CD1' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -151.26 170.58 19.16 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.405 0.621 . . . . 1.0 111.722 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.492 ' CE1' ' NE2' ' A' ' 113' ' ' GLN . 0.3 OUTLIER -144.68 160.67 40.82 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.761 0.791 . . . . 1.0 111.318 179.354 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.493 HG11 HE21 ' A' ' 76' ' ' GLN . 61.5 t -104.5 129.19 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 115.171 -0.922 . . . . 1.0 109.458 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.8 t -96.26 132.79 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.987 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -123.18 121.63 36.42 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.378 0.609 . . . . 1.0 110.612 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.1 mm -107.15 131.76 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.468 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.1 m -118.89 114.36 22.48 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.356 0.598 . . . . 1.0 110.115 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.4 mt -122.94 122.94 39.81 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.641 0.734 . . . . 1.0 110.829 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 m -131.29 132.39 44.51 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.491 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -85.28 123.42 30.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.043 0.449 . . . . 1.0 110.38 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.6 mt -93.21 -152.56 0.33 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.007 0.432 . . . . 1.0 110.508 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.555 ' CD ' ' H ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -77.7 -48.73 16.0 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.187 0.44 . . . . 1.0 112.187 -178.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -136.95 35.47 2.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.81 0.844 . . . . 1.0 110.001 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 179.21 169.14 39.3 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.915 -0.874 . . . . 1.0 110.915 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.8 p -127.07 133.08 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.04 0.448 . . . . 1.0 111.302 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -88.72 139.87 30.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.589 . . . . 1.0 109.741 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.77 138.7 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.536 0.684 . . . . 1.0 110.248 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -150.33 136.37 18.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.307 0.575 . . . . 1.0 110.513 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 tt -122.12 132.59 54.55 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.982 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.2 m -124.2 143.38 50.55 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.491 0.662 . . . . 1.0 111.419 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.492 ' NE2' ' CE1' ' A' ' 94' ' ' HIS . 43.1 tt0 -145.4 135.5 23.82 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.419 -0.81 . . . . 1.0 109.947 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -110.24 -165.25 0.98 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.474 0.654 . . . . 1.0 112.407 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.0 t30 60.01 37.16 21.39 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.751 1.019 . . . . 1.0 113.751 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -83.63 113.15 20.64 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.663 -1.236 . . . . 1.0 107.663 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -62.58 -35.77 80.55 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.006 -1.058 . . . . 1.0 111.584 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.0 p -143.89 164.91 29.21 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.877 -0.514 . . . . 1.0 111.067 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -58.66 -35.65 72.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.57 0.7 . . . . 1.0 109.23 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -58.66 -41.14 85.43 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.92 -0.582 . . . . 1.0 109.443 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -68.28 -41.45 80.99 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.981 -0.45 . . . . 1.0 110.084 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -64.16 -47.64 79.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -59.26 -42.93 92.3 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -63.32 -37.78 88.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 71.0 m -67.95 -54.51 18.1 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -52.6 -43.95 65.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.34 -0.391 . . . . 1.0 109.963 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -62.97 -39.44 94.7 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.758 -0.46 . . . . 1.0 109.758 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -67.39 -51.69 48.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.045 0.45 . . . . 1.0 110.175 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -64.05 -42.25 97.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -58.39 -39.79 80.6 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.628 -0.878 . . . . 1.0 108.628 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.2 m -63.94 -40.93 97.56 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.919 -0.771 . . . . 1.0 108.919 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 39.5 ttm -65.8 -50.39 64.82 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.7 -40.7 95.93 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -66.23 -44.21 84.45 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.16 -37.25 91.26 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.106 -1.198 . . . . 1.0 110.106 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 49.0 tp -71.44 -44.78 64.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.4 0.619 . . . . 1.0 110.072 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -60.87 -43.93 97.74 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.108 -0.37 . . . . 1.0 110.461 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.67 -36.29 76.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.69 0.281 . . . . 1.0 110.847 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -62.02 -48.5 80.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.215 0.531 . . . . 1.0 110.399 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.31 -37.18 84.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.653 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.88 -0.54 13.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.296 0.569 . . . . 1.0 110.152 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -62.41 -35.96 80.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.665 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -61.69 -54.05 47.82 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 122.388 -0.195 . . . . 1.0 110.864 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.21 -31.03 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 1.0 110.564 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.5 t -59.64 -44.13 93.62 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.152 -0.343 . . . . 1.0 110.446 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.579 0 CA-C-O 118.018 -0.991 . . . . 1.0 110.329 179.933 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.529 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -163.08 147.56 11.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.166 0.508 . . . . 1.0 109.946 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.663 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -144.07 -179.22 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-O 121.44 0.638 . . . . 1.0 110.951 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -75.8 -153.82 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.21 0.528 . . . . 1.0 110.805 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 5' ' ' LEU . 3.3 mm? -79.0 141.6 37.34 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.618 0.723 . . . . 1.0 111.57 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.9 mt -117.92 128.64 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.0 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.17 138.99 33.42 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.991 -0.443 . . . . 1.0 110.651 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -136.35 126.5 26.27 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.265 0.555 . . . . 1.0 111.01 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.52 156.15 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.053 0.454 . . . . 1.0 110.626 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -170.75 144.59 2.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.018 0.437 . . . . 1.0 111.013 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 t -147.09 145.15 29.52 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.365 0.602 . . . . 1.0 111.034 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 12' ' ' VAL . 13.5 p -90.03 128.6 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.245 0.545 . . . . 1.0 110.439 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.5 mt -131.77 135.37 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.724 0.773 . . . . 1.0 110.613 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -88.01 94.4 9.78 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.476 0.655 . . . . 1.0 110.052 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.68 156.65 2.19 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.683 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.93 149.64 90.14 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.208 1.939 . . . . 1.0 112.401 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.9 tt -68.93 -29.01 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.91 -0.586 . . . . 1.0 111.263 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.44 -54.23 43.56 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.953 -0.467 . . . . 1.0 111.859 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.46 -40.06 89.17 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.97 0.359 . . . . 1.0 111.97 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.7 t -66.11 -46.93 86.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 30.2 t-105 -58.08 -41.53 83.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.727 0.775 . . . . 1.0 109.01 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -60.67 -44.13 96.85 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.993 -0.442 . . . . 1.0 110.38 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.2 69.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.578 -0.283 . . . . 1.0 111.687 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.55 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.1 tt -70.2 -41.74 73.29 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.231 -0.293 . . . . 1.0 111.469 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 m -121.21 79.06 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 121.749 0.785 . . . . 1.0 111.149 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.66 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -160.75 103.19 1.31 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.228 179.138 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.439 ' N ' HD22 ' A' ' 26' ' ' ASN . 47.2 Cg_exo -54.08 -27.33 45.47 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.064 1.843 . . . . 1.0 112.791 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.66 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 96.2 mt-10 -70.12 -53.44 17.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.147 0.499 . . . . 1.0 110.533 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.04 -42.19 88.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.401 0.619 . . . . 1.0 109.334 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.1 mm -59.43 -42.49 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.003 -0.74 . . . . 1.0 109.003 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -69.93 -31.76 69.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.016 0.436 . . . . 1.0 110.4 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -57.39 -41.98 81.29 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -70.27 -34.1 72.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.848 0.356 . . . . 1.0 110.37 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.2 mmt -85.07 148.25 26.25 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.582 0.706 . . . . 1.0 111.052 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -60.67 -43.68 97.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.633 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.41 41.58 0.24 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.106 -0.569 . . . . 1.0 112.061 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.7 m -85.27 126.96 34.12 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.448 0.642 . . . . 1.0 110.675 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.1 m -92.71 106.33 18.32 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.954 0.407 . . . . 1.0 110.599 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.0 t -106.19 135.32 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.659 0.743 . . . . 1.0 110.484 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.2 m -129.73 130.96 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.512 0.672 . . . . 1.0 110.549 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.2 t -155.78 154.18 31.0 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.535 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -92.75 -18.77 22.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.854 0.835 . . . . 1.0 108.948 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 2.2 m0 66.68 46.84 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 1.0 111.409 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -149.76 157.19 42.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.576 0.703 . . . . 1.0 111.334 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -52.22 129.55 28.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.865 0.84 . . . . 1.0 112.296 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.04 1.68 90.37 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.648 -0.706 . . . . 1.0 112.172 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.0 t -68.17 133.41 48.85 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 122.305 -0.527 . . . . 1.0 111.589 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -79.46 144.58 33.9 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.9 tt -138.25 136.93 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.608 0.718 . . . . 1.0 111.205 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.2 m -140.56 151.58 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.542 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -124.36 131.54 53.51 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.238 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -94.16 137.17 33.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.515 0.674 . . . . 1.0 109.694 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.78 169.9 37.34 Favored Glycine 0 C--N 1.33 0.239 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.55 122.78 40.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.816 0.817 . . . . 1.0 110.017 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' A' ' 58' ' ' LYS . 43.1 t-105 -117.58 115.87 25.96 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.576 0.703 . . . . 1.0 109.913 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.432 ' HG2' ' CD1' ' A' ' 55' ' ' TRP . 9.5 ptmm? 40.07 46.33 1.8 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.89 -0.596 . . . . 1.0 111.548 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.15 -17.77 9.19 Favored Glycine 0 N--CA 1.472 1.045 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 55' ' ' TRP . 37.5 ttmt -91.22 114.78 27.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.404 0.621 . . . . 1.0 110.299 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.37 136.59 46.16 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.108 -0.37 . . . . 1.0 110.33 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -138.61 155.82 47.99 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.558 0.695 . . . . 1.0 110.948 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.446 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 1.5 pm0 -138.73 131.78 29.72 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.542 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -87.09 136.81 32.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -120.52 127.74 52.46 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.56 0.695 . . . . 1.0 112.478 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.95 178.79 33.18 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.362 -1.095 . . . . 1.0 110.362 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 66' ' ' ILE . 58.1 m -148.12 157.9 43.77 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.86 -0.788 . . . . 1.0 111.132 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.454 ' N ' HG22 ' A' ' 65' ' ' THR . 31.8 mm -73.39 115.54 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.506 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.402 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 38.3 tp -69.73 -44.34 70.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.363 0.602 . . . . 1.0 110.137 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -155.97 147.53 22.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -131.06 110.17 11.02 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.649 0.738 . . . . 1.0 111.597 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.39 95.36 4.44 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.338 -0.615 . . . . 1.0 109.338 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -40.78 131.76 2.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.388 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.6 mtm-85 40.38 55.04 2.86 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.5 m -163.37 -70.65 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.757 -0.589 . . . . 1.0 111.976 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.1 mt -140.88 133.97 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 121.491 0.662 . . . . 1.0 111.408 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 tp -136.19 126.31 26.23 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.377 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -142.97 146.43 33.92 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.114 0.483 . . . . 1.0 110.226 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.402 ' HA ' ' H ' ' A' ' 67' ' ' LEU . 29.5 p90 -150.26 155.03 38.94 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.142 0.973 . . . . 1.0 112.204 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 93.8 p -95.18 152.68 18.15 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.469 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -152.06 151.42 31.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.844 0.83 . . . . 1.0 111.554 -179.482 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -142.35 134.72 27.81 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.752 -1.113 . . . . 1.0 110.463 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.0 m -104.49 114.19 64.35 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-O 118.686 -0.673 . . . . 1.0 110.546 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.17 -18.25 23.85 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 120.945 1.097 . . . . 1.0 112.137 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.9 mt -60.51 -14.29 18.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.979 0.419 . . . . 1.0 110.379 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.2 p -65.35 -34.58 78.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.015 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.02 29.31 27.65 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.972 -0.851 . . . . 1.0 110.972 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -90.69 153.89 45.73 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 120.791 -0.363 . . . . 1.0 111.249 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.94 148.16 23.9 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 121.124 1.216 . . . . 1.0 111.964 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -45.13 101.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.693 0.758 . . . . 1.0 111.981 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.1 tp -152.38 91.42 3.6 Favored Pre-proline 0 CA--C 1.544 0.741 0 O-C-N 121.994 -0.441 . . . . 1.0 110.293 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.412 ' O ' ' CD1' ' A' ' 93' ' ' TYR . 65.4 Cg_exo -51.03 -32.98 40.91 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.064 1.843 . . . . 1.0 112.738 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.4 -3.77 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.267 0.556 . . . . 1.0 110.493 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.48 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 43.7 t30 -68.77 -35.45 77.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 1.0 112.292 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.469 ' CD2' ' O ' ' A' ' 79' ' ' HIS . 39.5 p90 -101.38 177.65 4.87 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.626 0.726 . . . . 1.0 112.053 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -134.96 162.5 32.27 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.892 0.853 . . . . 1.0 111.416 -179.316 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.6 p -101.3 129.86 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.012 -0.995 . . . . 1.0 109.8 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 t -94.76 133.5 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.9 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.4 t -128.75 121.96 29.56 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.494 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.15 132.4 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.35 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.3 m -111.88 124.63 52.79 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.421 0.629 . . . . 1.0 109.999 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 74.9 mt -125.51 117.67 24.12 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.428 0.632 . . . . 1.0 110.794 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.9 m -133.25 134.67 44.28 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.431 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -85.7 126.3 33.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.296 0.57 . . . . 1.0 110.29 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 47.7 mt -110.14 172.24 6.98 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.167 0.508 . . . . 1.0 110.589 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -64.54 -40.28 95.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.47 0.545 . . . . 1.0 112.47 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -83.73 -34.98 24.76 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.276 0.56 . . . . 1.0 110.875 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.25 -146.58 5.86 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.909 -0.876 . . . . 1.0 110.909 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.2 p -125.44 128.64 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.248 0.547 . . . . 1.0 111.016 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -95.81 142.15 28.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.611 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.3 m -130.14 148.7 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.622 0.725 . . . . 1.0 110.558 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -151.1 133.07 15.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.152 0.501 . . . . 1.0 110.514 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.6 tt -124.6 131.82 53.46 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.806 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.8 m -123.28 143.34 50.13 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.648 0.737 . . . . 1.0 111.142 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.438 ' OE1' ' ND2' ' A' ' 116' ' ' ASN . 0.9 OUTLIER -142.32 136.74 30.01 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.309 -0.86 . . . . 1.0 110.034 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 0.7 OUTLIER -114.23 -164.67 0.95 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.631 0.729 . . . . 1.0 112.334 -179.04 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 92' ' ' ASN . 64.4 t30 59.03 35.39 23.97 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.469 0.915 . . . . 1.0 113.469 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.438 ' ND2' ' OE1' ' A' ' 113' ' ' GLN . 83.5 m-20 -83.64 133.75 34.82 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.557 -1.275 . . . . 1.0 107.557 177.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -64.07 -46.17 85.49 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.028 -1.045 . . . . 1.0 112.066 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 62.0 p -147.79 179.71 7.51 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.843 -0.535 . . . . 1.0 110.835 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -60.39 -37.07 79.63 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -61.34 -43.96 98.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -71.32 -41.69 69.54 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.967 -0.458 . . . . 1.0 110.075 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.8 tm0? -63.24 -44.89 93.92 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -62.8 -42.82 99.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.698 -0.852 . . . . 1.0 108.698 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -59.57 -39.94 85.75 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 16.8 t -69.73 -44.75 69.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -56.01 -47.73 77.23 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.98 -39.15 91.21 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.787 -0.449 . . . . 1.0 109.787 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -64.28 -53.11 54.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 1.0 110.068 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.506 ' CE3' ' SD ' ' A' ' 132' ' ' MET . 86.5 m95 -60.61 -39.18 87.21 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -59.08 -39.89 83.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.396 -0.965 . . . . 1.0 108.396 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.4 m -63.5 -43.13 98.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.506 ' SD ' ' CE3' ' A' ' 129' ' ' TRP . 77.2 mtp -62.7 -50.7 70.07 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.497 -0.556 . . . . 1.0 109.497 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.54 -38.8 88.76 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.41 ' HA ' ' HZ3' ' A' ' 137' ' ' LYS . 78.8 tt0 -65.66 -34.04 77.28 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.68 -32.34 33.78 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.155 -1.178 . . . . 1.0 110.155 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.453 ' O ' HD23 ' A' ' 136' ' ' LEU . 1.7 tt -68.56 -54.13 18.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.641 0.734 . . . . 1.0 109.871 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.41 ' HZ3' ' HA ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -61.84 -27.0 68.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.534 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -56.36 -32.18 64.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.891 0.377 . . . . 1.0 110.613 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -79.22 -41.95 27.11 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.036 0.446 . . . . 1.0 110.7 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 140' ' ' LEU . 4.1 mm? -63.24 -41.87 99.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.838 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -75.74 -1.98 27.52 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.338 0.59 . . . . 1.0 110.231 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -63.5 -41.2 98.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.661 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -60.39 -56.47 21.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.748 0.308 . . . . 1.0 110.902 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.48 -43.52 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 110.155 -0.313 . . . . 1.0 110.155 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.9 m -60.51 -41.29 94.06 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.152 -0.343 . . . . 1.0 110.211 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.966 -1.016 . . . . 1.0 110.372 -179.961 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.439 ' O ' ' N ' ' A' ' 3' ' ' ILE . 79.1 mtp . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.41 ' N ' ' CD ' ' A' ' 2' ' ' GLU . 23.7 mp0 51.94 -88.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.549 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 1' ' ' MET . 39.1 pt -140.73 168.38 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.903 0.859 . . . . 1.0 110.931 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -74.9 -175.8 2.67 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.7 -0.625 . . . . 1.0 110.971 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.7 mp -68.2 140.2 56.08 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.03 0.919 . . . . 1.0 111.182 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.563 ' C ' HE21 ' A' ' 122' ' ' GLN . 5.1 mp -112.21 124.33 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.687 -0.688 . . . . 1.0 111.099 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.08 134.21 36.75 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.029 -0.42 . . . . 1.0 110.372 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -133.7 122.36 23.27 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.976 0.417 . . . . 1.0 110.804 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.3 m -139.89 135.59 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.099 0.476 . . . . 1.0 110.576 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -152.64 150.69 29.75 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.089 0.471 . . . . 1.0 111.033 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.479 HG23 ' NZ ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -145.87 142.39 28.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.541 0.686 . . . . 1.0 111.143 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 t -85.62 114.51 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.416 0.627 . . . . 1.0 110.715 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.9 mm -127.84 138.77 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 122.183 0.992 . . . . 1.0 110.733 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -98.04 105.93 18.15 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.397 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' A' ' 16' ' ' PRO . . . -173.24 160.6 3.46 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 120.977 -0.289 . . . . 1.0 110.416 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.436 ' HD2' ' HB1' ' A' ' 15' ' ' ALA . 26.0 Cg_endo -59.85 140.5 93.45 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.341 2.027 . . . . 1.0 112.135 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.1 tp -68.21 -32.87 57.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.649 0.738 . . . . 1.0 111.221 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -57.4 -52.39 65.58 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.886 -0.508 . . . . 1.0 111.859 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' CD ' ' N ' ' A' ' 19' ' ' LYS . 12.2 mptt -64.49 -42.91 95.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.986 0.365 . . . . 1.0 111.986 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.52 -47.54 91.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.46 ' CH2' ' O ' ' A' ' 70' ' ' ASN . 62.3 t-105 -60.23 -42.42 95.19 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -58.99 -47.39 85.34 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.977 -0.452 . . . . 1.0 110.206 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.79 -28.82 69.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.647 0.261 . . . . 1.0 111.702 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -70.56 -41.73 72.07 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.237 -0.289 . . . . 1.0 111.489 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 m -120.27 78.89 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 121.759 0.79 . . . . 1.0 111.226 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.773 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -158.63 113.22 1.66 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.56 179.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.578 ' N ' HD22 ' A' ' 26' ' ' ASN . 57.0 Cg_endo -68.99 -11.34 31.59 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.237 1.291 . . . . 1.0 112.649 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.773 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 45.6 mt-10 -86.28 -47.66 9.21 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.804 0.335 . . . . 1.0 110.332 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.1 mt -72.18 -41.46 66.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.295 -0.632 . . . . 1.0 109.295 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.31 -42.3 86.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -65.46 -31.26 72.24 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.292 -0.262 . . . . 1.0 110.292 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -56.6 -42.77 79.28 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.824 -0.435 . . . . 1.0 109.824 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -69.81 -33.8 72.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.942 0.401 . . . . 1.0 110.389 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 79.8 mmm -85.22 153.72 22.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.66 0.743 . . . . 1.0 110.816 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -62.56 -35.83 80.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.63 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.28 42.62 0.07 OUTLIER Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.017 -0.611 . . . . 1.0 111.943 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.2 m -85.8 125.73 33.48 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.601 0.715 . . . . 1.0 110.74 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.0 p -88.95 102.42 15.05 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.636 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.53 130.64 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.471 0.653 . . . . 1.0 110.419 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.05 128.42 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 121.408 0.623 . . . . 1.0 110.264 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.507 ' HG ' ' HD1' ' A' ' 43' ' ' TRP . 31.5 t -155.6 153.42 30.07 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.125 -0.488 . . . . 1.0 111.384 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 8.1 t0 -92.77 -20.61 20.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.945 0.879 . . . . 1.0 108.958 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.507 ' HD1' ' HG ' ' A' ' 41' ' ' SER . 2.6 m0 67.8 49.75 0.91 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.828 -0.624 . . . . 1.0 111.559 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -151.77 155.18 37.73 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.519 0.676 . . . . 1.0 111.186 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -49.64 127.41 15.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.794 0.807 . . . . 1.0 112.176 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.4 0.75 90.2 Favored Glycine 0 N--CA 1.468 0.833 0 CA-C-N 115.678 -0.692 . . . . 1.0 112.115 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.0 t -66.31 135.9 55.06 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.232 -0.57 . . . . 1.0 111.694 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 64' ' ' GLY . 68.0 tp60 -84.67 147.01 27.16 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.44 HD11 ' HE1' ' A' ' 51' ' ' TRP . 19.8 tt -136.91 136.15 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.539 0.685 . . . . 1.0 111.338 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -138.66 142.47 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 115.505 -0.77 . . . . 1.0 110.556 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.44 ' HE1' HD11 ' A' ' 49' ' ' ILE . 14.1 m0 -119.67 136.64 54.32 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.052 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -101.97 143.53 31.71 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.332 0.587 . . . . 1.0 109.578 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.41 175.41 43.68 Favored Glycine 0 C--N 1.329 0.167 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -125.53 127.01 45.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.97 0.89 . . . . 1.0 109.791 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.587 ' O ' ' N ' ' A' ' 58' ' ' LYS . 36.2 t-105 -120.34 119.17 32.33 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.384 0.612 . . . . 1.0 109.645 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.415 ' HG2' ' CD1' ' A' ' 55' ' ' TRP . 9.9 ptmm? 39.66 42.02 0.88 Allowed 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.346 0.594 . . . . 1.0 111.7 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.02 -18.01 19.12 Favored Glycine 0 N--CA 1.476 1.316 0 N-CA-C 110.768 -0.933 . . . . 1.0 110.768 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.587 ' N ' ' O ' ' A' ' 55' ' ' TRP . 74.4 mmtt -91.36 110.5 21.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.98 0.895 . . . . 1.0 110.655 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.03 132.15 47.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.65 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -134.38 152.56 51.87 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.612 0.72 . . . . 1.0 110.909 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.448 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 2.0 pm0 -138.03 136.07 36.5 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.497 0.665 . . . . 1.0 110.498 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -88.49 167.85 13.09 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -153.69 127.19 8.64 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.139 -0.624 . . . . 1.0 112.37 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.429 ' O ' ' NE2' ' A' ' 48' ' ' GLN . . . -153.78 178.23 30.84 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.399 -1.081 . . . . 1.0 110.399 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 66' ' ' ILE . 79.2 m -148.51 154.03 39.25 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.997 -0.708 . . . . 1.0 111.24 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.408 ' N ' HG22 ' A' ' 65' ' ' THR . 32.1 mm -80.4 121.95 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.403 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -90.97 -44.54 9.28 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.426 0.631 . . . . 1.0 109.964 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.672 HE21 ' ND2' ' A' ' 70' ' ' ASN . 58.5 tt0 -133.8 135.24 43.71 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.718 -0.475 . . . . 1.0 109.718 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -135.08 102.64 5.27 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.726 0.774 . . . . 1.0 111.516 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.672 ' ND2' HE21 ' A' ' 68' ' ' GLN . 82.6 m-20 -124.83 102.89 7.78 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.345 -0.613 . . . . 1.0 109.345 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -42.94 127.53 4.12 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.729 -0.668 . . . . 1.0 112.261 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 45.15 53.98 7.45 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.051 0.54 . . . . 1.0 112.352 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.7 t -160.05 -74.32 0.07 Allowed 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.782 -0.574 . . . . 1.0 112.027 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.5 mt -138.15 133.02 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.656 0.741 . . . . 1.0 111.374 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.1 tp -132.08 125.48 31.49 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.32 -0.855 . . . . 1.0 110.57 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.499 HE21 HG11 ' A' ' 95' ' ' VAL . 58.3 tt0 -135.13 136.71 42.12 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.452 0.644 . . . . 1.0 110.235 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -149.7 152.98 36.21 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.019 0.914 . . . . 1.0 112.0 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 p -86.94 151.07 23.62 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.152 -1.055 . . . . 1.0 108.152 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.413 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 15.2 t-80 -151.19 142.11 22.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.544 0.688 . . . . 1.0 111.939 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -144.91 148.65 34.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.048 -0.978 . . . . 1.0 110.351 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 74.8 m -122.25 118.85 28.8 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.63 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.58 -16.82 26.92 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 121.008 1.139 . . . . 1.0 112.354 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.2 mt -65.2 -12.19 48.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.948 0.404 . . . . 1.0 110.35 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.6 p -64.61 -33.04 74.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.791 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.1 3.8 32.22 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.648 -0.981 . . . . 1.0 110.648 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -88.25 150.11 46.35 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-O 119.352 -0.356 . . . . 1.0 111.398 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.34 141.45 18.85 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 121.163 1.242 . . . . 1.0 111.708 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -79.52 77.82 6.09 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.364 0.602 . . . . 1.0 111.642 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.427 ' H ' ' HB2' ' A' ' 92' ' ' ASN . 4.7 mp -115.79 161.27 31.45 Favored Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.936 -0.477 . . . . 1.0 110.778 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.29 -31.74 38.53 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 122.465 2.11 . . . . 1.0 112.626 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.442 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 80.9 mm-40 -86.47 -7.2 58.61 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.223 0.535 . . . . 1.0 110.44 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.427 ' HB2' ' H ' ' A' ' 89' ' ' LEU . 66.9 t30 -77.22 -10.14 59.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 1.0 112.227 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.59 173.2 12.94 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.616 0.722 . . . . 1.0 112.031 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -139.61 165.15 28.03 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 122.138 0.97 . . . . 1.0 111.19 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.499 HG11 HE21 ' A' ' 76' ' ' GLN . 59.2 t -107.28 128.9 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 114.829 -1.078 . . . . 1.0 109.657 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.0 t -92.82 134.13 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.919 -0.582 . . . . 1.0 111.14 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.9 t -132.03 124.78 29.97 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.51 0.671 . . . . 1.0 110.443 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.95 129.96 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.17 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.5 m -106.87 120.85 43.15 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.555 0.693 . . . . 1.0 109.831 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 mp -117.21 124.1 48.27 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.613 0.721 . . . . 1.0 110.816 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.7 p -131.02 134.08 46.35 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.824 0.821 . . . . 1.0 110.477 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -101.98 111.37 23.61 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.119 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.5 mt -77.76 -168.98 1.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.042 0.449 . . . . 1.0 110.464 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -64.47 -48.34 75.62 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.515 0.561 . . . . 1.0 112.515 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -137.48 38.5 2.46 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.407 0.683 . . . . 1.0 109.942 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.91 168.84 41.31 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.84 -0.904 . . . . 1.0 110.84 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.9 p -134.4 144.4 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.742 0.782 . . . . 1.0 110.776 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -120.27 143.03 48.54 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.698 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.0 m -129.91 149.98 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.643 0.735 . . . . 1.0 110.345 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -152.2 134.14 14.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.698 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.9 tt -119.98 131.05 55.04 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.365 0.603 . . . . 1.0 109.957 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 m -120.67 142.65 49.27 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.415 0.626 . . . . 1.0 111.265 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -145.52 136.63 24.77 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.462 -0.79 . . . . 1.0 110.046 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 10.9 p-10 -116.48 -171.09 1.94 Allowed 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.655 0.74 . . . . 1.0 112.341 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 91' ' ' GLU . 67.0 t30 65.01 38.76 6.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.627 0.973 . . . . 1.0 113.627 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -84.91 116.65 23.46 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 107.638 -1.245 . . . . 1.0 107.638 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -58.87 -36.92 75.41 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 120.954 -1.092 . . . . 1.0 111.773 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.6 p -140.96 163.6 32.52 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.872 -0.518 . . . . 1.0 111.045 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.1 -34.59 77.92 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -57.9 -38.94 76.73 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.535 -0.542 . . . . 1.0 109.535 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.49 -35.04 70.66 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.87 -0.519 . . . . 1.0 110.21 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.563 HE21 ' C ' ' A' ' 6' ' ' ILE . 54.9 tt0 -62.16 -47.72 83.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.792 -0.818 . . . . 1.0 108.792 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -60.23 -42.46 95.28 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.827 -0.805 . . . . 1.0 108.827 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -61.0 -38.38 85.84 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.6 t -68.42 -53.46 23.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.638 -0.505 . . . . 1.0 109.638 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -55.41 -45.46 76.71 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.999 -0.371 . . . . 1.0 109.999 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -62.76 -40.2 96.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -66.74 -51.6 54.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.373 0.606 . . . . 1.0 110.136 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -61.26 -35.68 77.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.495 -0.557 . . . . 1.0 109.495 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -59.69 -40.4 87.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.569 -0.9 . . . . 1.0 108.569 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.7 m -63.77 -43.01 97.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.252 -0.647 . . . . 1.0 109.252 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 83.4 mmm -61.42 -50.34 73.22 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.52 -40.35 94.32 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -62.8 -44.25 96.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.91 -41.94 86.93 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.224 -1.15 . . . . 1.0 110.224 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.517 ' O ' HD23 ' A' ' 136' ' ' LEU . 2.4 tt -63.03 -50.41 70.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.691 0.758 . . . . 1.0 110.179 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.479 ' NZ ' HG23 ' A' ' 11' ' ' THR . 1.0 OUTLIER -62.54 -36.86 83.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.229 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.68 -35.1 54.74 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 122.378 -0.201 . . . . 1.0 110.761 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -65.48 -51.06 62.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.915 0.388 . . . . 1.0 110.423 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.75 -41.05 88.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.488 -0.324 . . . . 1.0 110.905 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -68.58 -18.08 64.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.249 0.547 . . . . 1.0 109.935 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -48.7 -30.87 6.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 1.0 110.721 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -45.71 -25.29 0.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.722 0.296 . . . . 1.0 111.278 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 145' ' ' SER . 12.1 p -60.25 -42.44 90.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 O-C-N 122.255 -0.278 . . . . 1.0 110.454 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.455 ' N ' HG13 ' A' ' 144' ' ' VAL . 78.1 p -61.79 -35.0 76.89 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 122.117 -0.365 . . . . 1.0 110.419 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.969 -1.015 . . . . 1.0 110.488 -179.968 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.9 ttp . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.091 -0.707 . . . . 1.0 109.091 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.7 mp0 -66.23 -45.53 80.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.51 -0.314 . . . . 1.0 110.749 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.1 pt -138.45 148.84 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.757 0.789 . . . . 1.0 110.928 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -77.26 -165.23 0.55 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.771 -0.581 . . . . 1.0 111.059 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.3 mp -68.61 139.12 55.51 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.65 0.738 . . . . 1.0 111.306 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.482 ' C ' HE21 ' A' ' 122' ' ' GLN . 28.5 mm -110.0 124.81 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.934 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.31 136.31 42.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.956 0.407 . . . . 1.0 110.637 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -131.92 119.84 21.71 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.079 0.466 . . . . 1.0 110.935 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.9 m -143.95 136.29 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 121.095 0.474 . . . . 1.0 110.609 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -150.66 149.97 30.52 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.989 0.423 . . . . 1.0 111.305 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 t -146.98 144.56 29.27 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.404 0.621 . . . . 1.0 111.136 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.1 t -85.27 113.34 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.262 0.553 . . . . 1.0 110.586 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mm -110.51 126.83 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.682 0.753 . . . . 1.0 110.512 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -92.51 94.95 9.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.21 0.529 . . . . 1.0 109.806 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' HB1' ' HD2' ' A' ' 16' ' ' PRO . . . -171.62 169.7 2.91 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.806 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD2' ' HB1' ' A' ' 15' ' ' ALA . 27.2 Cg_exo -61.52 148.13 93.74 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 122.286 1.991 . . . . 1.0 112.477 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 tp -68.41 -36.25 74.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.17 0.509 . . . . 1.0 111.336 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -66.29 -48.46 70.32 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.878 -0.514 . . . . 1.0 112.084 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.13 -42.72 99.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.916 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.2 t -68.26 -45.6 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -59.47 -41.59 90.1 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.086 -0.709 . . . . 1.0 109.086 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -56.3 -43.22 78.67 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 122.044 -0.41 . . . . 1.0 110.367 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.43 -31.81 66.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.336 . . . . 1.0 111.669 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.515 ' O ' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -66.42 -45.88 78.41 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.766 0.317 . . . . 1.0 111.643 -179.066 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 m -116.5 82.01 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.585 0.707 . . . . 1.0 110.78 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.724 ' ND2' ' H ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -160.2 113.78 1.42 Allowed Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.491 179.15 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.556 ' N ' HD22 ' A' ' 26' ' ' ASN . 61.3 Cg_endo -71.94 -12.65 28.58 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 121.635 1.556 . . . . 1.0 112.362 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.724 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 50.0 mt-10 -86.43 -46.24 10.41 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.647 0.26 . . . . 1.0 110.453 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.7 mt -71.75 -43.36 70.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.5 mt -59.66 -43.08 90.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.03 -0.73 . . . . 1.0 109.03 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -70.9 -29.28 65.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.997 0.427 . . . . 1.0 110.353 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -57.25 -40.93 78.66 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -70.08 -33.52 72.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 1.0 110.249 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.413 ' CE ' ' OG1' ' A' ' 37' ' ' THR . 64.7 mtp -87.81 154.85 20.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.602 0.715 . . . . 1.0 111.167 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -60.75 -43.7 97.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.696 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.26 49.82 0.14 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.966 -0.635 . . . . 1.0 111.919 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.413 ' OG1' ' CE ' ' A' ' 34' ' ' MET . 88.8 m -81.94 128.87 34.51 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.73 0.776 . . . . 1.0 110.761 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.4 m -91.29 91.83 8.35 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.755 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p -103.93 134.1 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.702 0.763 . . . . 1.0 110.383 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.6 t -126.41 134.54 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.671 0.748 . . . . 1.0 110.409 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.1 t -155.45 143.37 19.9 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.386 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -81.92 -19.53 40.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.84 0.829 . . . . 1.0 109.098 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.2 m0 69.42 48.11 0.65 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.523 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -157.46 168.47 27.23 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.428 0.633 . . . . 1.0 111.195 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -58.68 127.63 33.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.689 0.757 . . . . 1.0 112.294 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.23 -1.42 84.51 Favored Glycine 0 N--CA 1.47 0.934 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.994 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.2 m -67.59 133.2 48.98 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.235 -0.568 . . . . 1.0 111.805 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 64' ' ' GLY . 68.0 tp60 -83.24 145.88 28.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.821 -0.807 . . . . 1.0 108.821 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.0 tt -136.83 137.35 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.457 0.646 . . . . 1.0 111.134 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.9 p -143.46 149.73 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.628 -0.715 . . . . 1.0 110.696 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.511 ' CZ3' ' NE2' ' A' ' 79' ' ' HIS . 9.6 m0 -124.55 140.45 52.93 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.039 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -103.61 137.46 41.64 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.099 0.476 . . . . 1.0 109.798 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.95 176.35 40.73 Favored Glycine 0 N--CA 1.46 0.27 0 N-CA-C 111.041 -0.824 . . . . 1.0 111.041 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -127.09 138.65 53.24 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.802 0.811 . . . . 1.0 110.19 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -143.16 117.43 9.58 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.285 0.564 . . . . 1.0 110.293 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 54.56 34.85 22.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.581 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.85 -9.34 38.16 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -97.99 117.3 32.03 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.656 0.741 . . . . 1.0 110.147 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.38 129.06 38.81 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.301 0.572 . . . . 1.0 110.085 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -128.9 150.37 50.39 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.66 0.743 . . . . 1.0 110.803 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -136.58 133.72 36.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.493 0.663 . . . . 1.0 110.341 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -92.71 142.52 27.26 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -127.69 129.37 47.03 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.62 0.724 . . . . 1.0 112.517 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.469 ' O ' ' NE2' ' A' ' 48' ' ' GLN . . . -151.71 177.97 29.29 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.378 -1.089 . . . . 1.0 110.378 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 66' ' ' ILE . 71.5 m -149.96 156.06 41.06 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 122.047 -0.679 . . . . 1.0 111.193 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.421 ' N ' HG22 ' A' ' 65' ' ' THR . 38.4 mm -77.68 115.29 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.269 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.4 tp -73.3 -44.28 59.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.707 0.765 . . . . 1.0 110.154 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -150.15 147.87 28.26 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.63 -0.507 . . . . 1.0 109.63 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -132.04 110.05 10.45 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.97 0.89 . . . . 1.0 111.494 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -124.84 94.57 4.22 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.798 -0.637 . . . . 1.0 109.355 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -40.15 130.46 2.16 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.935 -0.575 . . . . 1.0 112.533 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 42.93 54.57 4.71 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.194 0.598 . . . . 1.0 112.432 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.0 t -163.46 -71.06 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.716 -0.615 . . . . 1.0 112.192 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 94.8 mt -138.0 136.31 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 121.511 0.672 . . . . 1.0 111.448 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.571 HD13 ' N ' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -135.83 120.28 18.08 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.429 -0.805 . . . . 1.0 110.328 178.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.571 ' N ' HD13 ' A' ' 75' ' ' LEU . 7.3 tt0 -133.37 138.75 46.45 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.474 0.654 . . . . 1.0 110.34 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -149.46 150.86 33.02 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.944 0.878 . . . . 1.0 111.922 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.2 p -85.33 152.29 23.39 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.511 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 45.8 t-80 -148.77 136.82 20.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.686 0.755 . . . . 1.0 111.986 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -138.04 144.31 40.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.918 -1.037 . . . . 1.0 110.31 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.9 t -134.69 129.67 19.46 Favored Pre-proline 0 N--CA 1.476 0.84 0 CA-C-N 115.746 -0.661 . . . . 1.0 110.767 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 84' ' ' THR . 56.1 Cg_endo -71.38 -22.14 25.47 Favored 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 121.356 1.371 . . . . 1.0 112.29 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.4 mt -56.04 -6.53 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.448 . . . . 1.0 110.523 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 82' ' ' PRO . 3.6 t -64.4 -35.87 82.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.692 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 73.3 -1.02 44.71 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -98.7 146.1 31.05 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 119.273 -0.394 . . . . 1.0 111.451 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -46.97 160.09 0.28 Allowed 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 121.426 1.417 . . . . 1.0 112.016 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -76.74 86.37 3.36 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.721 0.772 . . . . 1.0 111.474 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.3 mt -117.01 146.05 37.05 Favored Pre-proline 0 N--CA 1.48 1.073 0 O-C-N 121.874 -0.516 . . . . 1.0 110.957 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.51 -20.28 60.67 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 122.216 1.944 . . . . 1.0 112.481 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.502 ' O ' ' ND2' ' A' ' 115' ' ' ASN . 98.0 mt-10 -87.07 -16.42 35.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.936 0.398 . . . . 1.0 110.31 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -71.36 -39.56 71.18 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.587 0.588 . . . . 1.0 112.587 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -101.55 172.09 7.18 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.519 0.676 . . . . 1.0 112.0 -178.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -140.66 162.75 34.65 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.849 0.833 . . . . 1.0 111.342 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.2 p -106.62 131.23 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 115.057 -0.974 . . . . 1.0 109.677 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.1 t -96.51 131.41 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.238 0.542 . . . . 1.0 110.679 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.1 t -121.82 120.76 35.5 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.604 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.6 mm -110.3 131.77 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.591 -0.731 . . . . 1.0 110.414 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.406 ' C ' HD12 ' A' ' 100' ' ' LEU . 91.7 m -124.09 120.42 32.32 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.391 0.615 . . . . 1.0 110.288 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.406 HD12 ' C ' ' A' ' 99' ' ' THR . 9.6 mp -115.31 131.61 56.87 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 122.119 0.961 . . . . 1.0 110.772 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.42 ' OG1' ' CG ' ' A' ' 108' ' ' GLU . 32.0 p -133.45 128.83 36.3 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.076 -0.966 . . . . 1.0 110.337 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -84.57 108.82 17.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.13 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 106' ' ' GLY . 25.8 mt -91.79 170.76 9.63 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.072 0.463 . . . . 1.0 110.482 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -63.87 -39.03 93.25 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.452 0.538 . . . . 1.0 112.452 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -84.08 -33.35 24.41 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.298 0.571 . . . . 1.0 110.728 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 103' ' ' LEU . . . -175.86 -139.06 3.01 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.8 p -134.22 139.27 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.437 0.637 . . . . 1.0 110.79 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.42 ' CG ' ' OG1' ' A' ' 101' ' ' THR . 19.0 pt-20 -105.49 142.02 35.97 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.463 -0.789 . . . . 1.0 109.768 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -124.06 139.33 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.716 0.769 . . . . 1.0 110.408 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -135.76 132.08 36.33 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.349 0.595 . . . . 1.0 110.77 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 tt -128.41 134.73 48.86 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.073 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 75.6 p -131.29 150.57 52.09 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.654 0.74 . . . . 1.0 111.357 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -146.14 108.92 4.54 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.278 -0.874 . . . . 1.0 110.053 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -82.38 -170.19 2.81 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.646 0.736 . . . . 1.0 112.521 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.502 ' ND2' ' O ' ' A' ' 91' ' ' GLU . 65.9 t30 62.25 36.71 14.6 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.737 1.014 . . . . 1.0 113.737 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -81.44 122.12 27.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.597 -1.261 . . . . 1.0 107.597 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -65.23 -36.25 83.58 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 120.999 -1.063 . . . . 1.0 111.839 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.418 HG23 ' H ' ' A' ' 121' ' ' GLU . 1.6 t -151.08 168.48 24.48 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.17 0.509 . . . . 1.0 111.042 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -57.53 -36.67 71.89 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -58.39 -41.9 85.86 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.418 ' H ' HG23 ' A' ' 118' ' ' THR . 78.6 tt0 -70.43 -39.72 74.21 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.932 -0.48 . . . . 1.0 110.213 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.482 HE21 ' C ' ' A' ' 6' ' ' ILE . 53.2 tt0 -64.01 -48.91 74.49 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.729 -0.841 . . . . 1.0 108.729 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -59.35 -46.84 87.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -57.81 -39.55 77.85 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.1 t -67.78 -56.09 10.55 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.647 -0.501 . . . . 1.0 109.647 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -54.29 -44.03 71.57 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.13 -39.22 91.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.008 0.432 . . . . 1.0 109.951 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -69.91 -51.28 34.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.188 0.518 . . . . 1.0 110.146 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -62.59 -39.18 92.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -57.71 -40.26 79.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.0 m -61.59 -39.51 91.43 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -65.81 -48.21 72.48 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 133' ' ' LEU . 4.2 mm? -61.0 -41.51 96.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.372 -0.603 . . . . 1.0 109.372 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -64.99 -41.39 95.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.78 -35.65 87.17 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.472 ' O ' HD13 ' A' ' 136' ' ' LEU . 0.2 OUTLIER -70.83 -48.32 54.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.199 0.523 . . . . 1.0 109.971 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -59.02 -43.91 91.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.931 -0.396 . . . . 1.0 109.931 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.99 -41.99 98.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.713 0.292 . . . . 1.0 110.775 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -71.66 -45.86 60.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.222 0.534 . . . . 1.0 110.755 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.528 HD13 ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -65.09 -45.66 84.31 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.859 -179.328 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -73.45 -1.62 19.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.105 0.479 . . . . 1.0 109.767 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 144' ' ' VAL . 15.1 t-20 -61.41 -37.34 83.12 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.272 -0.268 . . . . 1.0 110.445 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -46.55 -15.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.74 0.305 . . . . 1.0 111.291 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 145' ' ' SER . 12.1 p -60.35 -40.9 85.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 O-C-N 122.309 -0.244 . . . . 1.0 110.387 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.431 ' N ' HG13 ' A' ' 144' ' ' VAL . 44.1 m -58.72 -40.68 84.46 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 122.239 -0.288 . . . . 1.0 110.354 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.985 -1.007 . . . . 1.0 110.441 179.923 . . . . . . . . 0 0 . 1 stop_ save_